assay_category,assay_tax_id,doc_id,description,assay_strain,assay_id,tid,assay_organism,assay_subcellular_fraction,assay_cell_type,assay_tissue,tissue_id,assay_type,src_assay_id,variant_id,cell_id,src_id,confidence_score,bao_format,relationship_type,assay_test_type,chembl_id,curated_by
,10116.0,9866,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,7524,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618647,Intermediate
,10116.0,9866,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,7525,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618648,Intermediate
,10116.0,9866,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,7526,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618649,Intermediate
,10116.0,9866,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,7527,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618650,Intermediate
,10116.0,9866,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,7528,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618651,Intermediate
,10116.0,9866,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,7529,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876497,Intermediate
,10116.0,9866,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,7530,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618652,Intermediate
,10116.0,9866,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,7531,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618653,Intermediate
,10116.0,9866,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,7532,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618654,Intermediate
,10116.0,6351,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,7533,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618655,Intermediate
,10116.0,1465,Compound was tested for solubility in water,,7534,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618656,Intermediate
,,5182,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,7535,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL618657,Intermediate
,10116.0,17847,Solubility was determined,,7536,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618658,Intermediate
,10116.0,15339,solubility in water (ug/mL) at 37 degree C.,,7537,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618659,Intermediate
,10116.0,5202,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,7538,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618660,Intermediate
,10116.0,1088,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,7539,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618661,Intermediate
,10116.0,3169,Half life in rats,,7540,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL873807,Intermediate
,10116.0,5353,Half life in Dawley rat,,7541,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618662,Intermediate
,10116.0,2864,Half life period after 3 mg/kg iv administration,,7542,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618663,Intermediate
,10116.0,2864,Half life period after 3 mg/kg iv administration in rat,,7543,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618664,Intermediate
,10116.0,2864,Half life period after 3 mg/kg iv administration in the rat,,7544,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618665,Intermediate
,10116.0,6362,Half life period in female Sprague-Dawley rats,,7545,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876498,Intermediate
,10116.0,6249,Half life period in rat,,7546,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618666,Intermediate
,10116.0,3169,Half-life in rats was determined,,7547,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620440,Intermediate
,10116.0,3169,Half-life in rats with metabolic oxidation,,7548,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620441,Intermediate
,10116.0,3169,Half-life in rats,,7549,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620442,Intermediate
,10116.0,17260,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,7550,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620443,Intermediate
,10116.0,17260,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,7551,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620444,Intermediate
,10116.0,17260,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,7552,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620445,Intermediate
,10116.0,17260,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,7553,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620446,Intermediate
,10116.0,2879,Biological half-life measured in plasma of rat,,7554,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620447,Intermediate
,10116.0,2879,Biological half-life measured in plasma of rat; 22-25,,7555,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621129,Intermediate
,10116.0,2879,Biological half-life measured in plasma of rat; 9-16,,7556,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621130,Intermediate
,10116.0,3184,Compound was evaluated for its half life when administered intravenously in rat,,7557,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873808,Intermediate
,10116.0,4891,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,7558,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876598,Intermediate
,10116.0,429,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,7559,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621131,Intermediate
,10116.0,5656,Half life (T1/2) after oral administration in rat,,7560,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621132,Intermediate
,10116.0,4413,Half life of compound after iv administration of 20 mg/kg dose in rat,,7561,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621133,Intermediate
,10116.0,3598,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,7562,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621312,Expert
,10116.0,17267,Half life of compound was determined in rat,,7563,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621313,Intermediate
,10116.0,4727,Half life of compound was determined in rat blood,,7564,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621314,Intermediate
,10116.0,17651,Half life at 1 mg/kg was determined in rat,,7565,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621315,Intermediate
,10116.0,17651,Half life at 10 mg/kg was determined in rat,,7566,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621316,Intermediate
,10116.0,401,Half life in rats,,7567,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621317,Intermediate
,10116.0,4942,Half life in rats in hours,,7568,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621318,Intermediate
,10116.0,17735,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,7569,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621319,Intermediate
,10116.0,6056,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,7570,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621377,Intermediate
,10116.0,5213,Half life was determined,,7571,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621378,Intermediate
,10116.0,6616,Half life after i.v. administration,,7572,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876599,Intermediate
,10116.0,5937,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,7573,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621379,Intermediate
,10116.0,5819,Half life in rat plasma,,7574,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621380,Intermediate
,10116.0,5819,Half life in rat plasma; Not detected,,7575,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621381,Intermediate
,10116.0,6803,Half life in rats,,7576,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618515,Intermediate
,10116.0,17804,Half life period of compound was determined after peroral administration,,7577,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618516,Intermediate
,10116.0,17804,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,7578,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618517,Intermediate
,10116.0,5948,Half life period in rat,,7579,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618518,Intermediate
,10116.0,1916,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,7580,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618519,Intermediate
,10116.0,1916,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,7581,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618698,Intermediate
,10116.0,1916,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,7582,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618862,Intermediate
,10116.0,4890,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,7583,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618863,Intermediate
,10116.0,17764,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,7584,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618864,Intermediate
,10116.0,4727,Half life time in rat the dose of 2 mg/kg,,7585,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618865,Intermediate
,10116.0,17509,Half-life 24 hr after 10 mg/kg iv administration in rats,,7586,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618866,Intermediate
,10116.0,17509,Half-life 24 hr after 2 mg/kg iv administration in rats,,7587,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618867,Intermediate
,10116.0,6597,Half-life consistent with the observed metabolic steady state in rats,,7588,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875828,Intermediate
,10116.0,17735,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,7589,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618868,Intermediate
,10116.0,6597,Half-life for oxidative metabolic stability was determined using male human,,7590,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618869,Intermediate
,10116.0,17670,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,7591,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618870,Intermediate
,10116.0,1696,Half-life in rat plasma,,7592,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618871,Intermediate
,10116.0,1742,Half-life in rat plasma was determined,,7593,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618872,Intermediate
,10116.0,17800,Half-life in rats was determined,,7594,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL873816,Intermediate
,,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,7595,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL618873,Autocuration
,,11954,Area under curve after oral dose of 0.1 mg//kg,,7596,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL621602,Autocuration
,,11954,Area under curve after oral dose of 0.3 mg/kg,,7597,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL621603,Autocuration
,,11954,Area under curve after oral dose of 1 mg/kg,,7598,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL621604,Autocuration
,,11954,Area under curve after oral dose of 10 mg/kg,,7599,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL621605,Autocuration
,,11954,Area under curve after oral dose of 23.4 mg/kg,,7600,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL621606,Autocuration
,,11954,Area under curve after oral dose of 3 mg/kg,,7601,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL621607,Autocuration
,,11954,Area under curve after oral dose of 3.87 mg/kg,,7602,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL621608,Autocuration
,,5237,Area under curve was determined,,7603,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL621609,Autocuration
,,4026,Area under curve at a dose of 10 mg/kg,,7604,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL621610,Autocuration
,10116.0,5237,Area under curve was determined; ND=No data,,7605,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621611,Intermediate
,10116.0,14793,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,7606,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621612,Intermediate
,10116.0,14793,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,7607,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622308,Intermediate
,10116.0,14793,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,7608,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622309,Intermediate
,10116.0,14793,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,7609,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622310,Intermediate
,10116.0,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,7610,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622311,Intermediate
,10116.0,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,7611,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622312,Intermediate
,10116.0,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,7612,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622931,Intermediate
,10116.0,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,7613,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622932,Intermediate
,10116.0,14793,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,7614,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622736,Intermediate
,10116.0,14793,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,7615,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622737,Intermediate
,10116.0,14793,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,7616,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622738,Intermediate
,10116.0,14793,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,7617,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622739,Intermediate
,10116.0,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,7618,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622740,Intermediate
,10116.0,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,7619,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622741,Intermediate
,10116.0,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,7620,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622742,Intermediate
,10116.0,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,7621,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622743,Intermediate
,10090.0,11637,AUC in mice,,7622,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622744,Intermediate
,,11149,Area under curve was measured from the graph obtained from concentration Vs time,,7623,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624134,Autocuration
,,10016,Area under curve value of compound per hour after oral administration,,7624,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624135,Autocuration
,10116.0,17796,Area under curve was determined after oral administration in rats,,7625,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624136,Intermediate
,10116.0,17796,Area under curve was determined after oral administration in rats; No data,,7626,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624137,Intermediate
,10116.0,17796,Area under curve was determined after oral administration in rats;No data,,7627,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624320,Intermediate
,9615.0,12923,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,7628,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624321,Intermediate
,10116.0,15372,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,7629,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624322,Intermediate
,10116.0,15372,Area under curve was determined for the compound after iv dose of 5.06 in rats,,7630,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624323,Intermediate
,10116.0,15372,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,7631,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624324,Intermediate
,10116.0,15372,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,7632,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624325,Intermediate
,10116.0,15372,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,7633,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624326,Intermediate
,10116.0,15372,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,7634,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624327,Intermediate
,10116.0,15372,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,7635,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624328,Intermediate
,9615.0,14169,Area under curve was determined in Dogs after peroral administration,,7636,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627848,Intermediate
,10116.0,14169,Area under curve was determined in Rats after peroral administration,,7637,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627849,Intermediate
,10116.0,14258,Area under curve was determined in carotid blood of rat when administered intradermally,,7638,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627850,Intermediate
,10116.0,14258,Area under curve was determined in portal blood of rat when administered intradermally,,7639,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627851,Intermediate
,10090.0,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,7640,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627852,Intermediate
,10090.0,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,7641,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627853,Intermediate
,10090.0,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,7642,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627854,Intermediate
,10090.0,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,7643,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627855,Intermediate
,10090.0,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,7644,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627856,Intermediate
,10090.0,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,7645,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875339,Intermediate
,10090.0,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,7646,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627857,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,7647,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627858,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,7648,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627859,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,7649,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627860,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,7650,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627019,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,7651,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627020,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,7652,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627021,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,7653,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627022,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,7654,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627023,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,7655,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627024,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,7656,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627025,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,7657,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627026,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,7658,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627027,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,7659,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627028,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,7660,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627029,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,7661,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627030,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,7662,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627031,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,7663,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627032,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,7664,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627033,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,7665,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627034,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,7666,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627035,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,7667,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627036,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,7668,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875340,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,7669,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627037,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,7670,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627038,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,7671,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627039,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,7672,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627040,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,7673,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624663,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,7674,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625963,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,7675,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876799,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,7676,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626133,Intermediate
,10116.0,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,7677,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626134,Intermediate
,10116.0,6295,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,7678,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626135,Intermediate
,10116.0,6296,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,7679,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626136,Intermediate
,10116.0,6296,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,7680,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626137,Intermediate
,10116.0,6295,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,7681,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626138,Intermediate
,10116.0,6296,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,7682,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626139,Intermediate
,10116.0,17260,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,7683,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626140,Intermediate
,10116.0,17260,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,7684,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626141,Intermediate
,10116.0,17686,C24h in rat p.o. at 20 mg/kg concentration,,7685,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626142,Intermediate
,10116.0,9866,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,7686,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627930,Intermediate
,10116.0,9866,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,7687,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627931,Intermediate
,10116.0,9866,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,7688,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627932,Intermediate
,10116.0,9866,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,7689,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627933,Intermediate
,10116.0,9866,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,7690,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627934,Intermediate
,10116.0,9866,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,7691,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627935,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,7692,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627936,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,7693,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627937,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,7694,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627938,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,7695,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627939,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,7696,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627940,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,7697,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627941,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,7698,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876800,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,7699,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627942,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,7700,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627943,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,7701,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627944,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,7702,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627945,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,7703,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628584,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,7704,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628585,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,7705,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628586,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,7706,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628587,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,7707,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628588,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,7708,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628589,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,7709,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625304,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,7710,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625305,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,7711,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625306,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,7712,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625307,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,7713,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625308,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,7714,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627740,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,7715,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627741,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,7716,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627742,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,7717,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627743,Intermediate
,10116.0,9866,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,7718,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627744,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,7719,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627745,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,7720,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627746,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,7721,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627747,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,7722,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876810,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,7723,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627748,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,7724,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627749,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,7725,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627750,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,7726,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618728,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,7727,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618729,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,7728,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618730,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,7729,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618731,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,7730,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618732,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,7731,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618733,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,7732,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618734,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,7733,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618735,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,7734,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876602,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,7735,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618736,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,7736,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618737,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,7737,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618738,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,7738,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618739,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,7739,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618740,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,7740,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618741,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,7741,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618742,Intermediate
,10116.0,9866,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,7742,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618743,Intermediate
,10116.0,17752,Half-life from rat plasma at a single oral dose of 25 mg/kg,,7743,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618744,Intermediate
,10116.0,5610,Half-life in male rat,,7744,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618745,Intermediate
,10116.0,5939,Half-life in rat after peroral administration at 10 mg/kg concentration,,7745,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620479,Intermediate
,10116.0,5939,Half-life in rat after peroral administration at 5 mg/kg concentration,,7746,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620480,Intermediate
,10116.0,17771,Half-life in rat at a dose of 3 mg/kg,,7747,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620481,Intermediate
,10116.0,1974,Half-life was evaluated in rats,,7748,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620482,Intermediate
,10116.0,4239,Half-life was measured in rat,,7749,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876603,Intermediate
,10116.0,6681,Half-life period for the compound was determined in rats at 50 mg/kg dose,,7750,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620483,Intermediate
,10116.0,17752,Half-life period in rats after intravenous administration at 5 mg/kg,,7751,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620484,Intermediate
,10116.0,6046,Half-life period in rat at 10 mg/kg,,7752,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620485,Intermediate
,10116.0,6685,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,7753,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620486,Intermediate
,10116.0,6685,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,7754,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620487,Intermediate
,10116.0,6685,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,7755,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620488,Intermediate
,10116.0,4727,Half-life time in rat the dose of 2 mg/kg,,7756,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620489,Intermediate
,10116.0,1088,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,7757,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620490,Intermediate
,10116.0,5610,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,7758,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620491,Intermediate
,10116.0,3032,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,7759,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876604,Intermediate
,10116.0,5199,Oral half life was determined,,7760,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620492,Intermediate
,10116.0,14941,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,7761,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620493,Intermediate
,10116.0,4408,Pharmacokinetic property (t1/2) in rat,,7762,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620494,Intermediate
,10116.0,2552,Plasma elimination half-life was determined,,7763,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620495,Intermediate
,10116.0,5199,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,7764,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620496,Intermediate
,10116.0,15662,Plasma half life was observed after intravenous administration in rat,,7765,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620497,Intermediate
,10116.0,1465,Plasma half-life was determined,,7766,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620498,Intermediate
,10116.0,1446,Plasma half-life following oral administration in Fisher rats,,7767,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620499,Intermediate
,10116.0,6824,Plasma half-life in rat,,7768,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620500,Intermediate
,10116.0,17533,Plasmatic Half-life after intravenous administration to rat,,7769,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873809,Intermediate
,10116.0,5979,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,7770,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620501,Intermediate
,10116.0,4689,Terminal half life after intravenous administration (1 mg/kg) in rat,,7771,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620502,Intermediate
,10116.0,4689,Terminal half life in Rat at a oral dose of 5 mg/kg,,7772,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620503,Intermediate
,10116.0,2463,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,7773,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620504,Intermediate
,10116.0,4883,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,7774,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876605,Intermediate
,10116.0,4883,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,7775,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620505,Intermediate
,10116.0,15662,plasma half life was observed after intravenous administration in rat,,7776,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873811,Intermediate
,10116.0,3598,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,7777,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624016,Expert
,10116.0,4576,Half life of compound determined in rat,,7778,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624017,Intermediate
,10116.0,4576,Mean residence time determined in rat,,7779,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624018,Intermediate
,10116.0,4576,Plasma half life determined in rat,,7780,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624019,Intermediate
,10116.0,4910,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,7781,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624020,Intermediate
,10116.0,4891,Compound was evaluated for pharmacokinetic parameter maximum time period,,7782,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624201,Intermediate
,10116.0,429,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,7783,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL872528,Intermediate
,10116.0,5974,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,7784,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624202,Intermediate
,10116.0,5974,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,7785,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624203,Intermediate
,10116.0,5974,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,7786,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624350,Intermediate
,10116.0,5974,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,7787,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621320,Intermediate
,10116.0,17582,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,7788,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621321,Intermediate
,10116.0,4026,Maximum time (Tmax) required to reach Cmax in rats,,7789,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621322,Intermediate
,10116.0,4890,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,7790,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621323,Intermediate
,10116.0,6571,Maximum time of clearance of compound in rats after peroral administration,,7791,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621324,Intermediate
,10116.0,4727,Maximum time at the dose of 2 mg/kg in rat,,7792,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621325,Intermediate
,10116.0,17651,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,7793,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875837,Intermediate
,10116.0,17651,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,7794,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621326,Intermediate
,10116.0,14465,Tmax in Guinea pig (PO dose),,7795,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621327,Intermediate
,10116.0,14941,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,7796,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621328,Intermediate
,10116.0,5960,Pharmacokinetic parameter (Tmax) in rat,,7797,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621329,Intermediate
,10116.0,5022,Pharmacokinetic parameter (Tmax) was estimated,,7798,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621330,Intermediate
,10116.0,4408,Pharmacokinetic property (Tmax) in rat,,7799,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621331,Intermediate
,10116.0,5983,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,7800,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621332,Intermediate
,10116.0,4689,T max in Rat at a oral dose of 5 mg/kg,,7801,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621333,Intermediate
,10116.0,2792,T max was determined at 10 mg/kg po dose in rats,,7802,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621334,Intermediate
,10090.0,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,7803,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621335,Intermediate
,9615.0,14180,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,7804,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621336,Intermediate
,10116.0,14180,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,7805,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621337,Intermediate
,9615.0,14599,Area under curve was measured after i.v. administration into Beagle dog.,,7806,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621338,Intermediate
,9615.0,14599,Area under curve was measured after iv administration into Beagle dog,,7807,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875838,Intermediate
,9615.0,14599,Area under curve was measured after po administration into Beagle dog,,7808,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621339,Intermediate
,9615.0,14599,Area under curve was measured after po administration into Beagle dog.,,7809,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621340,Intermediate
,,15675,Area under curve was measured at peroral dose of 3 mg/kg,,7810,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL621341,Autocuration
,,12706,Area under curve was measured by using concentration Vs time,,7811,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL621342,Autocuration
,,12706,Area under curve was measured by using concentration Vs time; not tested,,7812,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL621343,Autocuration
,10090.0,9750,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,7813,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621344,Intermediate
,10090.0,9750,Area under curve(AUC) was measured in mice after oral administration.,,7814,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621345,Intermediate
,,14691,Area under curve(AUC) value of the compound,,7815,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL621346,Autocuration
,,14691,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,7816,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL621347,Autocuration
,9615.0,14691,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,7817,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621348,Intermediate
,,2939,Area under curve(carotid artery) was determined by the availability in blood,,7818,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000019,U,,CHEMBL621349,Autocuration
,,2939,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,7819,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000019,U,,CHEMBL621350,Autocuration
,,2939,Area under curve(carotid artery) was determined by the availability in blood; No data,,7820,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000019,U,,CHEMBL875839,Autocuration
,,2939,Area under curve(portal vein) was determined by the availability in blood,,7821,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000019,U,,CHEMBL620211,Autocuration
,,2939,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,7822,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000019,U,,CHEMBL620212,Autocuration
,,2939,Area under curve(portal vein) was determined by the availability in blood; No data,,7823,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000019,U,,CHEMBL620213,Autocuration
,9544.0,9552,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,7824,50797,Macaca mulatta,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620214,Intermediate
,9544.0,9552,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,7825,50797,Macaca mulatta,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620215,Intermediate
,9544.0,9552,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,7826,50797,Macaca mulatta,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620216,Intermediate
,9615.0,9552,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,7827,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620888,Intermediate
,9615.0,9552,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,7828,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620889,Intermediate
,,9552,Area under plasma concentration vs time curve observed in rats for 0-3 h,,7829,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000019,U,,CHEMBL620890,Autocuration
,10116.0,11911,Area under plasma time curve determined in male rat,,7830,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620891,Intermediate
,,16618,Area under the MAP curve measured over 5 min.,,7831,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL620892,Autocuration
,10090.0,14387,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,7832,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621079,Intermediate
,10090.0,14387,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,7833,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621080,Intermediate
,9615.0,12836,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,7834,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621081,Intermediate
,10026.0,12836,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,7835,100712,Cricetinae,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621082,Intermediate
,10116.0,12836,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,7836,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621083,Intermediate
,9615.0,14339,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,7837,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621084,Intermediate
,9615.0,14339,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,7838,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621085,Intermediate
,9615.0,14339,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,7839,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621086,Intermediate
,9615.0,10524,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,7840,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621087,Intermediate
,9615.0,9994,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,7841,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622607,Intermediate
,9615.0,11325,Serum AUC in marmosets (IV dose),,7842,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622608,Intermediate
,,12536,Area under the curve after intravenous administration at a dose of 10 umol/kg,,7843,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624481,Autocuration
,,12536,Area under the curve after intravenous administration at a dose of 2 umol/kg,,7844,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624482,Autocuration
,,12536,Area under the curve after intravenous administration at a dose of 4 umol/kg,,7845,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624483,Autocuration
,,12536,Area under the curve after intravenous administration at a dose of 40 umol/kg,,7846,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624484,Autocuration
,,12536,Area under the curve after intravenous administration at a dose of 5 umol/kg,,7847,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624485,Autocuration
,10116.0,15556,Area under the curve for fumarate salt was evaluated in F344 Rats.,,7848,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624486,Intermediate
,,2809,Area under the curve for the compound was calculated.,,7849,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624487,Autocuration
,,9511,Area under the curve in concentration/ time,,7850,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624488,Autocuration
,10116.0,12818,Area under the curve administered intraintestinal in rats.,,7851,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624489,Intermediate
,10116.0,12818,Area under the curve administered intravenously in rats.,,7852,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625184,Intermediate
,,15118,Area under the curve during intravenous administration,,7853,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625185,Autocuration
,,15118,Area under the curve during intravenous administration; Not determined,,7854,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL875954,Autocuration
,,15118,Area under the curve during systemic administration,,7855,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625186,Autocuration
,,15118,Area under the curve during systemic administration; Not determined,,7856,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625187,Autocuration
,,2632,Area under the curve was calculated for the compound.,,7857,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625188,Autocuration
,9615.0,14346,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,7858,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625189,Intermediate
,9615.0,14346,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,7859,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625190,Intermediate
,10116.0,14346,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,7860,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621733,Intermediate
,10116.0,14346,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,7861,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621734,Intermediate
,10116.0,11149,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,7862,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621735,Intermediate
,10116.0,17796,Clearance of the drug was measured in the plasma of rat; No data,,7863,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621736,Intermediate
,10116.0,5247,The pharmacokinetic parameter plasma clearance in vivo in rats,,7864,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621737,Intermediate
,10116.0,4727,Plasma clearance at the dose of 2 mg/kg in rat,,7865,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621738,Intermediate
,10116.0,5654,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,7866,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622806,Intermediate
,10116.0,5654,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,7867,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623519,Intermediate
,10116.0,17260,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,7868,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623520,Intermediate
,10116.0,17065,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,7869,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623521,Intermediate
,10116.0,17671,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,7870,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623522,Intermediate
,10116.0,6672,Clearance rate in rat,,7871,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623523,Intermediate
,10116.0,6673,Clearance rate in rat,,7872,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623690,Intermediate
,10116.0,5978,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,7873,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623691,Intermediate
,10116.0,5978,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,7874,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623692,Intermediate
,10116.0,5978,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,7875,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623693,Intermediate
,10116.0,5978,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,7876,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623694,Intermediate
,10116.0,4413,Clearance of compound after iv administration of 20 mg/kg dose in rat,,7877,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623695,Intermediate
,10116.0,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,7878,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623696,Intermediate
,10116.0,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,7879,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623697,Intermediate
,9544.0,5005,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,7880,22224,Macaca mulatta,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623698,Intermediate
,10116.0,5005,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,7881,22224,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623699,Intermediate
,10116.0,15765,Mean (%CV) PK parameters for CL(mL/min/kg).,,7882,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623700,Intermediate
,10116.0,3747,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,7883,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623701,Intermediate
,10116.0,16366,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,7884,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623702,Intermediate
,10116.0,4199,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,7885,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623703,Intermediate
,10116.0,17267,Plasma clearance in rat was determined,,7886,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623704,Intermediate
,10116.0,6535,Plasma clearance in rat after administration of 2 mg/kg iv,,7887,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623705,Intermediate
,10116.0,6535,Plasma clearance in rat after administration of 2 mg/kg iv,,7888,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623706,Intermediate
,10116.0,5041,Plasma clearance was determined,,7889,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623707,Intermediate
,10116.0,5960,Plasma clearance in rat,,7890,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623708,Intermediate
,10116.0,5937,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,7891,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623709,Intermediate
,10116.0,5871,Plasma clearance in rat by iv administration,,7892,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623710,Intermediate
,10116.0,5874,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,7893,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623711,Intermediate
,10116.0,6504,Plasma clearance in rat p.o.,,7894,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623712,Intermediate
,10116.0,6803,Plasma clearance in rats,,7895,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623713,Intermediate
,10116.0,5041,Plasma clearance was determined; ND denotes no data,,7896,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623714,Intermediate
,10116.0,5041,Plasma clearance was determined; ND denotes not determined,,7897,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623715,Intermediate
,10116.0,1916,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,7898,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623716,Intermediate
,10116.0,5199,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,7899,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622980,Intermediate
,10116.0,16367,Plasma administration to rats,,7900,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622981,Intermediate
,10116.0,6362,Plasma clearance of the compound in female Sprague-Dawley rats,,7901,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622982,Intermediate
,10116.0,15662,Plasma clearance was observed after intravenous administration in rat,,7902,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622983,Intermediate
,10116.0,6215,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,7903,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622984,Intermediate
,10116.0,1466,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,7904,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622985,Intermediate
,10116.0,15662,plasma clearance was observed after intravenous administration in rat,,7905,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623631,Intermediate
,10116.0,4723,In vivo CL/F determined,,7906,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623632,Intermediate
,10116.0,2792,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,7907,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623633,Intermediate
,10116.0,2792,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,7908,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623634,Intermediate
,10116.0,5213,Compound was tested for the lower blood clearance in rat,,7909,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623635,Intermediate
,10116.0,4687,Evaluated for the low clearance in rat (in vivo),,7910,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621195,Intermediate
,10116.0,3371,Pharmacokinetic property (CLb)of the compound was determined in rat,,7911,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621196,Intermediate
,10116.0,4690,Rapid clearance after intravenous administration in rat was determined,,7912,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875287,Intermediate
,10116.0,5702,Clearance measured in rat,,7913,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621197,Intermediate
,10116.0,740,Compound was evaluated for plasma clearance in rat,,7914,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621198,Intermediate
,10116.0,4853,Low plasma clearance was calculated in rat,,7915,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621199,Intermediate
,10116.0,5789,Pharmacokinetic property (Clp) in rat,,7916,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621200,Intermediate
,10116.0,4527,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,7917,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621201,Intermediate
,10116.0,4527,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,7918,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621202,Intermediate
,10116.0,6518,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,7919,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621203,Intermediate
,10116.0,6518,Plasma clearance after IV dosing at 1 mg/kg in rat,,7920,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621204,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,7921,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621205,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,7922,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621206,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,7923,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621207,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,7924,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621208,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,7925,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621209,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,7926,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876484,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,7927,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621210,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,7928,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621211,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,7929,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621212,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,7930,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621213,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,7931,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621214,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,7932,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621215,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,7933,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621216,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,7934,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621217,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,7935,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621218,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,7936,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621219,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,7937,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621220,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,7938,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621221,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,7939,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621222,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,7940,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621223,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,7941,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876485,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,7942,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621224,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,7943,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621225,Intermediate
,10116.0,9866,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,7944,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621226,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,7945,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621227,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,7946,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621228,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,7947,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621229,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,7948,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621230,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,7949,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621231,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,7950,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621232,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,7951,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621233,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,7952,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621234,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,7953,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621235,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,7954,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621236,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,7955,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621237,Intermediate
,10116.0,9866,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,7956,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876486,Intermediate
,10116.0,9866,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,7957,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622436,Intermediate
,10116.0,9866,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,7958,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622437,Intermediate
,10116.0,9866,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,7959,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622438,Intermediate
,10116.0,9866,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,7960,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622439,Intermediate
,10116.0,9866,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,7961,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622440,Intermediate
,10116.0,9866,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,7962,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622441,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,7963,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622442,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,7964,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622443,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,7965,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622444,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,7966,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622445,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,7967,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622446,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,7968,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622447,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,7969,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622448,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,7970,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622449,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,7971,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622450,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,7972,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622451,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,7973,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622452,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,7974,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622453,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,7975,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622454,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,7976,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622455,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,7977,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876024,Intermediate
,10116.0,2792,T max was determined at 3 mg/kg po dose in rats,,7978,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622456,Intermediate
,10116.0,15078,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,7979,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622457,Intermediate
,10116.0,15078,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,7980,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622458,Intermediate
,10116.0,15022,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,7981,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622459,Intermediate
,10116.0,15022,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,7982,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL873343,Intermediate
,10116.0,15022,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,7983,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622460,Intermediate
,10116.0,4576,Time for maximum plasma concentration determined in rat,,7984,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622461,Intermediate
,10116.0,6681,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,7985,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622462,Intermediate
,10116.0,16365,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,7986,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622463,Intermediate
,10116.0,16365,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,7987,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622464,Intermediate
,10116.0,16365,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,7988,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622465,Intermediate
,10116.0,16365,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,7989,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622466,Intermediate
,10116.0,16365,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,7990,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622467,Intermediate
,10116.0,6824,Time of maximum plasma concentration in rat,,7991,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622468,Intermediate
,10116.0,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,7992,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876025,Intermediate
,10116.0,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,7993,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622469,Intermediate
,10116.0,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,7994,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622470,Intermediate
,10116.0,15662,Time required to reach maximum concentration (Cmax) after oral administration in rat,,7995,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622471,Intermediate
,10116.0,1742,Time required to reach maximum concentration in rat plasma,,7996,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622472,Intermediate
,10116.0,2774,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,7997,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622473,Intermediate
,10116.0,5199,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,7998,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624282,Intermediate
,10116.0,12873,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,7999,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624283,Intermediate
,10116.0,12873,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,8000,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624284,Intermediate
,10116.0,1916,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,8001,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624285,Intermediate
,10116.0,16367,Time to reach Cmax after oral administration to rats,,8002,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624286,Intermediate
,10116.0,16366,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,8003,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624287,Intermediate
,10116.0,216,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,8004,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624288,Intermediate
,10116.0,6410,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,8005,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624289,Intermediate
,10116.0,6410,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,8006,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873344,Intermediate
,10116.0,6215,Tmax after peroral administration (10 mg/kg) was determined in rat,,8007,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619623,Intermediate
,10116.0,3598,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,8008,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621399,Expert
,10116.0,4527,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,8009,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621400,Intermediate
,10116.0,17670,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,8010,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621401,Intermediate
,10116.0,1465,Tmax was determined,,8011,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621402,Intermediate
,10116.0,2552,Tmax was determined,,8012,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621403,Intermediate
,10116.0,5656,Tmax after oral administration in rat,,8013,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621121,Intermediate
,10116.0,17764,Tmax after peroral administration in rats at 2.4 uM/kg,,8014,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL872525,Intermediate
,10116.0,5610,Tmax in male rat,,8015,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621122,Intermediate
,10116.0,6046,Tmax in rat at 10 mg/kg,,8016,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621123,Intermediate
,10116.0,5874,Tmax in rat by po administration at a dose of 40 mg/kg,,8017,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621124,Intermediate
,10116.0,17596,Tmax in rats,,8018,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621125,Intermediate
,10116.0,17804,Tmax was measured in rats after peroral administration at 5 mg/kg,,8019,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621126,Intermediate
,10116.0,1908,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,8020,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621127,Intermediate
,10116.0,2959,Tmax value after administration of 20 mg/Kg oral dose in rat,,8021,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621128,Intermediate
,10116.0,6757,Tmax value at a dose of 10 mg/kg in male SD rats,,8022,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618263,Intermediate
,10116.0,6757,Tmax value at a dose of 100 mg/kg in male SD rats,,8023,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618264,Intermediate
,10116.0,6757,Tmax value at a dose of 50 mg/kg in male SD rats,,8024,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618265,Intermediate
,10116.0,4186,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,8025,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618266,Intermediate
,10116.0,15662,time required to reach maximum concentration (Cmax) after oral administration in rat,,8026,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618267,Intermediate
,10116.0,429,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,8027,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618450,Intermediate
,10116.0,429,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,8028,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618451,Intermediate
,10116.0,5546,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,8029,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618452,Intermediate
,10116.0,3173,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,8030,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618453,Intermediate
,10116.0,3173,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,8031,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618454,Intermediate
,10116.0,3173,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,8032,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618455,Intermediate
,10116.0,4257,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,8033,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618456,Intermediate
,10116.0,6011,Compound distribution in rat tissues was determined,,8034,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618457,Intermediate
,10116.0,5472,Volume of distribution was evaluated in rat,,8035,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618458,Intermediate
,10116.0,14346,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,8036,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618459,Intermediate
,10116.0,14346,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,8037,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876733,Intermediate
,9615.0,14346,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,8038,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618460,Intermediate
,10116.0,14346,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,8039,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618461,Intermediate
,,15469,Area under the curve was determined after oral administration (300 uM/Kg),,8040,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL618462,Autocuration
,10116.0,14346,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,8041,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618463,Intermediate
,10116.0,14346,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,8042,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618464,Intermediate
,10116.0,14346,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,8043,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618465,Intermediate
,10116.0,14346,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,8044,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618466,Intermediate
,10116.0,14346,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,8045,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618467,Intermediate
,10116.0,15372,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,8046,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618468,Intermediate
,9615.0,12935,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,8047,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618469,Intermediate
,9615.0,12935,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,8048,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618470,Intermediate
,,14813,Plasma drug AUC in rat (PO dose),,8049,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL618471,Autocuration
,10090.0,15792,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,8050,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618472,Intermediate
,,3579,Area under was determined at a dose of 30 mg/kg,,8051,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL618473,Autocuration
,9669.0,12487,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,8052,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621699,Intermediate
,10116.0,12487,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,8053,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621700,Intermediate
,10116.0,12487,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,8054,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621701,Intermediate
,9669.0,12487,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,8055,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621702,Intermediate
,9615.0,12487,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,8056,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621703,Intermediate
,9615.0,12487,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,8057,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621704,Intermediate
,10116.0,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,8058,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624259,Intermediate
,10116.0,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,8059,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624260,Intermediate
,10116.0,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,8060,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624430,Intermediate
,10116.0,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,8061,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624431,Intermediate
,10116.0,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,8062,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624432,Intermediate
,10116.0,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,8063,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624433,Intermediate
,10116.0,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,8064,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624434,Intermediate
,10116.0,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,8065,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624435,Intermediate
,10090.0,12745,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,8066,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618570,Intermediate
,10090.0,12745,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,8067,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618571,Intermediate
,10090.0,12745,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,8068,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618572,Intermediate
,10090.0,12745,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,8069,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618573,Intermediate
,10090.0,12745,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,8070,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL619267,Intermediate
,10090.0,12745,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,8071,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL619431,Intermediate
,10090.0,12745,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,8072,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL619432,Intermediate
,10090.0,12745,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,8073,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL619433,Intermediate
,,13298,AUC in mice after oral dose (50 mg/kg),,8074,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,,CHEMBL619434,Autocuration
,10090.0,12226,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,8075,50594,Mus musculus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619435,Intermediate
,,12634,AUC (0-4 hr) ug/ml/h,,8076,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000019,U,,CHEMBL619436,Autocuration
,10116.0,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,8077,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL619437,Intermediate
,,13889,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,8078,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL619438,Autocuration
,10090.0,10018,Compound was evaluated for Area under curve in mice,,8079,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL619439,Intermediate
,10116.0,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8080,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL619440,Intermediate
,,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8081,22224,,,,,,F,,,,1,0,BAO_0000218,U,,CHEMBL619441,Autocuration
,10116.0,8758,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,8082,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL619442,Intermediate
,,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,8083,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL875156,Autocuration
,,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,8084,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL619443,Autocuration
,,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,8085,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL619444,Autocuration
,,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,8086,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623464,Autocuration
,10090.0,15115,Compound was evaluated for area under curve when administered through oral route in mouse,,8087,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623465,Intermediate
,10116.0,6518,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,8088,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623466,Intermediate
,10116.0,6518,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,8089,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623467,Intermediate
,10116.0,6249,Plasma clearance in rat,,8090,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623468,Intermediate
,10116.0,2463,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,8091,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622660,Intermediate
,10116.0,4969,Plasma clearance rate in Sprague-Dawley rats,,8092,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622661,Intermediate
,10116.0,17720,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,8093,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622662,Intermediate
,10116.0,3457,Pharmacokinetic property (total body clearance) in rat,,8094,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622663,Intermediate
,10116.0,5983,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,8095,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622664,Intermediate
,10116.0,6295,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,8096,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622665,Intermediate
,10116.0,6296,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,8097,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622666,Intermediate
,10116.0,17686,Cl in rat i.v. at 2 mg/kg concentration,,8098,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621615,Intermediate
,10116.0,17764,Clearance of compound after intravenous administration in rats at 24 uM/kg,,8099,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621616,Intermediate
,10116.0,5503,Clearance was determined,,8100,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621617,Intermediate
,10116.0,4368,Clearance by intravenous administration of 3.4 mg/kg in rat,,8101,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621618,Intermediate
,10116.0,6005,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,8102,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621619,Intermediate
,10116.0,5031,Clearance rate after i.v. administration in rats,,8103,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621620,Intermediate
,10116.0,4890,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,8104,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621786,Intermediate
,10116.0,5182,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,8105,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621787,Intermediate
,10116.0,5979,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,8106,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621788,Intermediate
,10116.0,5656,Clearance (Cl) after oral administration in rat,,8107,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621789,Intermediate
,10116.0,17804,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,8108,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621790,Intermediate
,10116.0,4839,Compound was tested for plasma clearance in rat,,8109,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621791,Intermediate
,10116.0,5041,In vitro microsome metabolism clearance in rat was determined,,8110,50597,Rattus norvegicus,Microsomes,,,,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL621792,Intermediate
,10116.0,5041,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,8111,50597,Rattus norvegicus,Microsomes,,,,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL621793,Intermediate
,10116.0,5974,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,8112,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621794,Intermediate
,10116.0,5496,In vivo plasma clearance was determined,,8113,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621795,Intermediate
,10116.0,5739,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,8114,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621796,Intermediate
,10116.0,5676,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,8115,50597,Rattus norvegicus,,Hepatocyte,Liver,2107.0,A,,,401.0,1,1,BAO_0000218,N,In vivo,CHEMBL621797,Intermediate
,10116.0,4239,Pharmacokinetic property (Plasma clearance) was measured in rat,,8116,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621798,Intermediate
,10116.0,5676,Pharmacokinetic property (clearance) in rat i.v.,,8117,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621799,Intermediate
,10116.0,1918,"Plasma Clearance was evaluated in rats, iv",,8118,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621800,Intermediate
,10116.0,17800,Plasma clearance (in vivo) in rats was determined,,8119,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621801,Intermediate
,10116.0,6056,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,8120,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621802,Intermediate
,10116.0,5496,Plasma clearance was determined,,8121,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618596,Intermediate
,10116.0,5939,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,8122,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618597,Intermediate
,10116.0,5939,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,8123,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618598,Intermediate
,10116.0,17752,Plasma clearance in rats,,8124,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618599,Intermediate
,10116.0,4576,Plasma clearance rate determined in rat,,8125,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618600,Intermediate
,10116.0,6011,Plasma clearance was determined in rat,,8126,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618601,Intermediate
,10116.0,5510,Plasma clearance was determined,,8127,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618602,Intermediate
,10116.0,5948,Plasma clearance value in rat,,8128,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618603,Intermediate
,10116.0,6125,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,8129,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,Ex vivo,CHEMBL618604,Intermediate
,10116.0,4839,Clearance in rat,,8130,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618605,Intermediate
,10116.0,17686,Total body clearance in rat i.v. at 2 mg/kg concentration,,8131,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618606,Intermediate
,10116.0,6571,Clearance of compound in rats after intravenous administration,,8132,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618607,Intermediate
,10116.0,3364,Clearance after iv administration to rats,,8133,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618608,Intermediate
,10116.0,13569,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,8134,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618609,Intermediate
,10116.0,13569,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,8135,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618610,Intermediate
,10116.0,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,8136,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618611,Intermediate
,10116.0,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,8137,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618612,Intermediate
,10116.0,13569,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,8138,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618613,Intermediate
,10116.0,13569,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,8139,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621076,Intermediate
,10116.0,13569,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,8140,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621077,Intermediate
,10116.0,17670,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,8141,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621078,Intermediate
,10116.0,5970,Clearance in rat,,8142,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621251,Intermediate
,10116.0,6495,Clearance in rat after oral administration at 10 mg/kg,,8143,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621252,Intermediate
,10116.0,4590,Clearance in rat.,,8144,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621253,Intermediate
,10116.0,6193,Clearance rate following an oral dose of 20 mg/kg in rats,,8145,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621254,Intermediate
,10116.0,2832,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,8146,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621255,Intermediate
,10116.0,1052,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,8147,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621256,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,8148,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621257,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,8149,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621258,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,8150,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621259,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,8151,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621260,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,8152,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876494,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,8153,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621261,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,8154,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621262,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,8155,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621263,Intermediate
,10116.0,9866,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,8156,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621264,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,8157,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621265,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,8158,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621266,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,8159,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621267,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,8160,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621268,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,8161,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621269,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,8162,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621270,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,8163,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621271,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,8164,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621272,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,8165,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621273,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,8166,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621274,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,8167,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876495,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,8168,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621275,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,8169,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621276,Intermediate
,10116.0,9866,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,8170,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621277,Intermediate
,10116.0,9866,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,8171,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621278,Intermediate
,10116.0,9866,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,8172,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621279,Intermediate
,10116.0,9866,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,8173,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621280,Intermediate
,10116.0,9866,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,8174,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621281,Intermediate
,10116.0,9866,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,8175,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621282,Intermediate
,10116.0,9866,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,8176,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621283,Intermediate
,10116.0,9866,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,8177,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621284,Intermediate
,10116.0,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,8178,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621285,Intermediate
,10116.0,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,8179,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621286,Intermediate
,10116.0,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,8180,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623220,Intermediate
,10116.0,9866,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,8181,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623221,Intermediate
,10116.0,9866,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,8182,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876029,Intermediate
,10116.0,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,8183,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623222,Intermediate
,10116.0,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,8184,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623223,Intermediate
,10116.0,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,8185,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621445,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8186,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621446,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8187,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621447,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8188,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619681,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8189,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619682,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8190,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619683,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8191,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619684,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8192,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619685,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8193,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619686,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8194,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619687,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8195,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619688,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8196,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619689,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8197,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619690,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8198,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619691,Intermediate
,10116.0,6062,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,8199,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619692,Intermediate
,10116.0,3598,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,8200,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL619693,Expert
,10116.0,1908,Vc value after IV dose at a dose of 5 mg/kg in rats.,,8201,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619694,Intermediate
,10116.0,17596,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,8202,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619695,Intermediate
,10116.0,4891,Compound was evaluated for pharmacokinetic parameter volume of distribution,,8203,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619696,Intermediate
,10116.0,740,Compound was evaluated for volume of distribution in rat,,8204,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619697,Intermediate
,10116.0,16366,Steady state volume distribution was determined; steady state(ss),,8205,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619698,Intermediate
,10116.0,3364,Steady state volume of distribution after iv administration to rats,,8206,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619699,Intermediate
,10116.0,2552,Steady state volume of distribution dosing at 3 mg/kg iv,,8207,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619700,Intermediate
,10116.0,406,The compound was evaluated for volume of distribution in rat,,8208,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619701,Intermediate
,10116.0,12500,The compound was tested for volume of distribution in rat,,8209,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619702,Intermediate
,10116.0,12500,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,8210,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620335,Intermediate
,10116.0,5656,Volume distribution (VD) after oral administration in rat,,8211,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620336,Intermediate
,10116.0,17671,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,8212,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620337,Intermediate
,10116.0,1094,Volume distribution in rat,,8213,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620520,Intermediate
,10116.0,5833,Volume distribution in rat,,8214,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620521,Intermediate
,10116.0,5939,Volume distribution in rat after peroral administration at 10 mg/kg,,8215,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875825,Intermediate
,10116.0,5939,Volume distribution in rat after peroral administration at 5 mg/kg,,8216,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620522,Intermediate
,10116.0,6005,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,8217,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620523,Intermediate
,10116.0,1696,Volume of distribution in rat.,,8218,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620524,Intermediate
,10116.0,6672,Volume of distribution in rat,,8219,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620525,Intermediate
,10116.0,6673,Volume of distribution in rat,,8220,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620526,Intermediate
,10116.0,5871,Volume of distribution in rat by iv administration,,8221,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620527,Intermediate
,10116.0,6803,Volume of distribution in rats,,8222,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620528,Intermediate
,10116.0,5199,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,8223,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620529,Intermediate
,10116.0,4727,Volume distribution at the dose of 2 mg/kg in rat,,8224,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620530,Intermediate
,10116.0,16367,Steady state volume of distribution was determined,,8225,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620531,Intermediate
,9544.0,5005,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,8226,22224,Macaca mulatta,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620532,Intermediate
,10116.0,5005,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,8227,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620533,Intermediate
,10116.0,5005,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,8228,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620534,Intermediate
,10116.0,15765,Mean (%CV) PK parameters for Vdss(mL/kg).,,8229,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620535,Intermediate
,10116.0,2792,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,8230,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875826,Intermediate
,10116.0,2792,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,8231,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620536,Intermediate
,10116.0,5334,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,8232,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620537,Intermediate
,10116.0,5334,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,8233,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618526,Intermediate
,10116.0,5739,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,8234,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618527,Intermediate
,10116.0,5789,Pharmacokinetic property (Vdss) in rat,,8235,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618528,Intermediate
,10116.0,4239,Pharmacokinetic property (vdss) was measured in rat,,8236,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618529,Intermediate
,10116.0,4709,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,8237,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618530,Intermediate
,10116.0,6642,Volume of distribution in rat,,8238,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618531,Intermediate
,10116.0,5247,The pharmacokinetic parameter volume of distribution in vivo in rats,,8239,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618532,Intermediate
,10116.0,17720,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,8240,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618533,Intermediate
,10116.0,17686,Vdss in rat i.v. at 2 mg/kg concentration,,8241,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618534,Intermediate
,10116.0,4689,Volume distribution after intravenous administration (1 mg/kg) in rat,,8242,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618535,Intermediate
,10116.0,5654,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,8243,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618536,Intermediate
,10116.0,5654,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,8244,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618537,Intermediate
,10116.0,4527,Volume distribution at a dose of 10 uM/kg in rat was determined,,8245,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618538,Intermediate
,10116.0,4521,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,8246,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618539,Intermediate
,10116.0,6057,Volume distribution was calculated in rat,,8247,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618540,Intermediate
,10116.0,5510,Volume distribution was determined,,8248,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618541,Intermediate
,10116.0,2938,Volume of distribution after intravenous administration was evaluated in rat,,8249,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618542,Intermediate
,10116.0,6679,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,8250,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622544,Intermediate
,10116.0,6685,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,8251,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622545,Intermediate
,10116.0,6685,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,8252,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622546,Intermediate
,10116.0,6685,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,8253,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622547,Intermediate
,10116.0,5145,Volume of distribution in steady state was determined in rat,,8254,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622548,Intermediate
,10116.0,6467,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,8255,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622549,Intermediate
,10116.0,6467,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,8256,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622550,Intermediate
,10090.0,15115,Compound was evaluated for area under curve when administered through oral route to mouse,,8257,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622551,Intermediate
,10116.0,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8258,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622552,Intermediate
,10116.0,8758,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,8259,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622553,Intermediate
,,8267,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,8260,22224,,,,,,F,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622554,Autocuration
,9615.0,8267,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,8261,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622555,Intermediate
,10090.0,14239,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,8262,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622556,Intermediate
,10090.0,14239,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,8263,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622557,Intermediate
,10090.0,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,8264,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622558,Intermediate
,10090.0,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,8265,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622559,Intermediate
,9615.0,10754,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,8266,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622560,Intermediate
,10116.0,14681,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,8267,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622561,Intermediate
,10116.0,14681,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,8268,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622562,Intermediate
,10116.0,14681,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,8269,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622563,Intermediate
,,13118,Concentration of compound in Central nervous system,,8270,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622564,Autocuration
,,13118,Concentration of compound in Central nervous system; Not detectable,,8271,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622565,Autocuration
,10090.0,13318,"Concentration of diester in the blood, following oral administration in mice",,8272,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622566,Intermediate
,10090.0,13318,"Concentration of monoester in the blood, following oral administration in mice",,8273,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624515,Intermediate
,10090.0,13318,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,8274,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624516,Intermediate
,,15692,Evaluated for Pharmacokinetic property: Area under the curve,,8275,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624517,Autocuration
,10090.0,14839,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,8276,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624518,Intermediate
,9541.0,14839,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,8277,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624519,Intermediate
,9541.0,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,8278,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624520,Intermediate
,9541.0,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,8279,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624521,Intermediate
,9541.0,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,8280,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624522,Intermediate
,9541.0,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,8281,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624523,Intermediate
,9541.0,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,8282,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624409,Intermediate
,9541.0,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,8283,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624410,Intermediate
,9541.0,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,8284,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624411,Intermediate
,9541.0,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,8285,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623531,Intermediate
,9541.0,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,8286,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623532,Intermediate
,9541.0,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,8287,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623533,Intermediate
,9541.0,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,8288,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623534,Intermediate
,10090.0,14839,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,8289,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623535,Intermediate
,10090.0,14839,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,8290,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623536,Intermediate
,10090.0,14839,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,8291,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623537,Intermediate
,10090.0,14839,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,8292,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623538,Intermediate
,10090.0,14839,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,8293,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623539,Intermediate
,10090.0,14839,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,8294,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623540,Intermediate
,10090.0,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,8295,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623541,Intermediate
,10090.0,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,8296,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623542,Intermediate
,10090.0,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,8297,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623543,Intermediate
,10090.0,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,8298,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623544,Intermediate
,10090.0,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,8299,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623545,Intermediate
,10090.0,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,8300,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623546,Intermediate
,10116.0,5408,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,8301,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623547,Intermediate
,10116.0,6827,High i.v. clearance in Dawley rats,,8302,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623548,Intermediate
,10116.0,17538,In vitro clearance in rat liver microsomes,,8303,50597,Rattus norvegicus,Microsomes,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL623549,Intermediate
,10116.0,6331,Intrinsic clearance in rat liver microsomes was determined,,8304,50597,Rattus norvegicus,Microsomes,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL623550,Intermediate
,10116.0,5948,Intrinsic clearance in rat hepatocytes was determined,,8305,50597,Rattus norvegicus,,Hepatocyte,Liver,2107.0,A,,,401.0,1,1,BAO_0000218,N,In vitro,CHEMBL875276,Intermediate
,10116.0,4026,Plasma Clearance was determined,,8306,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621872,Intermediate
,10116.0,6647,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,8307,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621873,Intermediate
,10116.0,1696,Plasma clearance in rat.,,8308,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621874,Intermediate
,10116.0,6597,Plasma clearance in rats,,8309,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621875,Intermediate
,10116.0,347,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,8310,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621876,Intermediate
,10116.0,16423,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,8311,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621877,Intermediate
,10116.0,2879,Plasma clearance was measured in rat,,8312,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621878,Intermediate
,10116.0,4883,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,8313,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621879,Intermediate
,10116.0,5328,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,8314,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621880,Intermediate
,10116.0,5160,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,8315,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621881,Intermediate
,10116.0,17582,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,8316,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621882,Intermediate
,10116.0,17651,Total clearance at 1 mg/kg was determined in rat,,8317,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875283,Intermediate
,10116.0,17651,Total clearance at 10 mg/kg was determined in rat,,8318,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621883,Intermediate
,10116.0,6596,Clearance in rat,,8319,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621884,Intermediate
,10116.0,4796,Plasma clearance rate determined in rats,,8320,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621885,Intermediate
,10116.0,6850,Clearance of compound in rat was evaluated,,8321,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621886,Intermediate
,10116.0,5932,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,8322,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621887,Intermediate
,10116.0,3371,Pharmacokinetic property (blood clearance) in rat,,8323,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621888,Intermediate
,10116.0,2083,Plasma clearance in rat,,8324,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621889,Intermediate
,10116.0,4942,Plasma clearance in rats,,8325,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621890,Intermediate
,10116.0,6838,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,,8326,50597,Rattus norvegicus,Microsomes,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL621891,Intermediate
,10116.0,5353,Clearance in Dawley rat,,8327,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621892,Intermediate
,10116.0,6641,Clearance rat,,8328,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621893,Intermediate
,10116.0,6641,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,8329,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621894,Intermediate
,10116.0,6641,Clearance rat; Not determined,,8330,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621895,Intermediate
,10116.0,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,8331,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875284,Intermediate
,10116.0,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,8332,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618699,Intermediate
,10116.0,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,8333,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618700,Intermediate
,10116.0,6211,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,8334,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618701,Intermediate
,10116.0,12873,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,8335,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876600,Intermediate
,10116.0,6570,Clearance of compound in rat after 1 mg/kg i.v. administration,,8336,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618702,Intermediate
,10116.0,3341,Compound was evaluated for Hepatic clearance in rat,,8337,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618703,Intermediate
,10116.0,4891,In vivo clearance after 5 mg/kg dose,,8338,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618704,Intermediate
,10116.0,1094,Compound was tested for plasma clearance in rats,,8339,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618705,Intermediate
,10116.0,2938,Hepatic clearance after intravenous administration was evaluated in rat,,8340,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618706,Intermediate
,10116.0,17853,Lower clearance in rat (i.v.) at 0.5 mpk,,8341,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618707,Intermediate
,10116.0,6049,Pharmacokinetic parameter expressed as plasma clearance in rat,,8342,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618708,Intermediate
,10116.0,5789,Pharmacokinetic property (Clp) in rat,,8343,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618709,Intermediate
,10116.0,4514,Plasma clearance in Sprague-Dawley rats,,8344,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618710,Intermediate
,10116.0,6448,Plasma clearance (Clp) in rat,,8345,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618711,Intermediate
,10116.0,6062,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,8346,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618712,Intermediate
,10116.0,5710,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,8347,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618713,Intermediate
,10116.0,4709,Plasma clearance after intravenous administration of 1 mg/kg in rat,,8348,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618714,Intermediate
,10116.0,4521,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,8349,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618715,Intermediate
,10116.0,1742,Plasma clearance in rat was determined,,8350,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618716,Intermediate
,10116.0,6057,Plasma clearance measured in rat,,8351,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876601,Intermediate
,10116.0,6057,Plasma clearance was calculated in rat,,8352,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618717,Intermediate
,10116.0,5145,Plasma clearance in rat,,8353,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618718,Intermediate
,10116.0,5833,Plasma clearance in rat,,8354,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618719,Intermediate
,10116.0,6453,Plasma clearance in rat,,8355,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618720,Intermediate
,10116.0,6640,Plasma clearance in rat,,8356,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618721,Intermediate
,10116.0,6305,Plasma clearance in rats,,8357,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621477,Intermediate
,10116.0,6642,Plasma clearance in rat,,8358,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621478,Intermediate
,10116.0,5472,Plasma clearance was evaluated in rat,,8359,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621479,Intermediate
,10116.0,5472,Plasma clearance was evaluated in rat; Not tested,,8360,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621480,Intermediate
,10116.0,5144,Plasma clearance rate was determined for the compound in rat,,8361,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621481,Intermediate
,10116.0,6685,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,8362,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621482,Intermediate
,10116.0,6685,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,8363,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621483,Intermediate
,10116.0,6685,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,8364,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621484,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8365,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621485,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8366,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621486,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8367,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621487,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8368,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621488,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8369,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621489,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8370,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621490,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8371,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621491,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8372,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621492,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,8373,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621493,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8374,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621494,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8375,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621495,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8376,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621496,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8377,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621497,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8378,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621498,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8379,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621499,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,8380,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618634,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8381,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618635,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8382,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618636,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8383,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619737,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8384,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619738,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8385,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624329,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8386,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624330,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8387,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624331,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8388,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624332,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8389,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624333,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8390,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624334,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8391,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624335,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8392,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620016,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8393,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620169,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8394,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620170,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,8395,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620171,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8396,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620172,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8397,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620173,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,8398,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620174,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8399,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620175,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8400,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620176,Intermediate
,10116.0,13950,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8401,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620177,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8402,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620178,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8403,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620179,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8404,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620180,Intermediate
,10116.0,6570,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,8405,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620181,Intermediate
,10116.0,6571,Volume of distribution of compound in rats after intravenous administration,,8406,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620182,Intermediate
,10116.0,6453,Volume of distribution in rat,,8407,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620183,Intermediate
,10116.0,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,8408,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620184,Intermediate
,10116.0,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,8409,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620185,Intermediate
,10116.0,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,8410,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620186,Intermediate
,10116.0,5353,Volume of distribution was determined in Dawley rat,,8411,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620187,Intermediate
,10116.0,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,8412,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620188,Intermediate
,10116.0,5334,Volume of distribution was reported in Sprague-Dawley rat,,8413,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620189,Intermediate
,10116.0,6641,Volumes of distribution in rat after peroral administration,,8414,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620190,Intermediate
,10116.0,6641,Volumes of distribution in rat after po administration,,8415,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620191,Intermediate
,10116.0,6641,Volumes of distribution in rat after po administration; Not determined,,8416,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620192,Intermediate
,10116.0,5676,Pharmacokinetic property (Volume) in rat i.v.,,8417,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620193,Intermediate
,10116.0,6410,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,8418,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620194,Intermediate
,10116.0,17670,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,8419,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876730,Intermediate
,10116.0,6495,Volume distribution in rat after oral administration at 10 mg/kg,,8420,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620195,Intermediate
,10116.0,5408,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,8421,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620196,Intermediate
,10116.0,4883,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,8422,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620197,Intermediate
,10116.0,6647,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,8423,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620198,Intermediate
,10116.0,6495,Volume of distribution in rats,,8424,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620199,Intermediate
,10116.0,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,8425,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620200,Intermediate
,10116.0,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,8426,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620201,Intermediate
,10116.0,5974,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,8427,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620202,Intermediate
,10116.0,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,8428,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620203,Intermediate
,10116.0,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,8429,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620204,Intermediate
,10116.0,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,8430,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620205,Intermediate
,10116.0,5960,Pharmacokinetic parameter (Vss) in rat,,8431,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624664,Intermediate
,10116.0,5676,Pharmacokinetic property (Volume) in rat i.v.,,8432,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624665,Intermediate
,10116.0,5948,Pharmacokinetic property (Vss) in rat,,8433,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624666,Intermediate
,10116.0,5979,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,8434,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624667,Intermediate
,10116.0,5978,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,8435,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624668,Intermediate
,10116.0,5978,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,8436,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624669,Intermediate
,10116.0,5978,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,8437,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624670,Intermediate
,10116.0,5978,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,8438,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624671,Intermediate
,10116.0,6448,Steady state volume distribution in rat,,8439,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624672,Intermediate
,10116.0,12873,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,8440,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624673,Intermediate
,10116.0,4576,Steady state volume of distribution determined in rat,,8441,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624674,Intermediate
,10116.0,17582,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,8442,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624675,Intermediate
,10116.0,1466,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,8443,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621728,Intermediate
,10116.0,5182,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,8444,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621729,Intermediate
,10116.0,5182,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,8445,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621730,Intermediate
,10116.0,6535,Volume distribution in rat after administration of 2 mg/kg iv,,8446,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621731,Intermediate
,10116.0,6535,Volume distribution in rat after administration of 2 mg/kg iv,,8447,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621732,Intermediate
,10116.0,5041,Volume in steady state distribution value was determined,,8448,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621908,Intermediate
,10116.0,5041,Volume in steady state distribution value was determined; ND denotes no data,,8449,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875347,Intermediate
,10116.0,5041,Volume in steady state distribution value was determined; ND denotes not determined,,8450,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621909,Intermediate
,10116.0,17065,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,8451,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621910,Intermediate
,10116.0,6597,Volume of distribution at steady state was evaluated in rats,,8452,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621911,Intermediate
,10116.0,15662,Volume of distribution at steady state was observed after intravenous administration in rat,,8453,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621912,Intermediate
,10116.0,6485,Volume of distribution in steady state was determined in rat,,8454,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621913,Intermediate
,10116.0,17655,Volume of distribution in steady state was determined in rat,,8455,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621914,Intermediate
,10116.0,6616,Volume of distribution after i.v. administration,,8456,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621915,Intermediate
,10116.0,1916,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,8457,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621916,Intermediate
,10090.0,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,8458,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621917,Intermediate
,10090.0,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,8459,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621918,Intermediate
,10090.0,16438,Biodistribution of compound (oxidized form) in spleen tissue,,8460,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621919,Intermediate
,10090.0,16438,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,8461,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621920,Intermediate
,10090.0,16438,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,8462,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621921,Intermediate
,10090.0,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8463,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622401,Intermediate
,10090.0,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,8464,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875348,Intermediate
,10090.0,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,8465,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622402,Intermediate
,10090.0,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,8466,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622403,Intermediate
,10090.0,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8467,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622404,Intermediate
,10090.0,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,8468,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622405,Intermediate
,10090.0,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,8469,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622406,Intermediate
,10090.0,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8470,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622407,Intermediate
,10090.0,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,8471,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622408,Intermediate
,10090.0,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,8472,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622409,Intermediate
,10090.0,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8473,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622410,Intermediate
,10090.0,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,8474,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622411,Intermediate
,10090.0,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,8475,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627864,Intermediate
,10090.0,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8476,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627865,Intermediate
,10090.0,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,8477,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627866,Intermediate
,10090.0,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8478,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627751,Intermediate
,10090.0,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,8479,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627752,Intermediate
,10090.0,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,8480,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627753,Intermediate
,10090.0,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8481,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627754,Intermediate
,10090.0,12467,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,8482,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627755,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,8483,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627756,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,8484,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627757,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,8485,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627758,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,8486,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627759,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,8487,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627760,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,8488,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627761,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,8489,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876811,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,8490,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627762,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,8491,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627763,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,8492,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627764,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,8493,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627765,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,8494,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627766,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,8495,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627767,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,8496,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627768,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,8497,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628422,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,8498,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628423,Intermediate
,10116.0,5089,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,8499,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628424,Intermediate
,10116.0,5089,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,8500,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628425,Intermediate
,10116.0,4257,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,8501,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628426,Intermediate
,10116.0,6679,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,8502,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628427,Intermediate
,10116.0,5546,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,8503,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626938,Intermediate
,10116.0,6141,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,8504,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626939,Intermediate
,10116.0,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,8505,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626940,Intermediate
,10116.0,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,8506,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626941,Intermediate
,10116.0,5334,Plasma clearance was reported in Sprague-Dawley rat,,8507,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626942,Intermediate
,10116.0,4689,Plasma clearance after intravenous administration (1 mg/kg) in rat,,8508,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876812,Intermediate
,10116.0,6848,Plasma clearance of compound in rats was evaluated,,8509,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626943,Intermediate
,10116.0,6848,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,8510,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626944,Intermediate
,10116.0,6467,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,8511,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626945,Intermediate
,10116.0,6467,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,8512,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626946,Intermediate
,10116.0,4956,Plasma clearance rate in Sprague-Dawley rats,,8513,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626856,Intermediate
,10116.0,5529,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,8514,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626857,Intermediate
,10116.0,406,The compound was evaluated for plasma clearance in rat,,8515,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626858,Intermediate
,10116.0,17655,Total plasma clearance in rat,,8516,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627018,Intermediate
,10116.0,3293,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,8517,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625331,Intermediate
,10116.0,4075,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,8518,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625332,Intermediate
,10116.0,2792,C max was determined at 10 mg/kg po dose in rats,,8519,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877590,Intermediate
,10116.0,2792,C max was determined at 3 mg/kg po dose in rats,,8520,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625333,Intermediate
,10116.0,17594,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,8521,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625334,Intermediate
,10116.0,17594,Cmax after single intravenous bolus of 1 mg/kg in rats,,8522,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625335,Intermediate
,10116.0,4762,Cmax of compound at 5 mg/kg after po administration was determined in rat,,8523,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625336,Intermediate
,10116.0,17509,Cmax 24 hr after 10 mg/kg oral administration in rats,,8524,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625337,Intermediate
,10116.0,17509,Cmax 24 hr after 2 mg/kg oral administration in rats,,8525,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625338,Intermediate
,10116.0,1466,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,8526,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625339,Intermediate
,10116.0,6535,Cmax in rat after administration of 2 mg/kg iv,,8527,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625340,Intermediate
,10116.0,6535,Cmax in rat after administration of 2 mg/kg iv,,8528,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625341,Intermediate
,10116.0,3169,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,8529,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622687,Intermediate
,10116.0,6515,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,8530,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622688,Intermediate
,10116.0,11149,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,8531,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622689,Intermediate
,10116.0,11149,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,8532,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620295,Intermediate
,10116.0,17858,Cmax after 10 mg/kg oral administration in rat,,8533,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620296,Intermediate
,10116.0,6518,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,8534,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620297,Intermediate
,10116.0,6518,Cmax after IV dosing at 1 mg/kg in rat; no data,,8535,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620298,Intermediate
,10116.0,4426,Cmax after oral administration at 20 mpk in rats,,8536,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620299,Intermediate
,10116.0,4426,Cmax after oral administration at 20 mpk in rats; Not performed.,,8537,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620300,Intermediate
,10116.0,4426,Cmax after oral administration at 20 mpk in rats d; Not performed.,,8538,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620301,Intermediate
,10116.0,5656,Cmax after oral administration in rat,,8539,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620302,Intermediate
,10116.0,6518,Cmax after oral administration at a dose of 2 mg/kg in rat,,8540,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620303,Intermediate
,10116.0,6518,Cmax after oral administration at a dose of 4 mg/kg in rat,,8541,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620304,Intermediate
,10116.0,6113,Cmax in rats after 20 mg/kg oral dose,,8542,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620305,Intermediate
,10116.0,17764,Cmax after peroral administration in rats at 2.4 uM/kg,,8543,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620306,Intermediate
,10116.0,4756,Cmax at the dose of 2 mg/Kg administered perorally in rats,,8544,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620307,Intermediate
,10116.0,4756,Cmax at the dose of 5 mg/Kg administered perorally in rats,,8545,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620308,Intermediate
,10116.0,6402,Cmax by administering at 20 mg/kg p.o. in rats,,8546,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620309,Intermediate
,10116.0,5610,Cmax in male rat,,8547,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620310,Intermediate
,10116.0,5207,Cmax in rat,,8548,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620311,Intermediate
,10116.0,6011,Cmax in rat,,8549,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620312,Intermediate
,10116.0,6504,Cmax in rat,,8550,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620313,Intermediate
,10116.0,6046,Cmax in rat at 10 mg/kg,,8551,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620314,Intermediate
,10116.0,6504,Cmax in rat at the dose of 1 mg/kg i.v.,,8552,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620315,Intermediate
,10116.0,5874,Cmax in rat by po administration at a dose of 40 mg/kg,,8553,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620316,Intermediate
,10116.0,17686,Cmax in rat p.o. at 20 mg/kg concentration,,8554,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620317,Intermediate
,10116.0,5836,Cmax in rats,,8555,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620318,Intermediate
,10116.0,17596,Cmax in rats,,8556,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620319,Intermediate
,10116.0,16423,Cmax was evaluated after 20 uM/kg of peroral administration,,8557,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620320,Intermediate
,10116.0,17804,Cmax was measured in rats after peroral administration at 3 mg/kg,,8558,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620321,Intermediate
,10116.0,1908,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,8559,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620322,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8560,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620323,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8561,50597,Rattus norvegicus,,,Frontal cortex,1870.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620324,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8562,50597,Rattus norvegicus,,,Frontal cortex,1870.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620325,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8563,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620326,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8564,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620327,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8565,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620328,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8566,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620329,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8567,50597,Rattus norvegicus,,,Midbrain,1891.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620330,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8568,50597,Rattus norvegicus,,,Midbrain,1891.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875286,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8569,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620331,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8570,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620332,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8571,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620333,Intermediate
,10116.0,13950,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8572,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620334,Intermediate
,10116.0,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,8573,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621015,Intermediate
,10116.0,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,8574,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621016,Intermediate
,10116.0,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,8575,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621191,Intermediate
,10116.0,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,8576,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621192,Intermediate
,10116.0,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,8577,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621193,Intermediate
,10116.0,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,8578,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621194,Intermediate
,10116.0,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,8579,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624204,Intermediate
,10116.0,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,8580,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624205,Intermediate
,10116.0,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,8581,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624206,Intermediate
,10116.0,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,8582,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624207,Intermediate
,10116.0,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,8583,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624208,Intermediate
,10116.0,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,8584,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624209,Intermediate
,10116.0,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,8585,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624210,Intermediate
,10116.0,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,8586,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624211,Intermediate
,10116.0,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,8587,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624212,Intermediate
,10116.0,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,8588,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624213,Intermediate
,10116.0,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,8589,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876611,Intermediate
,10116.0,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,8590,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624214,Intermediate
,10116.0,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,8591,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624215,Intermediate
,10116.0,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,8592,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624216,Intermediate
,10116.0,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,8593,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624217,Intermediate
,10116.0,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,8594,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624218,Intermediate
,10116.0,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,8595,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624219,Intermediate
,10116.0,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,8596,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624220,Intermediate
,10116.0,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,8597,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624221,Intermediate
,10116.0,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,8598,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624222,Intermediate
,10116.0,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,8599,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624223,Intermediate
,10116.0,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,8600,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624224,Intermediate
,10116.0,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,8601,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624225,Intermediate
,10116.0,17764,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,8602,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622420,Intermediate
,10116.0,5031,Volume of steady state distribution after i.v. administration in rats,,8603,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622421,Intermediate
,10116.0,6215,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,8604,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622422,Intermediate
,10116.0,17671,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,8605,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622423,Intermediate
,10116.0,17752,Vss was determined,,8606,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622424,Intermediate
,10116.0,6596,Vss in rat,,8607,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622425,Intermediate
,10116.0,16423,Vss was evaluated after 10 uM/kg of intra arterial administration,,8608,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876612,Intermediate
,10116.0,15662,volume of distribution at steady state was observed after intravenous administration in rat,,8609,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622426,Intermediate
,10116.0,6062,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,8610,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622427,Intermediate
,10116.0,5874,Pharmacokinetic (PK) parameter Vz in rat,,8611,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622428,Intermediate
,10116.0,4942,Volume distribution in rats,,8612,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622429,Intermediate
,10116.0,17796,Volume of distribution in rat; No data,,8613,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622430,Intermediate
,10116.0,4890,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,8614,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622431,Intermediate
,10116.0,15765,% absorption predicted from in vitro rat ileum transport studies,,8615,50597,Rattus norvegicus,,,Ileum,2116.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622432,Intermediate
,10116.0,13569,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,8616,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622433,Intermediate
,10116.0,13569,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,8617,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622434,Intermediate
,10116.0,13569,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,8618,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622435,Intermediate
,10116.0,13569,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,8619,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618748,Intermediate
,10116.0,13569,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,8620,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618749,Intermediate
,10116.0,13569,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,8621,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618750,Intermediate
,10116.0,13569,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,8622,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618751,Intermediate
,10116.0,13569,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,8623,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618752,Intermediate
,10116.0,4576,Oral bioavailability in rat,,8624,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618753,Intermediate
,10116.0,750,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,8625,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618754,Intermediate
,10116.0,750,Oral bioavailability in rat,,8626,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618755,Intermediate
,10116.0,4590,Oral bioavailability in rat,,8627,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618756,Intermediate
,10116.0,1716,Oral bioavailability in rat,,8628,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618757,Intermediate
,10116.0,1974,Bioavailability in rat,,8629,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618758,Intermediate
,10116.0,4502,Oral bioavailability in rat (dose 30 mg/kg),,8630,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621088,Intermediate
,10116.0,3371,Pharmacokinetic property (cLogP) in rat,,8631,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621089,Intermediate
,10116.0,9099,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,8632,50597,Rattus norvegicus,,,Blood,178.0,F,,,,1,1,BAO_0000218,N,,CHEMBL621090,Intermediate
,10116.0,9099,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,8633,50597,Rattus norvegicus,,,Blood,178.0,F,,,,1,1,BAO_0000218,N,,CHEMBL621091,Intermediate
,10116.0,4590,Clearance in rat.,,8634,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876731,Intermediate
,10116.0,3184,Compound was evaluated for its clearance when administered intravenously in rat,,8635,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621092,Intermediate
,10116.0,16456,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,8636,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621093,Intermediate
,10116.0,4199,Blood: Brain distribution ratio is determined in rat,,8637,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621094,Intermediate
,10116.0,4199,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,8638,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621095,Intermediate
,10116.0,4199,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,8639,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621096,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8640,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621097,Intermediate
,10116.0,7449,Percent dose excreted in 0-48 hours administered ip to male rat,,8641,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL621098,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8642,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621099,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8643,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621100,Intermediate
,10116.0,11977,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8644,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621101,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8645,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621102,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8646,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876732,Intermediate
,10116.0,11977,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8647,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621103,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8648,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621104,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8649,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621105,Intermediate
,10116.0,11977,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8650,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621106,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8651,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621107,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8652,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621108,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8653,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621109,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,8654,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621110,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,8655,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621111,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,8656,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622541,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,8657,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622542,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,8658,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622543,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,8659,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624412,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,8660,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624413,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,8661,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624414,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,8662,50594,Mus musculus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624415,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,8663,50594,Mus musculus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624416,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,8664,50594,Mus musculus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624417,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,8665,50594,Mus musculus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624418,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,8666,50594,Mus musculus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624419,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,8667,50594,Mus musculus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624420,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,8668,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624421,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,8669,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624422,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,8670,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624423,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,8671,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625123,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,8672,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625124,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,8673,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625125,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,8674,50594,Mus musculus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625126,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,8675,50594,Mus musculus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626947,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,8676,50594,Mus musculus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626948,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,8677,50594,Mus musculus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626949,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,8678,50594,Mus musculus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626950,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,8679,50594,Mus musculus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626951,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,8680,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626952,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,8681,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626953,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,8682,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626954,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,8683,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626955,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,8684,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626956,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,8685,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626957,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,8686,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626958,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,8687,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626959,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,8688,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626960,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,8689,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626961,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,8690,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627589,Intermediate
,10090.0,17208,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,8691,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627590,Intermediate
,10090.0,3132,Time taken for EC90 was determined when tested in mouse,,8692,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627591,Intermediate
,10090.0,3132,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,8693,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627592,Intermediate
,10090.0,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,8694,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627593,Intermediate
,10090.0,5727,Half life in mice,,8695,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627594,Intermediate
,10090.0,5302,Half life period in mouse after 10 mg/Kg dose,,8696,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876813,Intermediate
,10090.0,5302,Half life period in mouse after 10 mg/kg dose,,8697,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627595,Intermediate
,10090.0,6348,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,8698,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627596,Intermediate
,10116.0,5964,Cmax value at 5 mg/kg po was determined in rat,,8699,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627597,Intermediate
,10116.0,6078,Cmax value evaluated in rat,,8700,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627598,Intermediate
,10116.0,5206,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,8701,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627599,Intermediate
,10116.0,2959,Cmax value after administration of 20 mg/Kg oral dose in rat,,8702,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627600,Intermediate
,10116.0,5964,Cmax value at 1 mg/kg po in rat,,8703,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627601,Intermediate
,10116.0,5964,Cmax value at 5 mg/kg po in rat,,8704,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627776,Intermediate
,10116.0,6757,Cmax value at a dose of 10 mg/kg in male SD rats,,8705,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627777,Intermediate
,10116.0,6757,Cmax value at a dose of 100 mg/kg in male SD rats,,8706,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627778,Intermediate
,10116.0,6757,Cmax value at a dose of 50 mg/kg in male SD rats,,8707,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627779,Intermediate
,10116.0,17617,Cmax value in rats at 10 mg/kg,,8708,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876814,Intermediate
,10116.0,1445,Cmax value was evaluated in rats at a dose of 20 mg/kg,,8709,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627780,Intermediate
,10116.0,6082,Cmax value was determined after peroral administration of 20 mg/kg in rat,,8710,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627781,Intermediate
,10116.0,1446,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,8711,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627782,Intermediate
,10116.0,5407,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,8712,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627783,Intermediate
,10116.0,2690,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,8713,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627784,Intermediate
,10116.0,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,8714,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627785,Intermediate
,10116.0,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,8715,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627786,Intermediate
,10116.0,4891,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,8716,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627787,Intermediate
,10116.0,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,8717,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627788,Intermediate
,10116.0,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,8718,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626579,Intermediate
,10116.0,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,8719,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626580,Intermediate
,10116.0,3634,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,8720,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876815,Intermediate
,10116.0,1881,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,8721,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626581,Intermediate
,10116.0,1881,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,8722,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626582,Intermediate
,10116.0,429,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,8723,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626583,Intermediate
,10116.0,5974,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,8724,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626205,Intermediate
,10116.0,5974,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,8725,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626206,Intermediate
,10116.0,5974,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,8726,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626207,Intermediate
,10116.0,5974,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,8727,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623882,Intermediate
,10116.0,17582,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,8728,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623883,Intermediate
,10116.0,17582,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,8729,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623884,Intermediate
,10116.0,3032,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,8730,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623885,Intermediate
,10116.0,6295,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,8731,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623886,Intermediate
,10116.0,6619,Maximal concentration in rat was determined,,8732,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623887,Intermediate
,10116.0,6616,Maximal concentration after i.v. administration,,8733,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623888,Intermediate
,10116.0,3249,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,8734,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623889,Intermediate
,10116.0,17791,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,8735,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623890,Intermediate
,10116.0,17791,Cmax in rat plasma after oral dose (50 mg/Kg),,8736,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623891,Intermediate
,10116.0,1360,Maximal plasma concentration was determined.,,8737,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623892,Intermediate
,10116.0,2552,Maximal plasma drug concentration was determined,,8738,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623893,Intermediate
,10116.0,6571,Maximal concentration in rats after peroral administration,,8739,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877616,Intermediate
,10116.0,6570,Maximum concentration in rat after 2 mg/kg peroral administration,,8740,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623894,Intermediate
,10116.0,6567,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,8741,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623895,Intermediate
,10116.0,3031,Maximum concentration of compound in rat was evaluated.,,8742,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623896,Intermediate
,10116.0,3436,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,8743,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623897,Intermediate
,10116.0,3436,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,8744,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623898,Intermediate
,10116.0,2083,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,8745,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623899,Intermediate
,10116.0,3436,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,8746,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623900,Intermediate
,10116.0,4527,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,8747,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623901,Intermediate
,10116.0,1974,Maximum concentration was evaluated in rats,,8748,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623902,Intermediate
,10116.0,3307,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,8749,50597,Rattus norvegicus,,,Cerebrospinal fluid,1359.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623903,Intermediate
,10116.0,3307,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,8750,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623904,Intermediate
,10116.0,1916,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,8751,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877617,Intermediate
,10116.0,1500,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,8752,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623905,Intermediate
,10116.0,1500,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,8753,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623906,Intermediate
,10116.0,4186,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,8754,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623907,Intermediate
,10116.0,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,8755,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623908,Intermediate
,10116.0,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,8756,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623909,Intermediate
,10116.0,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,8757,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623910,Intermediate
,10116.0,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,8758,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623911,Intermediate
,10116.0,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,8759,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623912,Intermediate
,10116.0,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,8760,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624616,Intermediate
,10116.0,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,8761,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624617,Intermediate
,10116.0,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,8762,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624618,Intermediate
,10116.0,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,8763,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624619,Intermediate
,10116.0,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,8764,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624794,Intermediate
,10116.0,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,8765,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624795,Intermediate
,10116.0,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,8766,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623921,Intermediate
,10116.0,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,8767,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623922,Intermediate
,10116.0,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,8768,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623923,Intermediate
,10116.0,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,8769,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623924,Intermediate
,10116.0,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,8770,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623925,Intermediate
,10116.0,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,8771,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623926,Intermediate
,10116.0,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,8772,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623927,Intermediate
,10116.0,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,8773,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623928,Intermediate
,10116.0,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,8774,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623929,Intermediate
,10116.0,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,8775,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623930,Intermediate
,10116.0,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,8776,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623931,Intermediate
,10116.0,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,8777,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622165,Intermediate
,10116.0,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,8778,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621249,Intermediate
,10116.0,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,8779,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621250,Intermediate
,10116.0,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,8780,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621448,Intermediate
,10116.0,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,8781,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621449,Intermediate
,10116.0,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,8782,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621450,Intermediate
,10116.0,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,8783,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621451,Intermediate
,10116.0,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,8784,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621452,Intermediate
,10116.0,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,8785,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621453,Intermediate
,10116.0,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,8786,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621454,Intermediate
,10116.0,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,8787,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621455,Intermediate
,10116.0,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,8788,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621456,Intermediate
,10116.0,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,8789,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625145,Intermediate
,10116.0,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,8790,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875847,Intermediate
,10116.0,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,8791,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625146,Intermediate
,10116.0,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,8792,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625147,Intermediate
,10116.0,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,8793,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625148,Intermediate
,10116.0,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,8794,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625149,Intermediate
,10116.0,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,8795,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625150,Intermediate
,10116.0,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,8796,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625151,Intermediate
,10116.0,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,8797,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625152,Intermediate
,10116.0,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,8798,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625153,Intermediate
,10116.0,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,8799,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625154,Intermediate
,10116.0,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,8800,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625155,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8801,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625156,Intermediate
,10116.0,11977,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8802,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624354,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8803,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624355,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8804,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624356,Intermediate
,10116.0,11977,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8805,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624357,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8806,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624358,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8807,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624359,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8808,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624360,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8809,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624361,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8810,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624362,Intermediate
,10116.0,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8811,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624363,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8812,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624364,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8813,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624365,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8814,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624366,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8815,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624367,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8816,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624368,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8817,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624369,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8818,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624370,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8819,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625069,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8820,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625070,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8821,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626051,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8822,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626052,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8823,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626053,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8824,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626054,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8825,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626055,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8826,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626056,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8827,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626057,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8828,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625193,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8829,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625194,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8830,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625195,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8831,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625196,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8832,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625197,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8833,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625198,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8834,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627929,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8835,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627074,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8836,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627075,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8837,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627076,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8838,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627077,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8839,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627078,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,8840,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627079,Intermediate
,10090.0,4573,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,8841,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873824,Intermediate
,10090.0,3132,Half life in mouse plasma was determined at dose 25 mg/kg,,8842,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627080,Intermediate
,10090.0,17718,Half life was determined,,8843,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627081,Intermediate
,10090.0,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,8844,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627082,Intermediate
,10090.0,5961,Half-life in male mice after 1 mg/kg intravenous dose,,8845,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627083,Intermediate
,10090.0,17731,Half life in mice plasma,,8847,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627085,Intermediate
,10090.0,17592,Half life in mouse,,8848,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627086,Intermediate
,10090.0,3132,Half life in mouse plasma at dose 25 mg/kg,,8849,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627087,Intermediate
,10090.0,17729,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,8850,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627088,Intermediate
,10090.0,17729,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,8851,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627089,Intermediate
,10090.0,17729,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,8852,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627090,Intermediate
,10090.0,3277,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,8853,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627091,Intermediate
,10090.0,3760,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,8854,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627092,Intermediate
,10090.0,3760,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,8855,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876785,Intermediate
,10090.0,2862,Half-life by iv administration in mouse,,8856,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627093,Intermediate
,10090.0,2862,Half-life by oral administration in mouse,,8857,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627094,Intermediate
,10090.0,5980,Half-life in mice,,8858,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627095,Intermediate
,10090.0,6159,Half-life using mouse brain homogenate,,8859,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627096,Intermediate
,10090.0,6254,Half-life was measured in mice,,8860,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627097,Intermediate
,10090.0,6062,Half-life was measured in mouse after an iv dose of 1 mg/kg,,8861,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627098,Intermediate
,10090.0,1574,Half-life period was determined in mouse blood,,8862,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627099,Intermediate
,10090.0,56,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,8863,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627100,Intermediate
,10090.0,993,Plasma half life in mouse,,8864,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627101,Intermediate
,10090.0,6652,Stability of the peptide in the presence of mouse serum,,8865,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627102,Intermediate
,10090.0,17852,Terminal half life of compound was determined in mouse,,8866,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627103,Intermediate
,10090.0,2675,Terminal half life was evaluated in mice after intravenous administration,,8867,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627104,Intermediate
,10090.0,2675,Terminal half life was evaluated in mice after oral administration,,8868,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627105,Intermediate
,10090.0,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,8869,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876786,Intermediate
,10090.0,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,8870,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL873825,Intermediate
,10090.0,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,8871,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627106,Intermediate
,10090.0,14239,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,8872,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626336,Intermediate
,10090.0,5506,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,8873,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877462,Intermediate
,10090.0,5506,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,8874,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626337,Intermediate
,10090.0,17734,Half life after intraperitoneal administration of 100 mg/kg in mice,,8875,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626338,Intermediate
,10090.0,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,8876,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626339,Intermediate
,10090.0,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,8877,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626340,Intermediate
,10090.0,17728,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,8878,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625377,Intermediate
,10090.0,17728,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,8879,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625378,Intermediate
,10090.0,17728,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,8880,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625379,Intermediate
,9823.0,14294,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,8881,22224,Sus scrofa,Microsomes,,,,A,,,,1,0,BAO_0000251,U,,CHEMBL625380,Autocuration
,9823.0,14294,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,8882,22224,Sus scrofa,Microsomes,,,,A,,,,1,0,BAO_0000251,U,,CHEMBL625381,Autocuration
,9823.0,6056,Stability to porcine renal DHP-I,,8883,22224,Sus scrofa,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625382,Autocuration
,9823.0,1317,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,8884,22224,Sus scrofa,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL873828,Autocuration
,9823.0,1317,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,8885,22224,Sus scrofa,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625383,Autocuration
,9823.0,5229,Half-life of the parent prodrug in porcine esterase solution,,8886,22224,Sus scrofa,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625384,Autocuration
,9823.0,4231,"First order rate constant, k was determined in in pig liver Esterase",,8887,22224,Sus scrofa,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625385,Autocuration
,9823.0,4231,Half life of the in pig liver Esterase,,8888,22224,Sus scrofa,,,Liver,2107.0,A,,,,1,0,BAO_0000221,U,,CHEMBL625386,Autocuration
,9823.0,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,8889,22224,Sus scrofa,,,Liver,2107.0,A,,,,1,0,BAO_0000221,U,,CHEMBL623571,Autocuration
,9823.0,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,8890,22224,Sus scrofa,,,Liver,2107.0,A,,,,1,0,BAO_0000221,U,,CHEMBL623572,Autocuration
,9823.0,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,8891,22224,Sus scrofa,,,Liver,2107.0,A,,,,1,0,BAO_0000221,U,,CHEMBL623573,Autocuration
,9823.0,3305,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,8892,22224,Sus scrofa,,,Liver,2107.0,A,,,,1,0,BAO_0000221,U,,CHEMBL623574,Autocuration
,9823.0,3305,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,8893,22224,Sus scrofa,,,Liver,2107.0,A,,,,1,0,BAO_0000221,U,,CHEMBL623575,Autocuration
,9823.0,2842,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,8894,22224,Sus scrofa,,,Liver,2107.0,A,,,,1,0,BAO_0000221,U,,CHEMBL623749,Autocuration
,9823.0,2842,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,8895,22224,Sus scrofa,,,Liver,2107.0,A,,,,1,0,BAO_0000221,U,,CHEMBL623750,Autocuration
,9823.0,889,Half-life in vitro in pig liver,,8896,22224,Sus scrofa,,,Liver,2107.0,A,,,,1,0,BAO_0000221,U,In vitro,CHEMBL623751,Autocuration
,9823.0,1904,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,8897,22224,Sus scrofa,,,Liver,2107.0,A,,,,1,0,BAO_0000221,U,,CHEMBL623752,Autocuration
,10116.0,4186,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,8898,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623753,Intermediate
,10116.0,2774,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,8899,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623754,Intermediate
,10116.0,1742,Maximum concentration in rat plasma was determined,,8900,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623755,Intermediate
,10116.0,3169,Maximum concentration in rats,,8901,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623756,Intermediate
,10116.0,3169,Maximum concentration in rats at 1-2 hours,,8902,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623757,Intermediate
,10116.0,2081,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,8903,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623758,Intermediate
,10116.0,3307,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,8904,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623759,Intermediate
,10116.0,4727,Maximum concentration at the dose of 2 mg/kg in rat,,8905,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623760,Intermediate
,10116.0,6597,Maximum concentration was evaluated in rats,,8906,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623761,Intermediate
,10116.0,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,8907,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623762,Intermediate
,10116.0,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,8908,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877594,Intermediate
,10116.0,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,8909,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623763,Intermediate
,10116.0,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,8910,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623764,Intermediate
,10116.0,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,8911,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623765,Intermediate
,10116.0,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,8912,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623766,Intermediate
,10116.0,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,8913,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623767,Intermediate
,10116.0,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,8914,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623768,Intermediate
,10116.0,5978,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,8915,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623769,Intermediate
,10116.0,5978,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,8916,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623770,Intermediate
,10116.0,5978,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,8917,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623771,Intermediate
,10116.0,5978,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,8918,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623772,Intermediate
,10116.0,5978,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,8919,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623773,Intermediate
,10116.0,5978,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,8920,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623774,Intermediate
,10116.0,5978,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,8921,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623775,Intermediate
,10116.0,14465,Cmax in rat (PO dose),,8922,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623776,Intermediate
,10116.0,4723,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,8923,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622191,Intermediate
,10116.0,4723,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,8924,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622192,Intermediate
,10116.0,4576,Maximum plasma concentration determined in rat,,8925,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622193,Intermediate
,10116.0,12873,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,8926,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622194,Intermediate
,10116.0,12873,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,8927,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622195,Intermediate
,10116.0,6824,Maximum plasma concentration in rat,,8928,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622196,Intermediate
,10116.0,17065,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,8929,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622197,Intermediate
,10116.0,2932,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,8930,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622198,Intermediate
,10116.0,2932,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,8931,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622199,Intermediate
,10116.0,2879,Maximum plasma concentration of compound was measured in rat,,8932,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622200,Intermediate
,10116.0,2864,Maximum plasma concentration after 20 mg/kg oral administration in rat,,8933,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622201,Intermediate
,10116.0,16367,Maximum plasma concentration after oral administration to rats,,8934,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623990,Intermediate
,10116.0,17717,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,8935,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623991,Intermediate
,10116.0,17717,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,8936,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623992,Intermediate
,10116.0,17717,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,8937,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623993,Intermediate
,10116.0,17717,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,8938,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623994,Intermediate
,10116.0,17720,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,8939,50597,Rattus norvegicus,,,Plasma,1969.0,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623995,Intermediate
,10116.0,17720,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,8940,50597,Rattus norvegicus,,,Plasma,1969.0,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623996,Intermediate
,10116.0,17720,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,8941,50597,Rattus norvegicus,,,Plasma,1969.0,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623997,Intermediate
,10116.0,4516,Maximum plasma concentration dosed orally in rats,,8942,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623998,Intermediate
,10116.0,4516,Maximum plasma concentration dosed orally in rats after 6 hours,,8943,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623999,Intermediate
,10116.0,4516,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,8944,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624000,Intermediate
,10116.0,5199,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,8945,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624001,Intermediate
,10116.0,17538,Maximum plasma concentration in rat after po administration,,8946,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624002,Intermediate
,10116.0,6685,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,8947,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624003,Intermediate
,10116.0,6685,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,8948,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624004,Intermediate
,10116.0,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,8949,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624005,Intermediate
,10116.0,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,8950,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624006,Intermediate
,10116.0,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,8951,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624007,Intermediate
,10116.0,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,8952,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624008,Intermediate
,10116.0,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,8953,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624009,Intermediate
,10116.0,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,8954,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874387,Intermediate
,10116.0,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,8955,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624010,Intermediate
,10116.0,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,8956,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624011,Intermediate
,10116.0,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,8957,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624012,Intermediate
,10116.0,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,8958,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624013,Intermediate
,10116.0,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,8959,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624736,Intermediate
,10116.0,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,8960,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624737,Intermediate
,10116.0,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,8961,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624738,Intermediate
,10116.0,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,8962,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624739,Intermediate
,10116.0,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,8963,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624740,Intermediate
,10116.0,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,8964,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624896,Intermediate
,10116.0,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,8965,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624897,Intermediate
,10116.0,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,8966,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624108,Intermediate
,10116.0,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,8967,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624109,Intermediate
,10116.0,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,8968,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624110,Intermediate
,10116.0,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,8969,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624111,Intermediate
,10116.0,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,8970,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624112,Intermediate
,10116.0,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,8971,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624113,Intermediate
,10116.0,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,8972,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619709,Intermediate
,10116.0,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,8973,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619710,Intermediate
,10116.0,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,8974,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619711,Intermediate
,10116.0,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,8975,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619712,Intermediate
,10116.0,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,8976,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619713,Intermediate
,10116.0,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,8977,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619714,Intermediate
,10116.0,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,8978,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619715,Intermediate
,10116.0,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,8979,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619716,Intermediate
,10116.0,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,8980,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619717,Intermediate
,10116.0,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,8981,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619718,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,8982,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619719,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,8983,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875329,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,8984,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619720,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,8985,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619721,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,8986,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619722,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,8987,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619723,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,8988,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619724,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,8989,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619725,Intermediate
,10116.0,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,8990,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619726,Intermediate
,10116.0,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,8991,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619727,Intermediate
,10116.0,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,8992,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619728,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,8993,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619729,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8994,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619730,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8995,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619731,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8996,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619732,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8997,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619733,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8998,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619734,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8999,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619735,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,9000,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875330,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,9001,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628465,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,9002,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628466,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,9003,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628467,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,9004,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628468,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,9005,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628469,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,9006,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628470,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,9007,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628471,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,9008,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628472,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,9009,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625191,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,9010,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625192,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,9011,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875337,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,9012,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626341,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,9013,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626342,Intermediate
,10116.0,11977,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,9014,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621943,Intermediate
,10116.0,3748,Half life in rats,,9015,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621944,Intermediate
,10116.0,15765,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,9016,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621945,Intermediate
,10116.0,4871,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,9017,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621946,Intermediate
,10116.0,4871,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,9018,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621947,Intermediate
,10116.0,4872,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,9019,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621948,Intermediate
,10116.0,4872,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,9020,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621949,Intermediate
,10116.0,5413,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,9021,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621950,Intermediate
,10116.0,5413,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,9022,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621951,Intermediate
,10116.0,15272,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,9023,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621952,Intermediate
,10116.0,4689,Stability (%) in rat liver microsomes,,9024,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621953,Intermediate
,10116.0,6057,Area under curve was calculated after intravenous administration,,9025,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621954,Intermediate
,10116.0,6057,Area under the curve was calculated after iv administration in rat,,9026,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621955,Intermediate
,10116.0,6057,Area under the curve was calculated in rat after peroral administration,,9027,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621956,Intermediate
,10116.0,6211,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,9028,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621957,Intermediate
,10116.0,5710,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,9029,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621958,Intermediate
,10116.0,5710,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,9030,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621959,Intermediate
,10116.0,17853,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,9031,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621960,Intermediate
,10116.0,17853,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,9032,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621961,Intermediate
,10116.0,15765,p value of the compound,,9033,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621962,Intermediate
,10116.0,15765,p value of the compound,,9034,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL876787,Intermediate
,10116.0,15765,p value of the compound,,9035,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621963,Intermediate
,10116.0,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9036,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622637,Intermediate
,10116.0,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9037,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622638,Intermediate
,10116.0,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9038,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626561,Intermediate
,9986.0,7991,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,9039,22224,Oryctolagus cuniculus,,,,,F,,,,1,0,BAO_0000019,U,,CHEMBL626562,Autocuration
,9986.0,429,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,9040,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626563,Autocuration
,9986.0,429,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,9041,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626564,Autocuration
,9986.0,6253,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,9042,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626565,Autocuration
,9986.0,6253,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,9043,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626566,Autocuration
,9986.0,3615,Clearance rate in rabbits,,9044,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626567,Autocuration
,9986.0,4059,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,9045,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626568,Autocuration
,9986.0,5124,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,9046,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626569,Autocuration
,9986.0,5124,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,9047,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626570,Autocuration
,9986.0,5124,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,9048,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626571,Autocuration
,9986.0,429,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,9049,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626572,Autocuration
,9986.0,4059,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,9050,22224,Oryctolagus cuniculus,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626573,Autocuration
,9986.0,9659,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,9051,22224,Oryctolagus cuniculus,Microsomes,,Liver,2107.0,A,,,,1,0,BAO_0000251,U,,CHEMBL626574,Autocuration
,9986.0,9659,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,9052,22224,Oryctolagus cuniculus,Microsomes,,Liver,2107.0,A,,,,1,0,BAO_0000251,U,,CHEMBL626575,Autocuration
,9986.0,3639,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,9053,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626576,Autocuration
,9986.0,3639,Dose at which bioavailability of perorally administered compound was tested in rabbit,,9054,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626577,Autocuration
,9986.0,3639,The compound was tested for its bioavailability in rabbit (by oral dosage).,,9055,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626578,Autocuration
,9986.0,5124,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,9056,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625263,Autocuration
,9986.0,5124,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,9057,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625264,Autocuration
,9986.0,5124,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,9058,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625265,Autocuration
,9986.0,14294,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,9059,22224,Oryctolagus cuniculus,Microsomes,,,,A,,,,1,0,BAO_0000251,U,,CHEMBL625266,Autocuration
,9986.0,14294,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,9060,22224,Oryctolagus cuniculus,Microsomes,,,,A,,,,1,0,BAO_0000251,U,,CHEMBL876796,Autocuration
,9986.0,429,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,9061,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625267,Autocuration
,9986.0,5124,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,9062,22224,Oryctolagus cuniculus,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625268,Autocuration
,9986.0,5124,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,9063,22224,Oryctolagus cuniculus,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625269,Autocuration
,9986.0,5124,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,9064,22224,Oryctolagus cuniculus,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624689,Autocuration
,9986.0,429,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,9065,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624690,Autocuration
,9986.0,429,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,9066,22224,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL624691,Autocuration
,9986.0,429,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,9067,22224,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL624692,Autocuration
,9986.0,4059,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,9068,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624693,Autocuration
,9986.0,4137,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,9069,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624694,Autocuration
,9986.0,11672,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,9070,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000221,U,In vitro,CHEMBL877596,Autocuration
,9986.0,12886,Time within which only 10% of the drug was degraded,,9071,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624695,Autocuration
,9986.0,3853,Half life period in rabbit liver homogenate,,9072,22224,Oryctolagus cuniculus,,,Liver,2107.0,A,,,,1,0,BAO_0000221,U,,CHEMBL624696,Autocuration
,9986.0,3615,Half life value in rabbits,,9073,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624697,Autocuration
,9986.0,6253,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,9074,22224,Oryctolagus cuniculus,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624698,Autocuration
,9986.0,6253,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,9075,22224,Oryctolagus cuniculus,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624699,Autocuration
,9986.0,6077,Half-life period in rabbits following intravenous administration at 2 mg/kg,,9076,22224,Oryctolagus cuniculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624700,Autocuration
,10116.0,17617,AUC 0-8 hr value in rats at 10 mg/kg,,9077,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622903,Intermediate
,10116.0,17594,AUC after administration at 2000 mg/kg/day in rats,,9078,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622904,Intermediate
,10116.0,6149,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,9079,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622905,Intermediate
,10116.0,17260,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,9080,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622906,Intermediate
,10116.0,17260,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,9081,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622907,Intermediate
,10116.0,6644,AUC in rat after oral administration at 10.5 mg/kg dose,,9082,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622908,Intermediate
,10116.0,6644,AUC in rat after oral administration at 11.2 mg/kg dose,,9083,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622909,Intermediate
,10116.0,6644,AUC in rat after oral administration at 9.7 mg/kg dose,,9084,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622910,Intermediate
,10116.0,6495,AUC in rat brain after oral administration at 10 mg/kg,,9085,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622911,Intermediate
,10116.0,6504,AUC in rat p.o.,,9086,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622912,Intermediate
,10116.0,17686,AUC in rat p.o. at 20 mg/kg concentration,,9087,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622913,Intermediate
,10116.0,6495,AUC in rat plasma after oral administration at 10 mg/kg,,9088,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622914,Intermediate
,10116.0,216,AUC in rats,,9089,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622915,Intermediate
,10116.0,1908,AUC value after IV dose at a dose of 5 mg/kg in rats.,,9090,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622916,Intermediate
,10116.0,1908,AUC value after oral dose at a dose of 10 mg/kg in rats.,,9091,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622917,Intermediate
,10116.0,6685,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,9092,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622918,Intermediate
,10116.0,216,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,9093,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622919,Intermediate
,10116.0,6049,Maximum plasma concentration was evaluated in rat,,9094,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622920,Intermediate
,10116.0,2463,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,9095,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622921,Intermediate
,10116.0,6679,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,9096,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622922,Intermediate
,10116.0,6681,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,9097,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622923,Intermediate
,10116.0,4890,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,9098,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877604,Intermediate
,10116.0,6410,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,9099,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622924,Intermediate
,10116.0,6410,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,9100,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622925,Intermediate
,10116.0,16366,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,9101,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622926,Intermediate
,10116.0,6227,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,9102,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623625,Intermediate
,10116.0,3598,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,9103,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623626,Expert
,10116.0,1465,Maximum plasma drug concentration was determined,,9104,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623627,Intermediate
,10116.0,4368,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,9105,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623628,Intermediate
,10116.0,15662,Mean peak plasma concentration was observed after intravenous administration in rat,,9106,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623629,Intermediate
,10116.0,15662,Mean peak plasma concentration was observed after oral administration in rat,,9107,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623630,Intermediate
,10116.0,5355,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,9108,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623804,Intermediate
,10116.0,5355,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,9109,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623805,Intermediate
,10116.0,1567,Peak oral plasma concentration was determined in rats by oral administration,,9110,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623806,Intermediate
,10116.0,4026,Peak plasma concentration (Cmax) was determined,,9111,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623807,Intermediate
,10116.0,6193,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,9112,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623808,Intermediate
,10116.0,4026,Peak plasma concentration (Cmax) in rats,,9113,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623809,Intermediate
,10116.0,6485,Peak plasma concentration at 1 mg/kg peroral administration,,9114,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623810,Intermediate
,10116.0,17655,Peak plasma concentration in rat,,9115,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623811,Intermediate
,10116.0,14941,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,9116,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623812,Intermediate
,10116.0,5394,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,9117,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877605,Intermediate
,10116.0,4408,Pharmacokinetic property (Cmax) in rat,,9118,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623813,Intermediate
,10116.0,5983,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,9119,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623814,Intermediate
,10116.0,4878,Cmax in rat after 3mg/kg oral dose,,9120,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623815,Intermediate
,10116.0,5862,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,Sprague-Dawley,9121,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623816,Intermediate
,10116.0,4517,Cmax in rats after 20 mg/kg oral dose,,9122,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623145,Intermediate
,10116.0,5932,Cmax in rat plasma after 30mg/kg oral dose,,9123,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623146,Intermediate
,10116.0,5436,Plasma concentration after oral administration of 100 mg/kg to rats,,9124,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623147,Intermediate
,10116.0,4910,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,9125,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623042,Intermediate
,10116.0,4950,Tested for the Cmax in rat at 10 mg/kg per orally,,9126,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623043,Intermediate
,10116.0,15078,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,9127,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623044,Intermediate
,10116.0,15078,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,9128,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623045,Intermediate
,10116.0,3360,Bioavailability as oral Cmax in rats at 30 mins,,9129,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623046,Intermediate
,10116.0,3360,Bioavailability as oral Cmax in rats at 6hr,,9130,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623226,Intermediate
,10116.0,15022,The maximum concentration of compound was measured at the dose of 100 umol/kg,,9131,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623227,Intermediate
,10116.0,15022,The maximum concentration of compound was measured at the dose of 300 umol/kg,,9132,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623228,Intermediate
,10116.0,15022,The maximum concentration of compound was measured at the dose of 30 umol/kg,,9133,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623229,Intermediate
,10116.0,5160,The maximum plasma levels for the compounds were determined by LC-MS.,,9134,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623230,Intermediate
,10116.0,15662,mean peak plasma concentration was observed after intravenous administration in rat,,9135,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623231,Intermediate
,10116.0,15662,mean peak plasma concentration was observed after oral administration in rat,,9136,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623232,Intermediate
,10116.0,4709,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,9137,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623233,Intermediate
,10116.0,3535,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,9138,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623234,Intermediate
,10116.0,3535,Concentration in plasma (portal) following oral dose in rats at 1 hr,,9139,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623235,Intermediate
,10116.0,3535,Concentration in plasma (portal) following oral dose in rats at 2 hr,,9140,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623236,Intermediate
,10116.0,3535,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,9141,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623237,Intermediate
,10116.0,3535,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,9142,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623238,Intermediate
,10116.0,3535,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,9143,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623239,Intermediate
,10116.0,5005,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,9144,22224,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623240,Intermediate
,10116.0,6326,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,9145,50597,Rattus norvegicus,,,Hypothalamus,1898.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623241,Intermediate
,10116.0,6326,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,9146,50597,Rattus norvegicus,,,Hypothalamus,1898.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623242,Intermediate
,10116.0,6326,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,9147,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874394,Intermediate
,10116.0,6326,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,9148,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623243,Intermediate
,10116.0,17411,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9149,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623244,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9150,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623245,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9151,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623246,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9152,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623247,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9153,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623248,Intermediate
,10116.0,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9154,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623249,Intermediate
,10116.0,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9155,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625072,Intermediate
,10116.0,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9156,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625073,Intermediate
,10116.0,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9157,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625074,Intermediate
,10116.0,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9158,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625075,Intermediate
,10116.0,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,9159,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625076,Intermediate
,10116.0,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9160,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625077,Intermediate
,10116.0,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,9161,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625078,Intermediate
,10116.0,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,9162,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874395,Intermediate
,10116.0,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9163,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625079,Intermediate
,10116.0,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9164,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625080,Intermediate
,10116.0,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9165,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625081,Intermediate
,10116.0,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9166,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625082,Intermediate
,10116.0,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9167,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625083,Intermediate
,10116.0,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9168,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625084,Intermediate
,10116.0,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9169,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625085,Intermediate
,10116.0,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9170,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625086,Intermediate
,10116.0,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9171,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625087,Intermediate
,10116.0,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,9172,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625088,Intermediate
,10116.0,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9173,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622205,Intermediate
,10116.0,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9174,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622206,Intermediate
,10116.0,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9175,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622207,Intermediate
,10116.0,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9176,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622366,Intermediate
,10116.0,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9177,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622367,Intermediate
,10116.0,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9178,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875331,Intermediate
,10116.0,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9179,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622368,Intermediate
,10116.0,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9180,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622369,Intermediate
,10116.0,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9181,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622370,Intermediate
,10116.0,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9182,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622371,Intermediate
,10116.0,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9183,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622372,Intermediate
,10116.0,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,9184,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622373,Intermediate
,10116.0,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9185,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622374,Intermediate
,10116.0,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,9186,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622375,Intermediate
,10116.0,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,9187,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622376,Intermediate
,10116.0,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9188,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622377,Intermediate
,10116.0,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9189,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622378,Intermediate
,10116.0,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9190,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622379,Intermediate
,10116.0,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9191,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622380,Intermediate
,10116.0,16435,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9192,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622381,Intermediate
,10116.0,16435,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9193,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622382,Intermediate
,10116.0,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,9194,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622383,Intermediate
,10116.0,6175,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9195,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875332,Intermediate
,10116.0,6175,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9196,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622384,Intermediate
,10116.0,6175,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9197,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622385,Intermediate
,10116.0,6175,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9198,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622386,Intermediate
,10116.0,10839,The compound was tested for the plasma binding in rat,,9199,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622387,Intermediate
,10116.0,16459,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,9200,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622388,Intermediate
,10116.0,16459,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,9201,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622389,Intermediate
,10116.0,16459,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,9202,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622390,Intermediate
,10116.0,16459,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,9203,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622391,Intermediate
,10116.0,16459,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,9204,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622392,Intermediate
,10116.0,16459,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,9205,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622393,Intermediate
,10116.0,3278,Plasma level at 2 hr after administration of the compound,,9206,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622394,Intermediate
,10116.0,3278,plasma level at 2 hr after administration of the compound,,9207,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622395,Intermediate
,10116.0,4684,Stability in rat serum measured as % recovery at 1 min,,9208,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622396,Intermediate
,10116.0,4684,Stability in rat serum measured as % recovery at 10 min,,9209,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624894,Intermediate
,10116.0,4684,Stability in rat serum measured as % recovery at 10 mins,,9210,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624895,Intermediate
,10116.0,4684,Stability in rat serum measured as % recovery at 2 hr,,9211,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624058,Intermediate
,10116.0,4684,Stability in rat serum measured as % recovery at 3 min,,9212,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624059,Intermediate
,10116.0,4684,Stability in rat serum measured as % recovery at 3 mins,,9213,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624060,Intermediate
,10116.0,4684,Stability in rat serum measured as % recovery at 5 min,,9214,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624061,Intermediate
,10116.0,4684,Stability in rat serum measured as % recovery at 5 mins,,9215,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624062,Intermediate
,10116.0,16456,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,9216,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624063,Intermediate
,10116.0,16456,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,9217,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624064,Intermediate
,10116.0,723,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,9218,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624065,Intermediate
,10116.0,723,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,9219,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624066,Intermediate
,10116.0,5160,Half life tested in mature male rat at a dose of 30 mg/kg,,9220,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877490,Intermediate
,10116.0,4709,Half life after intravenous administration of 1 mg/kg in rat,,9221,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874442,Intermediate
,10116.0,5633,Half life period after administration (30 mg/kg) in rat,,9222,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626890,Intermediate
,10116.0,5302,Half life period in rat after 5 mg/Kg dose,,9223,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626891,Intermediate
,10116.0,5302,Half life period in rat after 5 mg/kg dose,,9224,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626892,Intermediate
,10116.0,17791,Half life period was determined,,9225,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626893,Intermediate
,10116.0,17791,Half life period was evaluated in rat,,9226,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626894,Intermediate
,10116.0,17791,Half life period was evaluated in rat; 0.5-1.0,,9227,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626895,Intermediate
,10116.0,17791,Half life period was evaluated in rat; 5.9-7.5,,9228,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626896,Intermediate
,10116.0,14512,Half-life in rat plasma,,9229,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626897,Intermediate
,10116.0,6230,Half-life time in rat was determined,,9230,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626898,Intermediate
,10116.0,3364,Terminal half-life after iv administration to rats,,9231,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626899,Intermediate
,10116.0,6874,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,9232,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626900,Intermediate
,10116.0,857,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,9233,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626901,Intermediate
,10116.0,858,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,9234,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626902,Intermediate
,10116.0,858,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,9235,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626903,Intermediate
,10116.0,5355,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,9236,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874443,Intermediate
,10116.0,5355,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,9237,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626904,Intermediate
,10116.0,6305,Half life in rats,,9238,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626905,Intermediate
,10116.0,13501,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,9239,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873830,Intermediate
,10116.0,17594,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,9240,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626906,Intermediate
,10116.0,4186,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,9241,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631076,Intermediate
,10116.0,2932,Biological half-life was measured in plasma of rats,,9242,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631077,Intermediate
,10116.0,17065,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,9243,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631078,Intermediate
,10116.0,15765,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,9244,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631079,Intermediate
,10116.0,2713,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,9245,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631080,Intermediate
,10116.0,2661,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,9246,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631081,Intermediate
,10116.0,2661,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,9247,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631239,Intermediate
,10116.0,740,Compound was evaluated for plasma half life in rat,,9248,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631240,Intermediate
,10116.0,6597,AUC value at a dose of 5 mg/kg (p.o.) in rats,,9249,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631241,Intermediate
,10116.0,2959,AUC value after administration of 20 mg/Kg oral dose in rat,,9250,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631242,Intermediate
,10116.0,17594,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,9251,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631243,Intermediate
,10116.0,17596,AUC0-96 after administration at 50 mg/kg,,9252,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874444,Intermediate
,10116.0,17594,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,9253,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631244,Intermediate
,10116.0,3293,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,9254,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631245,Intermediate
,10116.0,6757,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,9255,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627162,Intermediate
,10116.0,6757,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,9256,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627163,Intermediate
,10116.0,6757,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,9257,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627164,Intermediate
,10116.0,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,9258,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627165,Intermediate
,10116.0,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,9259,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627166,Intermediate
,10116.0,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,9260,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627167,Intermediate
,10116.0,4026,Area under curve (AUC) at a dose of 30 mg/kg in rats,,9261,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627822,Intermediate
,10116.0,5355,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,9262,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627823,Intermediate
,10116.0,5355,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,9263,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627824,Intermediate
,10116.0,5355,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,9264,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627825,Intermediate
,10116.0,5633,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,9265,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627826,Intermediate
,10116.0,1716,Area under curve (Pharmacokinetic property) was determined,,9266,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627827,Intermediate
,10116.0,1716,Area under curve (Pharmacokinetic property) of the compound; Not determined,,9267,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627828,Intermediate
,10116.0,4689,Area under curve after intravenous administration (1 mg/kg) in rat,,9268,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627829,Intermediate
,10116.0,4527,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,9269,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627830,Intermediate
,10116.0,4527,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,9270,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627831,Intermediate
,10116.0,15662,Area under curve in male SD rats was observed after oral administration in rat,,9271,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627832,Intermediate
,10116.0,4413,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,9272,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627833,Intermediate
,10116.0,3598,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,9273,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627834,Expert
,10116.0,3598,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,9274,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628004,Expert
,10116.0,5964,Area under curve at 5 mg/kg po was determined in rat,,9275,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628005,Intermediate
,10116.0,4689,Area under curve in Rat at a oral dose of 5 mg/kg,,9276,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628006,Intermediate
,10116.0,4186,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,9277,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628007,Intermediate
,10116.0,5510,Area under curve was determined,,9278,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625676,Intermediate
,10116.0,17858,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,9279,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631309,Intermediate
,10116.0,17804,Area under curve after intravenous administration at 3 mg/kg,,9280,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631310,Intermediate
,10116.0,6106,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,9281,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631311,Intermediate
,10116.0,5964,Area under curve at 4 hr in rat,,9282,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631312,Intermediate
,10116.0,4026,Area under curve at a dose of 30 mg/kg,,9283,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631313,Intermediate
,10116.0,4756,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,9284,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631314,Intermediate
,10116.0,4756,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,9285,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631315,Intermediate
,10116.0,5862,Area under curve for a 2-mpk po dose in SD rats,,9286,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631316,Intermediate
,10116.0,5862,Area under curve in SD rats,,9287,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631317,Intermediate
,10116.0,6644,Area under curve in rat after oral administration at 13 mg/kg dose,,9288,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874471,Intermediate
,10116.0,5871,Area under curve in rat by po administration at 0-24 hr,,9289,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631318,Intermediate
,10116.0,5919,Area under curve in rat plasma,,9290,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631319,Intermediate
,10116.0,5939,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,9291,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631320,Intermediate
,10116.0,5939,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,9292,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631321,Intermediate
,10116.0,10,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,9293,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631322,Intermediate
,10116.0,11149,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,9294,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631323,Intermediate
,10116.0,5302,Area under curve value in rat at a dose of 5 mg/kg,,9295,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631324,Intermediate
,10116.0,17796,Area under curve was determined after oral administration in rats,,9296,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631325,Intermediate
,10116.0,4890,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,9297,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631326,Intermediate
,10116.0,6011,Area under curve was determined after peroral administration in rat,,9298,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631327,Intermediate
,10116.0,5375,Area under curve was determined at a dose 30 mpk administered orally.,,9299,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631328,Intermediate
,10116.0,17764,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,9300,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631329,Intermediate
,10116.0,4368,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,9301,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627217,Intermediate
,10116.0,5610,Area under curve was determined in male rat,,9302,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626352,Intermediate
,10116.0,5833,Area under curve was determined in rat after PO administration,,9303,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626353,Intermediate
,10116.0,4257,Area under curve was determined in rat after a 3 mg/kg of oral dose,,9304,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626354,Intermediate
,10116.0,5937,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,9305,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626355,Intermediate
,10116.0,5932,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,9306,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626356,Intermediate
,10116.0,5932,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,9307,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626357,Intermediate
,10116.0,17411,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9308,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626358,Intermediate
,10116.0,17411,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9309,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626359,Intermediate
,10116.0,17771,Peak plasma concentration in rat at a dose of 3 mg/kg,,9310,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626360,Intermediate
,10116.0,1628,Plasma concentration at 2 hr in rats was evaluated.,,9311,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626361,Intermediate
,10116.0,1628,Plasma concentration at 2 hr in rats was evaluated; Not available,,9312,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626362,Intermediate
,10116.0,17411,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9313,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626363,Intermediate
,10116.0,4910,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,9314,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626970,Intermediate
,10116.0,4910,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,9315,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626971,Intermediate
,10116.0,4910,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,9316,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626972,Intermediate
,10116.0,4910,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,9317,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626973,Intermediate
,10116.0,4910,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,9318,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626974,Intermediate
,10116.0,4910,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,9319,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874592,Intermediate
,10116.0,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,9320,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626975,Intermediate
,10116.0,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,9321,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626976,Intermediate
,10116.0,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,9322,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626977,Intermediate
,10116.0,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,9323,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626978,Intermediate
,10116.0,16427,PK study was carried to determine the relative absorption ranking in rat.,,9324,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626979,Intermediate
,10116.0,4689,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,9325,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626980,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,9326,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626981,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,9327,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626982,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,9328,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626983,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,9329,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622522,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,9330,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622523,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,9331,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622524,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,9332,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622525,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,9333,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622526,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,9334,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619849,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,9335,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL619850,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,9336,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623864,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,9337,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623865,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,9338,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623866,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,9339,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623867,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,9340,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL877615,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,9341,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623868,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,9342,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623869,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,9343,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623870,Intermediate
,10116.0,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,9344,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623871,Intermediate
,10116.0,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9345,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623872,Intermediate
,10116.0,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9346,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622129,Intermediate
,10116.0,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9347,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622130,Intermediate
,10116.0,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9348,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622131,Intermediate
,10116.0,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9349,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622132,Intermediate
,10116.0,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9350,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622133,Intermediate
,10116.0,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9351,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622134,Intermediate
,10116.0,16435,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9352,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622135,Intermediate
,10116.0,16435,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9353,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622136,Intermediate
,10116.0,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9354,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622137,Intermediate
,10116.0,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9355,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622138,Intermediate
,10116.0,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9356,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623017,Intermediate
,10116.0,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9357,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623018,Intermediate
,10116.0,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,9358,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623019,Intermediate
,10116.0,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9359,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623020,Intermediate
,10116.0,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,9360,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623021,Intermediate
,10116.0,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,9361,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623022,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9362,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623023,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9363,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623024,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9364,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623025,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9365,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620545,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9366,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620546,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9367,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620547,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9368,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620548,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9369,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620549,Intermediate
,10116.0,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9370,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620550,Intermediate
,10116.0,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,9371,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620551,Intermediate
,10116.0,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9372,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620552,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9373,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620553,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9374,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620554,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9375,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875845,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9376,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620555,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9377,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620556,Intermediate
,10116.0,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9378,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620557,Intermediate
,10116.0,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9379,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620558,Intermediate
,10116.0,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9380,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620559,Intermediate
,10116.0,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9381,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622939,Intermediate
,10116.0,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9382,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622940,Intermediate
,10116.0,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,9383,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622941,Intermediate
,10116.0,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9384,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622942,Intermediate
,10116.0,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,9385,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622943,Intermediate
,10116.0,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,9386,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622944,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9387,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622945,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9388,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622946,Intermediate
,10116.0,3341,Compound was evaluated for terminal half life in rat,,9389,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622947,Intermediate
,10116.0,3634,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,9390,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622948,Intermediate
,10116.0,3634,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,9391,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622949,Intermediate
,10116.0,4839,Compound was tested for its half life in rat,,9392,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622950,Intermediate
,9544.0,5005,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,9393,22224,Macaca mulatta,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622951,Intermediate
,10116.0,5005,Compound was tested for its plasma half life in Sprague Dawley rats,,9394,22224,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,0,BAO_0000366,U,,CHEMBL622952,Intermediate
,10116.0,5005,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,9395,22224,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,0,BAO_0000366,U,,CHEMBL622953,Intermediate
,10116.0,1094,Compound was tested for plasma half-life period in rat,,9396,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL873818,Intermediate
,10116.0,5031,Elimination half life after i.v. administration of compound in rats,,9397,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622954,Intermediate
,10116.0,6518,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,9398,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622955,Intermediate
,10116.0,6518,Elimination half-life after IV dosing at 1 mg/kg in rat,,9399,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875229,Intermediate
,10116.0,6518,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,9400,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622956,Intermediate
,10116.0,6518,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,9401,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622957,Intermediate
,10116.0,5408,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,9402,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622958,Intermediate
,10116.0,5408,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,9403,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622959,Intermediate
,10116.0,5408,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,9404,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622960,Intermediate
,10116.0,5408,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,9405,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622961,Intermediate
,10116.0,4687,Evaluated for the half life in rat (in vivo),,9406,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622962,Intermediate
,10116.0,6640,Hafl life in rat,,9407,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622963,Intermediate
,10116.0,6640,Hafl life rat,,9408,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622964,Intermediate
,10116.0,6641,Hafl life rat,,9409,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622965,Intermediate
,10116.0,6640,Hafl life rat; Not determined,,9410,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622966,Intermediate
,10116.0,6641,Hafl life rat; Not determined,,9411,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622967,Intermediate
,10116.0,17411,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,9412,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622968,Intermediate
,10116.0,17411,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,9413,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622969,Intermediate
,10116.0,17411,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,9414,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875327,Intermediate
,10116.0,6570,Half life in rat after 1 mg/kg i.v. administration,,9415,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628638,Intermediate
,10116.0,6570,Half life in rat after 2 mg/kg peroral administration,,9416,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628639,Intermediate
,10116.0,17411,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,9417,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625840,Intermediate
,10116.0,4722,Half life of 10 mg/kg oral dose determined in rats,,9418,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625841,Intermediate
,10116.0,5978,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,9419,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625842,Intermediate
,10116.0,5978,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,9420,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625843,Intermediate
,10116.0,5978,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,9421,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625844,Intermediate
,10116.0,5978,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,9422,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873822,Intermediate
,10116.0,5978,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,9423,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625845,Intermediate
,10116.0,5978,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,9424,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627059,Intermediate
,10116.0,5978,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,9425,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627060,Intermediate
,10116.0,5978,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,9426,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627061,Intermediate
,10116.0,4762,Half life of compound at 5 mg/kg after po administration was determined in rat,,9427,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627709,Intermediate
,10116.0,5327,Half life of compound determined after intravenous administration to rat,,9428,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627710,Intermediate
,10116.0,4847,Half life of compound was determined in rat,,9429,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627711,Intermediate
,10116.0,17720,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,9430,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627712,Intermediate
,10116.0,4723,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,9431,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627713,Intermediate
,10116.0,4723,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,9432,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627714,Intermediate
,9541.0,4256,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,9433,22224,Macaca fascicularis,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627889,Intermediate
,10116.0,4256,Half life determined in rat by intravenous administration,,9434,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627890,Intermediate
,10116.0,4722,Half life determined in rats after iv administration,,9435,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627891,Intermediate
,10116.0,6535,Half life in rat plasma after administration of 2 mg/kg iv,,9436,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627892,Intermediate
,10116.0,6535,Half life in rat plasma after administration of 2 mg/kg iv,,9437,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627893,Intermediate
,10116.0,1435,Half life in rat plasma was determined,,9438,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627894,Intermediate
,10116.0,1435,Half life in rat plasma was determined; NA means not applicable,,9439,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627895,Intermediate
,10116.0,5206,Half life in rat was tested,,9440,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627896,Intermediate
,10116.0,6080,Half life measured in rat plasma,,9441,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627897,Intermediate
,10116.0,4449,Half life recorded in rats,,9442,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627898,Intermediate
,10116.0,6057,Half life was calculated,,9443,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627899,Intermediate
,10116.0,6057,Half life was calculated in rat,,9444,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL873823,Intermediate
,10116.0,3747,Half life was determined,,9445,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627900,Intermediate
,10116.0,17858,Half life after 10 mg/kg oral administration in rat,,9446,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627901,Intermediate
,10116.0,16365,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,9447,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627902,Intermediate
,10116.0,16365,Half life after administering orally a dose of 30 mg/kg,,9448,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627903,Intermediate
,10116.0,5031,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,9449,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627904,Intermediate
,10116.0,4722,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,9450,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627905,Intermediate
,10116.0,6078,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,9451,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627906,Intermediate
,10116.0,6078,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,9452,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627907,Intermediate
,10116.0,6078,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,9453,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876783,Intermediate
,10116.0,6078,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,9454,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627908,Intermediate
,10116.0,17065,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,9455,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627909,Intermediate
,10116.0,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,9456,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627910,Intermediate
,10116.0,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,9457,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627911,Intermediate
,10116.0,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,9458,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627912,Intermediate
,10116.0,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,9459,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627913,Intermediate
,10116.0,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,9460,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627914,Intermediate
,10116.0,16423,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,9461,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627915,Intermediate
,10116.0,16423,Area under the curve was evaluated after 20 uM/kg of peroral administration,,9462,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627916,Intermediate
,10116.0,6062,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,9463,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627917,Intermediate
,10116.0,6056,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,9464,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627918,Intermediate
,10116.0,5182,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,9465,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627919,Intermediate
,10116.0,6410,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,9466,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627920,Intermediate
,10116.0,6410,Area under the curve was evaluated at an oral dose of 30 mg/kg,,9467,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627921,Intermediate
,10116.0,4723,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,9468,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627922,Intermediate
,10116.0,4723,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,9469,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876784,Intermediate
,10116.0,4723,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,9470,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627923,Intermediate
,10116.0,4723,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,9471,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626208,Intermediate
,10116.0,4723,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,9472,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626209,Intermediate
,10116.0,4723,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,9473,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626210,Intermediate
,10116.0,2463,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,9474,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627994,Intermediate
,10116.0,4709,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,9475,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627995,Intermediate
,10116.0,4075,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,9476,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627996,Intermediate
,10116.0,5394,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,9477,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627997,Intermediate
,10116.0,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,9478,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627998,Intermediate
,10116.0,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,9479,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628640,Intermediate
,10116.0,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,9480,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628641,Intermediate
,10116.0,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,9481,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628642,Intermediate
,10116.0,17791,Compound was evaluated for area under the curve expressed as (h*ug/ml),,9482,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628643,Intermediate
,10116.0,2591,Compound was tested for area under curve in rat,,9483,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628644,Intermediate
,10116.0,6567,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,9484,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628645,Intermediate
,10116.0,6211,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,9485,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628646,Intermediate
,10116.0,5529,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,9486,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628647,Intermediate
,10116.0,5408,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,9487,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628648,Intermediate
,10116.0,5408,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,9488,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625358,Intermediate
,10116.0,5408,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,9489,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625359,Intermediate
,10116.0,5408,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,9490,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625360,Intermediate
,10116.0,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,9491,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625361,Intermediate
,10116.0,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,9492,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625362,Intermediate
,10116.0,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,9493,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625363,Intermediate
,10116.0,4796,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,9494,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625364,Intermediate
,10116.0,5974,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,9495,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625365,Intermediate
,10116.0,5974,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,9496,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625366,Intermediate
,10116.0,5974,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,9497,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625367,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,9498,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625368,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,9499,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625369,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,9500,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625370,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,9501,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625371,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,9502,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625372,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,9503,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625373,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,9504,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625374,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,9505,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL877593,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,9506,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625375,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,9507,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625376,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,9508,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621973,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,9509,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621974,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,9510,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621975,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,9511,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622166,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,9512,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622167,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,9513,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622168,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,9514,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622169,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,9515,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622170,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,9516,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622171,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,9517,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622172,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,9518,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622173,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,9519,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622174,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,9520,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622175,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,9521,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622176,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,9522,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622177,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,9523,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622178,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,9524,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622179,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,9525,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622180,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9526,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622181,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9527,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622182,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9528,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622183,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9529,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622184,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9530,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622185,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9531,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622186,Intermediate
,10116.0,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9532,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622187,Intermediate
,10116.0,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,9533,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625002,Intermediate
,10116.0,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,9534,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622090,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9535,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622091,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9536,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622092,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9537,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622093,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9538,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622094,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9539,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622095,Intermediate
,10116.0,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9540,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622264,Intermediate
,10116.0,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9541,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622265,Intermediate
,10116.0,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9542,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622266,Intermediate
,10116.0,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9543,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622267,Intermediate
,10116.0,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9544,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622268,Intermediate
,10116.0,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,9545,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622269,Intermediate
,10116.0,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9546,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625071,Intermediate
,10116.0,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,9547,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621621,Intermediate
,10116.0,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,9548,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621622,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9549,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621623,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9550,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621624,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9551,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621625,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9552,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621626,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9553,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621627,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9554,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621628,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9555,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875328,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9556,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621629,Intermediate
,10116.0,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9557,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621630,Intermediate
,10116.0,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,9558,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621631,Intermediate
,10116.0,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9559,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621632,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9560,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621633,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9561,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621634,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9562,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621635,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9563,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621636,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9564,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621637,Intermediate
,10116.0,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9565,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621638,Intermediate
,10116.0,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9566,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618883,Intermediate
,10116.0,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9567,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618884,Intermediate
,10116.0,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9568,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628627,Intermediate
,10116.0,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9569,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628628,Intermediate
,10116.0,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,9570,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628629,Intermediate
,10116.0,16365,Half life after administering orally a dose of 3 mg/kg,,9571,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628630,Intermediate
,10116.0,16365,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,9572,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628631,Intermediate
,10116.0,16365,Half life after administering intravenously a dose of 1 mg/kg,,9573,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628632,Intermediate
,10116.0,526,Half life after oral dosing in rats,,9574,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628633,Intermediate
,10116.0,16365,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,9575,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628634,Intermediate
,10116.0,4368,Half life by intravenous administration of 3.4 mg/kg in rat,,9576,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627789,Intermediate
,10116.0,3371,Half life in rat,,9577,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627790,Intermediate
,10116.0,6448,Half life in rat,,9578,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627791,Intermediate
,10116.0,6453,Half life in rat,,9579,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627792,Intermediate
,10116.0,4353,Half life in rat after intravenous administration of the compound,,9580,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627793,Intermediate
,10116.0,4353,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,9581,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627794,Intermediate
,10116.0,4353,Half life in rat after po administration of the compound,,9582,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627795,Intermediate
,10116.0,4353,Half life in rat after po administration of the compound; ND means Not determined,,9583,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627796,Intermediate
,10116.0,4353,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,9584,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875335,Intermediate
,10116.0,4353,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,9585,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627797,Intermediate
,10116.0,5789,Half life in rat i.v.,,9586,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627798,Intermediate
,10116.0,17686,Half life in rat i.v. at 2 mg/kg concentration,,9587,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627799,Intermediate
,10116.0,6495,Half life in rats,,9588,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627800,Intermediate
,10116.0,484,Half life in rats after intravenous administration,,9589,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627801,Intermediate
,10116.0,6467,Half life in rats at the dose of 1.0 mpk by i.v. administration,,9590,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627802,Intermediate
,10116.0,6642,Half life in rat,,9591,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627803,Expert
,10116.0,16367,Half life was evaluated after intravenous administration to rats,,9592,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873820,Intermediate
,10116.0,1369,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,9593,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627804,Intermediate
,10116.0,5472,Half life was evaluated in rat,,9594,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627805,Intermediate
,10116.0,6049,Half life was evaluated in rat,,9595,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627806,Intermediate
,10116.0,5472,Half life was evaluated in rat; Not tested,,9596,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627107,Intermediate
,10116.0,16366,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,9597,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627108,Intermediate
,10116.0,11149,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,9598,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627109,Intermediate
,10116.0,11149,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,9599,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627110,Intermediate
,9443.0,2891,Half life was measured in monkey at dose of 10 mg/kg by po administration,,9600,22224,Primates,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627111,Intermediate
,9443.0,2891,Half life was measured in monkey at dose of 10 mg/kg by po administration,,9601,22224,Primates,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627112,Intermediate
,10116.0,2891,Half life was measured in rat at dose of 30 mg/kg by iv administration,,9602,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627113,Intermediate
,10116.0,2891,Half life was measured in rat at dose of 30 mg/kg by po administration,,9603,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627114,Intermediate
,10116.0,4026,Half life (t1/2) was determined,,9604,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627115,Intermediate
,10116.0,4527,Half life period at a dose of 10 uM/kg in rat was determined,,9605,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627116,Intermediate
,10116.0,4527,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,9606,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627117,Intermediate
,10116.0,5503,Half life period was determined,,9607,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627118,Intermediate
,10116.0,4426,Half life period after intravenous administration at 20 mpk in rats,,9608,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627119,Intermediate
,10116.0,4426,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,9609,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627120,Intermediate
,10116.0,6109,Half life period after intravenous administration in rat,,9610,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626922,Intermediate
,10116.0,5654,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,9611,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626923,Intermediate
,10116.0,5654,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,9612,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626924,Intermediate
,10116.0,4755,Half life period in 80% rat plasma at 37 degree Centigrade,,9613,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626925,Intermediate
,10116.0,5862,Half life period in SD rats,,9614,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626926,Intermediate
,10116.0,1515,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,9615,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626927,Intermediate
,10116.0,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,9616,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626928,Intermediate
,10116.0,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,9617,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626929,Intermediate
,10116.0,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,9618,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626930,Intermediate
,10116.0,5960,Half life period in rat,,9619,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626931,Intermediate
,10116.0,6103,Half life period in rat,,9620,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626932,Intermediate
,10116.0,6317,Half life period in rat,,9621,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626933,Intermediate
,10116.0,6644,Half life period in rat after oral administration at 10.5 mg/kg dose,,9622,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873826,Intermediate
,10116.0,6644,Half life period in rat after oral administration at 11.2 mg/kg dose,,9623,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626934,Intermediate
,10116.0,6644,Half life period in rat after oral administration at 13 mg/kg dose,,9624,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626935,Intermediate
,10116.0,6644,Half life period in rat after oral administration at 9.7 mg/kg dose,,9625,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626936,Intermediate
,10116.0,5974,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,9626,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626937,Intermediate
,10116.0,6295,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,9627,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625906,Intermediate
,10116.0,6296,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,9628,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625907,Intermediate
,10116.0,16427,PK study was carried to determine AUC (area under curve) value in rat,,9629,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625908,Intermediate
,10116.0,16367,Pharmacokinetic parameter AUC after intravenous administration to rats,,9630,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625909,Intermediate
,10116.0,16367,Pharmacokinetic parameter AUC after oral administration to rats,,9631,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625910,Intermediate
,10116.0,16365,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,9632,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625911,Intermediate
,10116.0,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,9633,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625912,Intermediate
,10116.0,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,9634,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626538,Intermediate
,10116.0,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,9635,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876794,Intermediate
,10116.0,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,9636,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626539,Intermediate
,10116.0,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,9637,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626540,Intermediate
,10116.0,5394,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,9638,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626541,Intermediate
,10116.0,5394,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,9639,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626542,Intermediate
,10116.0,2792,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,9640,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626543,Intermediate
,10116.0,2792,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,9641,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626544,Intermediate
,10116.0,2792,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,9642,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626545,Intermediate
,10116.0,2792,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,9643,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626546,Intermediate
,10116.0,5334,Pharmacokinetic parameter area under curve was reported,,9644,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626547,Intermediate
,10116.0,4408,Pharmacokinetic property (AUC) in rat,,9645,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626548,Intermediate
,10116.0,5983,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,9646,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626549,Intermediate
,10116.0,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,9647,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626550,Intermediate
,10116.0,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,9648,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626551,Intermediate
,10116.0,5491,Pharmacokinetic property was determined,,9649,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623777,Intermediate
,10116.0,5491,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,9650,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623778,Intermediate
,10116.0,5491,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,9651,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623779,Intermediate
,10116.0,4199,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,9652,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623780,Intermediate
,10116.0,4199,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,9653,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622015,Intermediate
,10116.0,4199,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,9654,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622016,Intermediate
,10116.0,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,9655,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622017,Intermediate
,10116.0,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,9656,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622018,Intermediate
,10116.0,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,9657,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622019,Intermediate
,10116.0,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,9658,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622020,Intermediate
,10116.0,16366,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,9659,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622021,Intermediate
,10116.0,16366,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,9660,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622022,Intermediate
,10116.0,5327,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,9661,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622023,Intermediate
,10116.0,6681,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,9662,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622024,Intermediate
,10116.0,12873,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,9663,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622693,Intermediate
,10116.0,12873,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,9664,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622694,Intermediate
,10116.0,6685,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,9665,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622695,Intermediate
,10116.0,6685,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,9666,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622696,Intermediate
,10116.0,6685,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,9667,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622697,Intermediate
,10116.0,6619,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,9668,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622874,Intermediate
,10116.0,6619,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,9669,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622875,Intermediate
,10116.0,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,9670,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622876,Intermediate
,10116.0,4796,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,9671,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622877,Intermediate
,10116.0,4910,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,9672,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622878,Intermediate
,10116.0,4910,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,9673,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622879,Intermediate
,10116.0,4839,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,9674,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877602,Intermediate
,10116.0,15078,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,9675,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622880,Intermediate
,10116.0,15078,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,9676,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622881,Intermediate
,10116.0,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,9677,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622882,Intermediate
,10116.0,15078,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,9678,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622883,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,9679,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622884,Intermediate
,10116.0,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,9680,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622885,Intermediate
,10116.0,8151,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,9681,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622886,Intermediate
,10116.0,8151,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,9682,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622887,Intermediate
,10116.0,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,9683,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622888,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9684,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622889,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9685,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622890,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9686,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622891,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9687,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877603,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9688,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622892,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9689,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622893,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9690,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622894,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9691,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622895,Intermediate
,10116.0,8677,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,9692,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622896,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9693,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622897,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9694,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622898,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9695,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622899,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9696,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622900,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9697,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624114,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9698,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624115,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9699,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624116,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9700,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624117,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9701,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624118,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9702,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624119,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9703,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624120,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9704,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624121,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9705,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624122,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9706,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624123,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9707,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624124,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9708,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624125,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9709,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624126,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9710,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624127,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9711,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624128,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9712,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624129,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9713,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624130,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9714,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622340,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9715,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622341,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9716,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622342,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9717,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622343,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9718,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622344,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9719,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622345,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9720,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622346,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9721,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622347,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9722,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622348,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9723,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622349,Intermediate
,10116.0,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9724,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622350,Intermediate
,10116.0,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,9725,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622351,Intermediate
,10116.0,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,9726,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622352,Intermediate
,10116.0,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9727,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622353,Intermediate
,10116.0,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9728,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622354,Intermediate
,10116.0,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9729,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622355,Intermediate
,10116.0,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9730,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622356,Intermediate
,10116.0,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9731,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622357,Intermediate
,10116.0,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9732,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622358,Intermediate
,10116.0,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9733,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622359,Intermediate
,10116.0,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9734,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874393,Intermediate
,10116.0,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9735,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622872,Intermediate
,10116.0,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,9736,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622873,Intermediate
,10116.0,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9737,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623047,Intermediate
,10116.0,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9738,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623048,Intermediate
,10116.0,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9739,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623049,Intermediate
,10116.0,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9740,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623050,Intermediate
,10116.0,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9741,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623051,Intermediate
,10116.0,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9742,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623052,Intermediate
,10116.0,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9743,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626343,Intermediate
,10116.0,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9744,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626344,Intermediate
,10116.0,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9745,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626345,Intermediate
,10116.0,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9746,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626346,Intermediate
,10116.0,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9747,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626347,Intermediate
,10116.0,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,9748,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626348,Intermediate
,10116.0,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9749,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626349,Intermediate
,10116.0,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9750,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL626350,Intermediate
,10116.0,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9751,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626351,Intermediate
,10116.0,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9752,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627650,Intermediate
,10116.0,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9753,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL627651,Intermediate
,10116.0,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9754,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627652,Intermediate
,10116.0,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9755,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627653,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,9756,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627654,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,9757,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627835,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,9758,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627836,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,9759,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627837,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,9760,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627838,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,9761,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875338,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,9762,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627839,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,9763,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627840,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,9764,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627841,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,9765,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627842,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,9766,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627843,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,9767,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627844,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,9768,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627845,Intermediate
,10116.0,5874,Half life period in rat by iv administration at a dose of 3 mg/kg,,9769,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627846,Intermediate
,10116.0,1515,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,9770,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627847,Intermediate
,10116.0,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,9771,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL873821,Intermediate
,10116.0,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,9772,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626079,Intermediate
,10116.0,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,9773,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626080,Intermediate
,10116.0,5491,Half life period was evaluated in rat plasma,,9774,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626081,Intermediate
,10116.0,5491,Half life period was evaluated in rat plasma; Not tested,,9775,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875344,Intermediate
,10116.0,1918,Half life period was evaluated in rats,,9776,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626082,Intermediate
,10116.0,1918,"Half life period was evaluated in rats, iv",,9777,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626250,Intermediate
,10116.0,6113,Half life period after intravenous administration at 5 mg/kg in rat,,9778,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626251,Intermediate
,10116.0,5546,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,9779,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626252,Intermediate
,10116.0,5553,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,9780,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626253,Intermediate
,10116.0,4188,Half life stability of compound was evaluated in rat plasma,,9781,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626254,Intermediate
,10116.0,6215,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,9782,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626255,Intermediate
,10116.0,6141,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,9783,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626256,Intermediate
,10116.0,5182,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,9784,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626257,Intermediate
,10116.0,5182,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,9785,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626258,Intermediate
,10116.0,5710,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,9786,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626259,Intermediate
,10116.0,5789,Half in rat i.v.,,9787,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626260,Intermediate
,10116.0,6011,Half period in rat after intravenous administration,,9788,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875345,Intermediate
,10116.0,17594,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,9789,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626261,Intermediate
,10116.0,12357,Half-life measured in in vitro Cathepsin B assay in rat liver,,9790,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL626262,Intermediate
,10116.0,5210,Half-life of compound was determined in rats,,9791,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626263,Intermediate
,10116.0,17596,Half-life at 10 mg/kg in rat upon intravenous administration,,9792,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625270,Intermediate
,10116.0,6672,Half-life determined in rat,,9793,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625271,Intermediate
,10116.0,6673,Half-life determined in rat,,9794,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625272,Intermediate
,10116.0,4910,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,9795,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625273,Intermediate
,10116.0,3741,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,9796,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625274,Intermediate
,10116.0,17671,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,9797,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625275,Intermediate
,10116.0,4910,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,9798,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625276,Intermediate
,10116.0,17537,Half-life in rat plasma,,9799,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625277,Intermediate
,10116.0,4965,Half-life in rat plasma was determined,,9800,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625278,Intermediate
,10116.0,17537,Half-life in rat plasma; Not tested,,9801,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625279,Intermediate
,10116.0,6124,Half-life in rat serum,,9802,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625280,Intermediate
,10116.0,6124,Half-life in rat serum; na is not available,,9803,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876797,Intermediate
,10116.0,6078,Half-life was calculated in rat,,9804,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625281,Intermediate
,10116.0,17668,Half-life was calculated in rat plasma,,9805,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL873827,Intermediate
,10116.0,3185,Half-life was determined,,9806,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625282,Intermediate
,10116.0,4883,Half-life was determined,,9807,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625283,Intermediate
,10116.0,2959,Half-life after administration of 20 mg/Kg oral dose in rat,,9808,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625284,Intermediate
,10116.0,4029,Half-life after administration of 3.2 mg/kg intravenously in male rat,,9809,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625285,Intermediate
,10116.0,4029,Half-life after intravenous administration in female rat,,9810,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625286,Intermediate
,10116.0,4029,Half-life after intravenous administration in male rat,,9811,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625287,Intermediate
,10116.0,6180,Half-life after intravenous dose in rat,,9812,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625288,Intermediate
,10116.0,1557,Half-life in a rat liver homogenate preparation,,9813,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625289,Intermediate
,10116.0,12500,Half-life in plasma of rat,,9814,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625290,Intermediate
,10116.0,12500,Half-life in plasma of rat at dose of 3-10 mgkg,,9815,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876798,Intermediate
,10116.0,5064,Half-life in rat,,9816,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625291,Intermediate
,10116.0,5145,Half-life in rat,,9817,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625292,Intermediate
,10116.0,5147,Half-life in rat,,9818,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625293,Intermediate
,10116.0,5833,Half-life in rat,,9819,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622832,Intermediate
,10116.0,6596,Half-life in rat,,9820,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622833,Intermediate
,10116.0,17655,Half-life in rat,,9821,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622834,Intermediate
,10116.0,6495,Half-life in rat after oral administration at 10 mg/kg,,9822,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622835,Intermediate
,10116.0,17538,Half-life in rat after po administration at a dose of 10 mg/kg,,9823,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622836,Intermediate
,10116.0,17538,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,9824,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622837,Intermediate
,10116.0,10,Half-life in rat at 3 mg/kg dose administered intravenously,,9825,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622838,Intermediate
,10116.0,17669,Half-life in rat brain homogenate,,9826,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622839,Intermediate
,10116.0,17065,Half-life in rat plasma,,9827,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622840,Intermediate
,10116.0,4333,Half-life in rats,,9828,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622841,Intermediate
,10116.0,6827,Half-life in Dawley rats,,9829,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622842,Intermediate
,10116.0,889,Half-life in vitro in rat plasma,,9830,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL622843,Intermediate
,10116.0,889,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,9831,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL622844,Intermediate
,10116.0,3747,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,9832,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622845,Intermediate
,10116.0,15022,The area under the curve of compound was measured at the dose of 100 umol/kg,,9833,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622846,Intermediate
,10116.0,15022,The area under the curve of compound was measured at the dose of 300 umol/kg,,9834,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622847,Intermediate
,10116.0,15022,The area under the curve of compound was measured at the dose of 30 umol/kg,,9835,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622848,Intermediate
,10116.0,3360,Bioavailability as oral AUC in rats,,9836,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622849,Intermediate
,10116.0,5334,The plasma concentration versus time curve (AUC) was determined,,9837,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622850,Intermediate
,10116.0,17411,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9838,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876807,Intermediate
,10116.0,17411,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9839,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622851,Intermediate
,10116.0,17411,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9840,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622852,Intermediate
,10116.0,6570,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,9841,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622853,Intermediate
,10116.0,6570,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,9842,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622854,Intermediate
,10116.0,17411,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9843,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622855,Intermediate
,10116.0,14941,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,9844,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622856,Intermediate
,10116.0,14941,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,9845,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622857,Intermediate
,10116.0,17538,AUC in rat after po administration at a dose of 10 mg/kg,,9846,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622858,Intermediate
,10116.0,17752,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,9847,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622859,Intermediate
,10116.0,17509,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,9848,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622860,Intermediate
,10116.0,17509,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,9849,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622861,Intermediate
,10116.0,17509,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,9850,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622862,Intermediate
,10116.0,17509,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,9851,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622863,Intermediate
,10116.0,17509,Area under curve value 6 hr after po administration in rat,,9852,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623817,Intermediate
,10116.0,17717,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,9853,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623818,Intermediate
,10116.0,17717,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,9854,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623819,Intermediate
,10116.0,17717,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,9855,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623820,Intermediate
,10116.0,17717,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,9856,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623821,Intermediate
,10116.0,6642,AUC normalized for dose (AUCN) in rat,,9857,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623822,Intermediate
,10116.0,6640,Area under curve in rat after p.o. administration,,9858,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623823,Intermediate
,10116.0,6641,Area under curve in rat after p.o. administration,,9859,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623824,Intermediate
,10116.0,6641,Area under curve in rat after p.o. administration; Not determined,,9860,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623825,Intermediate
,10116.0,6641,Area under curve in rat after peroral administration,,9861,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622070,Intermediate
,10116.0,3603,Area under curve (carotid artery) value of the compound,,9862,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622071,Intermediate
,10116.0,3550,Bioavailability expressed as the area under curve of rat carotid artery,,9863,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622072,Intermediate
,10116.0,15662,Area under curve in male SD rats was observed after intravenous administration in rat,,9864,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622073,Intermediate
,10116.0,17720,Area under curve of the compound was determined,,9865,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622074,Intermediate
,10116.0,5407,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,9866,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622075,Intermediate
,10116.0,17752,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,9867,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622076,Intermediate
,10116.0,17752,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,9868,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622077,Intermediate
,10116.0,3603,Area under curve (portal vein) value of the compound,,9869,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622078,Intermediate
,10116.0,3550,Bioavailability expressed as the area under curve of rat portal vein,,9870,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622079,Intermediate
,10116.0,17655,Area Under plasma concentration time curve in rat upon peroral administration,,9871,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622080,Intermediate
,10116.0,17582,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,9872,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877612,Intermediate
,10116.0,17582,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,9873,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622081,Intermediate
,10116.0,17791,Compound was evaluated for oral bioavailability in rats,,9874,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622082,Intermediate
,10116.0,17791,Compound was evaluated for oral bioavailability in rats after iv administration,,9875,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622083,Intermediate
,10116.0,17791,Compound was evaluated for oral bioavailability in rats; 30-80,,9876,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622084,Intermediate
,10116.0,17791,Compound was evaluated for oral bioavailability in rats; 50-60,,9877,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622085,Intermediate
,10116.0,17791,Compound was evaluated for oral bioavailability in rats; no data,,9878,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622086,Intermediate
,10116.0,17791,Compound was evaluated for oral bioavailability in rats; peptide,,9879,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622087,Intermediate
,10116.0,7768,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,9880,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622088,Intermediate
,10116.0,7768,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,9881,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622089,Intermediate
,10116.0,7768,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,9882,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623685,Intermediate
,10116.0,7768,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,9883,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623686,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9884,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623687,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9885,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623688,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9886,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623689,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9887,50597,Rattus norvegicus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622485,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9888,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622486,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9889,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877613,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9890,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622487,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9891,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622488,Intermediate
,10116.0,8677,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9892,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622489,Intermediate
,10116.0,6899,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,9893,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622490,Intermediate
,10116.0,6899,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,9894,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622491,Intermediate
,10116.0,6899,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,9895,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622492,Intermediate
,10116.0,6899,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,9896,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622493,Intermediate
,10116.0,6899,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,9897,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622494,Intermediate
,10116.0,8677,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9898,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622495,Intermediate
,10116.0,6899,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,9899,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622496,Intermediate
,10116.0,6899,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,9900,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622497,Intermediate
,10116.0,2189,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,9901,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622498,Intermediate
,10116.0,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,9902,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624918,Intermediate
,10116.0,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,9903,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624919,Intermediate
,10116.0,10839,Biodistribution of compound in rat blood after 5 min of administration,,9904,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624920,Intermediate
,10116.0,10839,Biodistribution of compound in rat blood after 5 min of administration.,,9905,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624921,Intermediate
,10116.0,10839,Biodistribution of compound in rat brain after 5 min of administration,,9906,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624922,Intermediate
,10116.0,10839,Biodistribution of compound in rat heart after 5 min of administration,,9907,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624923,Intermediate
,10116.0,10839,Biodistribution of compound in rat heart after 5 min of administration.,,9908,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624924,Intermediate
,10116.0,10839,Biodistribution of compound in rat kidney after 5 min of administration,,9909,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624925,Intermediate
,10116.0,10839,Biodistribution of compound in rat kidney after 5 min of administration.,,9910,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624926,Intermediate
,10116.0,10839,Biodistribution of compound in rat liver after 5 min of administration,,9911,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624927,Intermediate
,10116.0,10839,Biodistribution of compound in rat liver after 5 min of administration.,,9912,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874402,Intermediate
,10116.0,10839,Biodistribution of compound in rat lung after 5 min of administration,,9913,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624928,Intermediate
,10116.0,10839,Biodistribution of compound in rat lung after 5 min of administration.,,9914,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624929,Intermediate
,10116.0,10839,Biodistribution of compound in rat muscle after 5 min of administration,,9915,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624930,Intermediate
,10116.0,10839,Biodistribution of compound in rat muscle after 5 min of administration.,,9916,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624931,Intermediate
,10116.0,4043,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9917,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624932,Intermediate
,10116.0,4043,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9918,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624933,Intermediate
,10116.0,4043,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9919,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624934,Intermediate
,10116.0,4043,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9920,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624935,Intermediate
,10116.0,4043,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9921,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624936,Intermediate
,10116.0,4043,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9922,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624937,Intermediate
,10116.0,4043,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9923,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624938,Intermediate
,10116.0,4043,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9924,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624939,Intermediate
,10116.0,4043,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9925,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624940,Intermediate
,10116.0,4043,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9926,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874403,Intermediate
,10116.0,1446,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,9927,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624941,Intermediate
,10116.0,9971,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,9928,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624942,Intermediate
,10116.0,9971,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,9929,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624943,Intermediate
,10116.0,5765,% Bioavailability after 1 day of the drug administration in rats,,9930,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624944,Intermediate
,10116.0,5765,% Bioavailability after 4 day of the drug administration in rats,,9931,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624945,Intermediate
,10116.0,4257,Absolute bioavailability was evaluated in rat,,9932,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624946,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,9933,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624947,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,9934,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624948,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,9935,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624949,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,9936,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622025,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,9937,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622026,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,9938,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622027,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,9939,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622028,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,9940,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622029,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,9941,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622208,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,9942,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622209,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,9943,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622210,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,9944,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622211,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,9945,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622212,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,9946,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622213,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,9947,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874404,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,9948,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620452,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,9949,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620453,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,9950,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL620454,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,9951,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624067,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,9952,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624068,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,9953,50597,Rattus norvegicus,,,Female gonad,992.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624069,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,9954,50597,Rattus norvegicus,,,Female gonad,992.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624070,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,9955,50597,Rattus norvegicus,,,Female gonad,992.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624071,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,9956,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624072,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,9957,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624073,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,9958,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624788,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,9959,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624789,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,9960,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624790,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,9961,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624791,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,9962,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624792,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,9963,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624793,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,9964,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL877491,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,9965,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624957,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,9966,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624958,Intermediate
,10116.0,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,9967,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624959,Intermediate
,10116.0,11977,Dissociation constant was determined,,9968,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624960,Intermediate
,10116.0,14941,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,9969,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624961,Intermediate
,10116.0,15078,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,9970,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624962,Intermediate
,10116.0,15078,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,9971,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624963,Intermediate
,10116.0,4755,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,9972,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624964,Intermediate
,10116.0,589,LogP value was evaluated in the in situ rat gut perfusion assay,,9973,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624965,Intermediate
,10116.0,17582,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,9974,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624966,Intermediate
,10116.0,5031,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,9975,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624967,Intermediate
,10116.0,17764,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,9976,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624968,Intermediate
,10116.0,17720,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,9977,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624969,Intermediate
,10116.0,2862,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,9978,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL624970,Expert
,10116.0,16423,Half-life was evaluated after 10 uM/kg of intra arterial administration,,9979,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624971,Intermediate
,10116.0,16423,Half-life was evaluated after 20 uM/kg of peroral administration,,9980,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624972,Intermediate
,10116.0,6005,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,9981,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624973,Intermediate
,10116.0,2938,Half-life was evaluated in plasma of rat,,9982,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624974,Intermediate
,10116.0,6410,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,9983,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624975,Intermediate
,10116.0,6410,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,9984,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877492,Intermediate
,10116.0,6062,Half-life was measured in rat after an iv dose of 1 mg/kg,,9985,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624976,Intermediate
,10116.0,6571,Half-life period of compound in rats after peroral administration,,9986,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624977,Intermediate
,10116.0,3136,Half-life period of compound was measured in rat plasma.,,9987,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626848,Intermediate
,10116.0,3136,Half-life period of compound was measured in rat plasma; ND is not determined,,9988,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626849,Intermediate
,10116.0,3136,Half-life period of compound was measured in rat plasma; not determined,,9989,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626850,Intermediate
,10116.0,4521,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,9990,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626851,Intermediate
,10116.0,5871,Half-life period in rat by iv administration,,9991,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626852,Intermediate
,10116.0,6077,Half-life period in rats following intravenous administration at 2 mg/kg,,9992,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626853,Intermediate
,10116.0,6679,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,9993,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626854,Intermediate
,10116.0,5144,Half-life period was determined for the compound in rat,,9994,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627486,Intermediate
,10116.0,4498,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,9995,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627487,Intermediate
,10116.0,4498,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,9996,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627488,Intermediate
,10116.0,1908,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,9997,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627489,Intermediate
,10116.0,6211,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,9998,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627490,Intermediate
,10116.0,5529,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,9999,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873829,Intermediate
,10116.0,6444,Half-life was determined in rat at a dose of 1 mpk i.v.,,10000,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627655,Intermediate
,10116.0,6444,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,10001,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625994,Intermediate
,10116.0,6444,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,10002,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625995,Intermediate
,10116.0,5207,Half-life in rat,,10003,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625996,Intermediate
,10116.0,530,In vitro half life in rat plasma,,10004,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL625850,Intermediate
,10116.0,1116,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,10005,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL625851,Intermediate
,10116.0,3219,In vitro half life in rat,,10006,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL625852,Intermediate
,10116.0,6109,In vivo half life period after intravenous administration in rat,,10007,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625853,Intermediate
,10116.0,17582,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,10008,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625854,Intermediate
,10116.0,17582,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,10009,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874450,Intermediate
,10116.0,5974,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,10010,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625855,Intermediate
,10116.0,5974,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,10011,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625856,Intermediate
,10116.0,5974,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,10012,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625857,Intermediate
,10116.0,5974,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,10013,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873831,Intermediate
,10116.0,17853,Longer half-life in rat (i.v.) at 0.5 mpk,,10014,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625858,Intermediate
,10116.0,17853,Longer half-life in rat (p.o.) at 2.0 mpk,,10015,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625859,Intermediate
,10116.0,3457,Pharmacokinetic property (half life) in rat,,10016,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625860,Intermediate
,10116.0,2792,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,10017,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625861,Intermediate
,10116.0,2792,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,10018,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625862,Intermediate
,10116.0,2792,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,10019,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625863,Intermediate
,10116.0,2792,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,10020,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625864,Intermediate
,10116.0,5739,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,10021,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625865,Intermediate
,10116.0,15765,Pharmacokinetic half time was determined intravenously in rats.,,10022,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625866,Intermediate
,10116.0,6567,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,10023,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625867,Intermediate
,10116.0,2448,Plasma half life of hydrolysis of the compound,,10024,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625868,Intermediate
,10116.0,5423,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,10025,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625869,Intermediate
,10116.0,4853,Plasma half life period was calculated in rat,,10026,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874451,Intermediate
,10116.0,4514,Plasma half-life in Sprague-Dawley rats,,10027,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625870,Intermediate
,10116.0,4514,Plasma half-life in Sprague-Dawley rats; Not determined,,10028,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625871,Intermediate
,10116.0,1500,Plasma half-life in rats,,10029,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625872,Intermediate
,10116.0,1500,Plasma half-life in rats; <MQL,,10030,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625873,Intermediate
,10116.0,5334,Plasma half-life period (0-8 h) was determined,,10031,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625874,Intermediate
,10116.0,5334,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,10032,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625875,Intermediate
,10116.0,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,10033,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625876,Intermediate
,10116.0,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,10034,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631258,Intermediate
,10116.0,4956,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,10035,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631259,Intermediate
,10116.0,4956,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,10036,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631260,Intermediate
,10116.0,7768,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,10037,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631261,Intermediate
,10116.0,7768,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,10038,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631262,Intermediate
,10116.0,7768,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,10039,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631263,Intermediate
,10116.0,7768,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,10040,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631264,Intermediate
,10116.0,7768,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,10041,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631265,Intermediate
,10116.0,7768,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,10042,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631266,Intermediate
,10116.0,7768,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,10043,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631267,Intermediate
,10116.0,7768,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,10044,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631268,Intermediate
,10116.0,7768,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,10045,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631269,Intermediate
,10116.0,7768,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,10046,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631270,Intermediate
,10116.0,7768,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,10047,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631271,Intermediate
,10116.0,7768,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,10048,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631272,Intermediate
,10116.0,7768,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,10049,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631273,Intermediate
,10116.0,7768,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,10050,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631274,Intermediate
,10116.0,7768,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,10051,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631275,Intermediate
,10116.0,7768,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,10052,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626984,Intermediate
,10116.0,7768,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,10053,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626985,Intermediate
,10116.0,7768,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,10054,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626986,Intermediate
,10116.0,7768,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,10055,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626987,Intermediate
,10116.0,7768,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,10056,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626988,Intermediate
,10116.0,7768,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,10057,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626989,Intermediate
,10116.0,7768,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,10058,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626990,Intermediate
,10116.0,7768,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,10059,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626991,Intermediate
,10116.0,7768,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,10060,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626992,Intermediate
,10116.0,7768,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,10061,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626993,Intermediate
,10116.0,7768,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,10062,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874593,Intermediate
,10116.0,7768,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,10063,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626994,Intermediate
,10116.0,7768,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,10064,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626995,Intermediate
,10116.0,7768,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,10065,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626190,Intermediate
,10116.0,7768,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,10066,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626191,Intermediate
,10116.0,7768,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,10067,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626364,Intermediate
,10116.0,7768,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,10068,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626365,Intermediate
,10116.0,7768,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,10069,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626366,Intermediate
,10116.0,7768,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,10070,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626367,Intermediate
,10116.0,7768,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,10071,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626368,Intermediate
,10116.0,7768,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,10072,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626369,Intermediate
,10116.0,7768,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,10073,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626370,Intermediate
,10116.0,4498,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,10074,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626371,Intermediate
,10116.0,4498,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,10075,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626372,Intermediate
,10116.0,3603,Bioavailability after a dose of 10 mg/kg p.o.,,10076,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626373,Intermediate
,10116.0,6215,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,10077,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626374,Intermediate
,10116.0,5710,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,10078,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626375,Intermediate
,10116.0,5710,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,10079,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626376,Intermediate
,10116.0,5676,Bioavailability in rat po was determined,,10080,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626377,Intermediate
,10116.0,17667,Bioavailability of compound at 10 mg/kg in rat after oral administration,,10081,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626378,Intermediate
,10116.0,17667,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,10082,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626379,Intermediate
,10116.0,6848,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,10083,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626380,Intermediate
,10116.0,6848,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,10084,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626381,Intermediate
,10116.0,17267,Bioavailability in rat,,10085,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626382,Intermediate
,10116.0,6362,Bioavailability in rat (Sprague-Dawley) (female),,10086,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626383,Intermediate
,10116.0,17671,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,10087,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874652,Intermediate
,10116.0,17671,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,10088,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626384,Intermediate
,10116.0,4333,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,10089,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626385,Intermediate
,10116.0,6077,Bioavailability in rat at an oral dose of 2 mg/kg,,10090,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626386,Intermediate
,10116.0,3278,Bioavailability in rat,,10091,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626387,Intermediate
,10116.0,5964,Bioavailability in rat,,10092,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626388,Intermediate
,10116.0,4884,Bioavailability in rat,,10093,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626389,Intermediate
,10116.0,4905,Bioavailability in rat,,10094,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626390,Intermediate
,10116.0,4884,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,10095,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626391,Intermediate
,10116.0,6850,Bioavailability in rat,,10096,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626392,Intermediate
,10116.0,2864,Oral bioavailability in rat,,10097,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626393,Intermediate
,10116.0,5780,Bioavailability was determined in rat,,10098,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623026,Intermediate
,10116.0,1465,Bioavailability,,10099,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623027,Intermediate
,10116.0,5199,Bioavailability,,10100,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623028,Intermediate
,10116.0,5765,Bioavailability in rat after 1 day dosing,,10101,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623029,Intermediate
,10116.0,5765,Bioavailability in rat after 4 day dosing,,10102,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623030,Intermediate
,10116.0,6518,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,10103,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623031,Intermediate
,10116.0,6518,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,10104,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623032,Intermediate
,10116.0,6518,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,10105,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623033,Intermediate
,10116.0,6518,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,10106,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623034,Intermediate
,10116.0,2083,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,10107,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623035,Intermediate
,10116.0,17260,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,10108,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623036,Intermediate
,10116.0,4956,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,10109,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623037,Intermediate
,10116.0,4368,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,10110,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623038,Intermediate
,10116.0,17752,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,10111,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874385,Intermediate
,10116.0,1446,Bioavailability in rat (Fisher) (fasted),,10112,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623039,Intermediate
,9443.0,2891,Bioavailability in monkey after po administration of 10 mg/kg dose,,10113,22224,Primates,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623040,Intermediate
,9443.0,2891,Oral bioavailability in monkey (dose 10 mg/kg),,10114,22224,Primates,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623041,Intermediate
,10116.0,6672,Bioavailability in rat,,10115,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623741,Intermediate
,10116.0,6673,Bioavailability in rat,,10116,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623742,Intermediate
,10116.0,17655,Bioavailability in rat,,10117,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623743,Intermediate
,10116.0,17796,Bioavailability in rat,,10118,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623744,Intermediate
,10116.0,17853,Bioavailability in rat (dose 2.0 mg/kg p.o.),,10119,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623745,Intermediate
,10116.0,4521,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,10120,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623746,Intermediate
,10116.0,4940,Oral bioavailability in rat (dose 5 mg/kg p.o.),,10121,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623747,Intermediate
,10116.0,2891,Bioavailability in rat after po administration of 30 mg/kg dose,,10122,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623748,Intermediate
,10116.0,2891,Bioavailability in rat after po administration of 30 mg/kg dose,,10123,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623916,Intermediate
,10116.0,4521,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,10124,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623917,Intermediate
,10116.0,17686,Bioavailability in rat (dose 2 mg/kg i.v.),,10125,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623918,Intermediate
,10116.0,17796,Bioavailability in rat,,10126,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874386,Intermediate
,10116.0,17796,Bioavailability in rat; Only traces detected in rat plasma,,10127,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623919,Intermediate
,10116.0,5064,Bioavailability in rat,,10128,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623920,Intermediate
,10116.0,5147,Bioavailability upon oral administration of compound,,10129,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623148,Intermediate
,10116.0,1916,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,10130,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623149,Intermediate
,10116.0,6049,Bioavailability in rat,,10131,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623150,Intermediate
,10116.0,1445,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,10132,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623151,Intermediate
,10116.0,1445,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,10133,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623152,Intermediate
,10116.0,2862,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,10134,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL623153,Expert
,10116.0,2862,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,10135,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL623154,Expert
,10116.0,4194,In vitro and metabolic stability was determined,,10136,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623155,Intermediate
,10116.0,4194,In vitro metabolic stability in rat hepatocytes,,10137,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623156,Intermediate
,10116.0,5486,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,10138,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623157,Intermediate
,10116.0,17582,Metabolic rate for compound was observed in rat hepatocytes,,10139,50597,Rattus norvegicus,,Hepatocyte,Liver,2107.0,A,,,401.0,1,1,BAO_0000218,N,In vitro,CHEMBL623158,Intermediate
,10116.0,5600,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,10140,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623159,Intermediate
,10116.0,14294,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,10141,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874390,Intermediate
,10116.0,14294,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,10142,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623160,Intermediate
,10116.0,14294,Metabolism of compound in rat S9 microsomes; Trace,,10143,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623161,Intermediate
,10116.0,17847,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,10144,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623162,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,10145,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623163,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,10146,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623164,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,10147,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623165,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,10148,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623166,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,10149,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624983,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,10150,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624984,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,10151,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624985,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,10152,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622970,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,10153,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622971,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,10154,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622972,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,10155,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622973,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,10156,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622974,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,10157,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622975,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,10158,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622976,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,10159,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622977,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,10160,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624351,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,10161,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624352,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,10162,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624353,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,10163,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622397,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,10164,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622398,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,10165,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622399,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,10166,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622400,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,10167,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628428,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,10168,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628590,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,10169,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628591,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,10170,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628592,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,10171,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628593,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,10172,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875333,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,10173,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628594,Intermediate
,10116.0,4969,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,10174,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628595,Intermediate
,10116.0,6737,Stability in rat plasma was determined,,10175,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628596,Intermediate
,10116.0,6737,Stability in rat plasma was determined; ND= no data,,10176,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628597,Intermediate
,10116.0,5089,Tested for plasma half life period in rat (0-8 hr),,10177,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628598,Intermediate
,10116.0,5089,Tested for plasma half life period in rat (0-8 hr); Not determined,,10178,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628599,Intermediate
,10116.0,1466,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,10179,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628600,Intermediate
,10116.0,1466,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,10180,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628601,Intermediate
,10116.0,4950,Tested for the half life in rat,,10181,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628602,Intermediate
,10116.0,2412,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,10182,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL628603,Intermediate
,10116.0,2412,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,10183,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL628604,Intermediate
,10116.0,2412,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,10184,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL628605,Intermediate
,10116.0,2412,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,10185,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL628606,Intermediate
,10116.0,2412,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,10186,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL628607,Intermediate
,10116.0,15022,The biological half life the compound was measured at the dose of 100 umol/kg,,10187,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628608,Intermediate
,10116.0,15022,The biological half life the compound was measured at the dose of 30 umol/kg,,10188,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628609,Intermediate
,10116.0,406,The compound was evaluated for plasma half life period in rat,,10189,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628610,Intermediate
,10116.0,15078,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,10190,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL873819,Intermediate
,10116.0,15078,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,10191,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628611,Intermediate
,10116.0,5247,The pharmacokinetic parameter half-life period in vivo in rats,,10192,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628612,Intermediate
,10116.0,5041,"The pharmacokinetic property, Half-life was determined",,10193,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628613,Intermediate
,10116.0,5041,"The pharmacokinetic property, Half-life in rat in vivo",,10194,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628614,Intermediate
,10116.0,5041,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,10195,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628615,Intermediate
,10116.0,5041,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,10196,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628616,Intermediate
,10116.0,3918,The plasma half life period in rats,,10197,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627924,Intermediate
,10116.0,2906,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,10198,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627925,Intermediate
,10116.0,6467,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,10199,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627926,Intermediate
,10116.0,5510,t1/2 (apparent elimination)of the compound was determined,,10200,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627927,Intermediate
,10116.0,3788,t1/2 value in rat,,10201,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627928,Intermediate
,10116.0,17796,Half life in rat,,10202,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627539,Intermediate
,10116.0,12873,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,10203,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876790,Intermediate
,10116.0,5983,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,10204,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL858186,Intermediate
,10116.0,15765,Half-life period in fasted rats,,10205,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627540,Intermediate
,10116.0,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,10206,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627541,Intermediate
,10116.0,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,10207,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627715,Intermediate
,10116.0,429,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,10208,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627716,Intermediate
,10116.0,17655,Maximum time required to achieve Cmax was determined in rat,,10209,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627717,Intermediate
,10116.0,17717,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,10210,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627718,Intermediate
,10116.0,17717,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,10211,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627719,Intermediate
,10116.0,17717,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,10212,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627720,Intermediate
,10116.0,6570,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,10213,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627721,Intermediate
,10116.0,6570,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,10214,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627722,Intermediate
,10116.0,5978,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,10215,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627723,Intermediate
,10116.0,5978,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,10216,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626058,Intermediate
,10116.0,5978,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,10217,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626059,Intermediate
,10116.0,5978,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,10218,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626060,Intermediate
,10116.0,17720,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,10219,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626061,Intermediate
,10116.0,4723,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,10220,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876791,Intermediate
,10116.0,4723,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,10221,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626062,Intermediate
,10116.0,4756,Tmax at the dose of 2 mg/Kg administered perorally in rats,,10222,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626063,Intermediate
,10116.0,4756,Tmax at the dose of 5 mg/Kg administered perorally in rats,,10223,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626064,Intermediate
,10116.0,17720,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,10224,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626065,Intermediate
,10116.0,17720,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,10225,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626066,Intermediate
,10116.0,1466,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,10226,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626067,Intermediate
,10116.0,7449,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,10227,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL626068,Intermediate
,10116.0,7449,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,10228,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL626069,Intermediate
,10116.0,7449,Percent total excretion of 3-methoxyacetaminophen glucuronide,,10229,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL626070,Intermediate
,10116.0,7449,Percent total excretion of N-methoxyacetaminophen glucuronide,,10230,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL626071,Intermediate
,10116.0,7449,Percent total excretion of N-methoxyacetaminophen sulfate,,10231,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL626072,Intermediate
,10116.0,7449,Percent total excretion of acetaminophen,,10232,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL626073,Intermediate
,10116.0,7768,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,10233,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626741,Intermediate
,10116.0,17655,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,10234,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626742,Intermediate
,10116.0,17735,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,10235,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626743,Intermediate
,10116.0,5960,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,10236,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876792,Intermediate
,10116.0,17735,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,10237,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626744,Intermediate
,10116.0,7116,Compound was tested for antidiuretic activity in rats,,10238,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626745,Intermediate
,10116.0,4878,AUC in rat after 3mg/kg oral dose,,10239,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626746,Intermediate
,10116.0,5939,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,10240,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626747,Intermediate
,10116.0,5939,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,10241,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626748,Intermediate
,10116.0,16367,Bioavailability administered orally at a dose of 10 mg/kg to rats,,10242,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626749,Intermediate
,10116.0,16366,Oral Bioavailability was determined,,10243,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626750,Intermediate
,10116.0,4426,Oral bioavailability in rat,,10244,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626751,Intermediate
,10116.0,4426,Oral bioavailability in rat; Not performed.,,10245,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626913,Intermediate
,10116.0,5041,Bioavailability,,10246,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626914,Intermediate
,10116.0,5041,Bioavailability was determined; ND denotes no data,,10247,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626915,Intermediate
,10116.0,1500,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,10248,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626916,Intermediate
,10116.0,1500,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,10249,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626917,Intermediate
,10116.0,17409,Binding towards rat plasma protein at 10 uM,,10250,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626918,Intermediate
,10116.0,17409,Binding towards rat plasma protein at 100 uM,,10251,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626919,Intermediate
,10116.0,2959,Bioavailability in rat (dose 20 mg/kg p.o.),,10252,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626920,Intermediate
,10116.0,13501,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,10253,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621976,Intermediate
,10116.0,6567,Bioavailability in rat after 5 mg/kg oral gavage,,10254,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877599,Intermediate
,10116.0,6571,Bioavailability in rat,,10255,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621977,Intermediate
,10116.0,6715,Bioavailability in rat (dose 1 mg/kg i.v.),,10256,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621978,Intermediate
,10116.0,6715,Bioavailability in rat (dose 3 mg/kg p.o.),,10257,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621979,Intermediate
,10116.0,2932,Oral bioavailability in rat,,10258,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621980,Intermediate
,10116.0,4171,Bioavailability of the compound in rats after administration of 30 mg/kg,,10259,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621981,Intermediate
,10116.0,17509,Bioavailability after administration of 10 mg/kg in rats,,10260,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621982,Intermediate
,10116.0,17509,Bioavailability after administration of 2 mg/kg in rats,,10261,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL882953,Intermediate
,10116.0,4527,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,10262,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621983,Intermediate
,10116.0,4026,Bioavailability in dogs was determined; high,,10263,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621984,Intermediate
,10116.0,6659,Bioavailability in monkey after intravenous administration at 1 mpk,,10264,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621985,Intermediate
,10116.0,6659,Bioavailability in monkey after peroral administration at 10 mpk,,10265,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621986,Intermediate
,10116.0,6659,Bioavailability in rat after intravenous administration at 1 mpk,,10266,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621987,Intermediate
,10116.0,6659,Bioavailability in rat after intravenous administration at 2 mpk,,10267,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877600,Intermediate
,10116.0,6659,Bioavailability in rat after peroral administration at 30 mpk,,10268,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621988,Intermediate
,10116.0,6659,Bioavailability in rat after peroral administration at at 100 mpk,,10269,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621989,Intermediate
,10116.0,6597,Bioavailability in rats was evaluated,,10270,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621990,Intermediate
,10116.0,1202,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,10271,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621991,Intermediate
,10116.0,1202,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,10272,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621992,Intermediate
,10116.0,1202,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,10273,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621993,Intermediate
,10116.0,1202,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,10274,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621994,Intermediate
,10116.0,5207,Bioavailability in rat,,10275,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621995,Intermediate
,10116.0,5970,Bioavailability in rat,,10276,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621996,Intermediate
,10116.0,17538,Oral bioavailability in rat (dose 10 mg/kg),,10277,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621997,Intermediate
,10116.0,17538,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,10278,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621998,Intermediate
,10116.0,1466,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,10279,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621999,Intermediate
,10116.0,2879,Oral bioavailability in rat,,10280,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622000,Intermediate
,10116.0,2879,Bioavailability was measured in rat after oral administration; 2-4,,10281,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622001,Intermediate
,10116.0,2879,Bioavailability was measured in rat after oral administration; 3-7,,10282,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622002,Intermediate
,10116.0,3777,Bioavailability in rat (intraduodenal administration),,10283,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622003,Intermediate
,10116.0,3777,Bioavailability in rat (intraduodenal administration),,10284,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877601,Intermediate
,10116.0,3777,Oral bioavailability in rat,,10285,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624871,Intermediate
,10116.0,3777,Oral bioavailability in rat,,10286,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622004,Intermediate
,10116.0,5423,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,10287,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL882954,Intermediate
,10116.0,16365,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,10288,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622005,Intermediate
,10116.0,16365,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,10289,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622006,Intermediate
,10116.0,4239,Bioavailability was measured in rat,,10290,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622007,Intermediate
,10116.0,5438,Bioavailability was reported,,10291,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622008,Intermediate
,10116.0,5334,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,10292,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622009,Intermediate
,10116.0,5334,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,10293,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622010,Intermediate
,10116.0,4199,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,10294,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622011,Intermediate
,10116.0,4199,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,10295,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622012,Intermediate
,10116.0,4199,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,10296,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622013,Intermediate
,10116.0,4890,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,10297,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622014,Intermediate
,10116.0,2792,Bioavailability was determined at 3 mg/kg po dose in rats,,10298,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624749,Intermediate
,10116.0,5529,Oral bioavailability in rat (dose 2 mg/kg),,10299,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624750,Intermediate
,10116.0,6685,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,10300,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624751,Intermediate
,10116.0,6685,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,10301,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624752,Intermediate
,10116.0,6685,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,10302,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624753,Intermediate
,10116.0,6005,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,10303,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624754,Intermediate
,10116.0,6410,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,10304,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624755,Intermediate
,10116.0,6410,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,10305,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624756,Intermediate
,10116.0,6103,Bioavailability in rat,,10306,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624757,Intermediate
,10116.0,6410,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,10307,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624758,Intermediate
,10116.0,6410,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,10308,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622270,Intermediate
,10116.0,5353,Bioavailability in rat (Sprague-Dawley),,10309,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622271,Intermediate
,10116.0,4727,Bioavailability in rat at the dose of 2 mg/kg,,10310,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622272,Intermediate
,10116.0,17804,Oral bioavailability in rat,,10311,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622273,Intermediate
,10116.0,5809,Bioavailability in rat (cannulated) (dose 2 mg/kg),,10312,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622274,Intermediate
,10116.0,17804,Bioavailability value of compound in rats was determined after peroral administration,,10313,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622275,Intermediate
,10116.0,3634,Oral bioavailability in rat (dose 20 mg/kg),,10314,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622276,Intermediate
,10116.0,3341,Oral bioavailability in rat,,10315,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622277,Intermediate
,10116.0,2690,Oral bioavailability in rat (dose 5 mg/kg),,10316,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622278,Intermediate
,10116.0,3184,Oral bioavailability in rat,,10317,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622279,Intermediate
,10116.0,740,Oral bioavailability in rat,,10318,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622280,Intermediate
,10116.0,1806,Compound was evaluated for oral bioavailability in rats; 15-27 %,,10319,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624083,Intermediate
,10116.0,4891,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,10320,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624084,Intermediate
,10116.0,3634,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,10321,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624085,Intermediate
,10116.0,64,Compound was tested for bioavailability in rats,,10322,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624086,Intermediate
,10116.0,4839,Bioavailability in rat,,10323,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624087,Intermediate
,10116.0,1094,Oral bioavailability in rat,,10324,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624088,Intermediate
,9544.0,5005,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,10325,22224,Macaca mulatta,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624089,Intermediate
,10116.0,5005,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,10326,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624090,Intermediate
,10116.0,4687,Evaluated for the bioavailability in rat (in vivo),,10327,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624091,Intermediate
,10116.0,17804,F value of compound in rats was determined after peroral administration,,10328,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624092,Intermediate
,10116.0,5974,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,10329,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624093,Intermediate
,10116.0,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,10330,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624094,Intermediate
,10116.0,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,10331,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624095,Intermediate
,10116.0,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,10332,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624096,Intermediate
,10116.0,1088,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,10333,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624097,Intermediate
,10116.0,1742,Maximum fall in carotid flow in rat,,10334,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624098,Intermediate
,10116.0,4689,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,10335,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874392,Intermediate
,10116.0,2463,Oral bioavailability in rat (dose 5 mg/kg),,10336,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624099,Intermediate
,10116.0,5654,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,10337,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624100,Intermediate
,10116.0,5654,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,10338,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624101,Intermediate
,10116.0,6874,Oral bioavailability in rat (male Wistar),,10339,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624102,Intermediate
,10116.0,5633,Oral bioavailability after administration (30 mg/kg) in rat; good,,10340,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624103,Intermediate
,10116.0,5496,Oral bioavailability at the dose of 2 mg/kg in rat,,10341,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624104,Intermediate
,10116.0,2358,Oral bioavailability determined in rats,,10342,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624105,Intermediate
,10116.0,16456,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,10343,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624106,Intermediate
,10116.0,5302,Oral bioavailability in rat (dose single 10 mg/kg),,10344,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624107,Intermediate
,10116.0,5302,Oral bioavailability in rat (dose single 10 mg/kg),,10345,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623943,Intermediate
,10116.0,5302,Oral bioavailability in rat (dose 5 mg/kg,,10346,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623944,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,10347,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623945,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,10348,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623946,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,10349,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623947,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,10350,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623948,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,10351,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623949,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,10352,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623950,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,10353,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874398,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,10354,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623951,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,10355,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623952,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,10356,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623953,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,10357,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623954,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,10358,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623955,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,10359,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623956,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,10360,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627807,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,10361,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627808,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,10362,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627809,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,10363,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627810,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,10364,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627811,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,10365,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627812,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,10366,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627813,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,10367,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627814,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,10368,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875336,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,10369,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627815,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,10370,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627816,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,10371,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627817,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,10372,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627818,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,10373,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627819,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,10374,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627820,Intermediate
,10116.0,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,10375,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627821,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,10376,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628464,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,10377,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626239,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,10378,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626240,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,10379,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626241,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,10380,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626242,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,10381,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626243,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,10382,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626244,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,10383,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626907,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,10384,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626908,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,10385,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626909,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,10386,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626910,Intermediate
,10116.0,7449,Percent total excretion of acetaminophen cysteine conjugate,,10387,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL875342,Intermediate
,10116.0,7449,Percent total excretion of acetaminophen glucuronide,,10388,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL626911,Intermediate
,10116.0,7449,Percent total excretion of acetaminophen sulfate,,10389,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL626912,Intermediate
,10116.0,7449,Percent total excretion of acetaminophen-mercapturic acid,,10390,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL627065,Intermediate
,10116.0,3172,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,10391,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627066,Intermediate
,10116.0,16456,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,10392,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627067,Intermediate
,8656.0,10839,Biodistribution of compound in rat muscle after 5 min of administration,,10393,22224,ratrat,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627068,Autocuration
,8656.0,10839,Biodistribution of compound in rat muscle after 5 min of administration.,,10394,22224,ratrat,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627069,Autocuration
,9940.0,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,10395,22224,Ovis aries,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627070,Autocuration
,9940.0,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,10396,22224,Ovis aries,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627071,Autocuration
,9940.0,5334,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,10397,22224,Ovis aries,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627072,Autocuration
,9940.0,5334,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,10398,22224,Ovis aries,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627073,Autocuration
,9940.0,5334,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,10399,22224,Ovis aries,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625387,Autocuration
,9940.0,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,10400,22224,Ovis aries,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625388,Autocuration
,9940.0,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,10401,22224,Ovis aries,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625389,Autocuration
,9940.0,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,10402,22224,Ovis aries,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL875343,Autocuration
,8570.0,1735,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,10403,50497,Serpentes,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876795,Intermediate
,8570.0,1469,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,10404,50497,Serpentes,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626552,Intermediate
,8570.0,1336,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,10405,50497,Serpentes,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626553,Intermediate
,9606.0,12403,The human biological plasma half life of the compound,,10406,22224,Homo sapiens,,,Plasma,1969.0,A,,,,1,0,BAO_0000366,U,,CHEMBL626554,Autocuration
,10116.0,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,10407,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626555,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,10408,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626556,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,10409,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626557,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,10410,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626558,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,10411,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626559,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,10412,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626560,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,10413,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876803,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,10414,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627964,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,10415,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627965,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,10416,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627966,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,10417,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627967,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,10418,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627968,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,10419,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627969,Intermediate
,10116.0,8004,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,10420,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627970,Intermediate
,10116.0,8004,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,10421,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627971,Intermediate
,10116.0,8004,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,10422,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627972,Intermediate
,9606.0,15917,Dissociation constant against binding to human cyclophilin A,,10423,180,Homo sapiens,,,,,B,,,,1,9,BAO_0000357,D,,CHEMBL856029,Expert
,9913.0,12396,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,10424,11591,Bos taurus,,,,,B,,,,1,8,BAO_0000019,H,,CHEMBL627973,Expert
,,7065,-Log C was determined by performing the electroshock minimum test,,10425,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627974,Autocuration
,,7065,-Log C was determined by performing the foot shock test,,10426,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627975,Autocuration
,,7065,-Log C was determined by performing the incl screen test,,10427,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627976,Autocuration
,,7065,-Log C was determined by performing the maximum electroshock test,,10428,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627977,Autocuration
,,7065,-Log C was determined by performing the pentylenetetrazole test,,10429,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627978,Autocuration
,,12415,Tested for experimental arotinoid inhibitory dose,,10430,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627979,Autocuration
,,10256,Negative log transformed activity,,10431,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL876804,Autocuration
,,7991,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,10432,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627980,Autocuration
,10141.0,14342,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,10433,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627981,Intermediate
,10141.0,14342,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,10434,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627982,Intermediate
,10141.0,14342,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,10435,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627983,Intermediate
,10141.0,14342,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,10436,50512,Cavia porcellus,,,Ileum,2116.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627984,Intermediate
,,6047,Solubility in water was determined; values expressed as -log,,10437,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL627985,Autocuration
,,17269,Ratio of Kcat to that of Km was determined,,10438,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627986,Autocuration
,,10026,Observed first order rate constant,,10439,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627987,Autocuration
,,14583,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,10440,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627988,Autocuration
,10116.0,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,10441,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627989,Intermediate
,10116.0,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,10442,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627990,Intermediate
,10116.0,4029,Oral Bioavailability after administration of 10 mg/kg in male rat,,10443,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876805,Intermediate
,10116.0,17735,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,10444,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627991,Intermediate
,10116.0,4576,Oral bioavailability in rat,,10445,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627992,Intermediate
,10116.0,17582,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,10446,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627993,Intermediate
,10116.0,17651,Oral bioavailability at 1 mg/kg was determined in rat,,10447,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622817,Intermediate
,10116.0,17651,Oral bioavailability at 10 mg/kg was determined in rat,,10448,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622818,Intermediate
,10116.0,17670,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,10449,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622819,Intermediate
,10116.0,5045,Oral bioavailability in rat,,10450,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL872267,Intermediate
,10116.0,1696,Oral bioavailability in rat,,10451,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622820,Intermediate
,10116.0,17764,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,10452,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622821,Intermediate
,10116.0,6448,Oral bioavailability in rat,,10453,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622822,Intermediate
,10116.0,6596,Oral bioavailability in rat,,10454,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622823,Intermediate
,10116.0,17547,Oral bioavailability in rat,,10455,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622824,Intermediate
,10116.0,17771,Oral bioavailability in rat at a dose of 3 mg/kg,,10456,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622825,Intermediate
,10116.0,6495,Oral bioavailability in rat after oral administration at 10 mg/kg,,10457,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622901,Intermediate
,10116.0,4558,Oral bioavailability in rat,,10458,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622902,Intermediate
,10116.0,17596,Oral bioavailability in rat,,10459,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621844,Intermediate
,10116.0,6827,Oral bioavailability in Dawley rats,,10460,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621845,Intermediate
,10116.0,4026,Oral bioavailability,,10461,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621846,Intermediate
,10116.0,10,Oral bioavailability in rat (dose 30 mg/kg),,10462,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621847,Intermediate
,10116.0,17717,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,10463,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877609,Intermediate
,10116.0,17717,Bioavailability in rat (dose 3 mg/kg i.v.),,10464,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621848,Intermediate
,10116.0,17717,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,10465,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621849,Intermediate
,10116.0,17717,Oral bioavailability in rat (dose 60 mg/kg p.o.),,10466,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622030,Intermediate
,10116.0,4796,Percent oral bioavailability determined in rats,,10467,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622031,Intermediate
,10116.0,4883,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,10468,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622032,Intermediate
,10116.0,2137,The compound was evaluated for bioavailability in rats; 32-51,,10469,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622033,Intermediate
,10116.0,2959,Bioavailability in rat (dose 20 mg/kg p.o.),,10470,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622034,Intermediate
,10116.0,1361,Oral bioavailability in rat,,10471,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622035,Intermediate
,10116.0,4727,Bioavailability percent in rat at the dose of 2 mg/kg,,10472,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL882966,Intermediate
,10116.0,16423,Bioavailability was evaluated after 20 uM/kg of peroral administration,,10473,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622036,Intermediate
,10116.0,5206,Oral bioavailability in rat,,10474,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622037,Intermediate
,10116.0,6448,Oral bioavailability in rat,,10475,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622038,Intermediate
,10116.0,17723,Bioavailability in rats,,10476,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622039,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,10477,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622040,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,10478,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622041,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,10479,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622042,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,10480,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622043,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,10481,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622044,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,10482,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622045,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,10483,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622046,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,10484,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622047,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,10485,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877610,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,10486,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622048,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,10487,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622049,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,10488,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622050,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,10489,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622051,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,10490,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622052,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,10491,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622053,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,10492,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622054,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,10493,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622055,Intermediate
,10116.0,5237,Oral bioavailability in rats was determined; High,,10494,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622056,Intermediate
,10116.0,5503,Oral bioavailability in the rat was determined,,10495,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622057,Intermediate
,10116.0,15765,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,10496,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628008,Intermediate
,10116.0,15660,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,10497,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622058,Intermediate
,10116.0,5978,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,10498,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622059,Intermediate
,10116.0,5978,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,10499,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622060,Intermediate
,10116.0,5978,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,10500,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622061,Intermediate
,10116.0,5978,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,10501,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622062,Intermediate
,10116.0,5656,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,10502,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622063,Intermediate
,10116.0,3598,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,10503,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877611,Expert
,10116.0,4216,Oral bioavailability of compound in Sprague Dawley rats,,10504,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622064,Intermediate
,10116.0,17839,Oral bioavailability of compound in rat,,10505,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622065,Intermediate
,10116.0,6570,Oral bioavailability in rat (dose 2 mg/kg),,10506,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622066,Intermediate
,10116.0,5334,Oral bioavailability of compound in rat was determined,,10507,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622067,Intermediate
,10116.0,6886,Oral bioavailability of compound in rats,,10508,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622068,Intermediate
,10116.0,5210,Oral bioavailability of compound was determined in rats,,10509,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622069,Intermediate
,10116.0,4170,Oral bioavailability at a dose of 30 mg/kg in rats,,10510,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624796,Intermediate
,10116.0,6028,Oral bioavailability in rat (dose 10 mg/kg),,10511,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624797,Intermediate
,10116.0,6028,Oral bioavailability in rat (dose 10 mg/kg),,10512,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623053,Intermediate
,10116.0,6078,Oral bioavailability evaluated in rat,,10513,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623054,Intermediate
,10116.0,6168,Oral bioavailability in fasted rat,,10514,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623055,Intermediate
,10116.0,6168,Oral bioavailability in fed rat,,10515,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623056,Intermediate
,10116.0,5160,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,10516,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623057,Intermediate
,10116.0,6057,Oral bioavailability in rat,,10517,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623058,Intermediate
,10116.0,6535,Oral bioavailability in rat (dose 10 mg/kg p.o.),,10518,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623059,Intermediate
,10116.0,6535,Oral bioavailability in rat after administration of 10 mg/kg po,,10519,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623060,Intermediate
,10116.0,4194,Oral bioavailability in rat,,10520,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623061,Intermediate
,10116.0,6230,Oral bioavailability in rat,,10521,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623062,Intermediate
,10116.0,6619,Oral bioavailability in rat,,10522,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623063,Intermediate
,10116.0,17607,Oral bioavailability in rat,,10523,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623064,Intermediate
,10116.0,4942,Oral bioavailability in ratrs,,10524,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623065,Intermediate
,10116.0,4942,Oral bioavailability in rat,,10525,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623066,Intermediate
,10116.0,6646,Oral bioavailability in rat,,10526,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623067,Intermediate
,10116.0,5237,Oral bioavailability in rats was determined; High,,10527,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623068,Intermediate
,10116.0,6646,Oral bioavailability in rat,,10528,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623069,Intermediate
,10116.0,4449,Oral bioavailability in rat,,10529,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623070,Intermediate
,10116.0,6057,Oral bioavailability was calculated in rat,,10530,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623071,Intermediate
,10116.0,2552,Oral bioavailability,,10531,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623072,Intermediate
,10116.0,5496,Oral bioavailability,,10532,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623073,Intermediate
,10116.0,6484,Oral bioavailability,,10533,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623074,Intermediate
,10116.0,6485,Oral bioavailability,,10534,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623075,Intermediate
,10116.0,6616,Oral bioavailability after i.v. administration,,10535,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623076,Intermediate
,10116.0,4969,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,10536,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623077,Intermediate
,10116.0,5862,Oral bioavailability in rat (Sprague-Dawley),,10537,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623078,Intermediate
,10116.0,4514,Oral bioavailability in Sprague-Dawley rats,,10538,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623079,Intermediate
,10116.0,4514,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,10539,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623080,Intermediate
,10116.0,4514,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,10540,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623081,Intermediate
,10116.0,5546,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,10541,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623082,Intermediate
,10116.0,6168,Oral bioavailability in fasted rat,,10542,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874400,Intermediate
,10116.0,6168,Oral bioavailability in fed rat,,10543,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623083,Intermediate
,10116.0,3624,Oral bioavailability in rat,,10544,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623084,Intermediate
,10116.0,5213,Oral bioavailability in rat,,10545,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623085,Intermediate
,10116.0,5496,Oral bioavailability in rat,,10546,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623086,Intermediate
,10116.0,5553,Oral bioavailability in rat,,10547,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623087,Intermediate
,10116.0,5833,Oral bioavailability in rat,,10548,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623088,Intermediate
,10116.0,5836,Oral bioavailability in rat,,10549,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623089,Intermediate
,10116.0,5865,Oral bioavailability in rat,,10550,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623090,Intermediate
,10116.0,5960,Oral bioavailability in rat,,10551,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623091,Intermediate
,10116.0,6249,Oral bioavailability in rat,,10552,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623092,Intermediate
,10116.0,6448,Oral bioavailability in rat,,10553,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623093,Intermediate
,10116.0,6453,Oral bioavailability in rat,,10554,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874401,Intermediate
,10116.0,6640,Oral bioavailability in rat,,10555,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623094,Intermediate
,10116.0,17607,Oral bioavailability in rat,,10556,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623095,Intermediate
,10116.0,5939,Oral bioavailability in rat after peroral administration at 10 mg/kg,,10557,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623096,Intermediate
,10116.0,5939,Oral bioavailability in rat after peroral administration at 5 mg/kg,,10558,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624913,Intermediate
,10116.0,6281,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,10559,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624914,Intermediate
,10116.0,5874,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,10560,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624915,Intermediate
,10116.0,5213,Oral bioavailability in rat; Not measured,,10561,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624916,Intermediate
,10116.0,4964,Oral bioavailability in rat,,10562,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624917,Intermediate
,10116.0,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,10563,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625157,Intermediate
,10116.0,6251,In vitro metabolic potential in rat liver microsomes,,10564,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625158,Intermediate
,10116.0,1568,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,10565,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625159,Intermediate
,10116.0,3032,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,10566,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625160,Intermediate
,10116.0,3748,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,10567,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625161,Intermediate
,10116.0,401,Oral bioavailability in rat,,10568,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625162,Intermediate
,10116.0,6512,Oral bioavailability in rat,,10569,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625163,Intermediate
,10116.0,17617,Oral bioavailability in rats at 10 mg/kg,,10570,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625164,Intermediate
,10116.0,6679,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,10571,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625165,Intermediate
,10116.0,6742,Oral bioavailability in rat,,10572,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625166,Intermediate
,10116.0,589,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,10573,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625167,Intermediate
,10116.0,589,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,10574,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625168,Intermediate
,10116.0,3185,Plasma clearance of the compound,,10575,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625169,Intermediate
,10116.0,17596,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,10576,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626264,Intermediate
,10116.0,2713,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,10577,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626265,Intermediate
,10116.0,12500,The compound was tested for plasma clearance in rat,,10578,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626266,Intermediate
,10116.0,12500,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,10579,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626267,Intermediate
,10116.0,2713,Plasma concentration upon oral administration of 1 mg/Kg in rats,,10580,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626268,Intermediate
,10116.0,1446,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,10581,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626269,Intermediate
,10116.0,6227,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,10582,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626270,Intermediate
,10116.0,4709,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,10583,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626271,Intermediate
,10116.0,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,10584,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626272,Intermediate
,10116.0,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,10585,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626273,Intermediate
,10116.0,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,10586,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875346,Intermediate
,10116.0,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,10587,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626274,Intermediate
,10116.0,4514,Compound was tested for protein binding in rat plasma,,10588,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626275,Intermediate
,10116.0,2713,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,10589,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624646,Intermediate
,10116.0,2713,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,10590,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624647,Intermediate
,10116.0,5340,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,10591,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624648,Intermediate
,10116.0,12058,Area under curve ratio was determined (po/iv) in rat,,10592,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624649,Intermediate
,10116.0,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,10593,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624650,Intermediate
,10116.0,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,10594,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624651,Intermediate
,10116.0,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,10595,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624652,Intermediate
,10116.0,6495,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,10596,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624653,Intermediate
,10116.0,6078,Ratio of AUCbrain to AUCplasma,,10597,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624654,Intermediate
,10116.0,5656,Ratio of brain to plasma,,10598,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624655,Intermediate
,10116.0,4910,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,10599,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624656,Intermediate
,10116.0,4910,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,10600,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624657,Intermediate
,10116.0,4910,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,10601,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624658,Intermediate
,10116.0,10130,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,10602,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624659,Intermediate
,10116.0,10130,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,10603,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624660,Intermediate
,10116.0,10130,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,10604,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624661,Intermediate
,10116.0,5213,Steady state brain :blood ratio was determined,,10605,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624662,Intermediate
,10116.0,4910,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,10606,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625199,Intermediate
,10116.0,4910,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,10607,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625200,Intermediate
,10116.0,4910,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,10608,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625201,Intermediate
,10116.0,4910,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,10609,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625202,Intermediate
,10116.0,2083,Percentage recovery after 3h incubation with rat hapatocytes was determined,,10610,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625203,Intermediate
,10116.0,2082,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,10611,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625204,Intermediate
,10116.0,2082,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,10612,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625205,Intermediate
,10116.0,6351,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,10613,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625206,Intermediate
,,14583,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,10614,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625207,Autocuration
,,14583,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,10615,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625208,Autocuration
,9606.0,4608,In vivo absorption in Caco-2 cell line monolayers was determined,,10616,50587,Homo sapiens,,Caco-2,,,A,,,495.0,1,1,BAO_0000218,N,,CHEMBL625209,Intermediate
,,13668,Calculated partition coefficient (clogP),,10617,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625210,Autocuration
,10116.0,5669,Area under curve was determine after peroral administration at 10 mpk in Rat,,10618,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625211,Intermediate
,9544.0,5669,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,10619,50797,Macaca mulatta,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625212,Intermediate
,10116.0,5669,Area under curve was determine after peroral administration at 160 mpk in Rat,,10620,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625213,Intermediate
,10116.0,5669,Area under curve was determine after peroral administration at 20 mpk in Rat,,10621,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625214,Intermediate
,10116.0,5669,Area under curve was determine after peroral administration at 50 mpk in Rat,,10622,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874542,Intermediate
,,6472,Calculated partition coefficient (clogP) (AlogP),,10623,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625215,Autocuration
,,15106,Activated partial thromboplastin time measured,,10624,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625216,Autocuration
,,15207,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,10625,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625217,Autocuration
,,15207,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,10626,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625218,Autocuration
,9615.0,13941,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,10627,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622864,Intermediate
,10116.0,13941,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,10628,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622865,Intermediate
,10116.0,13941,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,10629,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622866,Intermediate
,9615.0,13941,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,10630,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622867,Intermediate
,10141.0,15240,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,10631,50512,Cavia porcellus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876808,Intermediate
,,10655,AUC in brain,,10632,22224,,,,Brain,955.0,A,,,,1,0,BAO_0000019,U,,CHEMBL627725,Autocuration
,,10655,AUC in serum,,10633,22224,,,,Serum,1977.0,A,,,,1,0,BAO_0000019,U,,CHEMBL627726,Autocuration
,,6504,AUC was determined,,10634,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000019,U,,CHEMBL627727,Autocuration
,,10615,AUC of the compound.,,10635,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000019,U,,CHEMBL627728,Autocuration
,,10353,AUC value (0-4 hr),,10636,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000019,U,,CHEMBL627729,Autocuration
,,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,10637,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000019,U,,CHEMBL627730,Autocuration
,,14907,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,10638,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000019,U,,CHEMBL627731,Autocuration
,,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,10639,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000019,U,,CHEMBL627732,Autocuration
,,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,10640,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000019,U,,CHEMBL627733,Autocuration
,10116.0,16359,AUC(area under curve) was determined after intravenous administration in rats,,10641,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627734,Intermediate
,10116.0,16359,AUC(area under curve) was determined after oral administration in rats,,10642,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627735,Intermediate
,10141.0,15240,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,10643,50512,Cavia porcellus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627736,Intermediate
,10116.0,15240,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,10644,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876809,Intermediate
,,15469,Area Under Curve after oral dosing of 100 uM/Kg,,10645,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627737,Autocuration
,,15469,Area Under Curve after oral dosing of 30 uM/Kg,,10646,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627738,Autocuration
,,13520,Area Under Curve was measured by ploting the graph between concentration verses time,,10647,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627739,Autocuration
,9615.0,17025,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,10648,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626143,Intermediate
,314293.0,17025,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,10649,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626144,Autocuration
,9986.0,17025,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,10650,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626145,Intermediate
,10116.0,17025,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,10651,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626146,Intermediate
,10116.0,12032,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,10652,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626147,Intermediate
,,10291,Area under curve (AUC) was determined,,10653,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626148,Autocuration
,,5767,Area under curve (AUC) following ip administration at 1 mg/kg,,10654,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626149,Autocuration
,,1434,Area under curve (AUC) was determined; ND is Not determined,,10655,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626150,Autocuration
,9615.0,14925,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,10656,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626151,Intermediate
,9615.0,14925,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,10657,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626152,Intermediate
,9615.0,14925,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,10658,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626153,Intermediate
,,1434,Area under curve (AUR) was determined,,10659,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626154,Autocuration
,,11883,Area under curve at 1 uM/dg administered intravenously,,10660,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626155,Autocuration
,,11883,Area under curve at 10 uM/dg administered perorally,,10661,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626156,Autocuration
,,11883,Area under curve at 2 uM/dg administered intravenously,,10662,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626157,Autocuration
,,11883,Area under curve at 20 uM/dg administered perorally,,10663,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626158,Autocuration
,9615.0,15233,Area under curve at a peroral dose of 3 mg/kg in dog,,10664,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626159,Intermediate
,10116.0,15233,Area under curve at a peroral dose of 3 mg/kg in rat,,10665,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626160,Intermediate
,9615.0,15233,Area under curve at an iv dose of 1 mg/kg in dog,,10666,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626161,Intermediate
,10116.0,15233,Area under curve at an iv dose of 1 mg/kg in rat,,10667,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626162,Intermediate
,,12978,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,10668,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626163,Autocuration
,,12978,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,10669,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626164,Autocuration
,10090.0,11355,Area under curve measured as conc vs time after intravenous administration to mice.,,10670,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626165,Intermediate
,10090.0,11355,Area under curve measured as conc vs time after peroral administration to mice.,,10671,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626166,Intermediate
,9615.0,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,10672,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626167,Intermediate
,9615.0,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,10673,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626168,Intermediate
,9615.0,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,10674,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877463,Intermediate
,9615.0,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,10675,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626169,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,10676,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626170,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,10677,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626171,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,10678,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626172,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,10679,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626173,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,10680,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626174,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,10681,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626175,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,10682,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626176,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,10683,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626177,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,10684,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622499,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,10685,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622500,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,10686,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622501,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,10687,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622502,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,10688,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622503,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,10689,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877614,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,10690,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624839,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,10691,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624840,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,10692,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624841,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,10693,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624842,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,10694,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624843,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,10695,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624844,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,10696,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624845,Intermediate
,10116.0,17738,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,10697,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621904,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,10698,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621905,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,10699,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874382,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,10700,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621906,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,10701,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621907,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,10702,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622096,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,10703,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622097,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,10704,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622098,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,10705,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622099,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,10706,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622100,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,10707,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622101,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,10708,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622102,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,10709,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622103,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,10710,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622104,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,10711,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622105,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,10712,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622106,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,10713,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622107,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,10714,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622108,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,10715,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622109,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,10716,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622110,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,10717,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622111,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,10718,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874383,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,10719,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622112,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,10720,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622113,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,10721,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622114,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,10722,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622115,Intermediate
,10116.0,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,10723,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622116,Intermediate
,10116.0,6193,Oral bioavailability in rat,,10724,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622117,Intermediate
,10116.0,6803,Oral bioavailability in rat,,10725,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622118,Intermediate
,10116.0,6647,Oral bioavailability in rats at 6 mg/kg,,10726,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622119,Intermediate
,10116.0,6647,Oral bioavailability in rat (dose 6 mg/kg),,10727,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622120,Intermediate
,10116.0,6647,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,10728,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622121,Intermediate
,10116.0,6640,Oral bioavailability in rat,,10729,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622122,Intermediate
,10116.0,6641,Oral bioavailability in rat,,10730,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622123,Intermediate
,10116.0,6641,Oral bioavailability in rat,,10731,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622124,Intermediate
,10116.0,6642,Bioavailability in rat,,10732,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622125,Intermediate
,10116.0,5472,Oral bioavailability,,10733,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622126,Intermediate
,10116.0,6141,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,10734,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620455,Intermediate
,10116.0,4390,Oral bioavailability in rat,,10735,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620456,Intermediate
,10116.0,5472,Oral bioavailability in rat,,10736,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620457,Intermediate
,10116.0,5472,Oral bioavailability was evaluated; Not tested,,10737,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620458,Intermediate
,10116.0,5438,Oral bioavailability,,10738,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620459,Intermediate
,10116.0,4883,Oral bioavailability in rat by oral dosing,,10739,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620460,Intermediate
,10116.0,1908,Oral bioavailability in rat (dose 10 mg/kg p.o.),,10740,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620461,Intermediate
,10116.0,4853,Oral bioavailability in rat (Sprague-Dawley),,10741,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620462,Intermediate
,10116.0,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,10742,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620463,Intermediate
,10116.0,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,10743,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620464,Intermediate
,10116.0,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,10744,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620465,Intermediate
,10116.0,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,10745,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620466,Intermediate
,10116.0,4853,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,10746,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620467,Intermediate
,10116.0,4853,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,10747,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620468,Intermediate
,10116.0,12873,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,10748,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620469,Intermediate
,10116.0,12873,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,10749,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620470,Intermediate
,10116.0,3169,Oral bioavailability in rat,,10750,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620471,Intermediate
,10116.0,6305,Oral bioavailability in rat,,10751,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620472,Intermediate
,10116.0,4762,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,10752,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620473,Intermediate
,10116.0,17847,Oral bioavailability in rat,,10753,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620474,Intermediate
,10116.0,6211,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,10754,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620475,Intermediate
,10116.0,6011,Oral bioavailability in rat,,10755,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620476,Intermediate
,10116.0,6317,Oral bioavailability in rat,,10756,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620477,Intermediate
,10116.0,6644,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,10757,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620478,Intermediate
,10116.0,6644,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,10758,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618768,Intermediate
,10116.0,6644,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,10759,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618769,Intermediate
,10116.0,6644,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,10760,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618770,Intermediate
,10116.0,6113,Oral bioavailability (dose 20 mg/kg p.o.),,10761,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618771,Intermediate
,10116.0,5937,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,10762,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618772,Intermediate
,10116.0,5711,Oral bioavailability in rat at 10 mg/kg of the compound,,10763,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618773,Intermediate
,10116.0,17717,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,10764,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875842,Intermediate
,10116.0,17717,Bioavailability in rat (dose 3 mg/kg i.v.),,10765,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618774,Intermediate
,10116.0,17717,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,10766,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618775,Intermediate
,10116.0,17717,Oral bioavailability in rat (dose 60 mg/kg p.o.),,10767,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618776,Intermediate
,10116.0,4722,Percent bioavailability (F) in rats after iv administration,,10768,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618777,Intermediate
,10116.0,4722,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,10769,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618778,Intermediate
,10116.0,4353,Bioavailability in rat (dose 5 uM/kg p.o.),,10770,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618779,Intermediate
,10116.0,15662,Oral bioavailability,,10771,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618780,Intermediate
,10116.0,4756,Bioavailability in rat (dose 2 mg/kg p.o.),,10772,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618781,Intermediate
,10116.0,4756,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,10773,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618782,Intermediate
,10116.0,3436,Oral bioavailability in rat (dose 20 mg/kg),,10774,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618783,Intermediate
,10116.0,17800,Oral bioavailability in rat,,10775,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618784,Intermediate
,10116.0,15762,Percent oral bioavailability evaluated in rat,,10776,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618785,Intermediate
,10116.0,5089,Oral bioavailability in rat,,10777,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618786,Intermediate
,10116.0,5089,Percent oral bioavailability in rat; Not determined,,10778,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618787,Intermediate
,10116.0,3185,Oral bioavailability in rat,,10779,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618788,Intermediate
,10116.0,5145,Bioavailability in rat,,10780,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618789,Intermediate
,10116.0,3457,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,10781,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618790,Intermediate
,10116.0,3457,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,10782,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618791,Intermediate
,10116.0,5983,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,10783,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875843,Intermediate
,10116.0,5739,Oral bioavailability in rat (dose 20 mg/kg p.o.),,10784,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618792,Intermediate
,10116.0,3579,Cmax at a dose of 30 mg/kg in rat,,10785,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623395,Intermediate
,314293.0,17788,Cmax in monkeys at a dose of 1 mg/kg,,10786,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623396,Autocuration
,10116.0,14956,Cmax in rat,,10787,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623397,Intermediate
,10116.0,17788,Cmax in rats at a dose of 1 mg/kg,,10788,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623398,Intermediate
,10090.0,9750,Cmax was measured in mice after an oral dose of 50 mg/kg.,,10789,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623399,Intermediate
,,12767,"Cmax value at a dose of 12.7 uM/kg, po",,10790,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623400,Autocuration
,,12767,"Cmax value at a dose of 6.3 uM/kg, iv",,10791,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623401,Autocuration
,,12767,"Cmax value at a dose of 7.1 uM/kg, iv",,10792,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623402,Autocuration
,,12703,Cmax value of compound was determined after 1 hr,,10793,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623403,Autocuration
,,15778,Cmax value of the compound,,10794,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623404,Autocuration
,10116.0,12818,Cmax value administered intraintestinal in rats.,,10795,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625997,Intermediate
,10116.0,14964,Cmax value administered perorally was determined in rat; Not determined,,10796,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625998,Intermediate
,,15808,Cmax value at the dose of 2.3 mg/kg,,10797,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625999,Autocuration
,,15808,Cmax value at the dose of 5 mg/kg,,10798,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626000,Autocuration
,,15778,Cmax value in the period of 8 hr after dosing. ,,10799,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626001,Autocuration
,,3715,Cmax value at a oral dose of 20 mg/kg; Not tested,,10800,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626002,Autocuration
,,3715,Cmax value at a oral dose of 20 mg/kg,,10801,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626003,Autocuration
,10116.0,1446,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,10802,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626004,Intermediate
,10141.0,15240,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,10803,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626005,Intermediate
,10116.0,15240,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,10804,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626006,Intermediate
,10116.0,14810,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,10805,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626007,Intermediate
,10090.0,14239,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,10806,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626008,Intermediate
,9615.0,12555,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,10807,50588,Canis lupus familiaris,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626009,Intermediate
,9615.0,10754,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,10808,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626010,Intermediate
,10090.0,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,10809,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626011,Intermediate
,10090.0,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,10810,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626012,Intermediate
,10090.0,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,10811,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626013,Intermediate
,10090.0,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,10812,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626014,Intermediate
,10090.0,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,10813,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877496,Intermediate
,9615.0,14600,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,10814,50588,Canis lupus familiaris,,,,,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626015,Intermediate
,9615.0,14600,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,10815,50588,Canis lupus familiaris,,,,,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626016,Intermediate
,9615.0,14600,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,10816,50588,Canis lupus familiaris,,,,,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626017,Intermediate
,9615.0,13543,Bioavailability as maximal plasma concentration in dogs,,10817,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626018,Intermediate
,9615.0,13543,Bioavailability as maximal plasma concentration in dogs,,10818,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626692,Intermediate
,10116.0,13543,Bioavailability as maximal plasma concentration in rats,,10819,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626693,Intermediate
,10116.0,13543,Bioavailability as maximal plasma concentration in rats,,10820,22224,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626694,Autocuration
,9615.0,14600,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,10821,50588,Canis lupus familiaris,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626695,Intermediate
,9615.0,14600,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,10822,50588,Canis lupus familiaris,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626696,Intermediate
,9615.0,14600,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,10823,50588,Canis lupus familiaris,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626697,Intermediate
,9615.0,14600,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,10824,50588,Canis lupus familiaris,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626859,Intermediate
,9615.0,14600,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,10825,50588,Canis lupus familiaris,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626860,Intermediate
,9615.0,14600,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,10826,50588,Canis lupus familiaris,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626861,Intermediate
,10116.0,14681,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,10827,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626296,Intermediate
,,15905,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,10828,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626297,Autocuration
,,15905,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,10829,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626298,Autocuration
,10116.0,13304,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,10830,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626299,Intermediate
,10116.0,15137,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,10831,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626300,Intermediate
,10116.0,15137,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,10832,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626301,Intermediate
,10116.0,15137,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,10833,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626962,Intermediate
,10116.0,15137,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,10834,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626963,Intermediate
,10116.0,15137,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,10835,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626964,Intermediate
,9541.0,14839,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,10836,100710,Macaca fascicularis,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626965,Intermediate
,10090.0,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10837,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626966,Intermediate
,10090.0,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10838,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626967,Intermediate
,9541.0,14839,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,10839,100710,Macaca fascicularis,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626968,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,10840,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626969,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,10841,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627126,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,10842,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631276,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,10843,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631277,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,10844,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631278,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,10845,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874457,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,10846,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631279,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,10847,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631280,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,10848,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631281,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,10849,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631968,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,10850,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631969,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,10851,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631970,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,10852,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631971,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,10853,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631972,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,10854,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630435,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,10855,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630436,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,10856,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630437,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,10857,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630438,Intermediate
,10116.0,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,10858,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630439,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,10859,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630440,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,10860,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630441,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,10861,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630442,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,10862,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625234,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,10863,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625235,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,10864,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625236,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,10865,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625237,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,10866,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626125,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,10867,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626126,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,10868,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626127,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,10869,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626128,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,10870,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626129,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,10871,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626130,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,10872,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626131,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,10873,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626132,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,10874,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626752,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,10875,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626753,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,10876,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626754,Intermediate
,10116.0,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,10877,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626755,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,10878,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626756,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,10879,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626757,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,10880,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626758,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,10881,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626759,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,10882,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626760,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,10883,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626394,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,10884,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626395,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,10885,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626396,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,10886,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626397,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,10887,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626398,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,10888,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626399,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,10889,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874653,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,10890,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626400,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,10891,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626401,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,10892,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626402,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,10893,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626403,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,10894,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626404,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,10895,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626405,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,10896,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625529,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,10897,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625530,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,10898,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625531,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,10899,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625532,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,10900,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625533,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,10901,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875474,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,10902,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625534,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,10903,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625535,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,10904,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625536,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,10905,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625537,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,10906,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625538,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,10907,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625539,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,10908,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625540,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,10909,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625541,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,10910,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625542,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,10911,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625543,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,10912,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625544,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,10913,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625545,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,10914,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625546,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,10915,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625547,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,10916,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625548,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,10917,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625549,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,10918,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625550,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,10919,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625551,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,10920,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875475,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,10921,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625552,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,10922,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625553,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,10923,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625554,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,10924,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625555,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,10925,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625556,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,10926,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624986,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,10927,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624987,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,10928,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624988,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,10929,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624989,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,10930,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624990,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,10931,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874391,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,10932,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624991,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,10933,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624992,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,10934,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624993,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,10935,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624994,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,10936,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624995,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,10937,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624996,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,10938,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624997,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,10939,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624998,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,10940,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624999,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,10941,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL882955,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,10942,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625000,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,10943,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625001,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,10944,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625089,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,10945,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625090,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,10946,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625091,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,10947,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625092,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,10948,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625093,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,10949,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625094,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,10950,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625095,Intermediate
,9615.0,2249,Compound was evaluated for its bioavailability in the dogs,,10951,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625096,Intermediate
,10116.0,2249,Compound was evaluated for its bioavailability in the rats,,10952,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625097,Intermediate
,,17515,Compound was evaluated for oral bioavailability,,10953,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL882956,Autocuration
,10116.0,14541,Compound was evaluated for percentage of Oral bioavailability in rats,,10954,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625098,Intermediate
,10141.0,12797,Bioavailability in guinea pig,,10955,22224,Cavia porcellus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625099,Autocuration
,10116.0,12797,Compound was evaluated for the oral bioavailability in rat,,10956,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625100,Intermediate
,9615.0,12797,Compound was evaluated for the oral bioavailability in dog,,10957,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625101,Intermediate
,10116.0,12797,Compound was evaluated for the oral bioavailability in rat,,10958,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874396,Intermediate
,9615.0,11727,Bioavailability in dog (dosed i.v.),,10959,22224,Canis lupus familiaris,,,,,F,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625102,Autocuration
,9615.0,13249,Compound was tested for in vivo bioavailability in dog,,10960,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625103,Intermediate
,10026.0,13249,Compound was tested for in vivo bioavailability in hamsters,,10961,100712,Cricetinae,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625104,Intermediate
,314293.0,13249,Compound was tested for in vivo bioavailability in monkey,,10962,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625105,Autocuration
,10116.0,13249,Compound was tested for in vivo bioavailability in rat,,10963,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625106,Intermediate
,10090.0,9552,Oral bioavailability in mouse,,10964,22224,Mus musculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625107,Autocuration
,10090.0,9552,Compound was tested for percent of oral bioavailability in mice; 56-74,,10965,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625108,Intermediate
,10090.0,14839,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,10966,22224,Mus musculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625109,Autocuration
,9541.0,14839,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,10967,22224,Macaca fascicularis,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625110,Autocuration
,9541.0,14839,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,10968,22224,Macaca fascicularis,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625111,Autocuration
,10090.0,14839,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,10969,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625112,Intermediate
,10090.0,14839,Oral bioavailability in nude mice,,10970,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875334,Intermediate
,9443.0,11219,Bioavailability in monkey (i.d. dosing),,10971,22224,Primates,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628617,Autocuration
,10116.0,9552,Bioavailability in rat,,10972,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628618,Autocuration
,,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,10973,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628619,Autocuration
,,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,10974,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628620,Autocuration
,9541.0,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,10975,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628621,Intermediate
,9541.0,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,10976,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628622,Intermediate
,9541.0,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,10977,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628623,Intermediate
,9541.0,14839,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,10978,100710,Macaca fascicularis,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628624,Intermediate
,10090.0,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10979,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628625,Intermediate
,9541.0,14839,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,10980,100710,Macaca fascicularis,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628626,Intermediate
,10090.0,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10981,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627041,Intermediate
,10090.0,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10982,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627042,Intermediate
,10090.0,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10983,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627043,Intermediate
,,13932,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,10984,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627044,Autocuration
,10090.0,11637,Cmax in mouse plasma,,10985,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627045,Intermediate
,,11637,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,10986,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627046,Autocuration
,10116.0,13960,Maximal plasma concentration in rat,,10987,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627047,Intermediate
,10116.0,15905,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,10988,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627048,Intermediate
,10116.0,14062,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,10989,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627049,Intermediate
,10116.0,14062,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,10990,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627050,Intermediate
,10116.0,14062,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,10991,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627051,Intermediate
,10116.0,14062,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,10992,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627052,Intermediate
,10116.0,14062,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,10993,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627053,Intermediate
,10116.0,14062,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,10994,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627054,Intermediate
,10090.0,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,10995,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627055,Intermediate
,10090.0,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,10996,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627056,Intermediate
,10090.0,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,10997,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627057,Intermediate
,10090.0,15011,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,10998,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627058,Intermediate
,10090.0,15011,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,10999,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626211,Intermediate
,,10291,Maximum Concentration of the compound.,,11000,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626212,Autocuration
,9615.0,14599,Maximum Concentration was measured after iv administration into Beagle dog,,11001,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626213,Intermediate
,9615.0,14599,Maximum Concentration was measured after iv administration into Beagle dog.,,11002,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626214,Intermediate
,9615.0,14599,Maximum Concentration was measured after po administration into Beagle dog,,11003,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626215,Intermediate
,9615.0,14599,Maximum Concentration was measured after po administration into Beagle dog.,,11004,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626216,Intermediate
,,12767,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,11005,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626217,Autocuration
,,12767,Maximum blood level reached after an iv dose of 12.2 uM/kg,,11006,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626218,Autocuration
,,12767,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,11007,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626219,Autocuration
,,12767,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,11008,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626220,Autocuration
,,12767,Maximum blood level reached after an oral dose of 5.0 mg/kg,,11009,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626221,Autocuration
,,12767,Maximum blood level reached at dose of 10.6 uM/kg orally,,11010,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626222,Autocuration
,10141.0,14706,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,11011,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626223,Intermediate
,10141.0,14706,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,11012,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626224,Intermediate
,10116.0,14793,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,11013,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626225,Intermediate
,10116.0,14793,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,11014,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626226,Intermediate
,10116.0,14793,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,11015,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626227,Intermediate
,10116.0,14793,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,11016,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626228,Intermediate
,10116.0,14793,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,11017,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626229,Intermediate
,10116.0,14793,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,11018,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626921,Intermediate
,10116.0,14793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,11019,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876793,Intermediate
,10116.0,14793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,11020,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625309,Intermediate
,1423.0,10524,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,11021,50278,Bacillus subtilis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625310,Intermediate
,314293.0,11871,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,11022,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625311,Autocuration
,10116.0,11871,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,11023,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625312,Intermediate
,,3437,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,11024,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625313,Autocuration
,10090.0,12038,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,11025,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625314,Intermediate
,10116.0,12038,Maximum concentration in male rats after iv administration of 20 mg/kg,,11026,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625315,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,11027,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625316,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,11028,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625317,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,11029,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625318,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,11030,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625319,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,11031,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625320,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,11032,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625321,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,11033,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625322,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,11034,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876801,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,11035,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625323,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,11036,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625324,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,11037,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625325,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,11038,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625326,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,11039,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625327,Intermediate
,10116.0,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,11040,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625328,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,11041,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625329,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,11042,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625330,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,11043,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627774,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,11044,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627775,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,11045,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627949,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,11046,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627950,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,11047,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627951,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,11048,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627952,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,11049,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627953,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,11050,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627954,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,11051,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627955,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,11052,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627956,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,11053,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876802,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,11054,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627957,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,11055,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627958,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,11056,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627959,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,11057,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627960,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,11058,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627961,Intermediate
,10116.0,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,11059,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627962,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,11060,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627963,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,11061,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624759,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,11062,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624760,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,11063,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624761,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,11064,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877607,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,11065,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624762,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,11066,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624763,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,11067,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624764,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,11068,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624765,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,11069,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624766,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,11070,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624767,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,11071,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624768,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,11072,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624769,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,11073,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624770,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,11074,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624771,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,11075,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624772,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,11076,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624773,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,11077,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624774,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,11078,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624775,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,11079,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624776,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,11080,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624777,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,11081,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624778,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,11082,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624779,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,11083,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624780,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,11084,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624781,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,11085,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877608,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,11086,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624782,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,11087,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624783,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,11088,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624784,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,11089,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624785,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,11090,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624786,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,11091,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624787,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,11092,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628676,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,11093,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621842,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,11094,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL621843,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,11095,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623873,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,11096,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623874,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,11097,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623875,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,11098,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623876,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,11099,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623877,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,11100,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623878,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,11101,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623879,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,11102,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623880,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,11103,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623881,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,11104,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623957,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,11105,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623958,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,11106,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623959,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,11107,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623960,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,11108,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623961,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,11109,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623962,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,11110,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624676,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,11111,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624677,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,11112,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624678,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,11113,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624679,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,11114,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624680,Intermediate
,,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,11115,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624849,Autocuration
,,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,11116,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624850,Autocuration
,,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,11117,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL874399,Autocuration
,,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,11118,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624851,Autocuration
,,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,11119,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624852,Autocuration
,10116.0,13359,Oral bioavailability in rat (dose 10 mg/kg),,11120,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624853,Autocuration
,10116.0,16618,Oral bioavailability in rat (Sprague-Dawley),,11121,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624854,Autocuration
,10116.0,13960,Oral bioavailability in rat,,11122,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624855,Autocuration
,10116.0,13917,Oral bioavailability in rats was determined in vivo,,11123,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624856,Autocuration
,9615.0,14266,Oral bioavailability in dog,,11124,22224,Canis lupus familiaris,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL882957,Autocuration
,314293.0,12359,Oral bioavailability of compound in monkey,,11125,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL624857,Autocuration
,10116.0,12359,Oral bioavailability of compound in rat,,11126,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622202,Intermediate
,10116.0,12359,Bioavailability in rat of PMEA prodrug,,11127,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622203,Autocuration
,10116.0,12359,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,11128,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625522,Intermediate
,9544.0,10791,Serum conc at 3 hours following 25 mg/kg dose,,11129,22224,Macaca mulatta,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622868,Autocuration
,9544.0,10791,Urine conc 0-5 hours following 25 mg/kg dose,,11130,22224,Macaca mulatta,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622869,Autocuration
,9544.0,10791,Urine conc 0-24 hours following 25 mg/kg dose,,11131,22224,Macaca mulatta,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622870,Autocuration
,9534.0,138,Oral bioavailability in African green monkeys; 20-25,,11132,22224,Chlorocebus aethiops,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622871,Autocuration
,9541.0,14521,Oral bioavailability in cynomolgus monkey.,,11133,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620560,Intermediate
,9615.0,13953,Oral bioavailability in dog,,11134,22224,Canis lupus familiaris,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620561,Autocuration
,9615.0,12836,Oral bioavailability in dog at 10 mg/kg oral dose,,11135,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620562,Intermediate
,10026.0,12836,Oral bioavailability in hamster at 10 mg/kg oral dose,,11136,100712,Cricetinae,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620563,Intermediate
,10116.0,12836,Oral bioavailability in rat at 10 mg/kg oral dose,,11137,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620564,Intermediate
,10116.0,14521,Oral bioavailability in rat,,11138,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL872265,Autocuration
,10116.0,13953,Oral bioavailability in rat,,11139,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620565,Autocuration
,9347.0,6799,Oral bioavailability,,11140,22224,Eutheria,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620566,Autocuration
,,11311,Oral bioavailability was determined; range 49-102%,,11141,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620567,Autocuration
,9615.0,4013,Oral bioavailability was determined in dogs,,11142,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620568,Intermediate
,10116.0,4013,Oral bioavailability in rat,,11143,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620569,Autocuration
,9347.0,17591,Oral bioavailability,,11144,22224,Eutheria,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620570,Autocuration
,,17591,Oral bioavailability was determined; Not orally available,,11145,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620571,Autocuration
,10090.0,15011,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,11146,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL620572,Intermediate
,10090.0,15011,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,11147,22224,Mus musculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620573,Autocuration
,10090.0,15011,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,11148,22224,Mus musculus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620574,Autocuration
,9544.0,9552,Oral bioavailability in Rhesus monkey,,11149,22224,Macaca mulatta,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620575,Autocuration
,9615.0,9552,Oral bioavailability in dog (female mongrel),,11150,22224,Canis lupus familiaris,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620576,Autocuration
,,3639,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,11151,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL875846,Autocuration
,9615.0,13397,Oral bioavailability in dog,,11152,22224,Canis lupus familiaris,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620577,Autocuration
,,3031,Percentage Bioavailability was evaluated.,,11153,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620578,Autocuration
,10116.0,12818,Bioavailability in rat administered i.d.,,11154,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL620579,Autocuration
,9347.0,4847,Bioavailability,,11155,22224,Eutheria,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL621248,Autocuration
,9615.0,12421,Bioavailability in dog (male Beagle) i.v. administration,,11156,22224,Canis lupus familiaris,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625390,Autocuration
,10116.0,11966,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,11157,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625391,Autocuration
,9443.0,11218,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,11158,22224,Primates,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL872266,Autocuration
,10116.0,13129,Oral bioavailability in rat (Sprague-Dawley) (male),,11159,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625392,Autocuration
,10116.0,12350,The oral bioavailability was measured on rats after oral administration,,11160,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625393,Intermediate
,10116.0,2231,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,11161,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625394,Intermediate
,9544.0,2231,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,11162,50797,Macaca mulatta,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625395,Intermediate
,10116.0,12187,Bioavailability in rat (dose 10 mg/kg i.d.),,11163,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625396,Autocuration
,9615.0,12421,Bioavailability in dog (male Beagle) i.v. administration,,11164,22224,Canis lupus familiaris,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625397,Autocuration
,10090.0,13256,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11165,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625398,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,11166,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625399,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11167,50594,Mus musculus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626074,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,11168,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626075,Intermediate
,10116.0,2231,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,11169,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626076,Intermediate
,9544.0,2231,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,11170,50797,Macaca mulatta,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626077,Intermediate
,10116.0,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,11171,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626078,Intermediate
,,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,11172,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625846,Autocuration
,,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,11173,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625847,Autocuration
,10116.0,15633,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,11174,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625848,Expert
,10116.0,14258,Maximum concentration of compound in plasma administered orally to rats,,11175,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625849,Intermediate
,9615.0,14224,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,11176,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626023,Intermediate
,9615.0,14224,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,11177,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626024,Intermediate
,9615.0,14224,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,11178,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626025,Intermediate
,,5566,Maximum concentration after 10 mg/kg by oral administration,,11179,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626026,Autocuration
,,16935,Maximum concentration at a dose of 1.5 mg/kg,,11180,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626027,Autocuration
,,16935,Maximum concentration at a dose of 2.0 mg/kg,,11181,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626028,Autocuration
,9615.0,14224,Maximum concentration in dog plasma,,11182,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626029,Intermediate
,,12536,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,11183,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626030,Autocuration
,,12536,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,11184,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626031,Autocuration
,,12536,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,11185,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626032,Autocuration
,,12536,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,11186,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626033,Autocuration
,,12536,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,11187,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626034,Autocuration
,9615.0,9994,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,11188,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626035,Intermediate
,,1434,Maximum concentration in plasma at Tmax,,11189,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626036,Autocuration
,9615.0,12836,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,11190,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626037,Expert
,10026.0,12836,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,11191,100712,Cricetinae,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626038,Intermediate
,10116.0,12836,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,11192,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626039,Intermediate
,10116.0,12545,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,11193,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626040,Intermediate
,9986.0,13856,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,11194,50592,Oryctolagus cuniculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626041,Intermediate
,,3550,Maximum concentration was calculated,,11195,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626042,Autocuration
,,2632,Maximum concentration was calculated.,,11196,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626043,Autocuration
,,5566,Maximum concentration at a peroral dose of 10 mg/kg,,11197,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626044,Autocuration
,,11883,Maximum concentration of the drug at 10 uM/dg administered perorally,,11198,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626045,Autocuration
,,11883,Maximum concentration of the drug at 2 uM/dg administered intravenously,,11199,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626046,Autocuration
,9615.0,14122,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,11200,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626047,Intermediate
,10026.0,14122,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,11201,100712,Cricetinae,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626048,Intermediate
,10116.0,14122,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,11202,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626049,Intermediate
,10116.0,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,11203,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626050,Intermediate
,9615.0,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,11204,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874541,Intermediate
,10026.0,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,11205,100712,Cricetinae,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622826,Intermediate
,10026.0,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,11206,100712,Cricetinae,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622827,Intermediate
,10116.0,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,11207,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622828,Intermediate
,10116.0,14080,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,11208,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622829,Intermediate
,10116.0,11911,Maximum concentration reached following intravenous administration in male rat,,11209,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876806,Intermediate
,9615.0,13204,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,11210,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622830,Intermediate
,10116.0,13204,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,11211,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622831,Intermediate
,9615.0,14346,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,11212,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626794,Intermediate
,10116.0,14346,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,11213,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626795,Intermediate
,10116.0,14346,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,11214,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626796,Intermediate
,10116.0,14346,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,11215,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626797,Intermediate
,10116.0,14127,Maximum drug concentration is determined after oral dosing in rats.,,11216,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626798,Intermediate
,9615.0,14339,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,11217,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626799,Intermediate
,9615.0,14339,Maximum observed concentration in oral (5 mg/kg) fed dogs,,11218,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626800,Intermediate
,,13494,Maximum plasma concentration,,11219,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626801,Autocuration
,10116.0,14925,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,11220,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876816,Intermediate
,10116.0,14474,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,11221,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626802,Intermediate
,9615.0,14474,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,11222,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626803,Intermediate
,,13917,Maximum plasma concentration following oral administration of 30 umol/kg,,11223,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626804,Autocuration
,10116.0,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,11224,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626805,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,11225,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626309,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,11226,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626310,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,11227,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626311,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,11228,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626312,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,11229,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626313,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,11230,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626314,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,11231,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626315,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,11232,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626316,Intermediate
,10116.0,9796,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,11233,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626317,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,11234,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626318,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,11235,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626319,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,11236,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626320,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,11237,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875053,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,11238,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626321,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,11239,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626322,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,11240,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626323,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,11241,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626324,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,11242,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626325,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,11243,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626326,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,11244,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626327,Intermediate
,10116.0,8363,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,11245,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626328,Intermediate
,10116.0,8684,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,11246,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626329,Intermediate
,10116.0,8684,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,11247,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626330,Intermediate
,10116.0,8684,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,11248,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626331,Intermediate
,10116.0,8684,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,11249,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626332,Intermediate
,10116.0,8684,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,11250,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626333,Intermediate
,10116.0,8684,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,11251,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626334,Intermediate
,10116.0,8684,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,11252,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626335,Intermediate
,10116.0,8684,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,11253,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624798,Intermediate
,10116.0,8684,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,11254,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624799,Intermediate
,10116.0,8684,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,11255,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624800,Intermediate
,10116.0,8684,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,11256,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624801,Intermediate
,10116.0,8684,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,11257,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624802,Intermediate
,10116.0,8684,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,11258,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624803,Intermediate
,10116.0,8684,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,11259,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624804,Intermediate
,10116.0,8684,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,11260,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624805,Intermediate
,10116.0,8684,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,11261,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624806,Intermediate
,10116.0,8684,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,11262,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624807,Intermediate
,10116.0,8684,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,11263,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624808,Intermediate
,10116.0,8684,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,11264,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624809,Intermediate
,10116.0,8684,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,11265,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624810,Intermediate
,10116.0,8684,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,11266,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877618,Intermediate
,10116.0,8684,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,11267,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624811,Intermediate
,10116.0,8684,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,11268,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624812,Intermediate
,10116.0,8684,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,11269,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624813,Intermediate
,10116.0,8684,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,11270,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624814,Intermediate
,10116.0,8684,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,11271,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624815,Intermediate
,10116.0,8684,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,11272,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624816,Intermediate
,10116.0,8684,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,11273,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624817,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,11274,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624818,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,11275,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624819,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,11276,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624820,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,11277,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624821,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,11278,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624822,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,11279,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624823,Intermediate
,562.0,15599,Observed diffusion coefficient in organic solvent for Escherichia coli,,11280,50212,Escherichia coli,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624824,Intermediate
,10116.0,9614,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11281,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624825,Intermediate
,10116.0,9614,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11282,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624826,Intermediate
,10116.0,9614,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11283,50597,Rattus norvegicus,,,Cardiac atrium,2081.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876817,Intermediate
,10116.0,9614,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11284,50597,Rattus norvegicus,,,Cardiac atrium,2081.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624827,Intermediate
,10116.0,9614,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11285,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624828,Intermediate
,10116.0,9614,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11286,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624829,Intermediate
,10116.0,9614,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11287,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624830,Intermediate
,10116.0,9614,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11288,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624831,Intermediate
,10116.0,9614,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11289,50597,Rattus norvegicus,,,Cardiac atrium,2081.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624832,Intermediate
,10116.0,9614,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11290,50597,Rattus norvegicus,,,Cardiac atrium,2081.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624833,Intermediate
,10116.0,9614,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11291,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624834,Intermediate
,10116.0,9614,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11292,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624835,Intermediate
,10116.0,9614,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11293,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624836,Intermediate
,10116.0,9614,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11294,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624837,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,11295,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624838,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,11296,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622188,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,11297,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622189,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,11298,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622190,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,11299,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625170,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,11300,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625171,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,11301,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625172,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,11302,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625173,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,11303,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625174,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,11304,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625175,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,11305,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625176,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,11306,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625177,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,11307,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625178,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,11308,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625179,Intermediate
,10116.0,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,11309,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625180,Intermediate
,,10677,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,11310,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625181,Autocuration
,10090.0,9750,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,11311,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625182,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,11312,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625183,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,11313,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875848,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,11314,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622260,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,11315,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622261,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,11316,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622262,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,11317,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622263,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,11318,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622418,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,11319,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622419,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,11320,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623388,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,11321,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623389,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,11322,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623390,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11323,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623391,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,11324,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623392,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11325,50594,Mus musculus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623393,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,11326,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623394,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,11327,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618885,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,11328,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618886,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,11329,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL618887,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,11330,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619535,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,11331,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619536,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,11332,50594,Mus musculus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619537,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,11333,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619705,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,11334,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619706,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,11335,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619707,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,11336,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619708,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11337,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625219,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,11338,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625220,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11339,50594,Mus musculus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625221,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,11340,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625222,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,11341,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625223,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,11342,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625224,Intermediate
,10090.0,13256,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,11343,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625225,Intermediate
,10116.0,8829,Biodistribution in Rat blood after 24 hours of iv administration,,11344,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625226,Intermediate
,10116.0,8829,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,11345,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625227,Intermediate
,10116.0,8829,Biodistribution in Rat blood after 30 minutes of iv administration,,11346,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625228,Intermediate
,10116.0,8829,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,11347,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875354,Intermediate
,10116.0,8829,Biodistribution in Rat blood after 5 minutes of iv administration,,11348,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625229,Intermediate
,10116.0,8829,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,11349,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625230,Intermediate
,10116.0,8829,Biodistribution in Rat heart after 24 hours of iv administration,,11350,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625231,Intermediate
,10116.0,8829,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,11351,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625900,Intermediate
,10116.0,8829,Biodistribution in Rat heart after 30 minutes of iv administration,,11352,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625901,Intermediate
,10116.0,8829,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,11353,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625902,Intermediate
,10116.0,8829,Biodistribution in Rat heart after 5 minutes of iv administration,,11354,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625903,Intermediate
,10116.0,8829,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,11355,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625904,Intermediate
,10116.0,8829,Biodistribution in Rat liver after 24 hours of iv administration,,11356,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625905,Intermediate
,10116.0,8829,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,11357,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627861,Intermediate
,10116.0,8829,Biodistribution in Rat liver after 30 minutes of iv administration,,11358,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627862,Intermediate
,10116.0,8829,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,11359,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627863,Intermediate
,10116.0,8829,Biodistribution in Rat liver after 30 minutes of iv administration,,11360,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627769,Intermediate
,9615.0,13249,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,11361,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627770,Intermediate
,9541.0,13622,Cmax in cynomolgus monkey (PO dose),,11362,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627771,Intermediate
,10116.0,13622,Cmax in rat (PO dose),,11363,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627772,Intermediate
,10116.0,13622,Cmax in rat (PO dose),,11364,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627773,Intermediate
,10116.0,13494,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,11365,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621922,Intermediate
,10116.0,12170,Cmax in rat plasma after oral dose (10 mg/kg),,11366,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621923,Intermediate
,,12170,Cmax in plasma after oral dose (10 mg/kg),,11367,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL621924,Autocuration
,9615.0,17025,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,11368,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621925,Intermediate
,314293.0,17025,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,11369,22224,Simiiformes,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL621926,Autocuration
,9986.0,17025,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,11370,50592,Oryctolagus cuniculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621927,Intermediate
,10116.0,17025,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,11371,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621928,Intermediate
,10116.0,14187,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,11372,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621929,Intermediate
,10090.0,14816,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,11373,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621930,Intermediate
,10116.0,17820,Maximum plasma concentration after oral dosing in rat,,11374,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621931,Intermediate
,,14380,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,11375,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL621932,Autocuration
,,14380,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,11376,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL621933,Autocuration
,9615.0,14691,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,11377,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621934,Intermediate
,9615.0,14691,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,11378,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621935,Intermediate
,10116.0,13375,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,11379,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL621936,Intermediate
,,6236,Maximum plasma concentration was determined,,11380,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL621937,Autocuration
,,14380,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,11381,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL621938,Autocuration
,,14380,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,11382,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL621939,Autocuration
,,14380,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,11383,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL621940,Autocuration
,,14380,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,11384,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL621941,Autocuration
,,14380,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,11385,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL621942,Autocuration
,,14380,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,11386,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626178,Autocuration
,,14380,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,11387,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626179,Autocuration
,,14380,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,11388,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626180,Autocuration
,10116.0,13622,Plasma Cmax in rat (PO dose),,11389,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626181,Intermediate
,10116.0,15372,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,11390,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626182,Intermediate
,10116.0,15372,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,11391,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626183,Intermediate
,10116.0,15372,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,11392,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626184,Intermediate
,10116.0,15372,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,11393,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626185,Intermediate
,9615.0,14925,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,11394,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626186,Intermediate
,9615.0,14925,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,11395,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877589,Intermediate
,,11883,Maximum concentration of the drug at 1 uM/dg administered intravenously,,11396,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626187,Autocuration
,,11883,Maximum concentration of the drug at 20 uM/dg administered perorally,,11397,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626188,Autocuration
,,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,11398,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626189,Autocuration
,,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,11399,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626855,Autocuration
,,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,11400,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623781,Autocuration
,,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,11401,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623782,Autocuration
,10116.0,16360,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,11402,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623783,Intermediate
,9615.0,3673,Cmax in dog plasma after 1mg/kg oral dose,,11403,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623784,Intermediate
,9615.0,14431,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,11404,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623785,Intermediate
,10116.0,14431,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,11405,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623786,Intermediate
,10116.0,14964,Oral maximum concentration in rat,,11406,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623787,Intermediate
,10116.0,14964,Oral maximum concentration in rat,,11407,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623788,Intermediate
,10090.0,14209,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,11408,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623789,Intermediate
,10090.0,11355,Peak concentration in blood after intravenous administration to mice,,11409,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623790,Intermediate
,10090.0,11355,Peak concentration in blood after peroral administration to mice,,11410,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623791,Intermediate
,10116.0,11966,Peak concentration in rat plasma was determined,,11411,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623792,Intermediate
,314293.0,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,11412,22224,Simiiformes,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623793,Autocuration
,10090.0,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,11413,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623794,Intermediate
,10116.0,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,11414,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623795,Intermediate
,10116.0,8684,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,11415,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623796,Intermediate
,10116.0,8684,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,11416,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623797,Intermediate
,10116.0,8684,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,11417,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623798,Intermediate
,10116.0,8684,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,11418,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623799,Intermediate
,10116.0,8684,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,11419,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624490,Intermediate
,10116.0,8684,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,11420,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624491,Intermediate
,10116.0,8684,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,11421,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624492,Intermediate
,10116.0,8684,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,11422,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624493,Intermediate
,10116.0,8684,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,11423,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL877595,Intermediate
,10116.0,8684,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,11424,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624494,Intermediate
,10116.0,8684,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,11425,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624495,Intermediate
,10116.0,8684,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,11426,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624681,Intermediate
,10116.0,8684,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,11427,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624682,Intermediate
,10116.0,8684,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,11428,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624683,Intermediate
,10116.0,8684,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,11429,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624684,Intermediate
,10116.0,8684,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,11430,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624685,Intermediate
,10116.0,8684,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,11431,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624686,Intermediate
,10116.0,8684,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,11432,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624687,Intermediate
,10116.0,8684,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,11433,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624688,Intermediate
,10116.0,8684,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,11434,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627161,Intermediate
,10116.0,8684,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,11435,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622127,Intermediate
,10116.0,8684,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,11436,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622128,Intermediate
,10116.0,8684,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,11437,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874384,Intermediate
,10116.0,8684,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,11438,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624898,Intermediate
,10116.0,8684,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,11439,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624899,Intermediate
,10116.0,8684,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,11440,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624900,Intermediate
,10116.0,8684,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,11441,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624901,Intermediate
,10116.0,8684,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,11442,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624902,Intermediate
,10116.0,8684,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,11443,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624903,Intermediate
,10116.0,8684,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,11444,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624904,Intermediate
,10116.0,8684,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,11445,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624905,Intermediate
,10116.0,8684,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,11446,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624906,Intermediate
,10116.0,8684,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,11447,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624907,Intermediate
,10116.0,8684,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,11448,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624908,Intermediate
,10116.0,8684,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,11449,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624909,Intermediate
,10116.0,8684,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,11450,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624910,Intermediate
,10116.0,8684,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,11451,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624911,Intermediate
,10116.0,8684,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,11452,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874388,Intermediate
,10116.0,8684,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,11453,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624912,Intermediate
,10116.0,8684,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,11454,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622930,Intermediate
,10116.0,8684,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,11455,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623121,Intermediate
,10116.0,8684,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,11456,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623122,Intermediate
,10116.0,8684,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,11457,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623123,Intermediate
,10116.0,8684,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,11458,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623124,Intermediate
,10116.0,8684,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,11459,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623125,Intermediate
,10116.0,8684,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,11460,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623126,Intermediate
,10116.0,8684,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,11461,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623127,Intermediate
,10116.0,8684,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,11462,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623128,Intermediate
,10116.0,8684,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,11463,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623129,Intermediate
,10116.0,8684,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,11464,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623130,Intermediate
,10116.0,8684,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,11465,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623131,Intermediate
,10116.0,8684,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,11466,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623132,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,11467,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623133,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,11468,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623134,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,11469,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874389,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,11470,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623135,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,11471,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623136,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,11472,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623137,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,11473,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623138,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,11474,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623139,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,11475,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623140,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,11476,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623141,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,11477,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623142,Intermediate
,10116.0,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,11478,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623143,Intermediate
,10090.0,14571,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,11479,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623144,Intermediate
,10116.0,14571,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,11480,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623405,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,11481,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624074,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,11482,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624075,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,11483,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624076,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,11484,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624077,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,11485,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624078,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,11486,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624079,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,11487,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624261,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,11488,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624262,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,11489,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624263,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,11490,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624264,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,11491,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624265,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,11492,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624266,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,11493,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624267,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,11494,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624268,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,11495,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875227,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,11496,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624269,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,11497,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624270,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,11498,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624271,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,11499,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624272,Intermediate
,10116.0,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,11500,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624273,Intermediate
,10116.0,12064,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,11501,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624274,Intermediate
,10116.0,12064,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,11502,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624275,Intermediate
,10116.0,12064,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,11503,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624276,Intermediate
,10116.0,12038,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,11504,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624277,Intermediate
,,14314,% dose converted to 2-amino-5-chlorophenyl sulfate,,11505,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624278,Autocuration
,,14314,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,11506,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624279,Autocuration
,10116.0,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,11507,50597,Rattus norvegicus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624280,Intermediate
,10116.0,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,11508,50597,Rattus norvegicus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624281,Intermediate
,10116.0,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,11509,50597,Rattus norvegicus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622933,Intermediate
,10116.0,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,11510,50597,Rattus norvegicus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622934,Intermediate
,10116.0,8829,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,11511,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622935,Intermediate
,10116.0,8829,Biodistribution in Rat liver after 5 minutes of iv administration,,11512,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622936,Intermediate
,10116.0,8829,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,11513,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875228,Intermediate
,10116.0,8829,Biodistribution in Rat lung after 24 hours of iv administration,,11514,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622937,Intermediate
,10116.0,8829,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,11515,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622938,Intermediate
,10116.0,8829,Biodistribution in Rat lung after 30 minutes of iv administration,,11516,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL619736,Intermediate
,10116.0,8829,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,11517,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625117,Intermediate
,10116.0,8829,Biodistribution in Rat lung after 5 minutes of iv administration,,11518,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625118,Intermediate
,10116.0,8829,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,11519,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625119,Intermediate
,10116.0,14972,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,11520,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625120,Intermediate
,10116.0,14972,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,11521,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625121,Intermediate
,10116.0,14972,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,11522,50597,Rattus norvegicus,,,Thalamus,10000006.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625122,Intermediate
,10116.0,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11523,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622204,Intermediate
,10116.0,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11524,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877503,Intermediate
,10116.0,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11525,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627127,Intermediate
,,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11526,22224,,,,Hippocampus,10000000.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627128,Autocuration
,,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11527,22224,,,,Hippocampus,10000000.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627129,Autocuration
,,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11528,22224,,,,Hippocampus,10000000.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627130,Autocuration
,10116.0,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11529,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627131,Intermediate
,10116.0,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11530,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627132,Intermediate
,10116.0,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11531,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627133,Intermediate
,10116.0,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11532,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627134,Intermediate
,10116.0,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11533,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627135,Intermediate
,10116.0,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11534,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627136,Intermediate
,10116.0,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11535,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628435,Intermediate
,10116.0,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11536,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628436,Intermediate
,10116.0,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11537,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628437,Intermediate
,10116.0,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11538,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628438,Intermediate
,10116.0,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11539,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628439,Intermediate
,10116.0,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11540,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628440,Intermediate
,10116.0,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11541,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628441,Intermediate
,10116.0,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11542,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628442,Intermediate
,10116.0,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11543,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628443,Intermediate
,10116.0,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11544,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628444,Intermediate
,10116.0,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11545,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628445,Intermediate
,10116.0,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11546,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877504,Intermediate
,10116.0,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11547,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628446,Intermediate
,10116.0,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11548,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626874,Intermediate
,10116.0,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11549,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626875,Intermediate
,10116.0,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11550,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626876,Intermediate
,10116.0,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11551,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626877,Intermediate
,10116.0,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11552,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626878,Intermediate
,10116.0,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11553,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626879,Intermediate
,314293.0,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,11554,22224,Simiiformes,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626880,Autocuration
,10090.0,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,11555,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626881,Intermediate
,10116.0,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,11556,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626882,Intermediate
,9615.0,14470,Peak plasma concentration was measured in dogs,,11557,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626883,Intermediate
,10116.0,14393,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,11558,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626884,Intermediate
,10116.0,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,11559,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626885,Intermediate
,10116.0,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,11560,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626886,Intermediate
,10116.0,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,11561,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626887,Intermediate
,10116.0,14393,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,11562,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626888,Intermediate
,9615.0,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,11563,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626889,Intermediate
,314293.0,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,11564,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626761,Autocuration
,9615.0,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,11565,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626762,Intermediate
,9615.0,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,11566,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626763,Intermediate
,10116.0,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,11567,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626764,Intermediate
,10116.0,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,11568,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626765,Intermediate
,9615.0,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,11569,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626766,Intermediate
,10116.0,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,11570,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626767,Intermediate
,10116.0,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,11571,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626768,Intermediate
,9615.0,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,11572,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626769,Intermediate
,9615.0,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,11573,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874463,Intermediate
,314293.0,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,11574,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626770,Autocuration
,314293.0,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,11575,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626771,Autocuration
,10116.0,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,11576,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626772,Intermediate
,9541.0,14731,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,11577,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626773,Intermediate
,10090.0,14731,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,11578,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626774,Intermediate
,9615.0,13376,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,11579,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626775,Intermediate
,9615.0,13376,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,11580,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626776,Intermediate
,10116.0,14443,Maximum concentration (Cmax) in rat when administered orally,,11581,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626777,Intermediate
,314293.0,13465,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,11582,22224,Simiiformes,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626778,Autocuration
,10116.0,16359,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,11583,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626779,Autocuration
,10116.0,16359,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,11584,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626780,Autocuration
,,15618,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,11585,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626781,Autocuration
,10116.0,14554,Pharmacokinetic profile Cmax was evaluated in rats,,11586,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632164,Intermediate
,9615.0,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,11587,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632165,Intermediate
,10090.0,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,11588,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632166,Intermediate
,9615.0,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,11589,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632167,Intermediate
,10090.0,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,11590,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632168,Intermediate
,10116.0,2021,Cmax in rat plasma,,11591,22224,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL632169,Autocuration
,9615.0,5932,Cmax in dog plasma after 30mg/kg oral dose,,11592,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632170,Intermediate
,10116.0,5932,Cmax in rat plasma after 30mg/kg oral dose,,11593,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632171,Intermediate
,10116.0,17320,Plasma level in rats at 30 mg/kg,,11594,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632172,Intermediate
,10090.0,15831,Tested for maximum plasma concentration in mice,,11595,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632173,Intermediate
,10116.0,15078,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,11596,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632174,Intermediate
,10116.0,14941,The Cmax values in female wistar rats.,,11597,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632175,Intermediate
,9615.0,15343,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,11598,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632176,Intermediate
,10116.0,15343,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,11599,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632177,Intermediate
,10116.0,14856,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,11600,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632178,Intermediate
,10116.0,13129,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,11601,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632179,Intermediate
,10116.0,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,11602,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632180,Intermediate
,10116.0,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,11603,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632181,Intermediate
,10116.0,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,11604,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632182,Intermediate
,10090.0,15478,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,11605,22224,Mus musculus,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL632183,Autocuration
,9615.0,15341,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,11606,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632184,Intermediate
,10116.0,15341,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,11607,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874470,Intermediate
,10116.0,8684,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,11608,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631302,Intermediate
,10116.0,8684,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,11609,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631303,Intermediate
,10116.0,8684,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,11610,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631304,Intermediate
,10116.0,8684,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,11611,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631305,Intermediate
,10116.0,8684,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,11612,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631306,Intermediate
,10116.0,8684,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,11613,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631307,Intermediate
,10116.0,8684,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,11614,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631308,Intermediate
,10116.0,8684,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,11615,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625557,Intermediate
,10116.0,8684,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,11616,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625558,Intermediate
,10116.0,8684,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,11617,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625559,Intermediate
,10116.0,8684,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,11618,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625560,Intermediate
,10116.0,8684,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,11619,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625561,Intermediate
,10116.0,8684,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,11620,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625562,Intermediate
,10116.0,8684,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,11621,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875320,Intermediate
,10116.0,8684,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,11622,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625563,Intermediate
,10116.0,8684,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,11623,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625564,Intermediate
,10116.0,8684,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,11624,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625565,Intermediate
,10116.0,8684,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,11625,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625566,Intermediate
,10116.0,8684,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,11626,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625567,Intermediate
,10116.0,8684,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,11627,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625568,Intermediate
,10116.0,8684,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,11628,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628217,Intermediate
,10116.0,8684,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,11629,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628218,Intermediate
,10116.0,8684,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,11630,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628219,Intermediate
,10116.0,8684,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,11631,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628220,Intermediate
,,8926,Distribution in the blood after 120 min of intravenous administration,,11632,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628221,Autocuration
,,8926,Distribution in the blood after 15 min of intravenous administration,,11633,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628222,Autocuration
,,8926,Distribution in the blood after 30 min of intravenous administration,,11634,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628223,Autocuration
,,8926,Distribution in the blood after 5 min of intravenous administration,,11635,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628224,Autocuration
,,8926,Distribution in the blood after 60 min of intravenous administration,,11636,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628225,Autocuration
,,8926,Distribution in the blood after 90 min of intravenous administration,,11637,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628226,Autocuration
,,8926,Distribution in the bone after 120 min of intravenous administration,,11638,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628227,Autocuration
,,8926,Distribution in the bone after 15 min of intravenous administration,,11639,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL875481,Autocuration
,,8926,Distribution in the bone after 30 min of intravenous administration,,11640,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628228,Autocuration
,,8926,Distribution in the bone after 5 min of intravenous administration,,11641,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628229,Autocuration
,,8926,Distribution in the bone after 60 min of intravenous administration,,11642,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628230,Autocuration
,,8926,Distribution in the bone after 90 min of intravenous administration,,11643,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628231,Autocuration
,,8926,Distribution in the heart after 120 min of intravenous administration,,11644,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628232,Autocuration
,,8926,Distribution in the heart after 15 min of intravenous administration,,11645,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628233,Autocuration
,,8926,Distribution in the heart after 30 min of intravenous administration,,11646,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628234,Autocuration
,,8926,Distribution in the heart after 5 min of intravenous administration,,11647,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628235,Autocuration
,,8926,Distribution in the heart after 60 min of intravenous administration,,11648,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628236,Autocuration
,,8926,Distribution in the heart after 90 min of intravenous administration,,11649,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628237,Autocuration
,,8926,Distribution in the kidneys after 120 min of intravenous administration,,11650,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628238,Autocuration
,,8926,Distribution in the kidneys after 15 min of intravenous administration,,11651,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628239,Autocuration
,,8926,Distribution in the kidneys after 30 min of intravenous administration,,11652,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628240,Autocuration
,,8926,Distribution in the kidneys after 5 min of intravenous administration,,11653,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628241,Autocuration
,,8926,Distribution in the kidneys after 60 min of intravenous administration,,11654,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628242,Autocuration
,,8926,Distribution in the kidneys after 90 min of intravenous administration,,11655,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL875482,Autocuration
,,8926,Distribution in the liver after 120 min of intravenous administration,,11656,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628243,Autocuration
,,8926,Distribution in the liver after 15 min of intravenous administration,,11657,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628244,Autocuration
,,8926,Distribution in the liver after 30 min of intravenous administration,,11658,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628245,Autocuration
,,8926,Distribution in the liver after 5 min of intravenous administration,,11659,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628246,Autocuration
,,8926,Distribution in the liver after 60 min of intravenous administration,,11660,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628247,Autocuration
,,8926,Distribution in the liver after 90 min of intravenous administration,,11661,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628248,Autocuration
,,8926,Distribution in the lung after 120 min of intravenous administration,,11662,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628249,Autocuration
,10090.0,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,11663,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625452,Intermediate
,10090.0,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,11664,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625453,Intermediate
,10090.0,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,11665,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625454,Intermediate
,10090.0,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,11666,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623844,Intermediate
,10116.0,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,11667,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623845,Intermediate
,10116.0,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,11668,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623846,Intermediate
,,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,11669,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL623847,Autocuration
,9541.0,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,11670,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623848,Intermediate
,9541.0,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,11671,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623849,Intermediate
,9541.0,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,11672,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623850,Intermediate
,9541.0,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,11673,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623851,Intermediate
,314293.0,12187,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,11674,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL623852,Autocuration
,9669.0,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,11675,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624551,Intermediate
,9669.0,12187,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,11676,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624552,Intermediate
,314293.0,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,11677,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL624553,Autocuration
,314293.0,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,11678,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL624554,Autocuration
,10116.0,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,11679,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624555,Intermediate
,10116.0,12187,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,11680,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624741,Intermediate
,9615.0,14122,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,11681,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624742,Intermediate
,10026.0,14122,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,11682,100712,Cricetinae,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624743,Intermediate
,10116.0,14122,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,11683,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877606,Intermediate
,,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,11684,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL624744,Autocuration
,,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,11685,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,,CHEMBL624745,Autocuration
,,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,11686,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,,CHEMBL624746,Autocuration
,,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,11687,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,,CHEMBL624747,Autocuration
,,16360,Oral absorption expressed as Area under curve was determined,,11688,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624748,Autocuration
,9615.0,3673,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,11689,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622504,Intermediate
,9615.0,14122,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,11690,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622505,Intermediate
,10026.0,14122,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,11691,100712,Cricetinae,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622506,Intermediate
,10026.0,14122,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,11692,100712,Cricetinae,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622507,Intermediate
,10116.0,14122,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,11693,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622508,Intermediate
,,13889,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,11694,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622509,Autocuration
,10116.0,14393,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,11695,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622510,Intermediate
,10116.0,17279,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,11696,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622511,Intermediate
,9541.0,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,11697,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622512,Intermediate
,9541.0,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,11698,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622513,Intermediate
,9541.0,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,11699,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622514,Intermediate
,9615.0,14548,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,11700,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622515,Intermediate
,9615.0,14548,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,11701,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622516,Intermediate
,10116.0,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,11702,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622517,Intermediate
,10116.0,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,11703,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622518,Intermediate
,10116.0,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,11704,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622519,Intermediate
,10116.0,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11705,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622520,Intermediate
,10116.0,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11706,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622521,Intermediate
,10090.0,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11707,50594,Mus musculus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625113,Intermediate
,10116.0,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11708,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625114,Intermediate
,10116.0,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11709,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874397,Intermediate
,10116.0,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11710,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625115,Intermediate
,10116.0,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11711,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625116,Intermediate
,10116.0,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11712,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623932,Intermediate
,10116.0,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11713,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623933,Intermediate
,10116.0,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11714,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623934,Intermediate
,10116.0,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11715,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623935,Intermediate
,10116.0,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11716,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623936,Intermediate
,10116.0,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11717,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623937,Intermediate
,10116.0,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11718,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623938,Intermediate
,10090.0,15383,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11719,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623939,Intermediate
,10090.0,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,11720,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623940,Intermediate
,10090.0,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,11721,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623941,Intermediate
,10090.0,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11722,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627216,Intermediate
,10090.0,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11723,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623942,Intermediate
,10090.0,15383,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11724,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618793,Intermediate
,10090.0,15383,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11725,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618794,Intermediate
,10090.0,15383,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11726,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618795,Intermediate
,10090.0,15383,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11727,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618796,Intermediate
,10090.0,15383,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11728,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618797,Intermediate
,10090.0,15383,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,11729,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618798,Intermediate
,10090.0,15383,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11730,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618799,Intermediate
,10090.0,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,11731,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618800,Intermediate
,10090.0,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,11732,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618801,Intermediate
,10090.0,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11733,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618802,Intermediate
,10090.0,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11734,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618803,Intermediate
,10090.0,15383,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,11735,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618804,Intermediate
,10090.0,15383,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11736,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618805,Intermediate
,10090.0,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,11737,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618806,Intermediate
,10090.0,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,11738,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618807,Intermediate
,10090.0,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11739,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618808,Intermediate
,10090.0,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11740,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618809,Intermediate
,10090.0,15383,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11741,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618810,Intermediate
,10090.0,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,11742,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618811,Intermediate
,10090.0,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,11743,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875844,Intermediate
,10090.0,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11744,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618812,Intermediate
,10090.0,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11745,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL618813,Intermediate
,10090.0,15383,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11746,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618814,Intermediate
,10090.0,15383,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11747,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618815,Intermediate
,10090.0,15383,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11748,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618816,Intermediate
,10090.0,15383,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11749,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL618817,Intermediate
,10090.0,15383,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11750,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL620544,Intermediate
,10116.0,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,11751,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626230,Intermediate
,10116.0,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,11752,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626231,Intermediate
,10116.0,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,11753,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626232,Intermediate
,9615.0,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,11754,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626233,Intermediate
,10116.0,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,11755,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626234,Intermediate
,10116.0,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,11756,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875341,Intermediate
,9606.0,14215,The maximum plasma concentration (100 mg/kg) administered orally in human,,11757,50587,Homo sapiens,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626235,Intermediate
,9481.0,14215,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,11758,22224,Callithrix,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626236,Autocuration
,314293.0,14215,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,11759,22224,Simiiformes,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626237,Autocuration
,9615.0,14215,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,11760,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626238,Intermediate
,9606.0,14215,The maximum plasma concentration (200 mg/kg) administered orally in human,,11761,50587,Homo sapiens,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622412,Intermediate
,10116.0,14215,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,11762,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623114,Intermediate
,9481.0,14215,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,11763,22224,Callithrix,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623115,Autocuration
,314293.0,14215,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,11764,22224,Simiiformes,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623116,Autocuration
,9615.0,14215,The maximum plasma concentration (30 mg/kg) administered orally in dog,,11765,22224,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623117,Autocuration
,9606.0,14215,The maximum plasma concentration (400 mg/kg) administered orally in human,,11766,50587,Homo sapiens,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623118,Intermediate
,10116.0,14215,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,11767,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623119,Intermediate
,10116.0,14215,The maximum plasma concentration (50 mg/kg) administered orally in rat,,11768,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623120,Intermediate
,9606.0,14215,The maximum plasma concentration (800 mg/kg) administered orally in human,,11769,50587,Homo sapiens,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623286,Intermediate
,10116.0,14067,The maximum plasma concentration was measured on rats,,11770,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623287,Intermediate
,10116.0,12350,The maximum plasma concentration was measured on rats after oral administration,,11771,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623288,Intermediate
,10116.0,14813,Plasma drug Cmax in rat (PO dose),,11772,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623289,Intermediate
,,12536,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,11773,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623290,Autocuration
,9615.0,14169,maximum Plasma concentration in Dog was determined after Peroral administration,,11774,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623291,Intermediate
,10116.0,14169,maximum Plasma concentration in Rats was determined after Peroral administration,,11775,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623292,Intermediate
,9615.0,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,11776,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623293,Intermediate
,314293.0,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,11777,22224,Simiiformes,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623294,Autocuration
,10116.0,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,11778,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623295,Intermediate
,10090.0,14387,maximum concentration was measured when administered through oral route in mice,,11779,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623296,Intermediate
,10090.0,15115,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,11780,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875349,Intermediate
,314293.0,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,11781,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623297,Autocuration
,314293.0,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,11782,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623298,Autocuration
,314293.0,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,11783,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623299,Autocuration
,10116.0,16359,Pharmacokinetic parameter was evaluated in rats,,11784,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623300,Intermediate
,10090.0,12829,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,11785,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623301,Intermediate
,10090.0,12829,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,11786,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623302,Intermediate
,10090.0,12829,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,11787,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623303,Intermediate
,10090.0,12829,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,11788,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623304,Intermediate
,10090.0,12829,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,11789,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623305,Intermediate
,10116.0,15137,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,11790,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623306,Intermediate
,10116.0,15137,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,11791,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623307,Intermediate
,10116.0,15137,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,11792,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623308,Intermediate
,10090.0,15137,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,11793,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623309,Intermediate
,10090.0,13509,Plasma Concentration after 120 min of oral administration to mice,,11794,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623310,Intermediate
,10090.0,13509,Plasma Concentration after 30 min of oral administration to mice,,11795,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623311,Intermediate
,9541.0,13509,Plasma Concentration after 60 min of oral administration to mice,,11796,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623312,Intermediate
,10090.0,13509,Plasma Concentration after 60 min of oral administration to mice; Not determined,,11797,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875350,Intermediate
,10090.0,13509,Plasma Concentration after 90 min of oral administration to mice,,11798,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628635,Intermediate
,10116.0,12064,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,11799,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628636,Intermediate
,10116.0,12064,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,11800,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628637,Intermediate
,10116.0,12064,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,11801,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628058,Intermediate
,10116.0,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,11802,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628059,Intermediate
,10116.0,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,11803,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628060,Intermediate
,,8926,Distribution in the lung after 15 min of intravenous administration,,11804,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628061,Autocuration
,,8926,Distribution in the lung after 30 min of intravenous administration,,11805,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628062,Autocuration
,,8926,Distribution in the lung after 5 min of intravenous administration,,11806,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628063,Autocuration
,,8926,Distribution in the lung after 60 min of intravenous administration,,11807,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628064,Autocuration
,,8926,Distribution in the lung after 90 min of intravenous administration,,11808,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628065,Autocuration
,,8926,Distribution in the muscle after 120 min of intravenous administration,,11809,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628066,Autocuration
,,8926,Distribution in the muscle after 15 min of intravenous administration,,11810,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628067,Autocuration
,10090.0,8926,Distribution in the muscle after 30 min of intravenous administration,,11811,50594,Mus musculus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874646,Intermediate
,,8926,Distribution in the muscle after 5 min of intravenous administration,,11812,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628068,Autocuration
,,8926,Distribution in the muscle after 60 min of intravenous administration,,11813,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628069,Autocuration
,,8926,Distribution in the muscle after 90 min of intravenous administration,,11814,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628070,Autocuration
,,8926,Distribution in the spleen after 120 min of intravenous administration,,11815,22224,,,,Spleen,2106.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628071,Autocuration
,,8926,Distribution in the spleen after 15 min of intravenous administration,,11816,22224,,,,Spleen,2106.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628072,Autocuration
,,8926,Distribution in the spleen after 30 min of intravenous administration,,11817,22224,,,,Spleen,2106.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628073,Autocuration
,,8926,Distribution in the spleen after 5 min of intravenous administration,,11818,22224,,,,Spleen,2106.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628074,Autocuration
,,8926,Distribution in the spleen after 60 min of intravenous administration,,11819,22224,,,,Spleen,2106.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628075,Autocuration
,,8926,Distribution in the spleen after 90 min of intravenous administration,,11820,22224,,,,Spleen,2106.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628076,Autocuration
,10116.0,7570,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,11821,50597,Rattus norvegicus,,,Adrenal cortex,1235.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628077,Intermediate
,10116.0,7570,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,11822,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628078,Intermediate
,10116.0,7570,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,11823,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628079,Intermediate
,10116.0,7570,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,11824,50597,Rattus norvegicus,,,Female gonad,992.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628080,Intermediate
,10116.0,7570,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,11825,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628081,Intermediate
,10116.0,7570,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,11826,50597,Rattus norvegicus,,,Adrenal cortex,1235.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628082,Intermediate
,10116.0,7570,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,11827,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874647,Intermediate
,10116.0,7570,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,11828,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626406,Intermediate
,10116.0,7570,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,11829,50597,Rattus norvegicus,,,Female gonad,992.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626407,Intermediate
,10116.0,7570,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,11830,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626408,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,11831,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626409,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,11832,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626410,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,11833,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626411,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,11834,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626412,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,11835,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626413,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,11836,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626414,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,11837,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626415,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,11838,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626416,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,11839,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627062,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,11840,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627063,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,11841,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627064,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,11842,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627227,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,11843,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627228,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,11844,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627229,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,11845,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625792,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,11846,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625793,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,11847,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625794,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,11848,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625795,Intermediate
,10090.0,13792,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,11849,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625796,Intermediate
,9615.0,13376,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,11850,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625797,Intermediate
,9615.0,13376,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,11851,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625798,Intermediate
,,14380,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,11852,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL875613,Autocuration
,,14380,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,11853,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625799,Autocuration
,,14380,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,11854,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625800,Autocuration
,,14380,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,11855,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625801,Autocuration
,,14380,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,11856,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625802,Autocuration
,,14380,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,11857,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625803,Autocuration
,,14380,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,11858,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625804,Autocuration
,,14380,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,11859,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL622530,Autocuration
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,11860,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622531,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,11861,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622532,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,11862,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623176,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,11863,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623177,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,11864,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623178,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,11865,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623179,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,11866,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623180,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,11867,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623181,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,11868,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624131,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,11869,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624132,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,11870,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624133,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,11871,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624846,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,11872,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624847,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,11873,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624848,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,11874,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625012,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,11875,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625013,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,11876,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625014,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,11877,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625015,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,11878,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625016,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,11879,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625017,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,11880,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625018,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,11881,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625019,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,11882,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625020,Intermediate
,10090.0,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,11883,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625021,Intermediate
,10116.0,14393,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,11884,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625022,Intermediate
,10090.0,14731,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,11885,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625023,Intermediate
,9541.0,14731,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,11886,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625024,Intermediate
,9541.0,14731,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,11887,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627626,Intermediate
,,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,11888,22224,,,,Brain,955.0,A,,,,1,0,BAO_0000218,U,,CHEMBL627627,Autocuration
,,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,11889,22224,,,,Serum,1977.0,A,,,,1,0,BAO_0000218,U,,CHEMBL627628,Autocuration
,,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,11890,22224,,,,Brain,955.0,A,,,,1,0,BAO_0000218,U,,CHEMBL627629,Autocuration
,,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,11891,22224,,,,Serum,1977.0,A,,,,1,0,BAO_0000218,U,,CHEMBL627630,Autocuration
,,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,11892,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627631,Autocuration
,,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,11893,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL629515,Autocuration
,10090.0,15383,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11894,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629516,Intermediate
,10090.0,15383,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11895,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629517,Intermediate
,10090.0,15383,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11896,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629518,Intermediate
,10090.0,15383,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11897,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877499,Intermediate
,10090.0,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,11898,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629519,Intermediate
,10090.0,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11899,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629520,Intermediate
,10090.0,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11900,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629521,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,11901,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629522,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,11902,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629523,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,11903,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629524,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,11904,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629525,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,11905,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629526,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,11906,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629527,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,11907,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629528,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,11908,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629529,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,11909,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629530,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,11910,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629531,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,11911,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628656,Intermediate
,10090.0,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,11912,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628657,Intermediate
,10116.0,13751,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,11913,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628658,Intermediate
,10116.0,13751,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,11914,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628659,Intermediate
,10116.0,13751,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,11915,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877500,Intermediate
,10116.0,13751,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,11916,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628660,Intermediate
,10116.0,13751,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,11917,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628661,Intermediate
,10116.0,13751,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,11918,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628662,Intermediate
,10116.0,13751,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,11919,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628663,Intermediate
,10116.0,13751,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,11920,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628664,Intermediate
,10116.0,13751,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,11921,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628665,Intermediate
,10116.0,13751,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,11922,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628666,Intermediate
,10116.0,13751,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,11923,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628667,Intermediate
,10116.0,13751,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,11924,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628668,Intermediate
,10116.0,13751,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,11925,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628669,Intermediate
,10116.0,13751,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,11926,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628670,Intermediate
,10116.0,13751,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,11927,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628671,Intermediate
,10116.0,13751,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,11928,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628672,Intermediate
,10116.0,13751,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,11929,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630300,Intermediate
,10116.0,13751,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,11930,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629787,Intermediate
,10116.0,13751,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,11931,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629788,Intermediate
,10116.0,13751,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,11932,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629789,Intermediate
,10116.0,13751,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,11933,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629790,Intermediate
,10116.0,13751,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,11934,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629791,Intermediate
,10116.0,13751,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,11935,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629792,Intermediate
,10116.0,13751,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,11936,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629793,Intermediate
,10116.0,13751,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,11937,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629794,Intermediate
,10116.0,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,11938,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874459,Intermediate
,10116.0,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,11939,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629795,Intermediate
,10116.0,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,11940,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629796,Intermediate
,10116.0,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,11941,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629797,Intermediate
,10116.0,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,11942,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629798,Intermediate
,10116.0,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11943,50597,Rattus norvegicus,,,Adrenal gland,2369.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629799,Intermediate
,10116.0,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11944,50597,Rattus norvegicus,,,Adrenal gland,2369.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629800,Intermediate
,10116.0,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11945,50597,Rattus norvegicus,,,Adrenal gland,2369.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629801,Intermediate
,10116.0,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,11946,50597,Rattus norvegicus,,,Adrenal gland,2369.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629802,Intermediate
,10116.0,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11947,50597,Rattus norvegicus,,,Adrenal gland,2369.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629803,Intermediate
,10116.0,10911,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11948,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629804,Intermediate
,10116.0,10911,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11949,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629805,Intermediate
,10116.0,10911,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,11950,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629806,Intermediate
,10116.0,10911,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11951,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629807,Intermediate
,10116.0,10911,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11952,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629808,Intermediate
,10116.0,10911,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11953,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629809,Intermediate
,10116.0,10911,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11954,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629810,Intermediate
,10116.0,10911,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,11955,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629811,Intermediate
,10116.0,10911,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11956,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629812,Intermediate
,10116.0,10911,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,11957,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629813,Intermediate
,10116.0,10911,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11958,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874460,Intermediate
,10116.0,10911,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11959,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629814,Intermediate
,10116.0,10911,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11960,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629815,Intermediate
,10116.0,10911,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11961,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629816,Intermediate
,10116.0,10911,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11962,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629817,Intermediate
,10116.0,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11963,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626643,Intermediate
,10116.0,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11964,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626644,Intermediate
,10116.0,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11965,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626806,Intermediate
,10116.0,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11966,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626807,Intermediate
,10116.0,10911,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11967,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627261,Intermediate
,10116.0,10911,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11968,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627262,Intermediate
,10116.0,10911,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11969,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627263,Intermediate
,10116.0,10911,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11970,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627264,Intermediate
,10116.0,10911,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11971,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627265,Intermediate
,10116.0,10911,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11972,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627266,Intermediate
,10116.0,10911,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11973,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627267,Intermediate
,10116.0,10911,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11974,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627268,Intermediate
,10116.0,10911,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11975,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627269,Intermediate
,10116.0,10911,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11976,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627270,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,11977,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627271,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,11978,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627946,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,11979,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875472,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,11980,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627947,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,11981,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627948,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,11982,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628113,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,11983,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628114,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,11984,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628115,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,11985,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628116,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,11986,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628117,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,11987,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628118,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,11988,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628119,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,11989,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628120,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,11990,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628121,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,11991,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628122,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,11992,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627297,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,11993,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627298,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,11994,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627299,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,11995,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627300,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,11996,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627301,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,11997,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627302,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,11998,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627303,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,11999,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627304,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,12000,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627305,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,12001,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627306,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,12002,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623982,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,12003,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623983,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,12004,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623984,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,12005,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623985,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,12006,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623986,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,12007,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623987,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,12008,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623988,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,12009,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623989,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,12010,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622215,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,12011,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622216,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,12012,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877481,Intermediate
,,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,12013,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL622217,Autocuration
,10090.0,13701,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,12014,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622218,Intermediate
,10116.0,14554,Pharmacokinetic profile AUC was evaluated in rats,,12015,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622219,Intermediate
,,6241,Pharmacokinetic property (Area under curve),,12016,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622220,Autocuration
,9615.0,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,12017,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622221,Intermediate
,10090.0,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,12018,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622222,Intermediate
,9615.0,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,12019,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622223,Intermediate
,10090.0,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,12020,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622224,Intermediate
,,13118,Plasma concentration (AUC) was determined,,12021,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622225,Autocuration
,,13118,Plasma concentration (AUC) was determined; Not detectable,,12022,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622226,Autocuration
,10141.0,9562,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,12023,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624154,Intermediate
,10116.0,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,12024,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624155,Intermediate
,10116.0,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,12025,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624156,Intermediate
,10116.0,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,12026,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624157,Intermediate
,10116.0,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,12027,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624158,Intermediate
,10116.0,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,12028,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624159,Intermediate
,10116.0,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,12029,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624160,Intermediate
,10116.0,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,12030,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624161,Intermediate
,10116.0,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,12031,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624162,Intermediate
,9615.0,13317,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,12032,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624163,Intermediate
,10116.0,15078,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,12033,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624164,Intermediate
,10116.0,14941,The AUC(0-infinity) values in female wistar rats.,,12034,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624165,Intermediate
,10116.0,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,12035,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624166,Intermediate
,10116.0,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,12036,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624167,Intermediate
,10116.0,14941,The AUC(0-t)values in female wistar rats.,,12037,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624168,Intermediate
,10116.0,14067,The Area under the concentration time curve of compound was measured on rats,,12038,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624169,Intermediate
,9606.0,14215,The area under curve (100 mg/kg) administered orally in humans,,12039,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624170,Intermediate
,9481.0,14215,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,12040,22224,Callithrix,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL624171,Autocuration
,314293.0,14215,The area under curve (12.5 mg/kg) administered intravenously in monkey,,12041,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL624172,Autocuration
,9615.0,14215,The area under curve (15 mg/kg) administered intravenously in dog,,12042,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624173,Intermediate
,9606.0,14215,The area under curve (200 mg/kg) administered orally in humans,,12043,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877488,Intermediate
,10116.0,14215,The area under curve (25 mg/kg) administered intravenously in rat,,12044,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624174,Intermediate
,9481.0,14215,The area under curve (25 mg/kg) administered orally in marmoset,,12045,22224,Callithrix,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL624175,Autocuration
,314293.0,14215,The area under curve (25 mg/kg) administered orally in monkey,,12046,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL624176,Autocuration
,9615.0,14215,The area under curve (30 mg/kg) administered orally in dog,,12047,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624177,Intermediate
,9606.0,14215,The area under curve (400 mg/kg) administered orally in humans,,12048,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624178,Intermediate
,10116.0,14215,The area under curve (50 mg/kg) administered orally in fasted rat,,12049,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624179,Intermediate
,10116.0,14215,The area under curve (50 mg/kg) administered orally in rat,,12050,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627689,Intermediate
,9606.0,14215,The area under curve (800 mg/kg) administered orally in humans,,12051,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627690,Intermediate
,,11324,The compound was evaluated for area under the curve,,12052,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627691,Autocuration
,9481.0,11324,The compound was evaluated for area under the curve in marmosets,,12053,22224,Callithrix,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627692,Autocuration
,9481.0,11324,The compound was evaluated for area under the curve in marmosets,,12054,22224,Callithrix,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627693,Autocuration
,10116.0,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,12055,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627694,Intermediate
,10116.0,13875,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,12056,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627695,Intermediate
,,13875,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,12057,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627696,Autocuration
,10116.0,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,12058,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627697,Intermediate
,10116.0,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,12059,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627698,Intermediate
,10116.0,13875,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,12060,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627699,Intermediate
,10116.0,13807,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,12061,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627700,Intermediate
,10116.0,14127,Total drug exposure is determined after oral dosing in rats.,,12062,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627701,Intermediate
,,15116,Total drug exposure (5 mg/kg) when administered intravenously,,12063,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627702,Autocuration
,,15116,Total drug exposure (5 mg/kg) when administered orally,,12064,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627703,Autocuration
,314293.0,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,12065,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626873,Autocuration
,10116.0,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,12066,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629583,Intermediate
,9615.0,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,12067,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629584,Intermediate
,9615.0,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,12068,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629585,Intermediate
,10116.0,13751,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12069,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629586,Intermediate
,10116.0,13751,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12070,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629587,Intermediate
,10116.0,13751,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12071,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629588,Intermediate
,10116.0,13751,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12072,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629589,Intermediate
,10116.0,13751,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12073,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629590,Intermediate
,10116.0,13751,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12074,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629591,Intermediate
,10116.0,13751,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12075,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629592,Intermediate
,10116.0,13751,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12076,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629593,Intermediate
,10116.0,13751,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12077,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629594,Intermediate
,10116.0,13751,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12078,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629595,Intermediate
,10116.0,13751,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12079,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630290,Intermediate
,10116.0,13751,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12080,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627137,Intermediate
,10116.0,13751,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12081,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627138,Intermediate
,10116.0,13751,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12082,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627139,Intermediate
,10116.0,13751,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12083,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627140,Intermediate
,10116.0,13751,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12084,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627141,Intermediate
,10116.0,13751,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12085,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627142,Intermediate
,10116.0,13751,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12086,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627143,Intermediate
,10116.0,13751,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12087,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874449,Intermediate
,10116.0,13751,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12088,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627144,Intermediate
,10116.0,13751,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12089,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627145,Intermediate
,10116.0,13751,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12090,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627146,Intermediate
,10116.0,13751,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12091,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627147,Intermediate
,10116.0,13751,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12092,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627148,Intermediate
,10116.0,13751,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12093,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627149,Intermediate
,10116.0,13751,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12094,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632160,Intermediate
,10116.0,13751,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12095,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632161,Intermediate
,10116.0,13751,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12096,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632162,Intermediate
,10116.0,13751,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12097,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632163,Intermediate
,10116.0,13751,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12098,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874469,Intermediate
,10116.0,13751,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12099,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627182,Intermediate
,10116.0,13751,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12100,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627183,Intermediate
,10116.0,13751,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12101,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627184,Intermediate
,10116.0,13751,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12102,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627185,Intermediate
,10116.0,13751,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12103,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627186,Intermediate
,10116.0,13751,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12104,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627187,Intermediate
,10116.0,13751,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12105,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627188,Intermediate
,10116.0,13751,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12106,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627189,Intermediate
,10116.0,13751,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12107,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627190,Intermediate
,10116.0,13751,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12108,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627191,Intermediate
,10116.0,13751,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12109,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627192,Intermediate
,10116.0,13751,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12110,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627193,Intermediate
,10116.0,10911,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,12111,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874590,Intermediate
,10116.0,10911,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12112,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627194,Intermediate
,10116.0,10911,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12113,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627195,Intermediate
,10116.0,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,12114,50597,Rattus norvegicus,,,Female gonad,992.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627196,Intermediate
,10116.0,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,12115,50597,Rattus norvegicus,,,Female gonad,992.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627197,Intermediate
,10116.0,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12116,50597,Rattus norvegicus,,,Female gonad,992.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627198,Intermediate
,10116.0,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,12117,50597,Rattus norvegicus,,,Female gonad,992.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627199,Intermediate
,10116.0,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12118,50597,Rattus norvegicus,,,Female gonad,992.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627200,Intermediate
,10116.0,10911,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,12119,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627201,Intermediate
,10116.0,10911,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,12120,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627202,Intermediate
,10116.0,10911,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12121,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627203,Intermediate
,10116.0,10911,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12122,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627204,Intermediate
,10116.0,10911,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,12123,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627205,Intermediate
,10116.0,10911,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,12124,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627206,Intermediate
,10116.0,10911,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12125,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627207,Intermediate
,10116.0,10911,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12126,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627208,Intermediate
,10116.0,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,12127,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627209,Intermediate
,10116.0,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,12128,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627210,Intermediate
,10116.0,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12129,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627211,Intermediate
,10116.0,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12130,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627212,Intermediate
,10116.0,10911,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,12131,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627213,Intermediate
,10116.0,10911,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,12132,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626599,Intermediate
,10116.0,10911,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12133,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626600,Intermediate
,10116.0,10911,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12134,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626601,Intermediate
,,8081,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,12135,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627484,Autocuration
,9541.0,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,12136,100710,Macaca fascicularis,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627485,Intermediate
,9541.0,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,12137,100710,Macaca fascicularis,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628147,Intermediate
,9541.0,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,12138,100710,Macaca fascicularis,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628148,Intermediate
,9615.0,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,12139,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628149,Intermediate
,9615.0,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,12140,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628150,Intermediate
,9615.0,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,12141,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628318,Intermediate
,9615.0,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,12142,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628319,Intermediate
,9615.0,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,12143,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875609,Intermediate
,,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,12144,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628320,Autocuration
,,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,12145,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628321,Autocuration
,,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,12146,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628322,Autocuration
,,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,12147,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628323,Autocuration
,,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,12148,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628324,Autocuration
,,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,12149,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628325,Autocuration
,,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,12150,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628326,Autocuration
,9615.0,9614,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,12151,50588,Canis lupus familiaris,,,Adrenal medulla,1236.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628327,Intermediate
,9615.0,9614,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,12152,50588,Canis lupus familiaris,,,Adrenal medulla,1236.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628328,Intermediate
,9615.0,9614,"Concentration of compound in blood of dog 1, after administering intravenously",,12153,50588,Canis lupus familiaris,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628329,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,12154,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628330,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,12155,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628331,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,12156,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628332,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,12157,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628333,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,12158,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628334,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,12159,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628335,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,12160,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628336,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,12161,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628337,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,12162,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628338,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,12163,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875610,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,12164,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628339,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,12165,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628340,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,12166,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628341,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,12167,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622214,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,12168,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623167,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,12169,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623168,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,12170,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623169,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,12171,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623170,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,12172,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627224,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,12173,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875634,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,12174,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627225,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,12175,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627226,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,12176,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626083,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,12177,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626084,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,12178,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626085,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,12179,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626086,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,12180,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626087,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,12181,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626088,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,12182,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626089,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,12183,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626090,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,12184,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626091,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,12185,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626092,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,12186,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626093,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,12187,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626094,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,12188,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626095,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,12189,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626096,Intermediate
,314293.0,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,12190,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626097,Autocuration
,10116.0,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,12191,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626098,Intermediate
,,1806,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,12192,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,,CHEMBL626099,Autocuration
,,1806,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,12193,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,,CHEMBL626100,Autocuration
,9615.0,17237,AUC 0-inf in dog,,12194,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626101,Intermediate
,10141.0,17237,AUC 0-inf in guinea pig,,12195,50512,Cavia porcellus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626102,Intermediate
,9615.0,17237,AUC 0-t in dog,,12196,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626103,Intermediate
,10141.0,17237,AUC 0-t in guinea pig,,12197,50512,Cavia porcellus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628391,Intermediate
,10116.0,15194,The compound was tested for brain to plasma partition in rat,,12198,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628392,Intermediate
,10116.0,15194,The compound was tested for brain to plasma partition in rat.,,12199,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628393,Intermediate
,,8787,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,12200,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628394,Autocuration
,9615.0,17025,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,12201,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628395,Intermediate
,314293.0,17025,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,12202,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628396,Autocuration
,9986.0,17025,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,12203,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628397,Intermediate
,10116.0,17025,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,12204,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628398,Intermediate
,9544.0,4236,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,12205,50797,Macaca mulatta,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628399,Intermediate
,9615.0,15343,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,12206,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628400,Intermediate
,10116.0,15343,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,12207,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874907,Intermediate
,,17720,Area under curve of the compound was determined,,12208,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628401,Autocuration
,314293.0,17788,AUC in monkeys at a dose of 1 mg/kg,,12209,22224,Simiiformes,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,,CHEMBL628402,Autocuration
,10116.0,17788,AUC in rats at a dose of 1 mg/kg,,12210,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628403,Intermediate
,,8778,Compound was evaluated for the overall absorbance loss at pH of 2,,12211,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628404,Autocuration
,,8778,Compound was evaluated for the overall absorbance loss at pH of 4,,12212,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628405,Autocuration
,,8778,Compound was evaluated for the overall absorbance loss at pH of 7,,12213,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628406,Autocuration
,10116.0,2249,Compound was evaluated for its absorption in the rats,,12214,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628407,Intermediate
,10116.0,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,12215,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628408,Intermediate
,10116.0,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,12216,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629171,Intermediate
,10116.0,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,12217,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629172,Intermediate
,10116.0,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,12218,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629173,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum,,12219,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629174,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 10-17,,12220,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629175,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 10-18,,12221,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629176,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 10-19,,12222,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629177,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 12-15,,12223,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629178,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 13-19,,12224,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631869,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 14-17,,12225,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631870,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 15-18,,12226,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631871,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 2-5,,12227,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631872,Intermediate
,,15286,In vitro percent permeability into rat ileum; Range is 23-42,,12228,22224,,,,Ileum,2116.0,A,,,,1,0,BAO_0000221,U,,CHEMBL875775,Autocuration
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 28-36,,12229,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631873,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 29-35,,12230,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631874,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 46-66,,12231,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631875,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 50-68,,12232,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631876,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; Range is 78-81,,12233,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631877,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,12234,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631878,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; nd indicates not detected,,12235,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631879,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; nt indicates not detected,,12236,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631880,Intermediate
,10116.0,15286,In vitro percent permeability into rat ileum; nt indicates not tested,,12237,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631881,Intermediate
,10116.0,13770,Compound was tested for oral absorption in bile-duct cannulated rats,,12238,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631882,Intermediate
,10116.0,13770,Compound was tested for oral absorption in bile-duct cannulated rats.,,12239,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630749,Intermediate
,9606.0,5202,Oral absorption using Caco-2 cell monolayers.,,12240,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630750,Intermediate
,9606.0,14920,Percent of the drug absorbed after administration to humans was determined,,12241,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630253,Intermediate
,10116.0,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,12242,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630254,Intermediate
,10116.0,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,12243,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630255,Intermediate
,10116.0,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,12244,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630256,Intermediate
,10116.0,13751,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12245,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875781,Intermediate
,10116.0,13751,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12246,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630257,Intermediate
,10116.0,13751,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12247,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630258,Intermediate
,10116.0,15807,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,12248,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630259,Intermediate
,10116.0,15807,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,12249,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630260,Intermediate
,10116.0,15807,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,12250,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630261,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,12251,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630262,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,12252,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630263,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,12253,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630264,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,12254,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630265,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,12255,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630266,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,12256,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630267,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,12257,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630268,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,12258,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630269,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,12259,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630270,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,12260,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630141,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,12261,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630142,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,12262,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630143,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,12263,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630144,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,12264,50597,Rattus norvegicus,,,Prostate gland,2367.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630145,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,12265,50597,Rattus norvegicus,,,Prostate gland,2367.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630146,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,12266,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630147,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,12267,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630148,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,12268,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630149,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,12269,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630150,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,12270,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630151,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,12271,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632031,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,12272,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632032,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,12273,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632033,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,12274,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632034,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,12275,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632035,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,12276,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632036,Intermediate
,10116.0,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,12277,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632037,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,12278,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632038,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,12279,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632039,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,12280,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632040,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,12281,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632041,Intermediate
,9615.0,9614,"Concentration of compound in blood of dog 2, after administering intravenously",,12282,50588,Canis lupus familiaris,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632042,Intermediate
,9615.0,9614,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,12283,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632043,Intermediate
,9615.0,9614,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,12284,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632044,Intermediate
,9615.0,9614,"Concentration of compound in liver of dog 1, after administering intravenously",,12285,50588,Canis lupus familiaris,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632045,Intermediate
,9615.0,9614,"Concentration of compound in liver of dog 2, after administering intravenously",,12286,50588,Canis lupus familiaris,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632046,Intermediate
,9615.0,9614,"Concentration of compound in lung of dog 1, after administering intravenously",,12287,50588,Canis lupus familiaris,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632047,Intermediate
,9615.0,9614,"Concentration of compound in lung of dog 2, after administering intravenously",,12288,50588,Canis lupus familiaris,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632048,Intermediate
,9615.0,9614,"Concentration of compound in muscle of dog 1, after administering intravenously",,12289,50588,Canis lupus familiaris,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632049,Intermediate
,9615.0,9614,"Concentration of compound in muscle of dog 2, after administering intravenously",,12290,50588,Canis lupus familiaris,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876418,Intermediate
,9615.0,9614,"Concentration of compound in spleen of dog 1,after administering intravenously",,12291,50588,Canis lupus familiaris,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632050,Intermediate
,9615.0,9614,"Concentration of compound in spleen of dog 2, after administering intravenously",,12292,50588,Canis lupus familiaris,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632051,Intermediate
,,10353,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,12293,22224,,,,,,F,,,,1,0,BAO_0000218,U,,CHEMBL632052,Autocuration
,,10353,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,12294,22224,,,,,,F,,,,1,0,BAO_0000218,U,,CHEMBL632053,Autocuration
,,10353,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,12295,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL632054,Autocuration
,,10353,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,12296,22224,,,,,,F,,,,1,0,BAO_0000218,U,,CHEMBL632055,Autocuration
,,10353,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,12297,22224,,,,,,F,,,,1,0,BAO_0000218,U,,CHEMBL631181,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,12298,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL631182,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,12299,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL631183,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,12300,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL631184,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,12301,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL629774,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,12302,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL629775,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,12303,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL876549,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,12304,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628172,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,12305,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628173,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,12306,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628174,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,12307,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628175,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,12308,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628176,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,12309,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628177,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,12310,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628178,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,12311,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628179,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,12312,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628180,Autocuration
,,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,12313,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628181,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,12314,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628182,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,12315,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628183,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,12316,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628184,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,12317,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628185,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,12318,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL875617,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,12319,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628186,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,12320,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628187,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,12321,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628188,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,12322,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628189,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,12323,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628190,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,12324,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628191,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,12325,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626513,Autocuration
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,12326,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626514,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,12327,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626515,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,12328,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626516,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,12329,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626517,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,12330,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626518,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,12331,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626519,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,12332,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626520,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,12333,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626521,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,12334,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626522,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,12335,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626523,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,12336,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626524,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,12337,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626688,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,12338,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626689,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,12339,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626690,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,12340,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626691,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,12341,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627319,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,12342,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624052,Intermediate
,10116.0,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,12343,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624053,Intermediate
,10116.0,8085,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12344,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624054,Intermediate
,10116.0,8085,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12345,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624055,Intermediate
,10116.0,8085,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12346,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624056,Intermediate
,10116.0,8085,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12347,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624057,Intermediate
,10116.0,8085,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12348,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622281,Intermediate
,10116.0,8085,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12349,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622282,Intermediate
,10116.0,8085,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12350,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622283,Intermediate
,10116.0,8085,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12351,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622284,Intermediate
,10116.0,8085,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12352,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622285,Intermediate
,10116.0,8085,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12353,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622286,Intermediate
,,7657,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,12354,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622287,Autocuration
,10090.0,8935,Partition coefficient (logD7.4),,12355,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622288,Intermediate
,10090.0,13792,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,12356,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622289,Intermediate
,10090.0,13792,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,12357,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622290,Intermediate
,10090.0,13792,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,12358,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622291,Intermediate
,10090.0,13792,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,12359,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622292,Intermediate
,10090.0,13792,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,12360,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622293,Intermediate
,10090.0,13792,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,12361,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622294,Intermediate
,10090.0,13792,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,12362,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622295,Intermediate
,10116.0,13792,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,12363,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622296,Intermediate
,10116.0,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,12364,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874409,Intermediate
,10116.0,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,12365,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622297,Intermediate
,10116.0,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,12366,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622298,Intermediate
,10116.0,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,12367,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622299,Intermediate
,10116.0,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,12368,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622300,Intermediate
,10116.0,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,12369,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622301,Intermediate
,10116.0,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,12370,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622302,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,12371,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622303,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,12372,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622304,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,12373,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622305,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,12374,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622306,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,12375,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626864,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,12376,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626865,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,12377,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626866,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,12378,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626867,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,12379,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626868,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,12380,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626869,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,12381,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626870,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,12382,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626871,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,12383,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626872,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,12384,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632185,Intermediate
,10116.0,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,12385,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632186,Intermediate
,,12904,Amount of acetic acid produced by the compound,,12386,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629310,Autocuration
,,12904,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,12387,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629311,Autocuration
,10116.0,9663,Log of (Cbrain/Cblood) in rats,,12388,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629312,Intermediate
,,7652,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,12389,22224,,,,,,A,,,,1,0,BAO_0000221,U,,CHEMBL629313,Autocuration
,,7652,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,12390,22224,,,,,,A,,,,1,0,BAO_0000221,U,,CHEMBL629314,Autocuration
,,7652,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,12391,22224,,,,,,A,,,,1,0,BAO_0000221,U,,CHEMBL629315,Autocuration
,,7652,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,12392,22224,,,,,,B,,,,1,0,BAO_0000219,U,,CHEMBL629316,Autocuration
,,7652,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,12393,22224,,,,,,A,,,,1,0,BAO_0000221,U,,CHEMBL629317,Autocuration
,,7652,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,12394,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629318,Autocuration
,,7652,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,12395,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL877497,Autocuration
,,7652,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,12396,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629319,Autocuration
,,7652,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,12397,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629320,Autocuration
,,7652,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,12398,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629496,Autocuration
,,7652,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,12399,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629497,Autocuration
,,7652,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,12400,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629498,Autocuration
,,7652,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,12401,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629499,Autocuration
,,7652,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,12402,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629500,Autocuration
,,7652,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,12403,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629501,Autocuration
,,7652,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,12404,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629502,Autocuration
,,8267,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,12405,22224,,,,,,F,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629503,Autocuration
,9615.0,8267,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,12406,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629504,Intermediate
,,14479,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,12407,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629505,Autocuration
,,17515,Compound was evaluated for total body clearance,,12408,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629506,Autocuration
,,17515,Compound was evaluated for volume of distribution at steady state,,12409,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629507,Autocuration
,,8142,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,12410,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL877498,Autocuration
,,14849,Percentage of the diamine which is monoprotonated at pH 7.4,,12411,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629508,Autocuration
,,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,12412,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629509,Autocuration
,10116.0,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,12413,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629510,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,12414,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629511,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,12415,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629512,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,12416,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629513,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,12417,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629514,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,12418,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628447,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,12419,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628448,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,12420,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628449,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,12421,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631119,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,12422,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631120,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,12423,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631121,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,12424,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874458,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,12425,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631122,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,12426,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631123,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,12427,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631124,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,12428,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631125,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,12429,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631290,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,12430,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631291,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,12431,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631292,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,12432,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631293,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,12433,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631294,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,12434,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631295,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,12435,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631296,Intermediate
,10116.0,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,12436,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631297,Intermediate
,,10263,Maximum biodistribution (Bmax) was determined.,,12437,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL631298,Autocuration
,10090.0,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,12438,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631299,Intermediate
,10090.0,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,12439,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631300,Intermediate
,10090.0,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,12440,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631301,Intermediate
,10090.0,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,12441,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630291,Intermediate
,,14793,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,12442,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL630292,Autocuration
,,14793,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,12443,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL630293,Autocuration
,,14793,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,12444,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL630294,Autocuration
,,14793,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,12445,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL630295,Autocuration
,,14793,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,12446,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL630296,Autocuration
,,14793,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,12447,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626782,Autocuration
,,14793,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,12448,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626783,Autocuration
,,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,12449,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626784,Autocuration
,,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,12450,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626785,Autocuration
,,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,12451,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626786,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,12452,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626787,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,12453,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626788,Autocuration
,,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,12454,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625927,Autocuration
,10116.0,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12455,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625928,Intermediate
,10116.0,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12456,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625929,Intermediate
,10116.0,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,12457,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625930,Intermediate
,10116.0,8374,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,12458,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625931,Intermediate
,10116.0,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,12459,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627230,Intermediate
,10116.0,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12460,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627231,Intermediate
,10116.0,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12461,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627232,Intermediate
,10116.0,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,12462,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627233,Intermediate
,10116.0,8374,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12463,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875470,Intermediate
,10116.0,8374,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12464,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627234,Intermediate
,10116.0,8374,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12465,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627235,Intermediate
,10116.0,8374,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12466,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627236,Intermediate
,10116.0,8374,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12467,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627237,Intermediate
,10116.0,8374,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12468,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627238,Intermediate
,10116.0,8374,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12469,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627239,Intermediate
,10116.0,8374,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12470,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627240,Intermediate
,10116.0,8374,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12471,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627241,Intermediate
,10116.0,8374,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12472,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627242,Intermediate
,10116.0,8374,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,12473,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627243,Intermediate
,10116.0,8374,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12474,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627244,Intermediate
,10116.0,8374,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12475,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627245,Intermediate
,10116.0,8374,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12476,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627246,Intermediate
,10116.0,8374,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12477,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627247,Intermediate
,10116.0,8374,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12478,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627248,Intermediate
,10116.0,8374,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12479,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627249,Intermediate
,10116.0,8374,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12480,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625569,Intermediate
,10116.0,8374,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12481,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625570,Intermediate
,10116.0,8374,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12482,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625571,Intermediate
,10116.0,8374,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12483,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625572,Intermediate
,10116.0,8374,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12484,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625573,Intermediate
,10116.0,8374,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,12485,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625574,Intermediate
,10116.0,8374,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12486,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626245,Intermediate
,10116.0,8374,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12487,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626246,Intermediate
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,12488,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626247,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,12489,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626248,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,12490,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626249,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,12491,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626420,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,12492,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626421,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,12493,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626422,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,12494,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626423,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,12495,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626424,Autocuration
,9615.0,12023,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,12496,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626425,Intermediate
,10116.0,12023,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,12497,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875476,Intermediate
,9541.0,12023,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,12498,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626426,Intermediate
,,10580,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,12499,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626427,Autocuration
,,10580,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,12500,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626428,Autocuration
,,16032,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,12501,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626429,Autocuration
,,16032,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,12502,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL625025,Autocuration
,10116.0,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12503,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625026,Intermediate
,10116.0,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12504,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625027,Intermediate
,10116.0,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12505,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874410,Intermediate
,10116.0,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12506,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625028,Intermediate
,10116.0,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12507,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625029,Intermediate
,10116.0,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12508,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625030,Intermediate
,10116.0,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12509,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625031,Intermediate
,10116.0,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12510,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625032,Intermediate
,10116.0,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12511,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625033,Intermediate
,10116.0,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12512,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625034,Intermediate
,10116.0,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12513,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624872,Intermediate
,10116.0,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12514,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624873,Intermediate
,10116.0,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12515,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624874,Intermediate
,10116.0,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12516,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624875,Intermediate
,10116.0,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12517,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624876,Intermediate
,10116.0,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12518,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624877,Intermediate
,10116.0,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12519,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624878,Intermediate
,10116.0,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12520,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624879,Intermediate
,10116.0,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12521,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624880,Intermediate
,10116.0,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,12522,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624881,Intermediate
,10116.0,8594,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,12523,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624882,Intermediate
,10116.0,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12524,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624883,Intermediate
,10116.0,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12525,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624884,Intermediate
,10116.0,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12526,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624885,Intermediate
,10116.0,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12527,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624886,Intermediate
,10116.0,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12528,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624887,Intermediate
,10116.0,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12529,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624888,Intermediate
,10116.0,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12530,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624889,Intermediate
,10116.0,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12531,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624890,Intermediate
,10116.0,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12532,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621964,Intermediate
,10116.0,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12533,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621965,Intermediate
,10116.0,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12534,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621966,Intermediate
,10116.0,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12535,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL621967,Intermediate
,10116.0,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12536,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622164,Intermediate
,,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,12537,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623097,Autocuration
,,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,12538,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623098,Autocuration
,,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,12539,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623099,Autocuration
,,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,12540,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623100,Autocuration
,10116.0,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,12541,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628673,Intermediate
,10116.0,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,12542,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628674,Intermediate
,10116.0,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,12543,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628675,Intermediate
,10116.0,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,12544,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627644,Intermediate
,10116.0,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,12545,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627645,Intermediate
,10116.0,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,12546,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627646,Intermediate
,10116.0,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,12547,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627647,Intermediate
,10116.0,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,12548,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627648,Intermediate
,10116.0,12902,Free level in rat plasma,,12549,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627649,Intermediate
,,6614,Level reaching in blood plasma of rat or human was determined,,12550,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628313,Autocuration
,10116.0,9663,Log (Cbrain/Cblood) in rats,,12551,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628314,Intermediate
,,17658,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,12552,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628315,Autocuration
,,17658,Mean percentage of compound transport through membrane; expressed as membrane transport,,12553,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628316,Autocuration
,,14314,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,12554,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628317,Autocuration
,,7385,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,12555,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628473,Autocuration
,,7385,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,12556,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628474,Autocuration
,,7385,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,12557,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628475,Autocuration
,,1329,Net water uptake by a carrier mediated transport (%cm) mechanism,,12558,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628476,Autocuration
,314293.0,12187,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,12559,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628477,Autocuration
,9669.0,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,12560,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628478,Intermediate
,9669.0,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,12561,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628479,Intermediate
,314293.0,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,12562,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628480,Autocuration
,314293.0,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,12563,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628481,Autocuration
,10116.0,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,12564,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628482,Intermediate
,10116.0,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,12565,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628483,Intermediate
,10116.0,9278,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,12566,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628484,Intermediate
,10116.0,9278,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,12567,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628485,Intermediate
,9541.0,9278,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,12568,100710,Macaca fascicularis,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628486,Intermediate
,9606.0,9278,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,12569,50587,Homo sapiens,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628487,Intermediate
,10116.0,9278,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,12570,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628488,Intermediate
,10116.0,9278,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,12571,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628489,Intermediate
,10116.0,9278,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,12572,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628490,Intermediate
,9541.0,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12573,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628491,Intermediate
,9541.0,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12574,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877507,Intermediate
,,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,12575,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628492,Autocuration
,314293.0,12041,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,12576,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628493,Autocuration
,314293.0,12041,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,12577,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628494,Autocuration
,314293.0,12041,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,12578,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628495,Autocuration
,9606.0,6737,Permeability in Caco-2 assay at 10E-6,,12579,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628496,Intermediate
,,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,12580,22224,,,,Brain,955.0,A,,,,1,0,BAO_0000218,U,,CHEMBL628497,Autocuration
,,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,12581,22224,,,,Brain,955.0,A,,,,1,0,BAO_0000218,U,,CHEMBL628498,Autocuration
,,5676,Plasma protein binding was determined,,12582,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628499,Autocuration
,,14793,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,12583,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627656,Autocuration
,,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,12584,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627657,Autocuration
,,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,12585,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626808,Autocuration
,,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,12586,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626809,Autocuration
,,14793,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,12587,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626810,Autocuration
,,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,12588,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626811,Autocuration
,,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,12589,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL874465,Autocuration
,,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,12590,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626812,Autocuration
,,14793,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,12591,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626813,Autocuration
,,14793,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,12592,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626814,Autocuration
,,14000,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,12593,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626815,Autocuration
,,5948,Partition coefficient (logP),,12594,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628566,Autocuration
,,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,12595,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL628567,Autocuration
,,10778,Calculated partition coefficient (clogP),,12596,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL628568,Autocuration
,9615.0,17237,C max in dog,,12597,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628569,Intermediate
,10141.0,17237,C max in guinea pig,,12598,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628570,Intermediate
,,2809,C max value was evaluated,,12599,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628571,Autocuration
,,11954,Cmax value after oral dose of 0.1 mg//kg,,12600,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628572,Autocuration
,,11954,Cmax value after oral dose of 0.3 mg/kg,,12601,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628573,Autocuration
,,11954,Cmax value after oral dose of 1 mg/kg,,12602,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628574,Autocuration
,,11954,Cmax value after oral dose of 10 mg/kg,,12603,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628575,Autocuration
,,11954,Cmax value after oral dose of 23.4 mg/kg,,12604,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628576,Autocuration
,,11954,Cmax value after oral dose of 3 mg/kg,,12605,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628577,Autocuration
,,11954,Cmax value after oral dose of 3.87 mg/kg,,12606,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628578,Autocuration
,9615.0,12768,Cmax value in female Beagle dogs,,12607,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874466,Intermediate
,10116.0,12768,Cmax value in male rats,,12608,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628579,Intermediate
,10116.0,12780,Cmax value in rat plasma when administered 20 mg/kg perorally,,12609,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628580,Intermediate
,9615.0,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,12610,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628581,Intermediate
,9615.0,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,12611,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628582,Intermediate
,9615.0,17025,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,12612,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628583,Intermediate
,314293.0,17025,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,12613,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625782,Autocuration
,9986.0,17025,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,12614,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625783,Intermediate
,10116.0,17025,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,12615,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625784,Intermediate
,9544.0,4236,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,12616,50797,Macaca mulatta,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625785,Intermediate
,10116.0,15791,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,12617,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625786,Intermediate
,,11149,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,12618,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL874467,Autocuration
,9615.0,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,12619,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625787,Intermediate
,12721.0,15778,cytotoxicity against HIV protease enzyme.,,12620,50677,Human immunodeficiency virus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625964,Intermediate
,10090.0,12745,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,12621,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625965,Intermediate
,10090.0,12745,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,12622,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625966,Intermediate
,9615.0,13941,The plasma clearance in dog.,,12623,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625967,Intermediate
,10116.0,13941,The plasma clearance in rat.,,12624,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625968,Intermediate
,10116.0,16449,Clearance from plasma in male Sprague-Dawley rats,,12625,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625969,Intermediate
,9541.0,16449,Clearance from plasma in male cynomolgus monkeys,,12626,100710,Macaca fascicularis,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625970,Intermediate
,9615.0,14224,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,12627,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625971,Intermediate
,9615.0,14224,Clearance of compound in dog plasma,,12628,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625972,Intermediate
,9606.0,14224,Clearance of compound in human plasma,,12629,50587,Homo sapiens,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625973,Intermediate
,9615.0,14317,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,12630,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625974,Intermediate
,9615.0,14317,Clearance of compound when administered intravenously as an individual dose to a single dog.,,12631,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625975,Intermediate
,9615.0,14224,"Clearance (10 mg/kg, intravenously) in dog plasma",,12632,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625976,Intermediate
,9615.0,17237,Clearance value in dog,,12633,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625977,Intermediate
,10141.0,17237,Clearance value in guinea pig,,12634,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625978,Intermediate
,10116.0,14187,Clearance values in rats after iv administration.,,12635,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874468,Intermediate
,,4806,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,12636,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625421,Autocuration
,9986.0,15025,In vivo clearance (5 mg/kg) was determined in rabbits,,12637,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625422,Intermediate
,10116.0,13197,Plasma Clearance rate was determined for the compound in rats,,12638,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625423,Intermediate
,9520.0,13197,Plasma Clearance rate was determined for the compound in squirrel monkeys,,12639,22224,Saimiri,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625424,Autocuration
,10116.0,13960,Plasma clearance in rat,,12640,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625425,Intermediate
,,17820,Plasma clearance of the compound,,12641,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625426,Autocuration
,10141.0,14706,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,12642,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625427,Intermediate
,10141.0,14706,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,12643,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625428,Intermediate
,,6504,Plasma clearance was determined,,12644,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625429,Autocuration
,9615.0,14925,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,12645,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625430,Intermediate
,10116.0,13197,Plasma clearance rate was determined for the compound in rats,,12646,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625431,Intermediate
,9520.0,13197,Plasma clearance rate was determined for the compound in squirrel monkeys,,12647,22224,Saimiri,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627307,Autocuration
,,3437,Slow clearance (CL) was determined,,12648,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627308,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,12649,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627309,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,12650,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627310,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,12651,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627311,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,12652,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627312,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,12653,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627313,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,12654,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627314,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,12655,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627315,Autocuration
,,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,12656,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627316,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,12657,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627317,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,12658,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627318,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,12659,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627999,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,12660,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628000,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,12661,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628001,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,12662,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL628002,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,12663,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625610,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,12664,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625611,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,12665,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625612,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,12666,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625613,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,12667,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL875479,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,12668,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625614,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,12669,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625615,Autocuration
,,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,12670,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626302,Autocuration
,10116.0,8374,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12671,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626303,Intermediate
,10116.0,8374,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12672,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627420,Intermediate
,10116.0,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,12673,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627421,Intermediate
,10116.0,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,12674,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625695,Intermediate
,10116.0,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,12675,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625696,Intermediate
,10090.0,10009,Distribution of compound in mice brain was measured after 1 hr,,12676,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875606,Intermediate
,10090.0,10009,Distribution of compound in mice brain was measured after 24 hr r,,12677,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625697,Intermediate
,10090.0,10009,Distribution of compound in mice brain was measured after 2 hr,,12678,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625698,Intermediate
,10090.0,10009,Distribution of compound in mice brain was measured after 3 hr,,12679,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625699,Intermediate
,10090.0,10009,Distribution of compound in mice brain was measured after 6 hr,,12680,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625700,Intermediate
,10090.0,10009,Distribution of compound in mice liver was measured after 1 hr,,12681,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625701,Intermediate
,10090.0,10009,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,12682,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625702,Intermediate
,10090.0,10009,Distribution of compound in mice liver was measured after 2 hr,,12683,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625703,Intermediate
,10090.0,10009,Distribution of compound in mice liver was measured after 3 hr,,12684,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625704,Intermediate
,10090.0,10009,Distribution of compound in mice liver was measured after 6 hr,,12685,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625705,Intermediate
,9615.0,8170,Distribution in dog adrenal medulla 30 min after administration.,,12686,50588,Canis lupus familiaris,,,Adrenal medulla,1236.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625706,Intermediate
,9615.0,8170,Distribution in dog adrenal medulla 72 hours after administration.,,12687,50588,Canis lupus familiaris,,,Adrenal medulla,1236.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625707,Intermediate
,9615.0,8170,Distribution in female dog Ovary 24 hours after administration.,,12688,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625708,Intermediate
,9615.0,8170,Distribution in female dog Ovary 72 hours after administration.,,12689,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625709,Intermediate
,9615.0,8170,Distribution in female dog adipose 24 hours after administration.,,12690,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624180,Intermediate
,9615.0,8170,Distribution in female dog adipose 72 hours after administration.,,12691,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624181,Intermediate
,9615.0,8170,Distribution in female dog adrenal cortex 72 hours after administration.,,12692,50588,Canis lupus familiaris,,,Adrenal cortex,1235.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624182,Intermediate
,9615.0,8170,Distribution in female dog adrenal cortex 72 hours after administration.,,12693,50588,Canis lupus familiaris,,,Adrenal cortex,1235.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624183,Intermediate
,10116.0,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12694,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624184,Intermediate
,10116.0,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12695,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL877489,Intermediate
,10116.0,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12696,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624185,Intermediate
,10116.0,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12697,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624186,Intermediate
,10116.0,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12698,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624187,Intermediate
,10116.0,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12699,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624188,Intermediate
,10116.0,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12700,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624189,Intermediate
,10116.0,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12701,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624190,Intermediate
,10116.0,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12702,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624191,Intermediate
,10116.0,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12703,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624192,Intermediate
,10116.0,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12704,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624193,Intermediate
,10116.0,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12705,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624194,Intermediate
,10116.0,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12706,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624891,Intermediate
,10116.0,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12707,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624892,Intermediate
,10116.0,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12708,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624893,Intermediate
,10116.0,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12709,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627632,Intermediate
,10116.0,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12710,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627633,Intermediate
,10116.0,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12711,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627634,Intermediate
,10116.0,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12712,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627635,Intermediate
,10116.0,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12713,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627636,Intermediate
,10116.0,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12714,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626816,Intermediate
,10116.0,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12715,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626817,Intermediate
,10116.0,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12716,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626818,Intermediate
,10116.0,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12717,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626819,Intermediate
,10116.0,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12718,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626820,Intermediate
,10116.0,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12719,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626821,Intermediate
,10116.0,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12720,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626822,Intermediate
,10116.0,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12721,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626823,Intermediate
,10116.0,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12722,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626824,Intermediate
,10116.0,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12723,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626825,Intermediate
,10116.0,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12724,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626826,Intermediate
,10116.0,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12725,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626827,Intermediate
,10116.0,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12726,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626828,Intermediate
,10116.0,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12727,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626829,Intermediate
,10116.0,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12728,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626830,Intermediate
,10116.0,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12729,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627150,Intermediate
,10116.0,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12730,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627151,Intermediate
,10116.0,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12731,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627152,Intermediate
,10116.0,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12732,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627153,Intermediate
,,12904,Rate of acetate production by the compound was determined,,12733,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627154,Autocuration
,,12904,Rate of acetate production by the compound was determined; Not determined,,12734,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627155,Autocuration
,,3730,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,12735,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627156,Autocuration
,,3627,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,12736,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627157,Autocuration
,9986.0,13799,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,12737,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627158,Intermediate
,9986.0,13799,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,12738,50592,Oryctolagus cuniculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627159,Intermediate
,10090.0,13799,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,12739,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627160,Intermediate
,10116.0,13799,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,12740,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628540,Intermediate
,10116.0,13799,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,12741,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628541,Intermediate
,10116.0,13799,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,12742,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628542,Intermediate
,,6629,Solubility after at a pH 1.2,,12743,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL628543,Autocuration
,,6629,Solubility after at pH 1.2,,12744,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL628544,Autocuration
,,6629,Solubility after injection of water,,12745,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL628545,Autocuration
,,14000,Statistical significance of IC 50 values; Expressed as R value,,12746,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628546,Autocuration
,,8267,Systemic availability with respect to methyldopa was determined,,12747,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL874455,Autocuration
,10116.0,13799,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,12748,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628547,Intermediate
,10116.0,13799,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,12749,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628548,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,12750,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628549,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,12751,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628550,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,12752,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628551,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,12753,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628552,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,12754,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628553,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,12755,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628554,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,12756,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628555,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,12757,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628556,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,12758,50592,Oryctolagus cuniculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628557,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,12759,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628558,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,12760,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628559,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,12761,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628560,Intermediate
,9986.0,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,12762,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874456,Intermediate
,9986.0,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,12763,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628561,Intermediate
,9986.0,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,12764,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628562,Intermediate
,9986.0,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,12765,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628563,Intermediate
,9986.0,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,12766,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628564,Intermediate
,9986.0,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,12767,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628565,Intermediate
,9986.0,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,12768,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631248,Intermediate
,9986.0,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,12769,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631249,Intermediate
,9986.0,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,12770,50592,Oryctolagus cuniculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627214,Intermediate
,9986.0,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,12771,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874591,Intermediate
,9986.0,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,12772,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627215,Intermediate
,9986.0,7132,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,12773,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625471,Intermediate
,9986.0,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,12774,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625472,Intermediate
,9986.0,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,12775,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625473,Intermediate
,9615.0,13317,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,12776,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625474,Intermediate
,9615.0,15341,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,12777,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625475,Intermediate
,10116.0,15341,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,12778,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625476,Intermediate
,10116.0,15341,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,12779,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625477,Intermediate
,10116.0,15341,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,12780,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625478,Intermediate
,10116.0,12801,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,12781,50597,Rattus norvegicus,,,esophageal tunica muscularis mucosae,,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL625479,Intermediate
,10116.0,12801,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,12782,50597,Rattus norvegicus,,,esophageal tunica muscularis mucosae,,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL625480,Intermediate
,10116.0,14856,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,12783,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625481,Intermediate
,10116.0,14062,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,12784,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625482,Intermediate
,10116.0,14062,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,12785,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625483,Intermediate
,10116.0,14062,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,12786,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625484,Intermediate
,10116.0,14062,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,12787,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625485,Intermediate
,9615.0,14346,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,12788,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625486,Intermediate
,10116.0,14346,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,12789,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625487,Intermediate
,10116.0,14346,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,12790,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625488,Intermediate
,10116.0,14346,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,12791,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625489,Intermediate
,10116.0,14346,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,12792,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625490,Intermediate
,9615.0,14346,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,12793,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625491,Intermediate
,10116.0,14346,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,12794,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625492,Intermediate
,9606.0,15711,plasma clearance in human,,12795,50587,Homo sapiens,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625493,Intermediate
,10116.0,14886,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,12796,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625494,Intermediate
,10116.0,14886,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,12797,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625495,Intermediate
,10116.0,14886,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,12798,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625496,Intermediate
,,4115,1-Octanol/water partition coefficient measured at 7.4,,12799,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625497,Autocuration
,,13733,Calculated partition coefficient (clogP),,12800,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625498,Autocuration
,,12102,Partition coefficient (logP),,12801,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625499,Autocuration
,,12676,Calculated partition coefficient (clogP),,12802,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625500,Autocuration
,,13733,Calculated partition coefficient (clogP),,12803,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625501,Autocuration
,,13740,Calculated partition coefficient (clogP),,12804,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625502,Autocuration
,,12766,Calculated partition coefficient (clogP) (relative to BAY K 8644),,12805,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625503,Autocuration
,,2764,Calculated partition coefficient (clogP),,12806,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625504,Autocuration
,,12355,Calculated partition coefficient (clogP),,12807,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625505,Autocuration
,,11314,Calculated partition coefficient of the compound,,12808,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625506,Autocuration
,,12706,Partition coefficient (logP),,12809,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625507,Autocuration
,,12645,Calculated partition coefficient (clogP),,12810,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625508,Autocuration
,,13668,Calculated partition coefficient (clogP),,12811,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625509,Autocuration
,,12819,Calculated partition coefficient (clogP),,12812,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625510,Autocuration
,,13668,Calculated partition coefficient (clogP),,12813,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL883125,Autocuration
,,13017,Calculated partition coefficient (clogP),,12814,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625511,Autocuration
,,2448,Partition coefficient of the compound,,12815,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL874650,Autocuration
,,11526,Partition coefficient of the compound,,12816,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625512,Autocuration
,,12426,Partition coefficient of compound was determined,,12817,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625513,Autocuration
,,2448,Partition coefficient was determined,,12818,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625514,Autocuration
,,12001,Calculated partition coefficient (clogP),,12819,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625515,Autocuration
,,12426,partition coefficient of compound was determined,,12820,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625516,Autocuration
,9615.0,13204,The total body administered intravenously in dog,,12821,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625517,Intermediate
,10116.0,13204,The total body administered intravenously in rats,,12822,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625518,Intermediate
,10090.0,13889,Time taken for the administration to female NIH mice weighing 25-30 g.,,12823,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625519,Intermediate
,,13889,Time taken for the administration,,12824,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625520,Autocuration
,9615.0,17025,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,12825,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874651,Intermediate
,314293.0,17025,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,12826,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625521,Autocuration
,9986.0,17025,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,12827,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623171,Intermediate
,10116.0,17025,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,12828,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623853,Intermediate
,,15067,Plasma clearance for the compound was determined.,,12829,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623854,Autocuration
,,3091,CLog P value of the compound,,12830,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL874405,Autocuration
,,15592,Calculated partition coefficient (clogP),,12831,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL623855,Autocuration
,,14738,Calculated partition coefficient (clogP),,12832,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL623856,Autocuration
,,14738,ClogP value of the compound; nd ='no data',,12833,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL623857,Autocuration
,,14738,ClogP value of the compound; nd ='not determined',,12834,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL623858,Autocuration
,,6076,CLog P was determined,,12835,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL623859,Autocuration
,,17840,Calculated partition coefficient (clogP),,12836,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL839829,Autocuration
,,13589,CLogP was calculated,,12837,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623860,Autocuration
,,17655,CLogP value was determined,,12838,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623861,Autocuration
,,5867,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,12839,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623862,Autocuration
,,5867,Calculated partition coefficient (clogP),,12840,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL874406,Autocuration
,,10783,Calculated partition coefficient (clogP),,12841,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL623863,Autocuration
,,14849,Calculated partition coefficient (clogP),,12842,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624021,Autocuration
,9615.0,8170,Distribution in female dog adrenal medulla 24 hours after administration.,,12843,50588,Canis lupus familiaris,,,Adrenal medulla,1236.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624022,Intermediate
,9615.0,8170,Distribution in female dog adrenal medulla 72 hours after administration.,,12844,50588,Canis lupus familiaris,,,Adrenal medulla,1236.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624023,Intermediate
,9615.0,8170,Distribution in female dog bile 24 hours after administration.,,12845,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624024,Intermediate
,9615.0,8170,Distribution in female dog bile 72 hr after administration.,,12846,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624025,Intermediate
,9615.0,8170,Distribution in female dog blood 24 hours after administration.,,12847,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624026,Intermediate
,9615.0,8170,Distribution in female dog blood 72 hours after administration.,,12848,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624027,Intermediate
,9615.0,8170,Distribution in female dog heart 24 hours after administration.,,12849,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624028,Intermediate
,9615.0,8170,Distribution in female dog heart 72 hours after administration.,,12850,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624029,Intermediate
,9615.0,8170,Distribution in female dog kidney 24 hours after administration.,,12851,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624030,Intermediate
,9615.0,8170,Distribution in female dog kidney 72 hours after administration.,,12852,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624031,Intermediate
,9615.0,8170,Distribution in female dog large intestine 24 hours after administration.,,12853,50588,Canis lupus familiaris,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624032,Intermediate
,9615.0,8170,Distribution in female dog large intestine 72 hours after administration.,,12854,50588,Canis lupus familiaris,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874407,Intermediate
,9615.0,8170,Distribution in female dog liver 24 hours after administration.,,12855,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624033,Intermediate
,9615.0,8170,Distribution in female dog liver 72 hours after administration.,,12856,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624034,Intermediate
,9615.0,8170,Distribution in female dog lung 24 hours after administration.,,12857,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624035,Intermediate
,9615.0,8170,Distribution in female dog lung 72 hours after administration.,,12858,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624036,Intermediate
,9615.0,8170,Distribution in female dog muscle 24 hours after administration.,,12859,50588,Canis lupus familiaris,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624037,Intermediate
,9615.0,8170,Distribution in female dog muscle 72 hours after administration.,,12860,50588,Canis lupus familiaris,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624038,Intermediate
,9615.0,8170,Distribution in female dog pancreas 24 hours after administration.,,12861,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624039,Intermediate
,9615.0,8170,Distribution in female dog pancreas 72 hours after administration.,,12862,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624040,Intermediate
,9615.0,8170,Distribution in female dog small intestine 24 hours after administration.,,12863,50588,Canis lupus familiaris,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624041,Intermediate
,9615.0,8170,Distribution in female dog small intestine 72 hours after administration.,,12864,50588,Canis lupus familiaris,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624042,Intermediate
,9615.0,8170,Distribution in female dog spleen 24 hours after administration.,,12865,50588,Canis lupus familiaris,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624043,Intermediate
,9615.0,8170,Distribution in female dog spleen 72 hours after administration.,,12866,50588,Canis lupus familiaris,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624044,Intermediate
,9615.0,8170,Distribution in female dog stomach 24 hours after administration.,,12867,50588,Canis lupus familiaris,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624045,Intermediate
,9615.0,8170,Distribution in female dog stomach 72 hours after administration.,,12868,50588,Canis lupus familiaris,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624046,Intermediate
,9615.0,8170,Distribution in female dog thyroid 24 hours after administration.,,12869,50588,Canis lupus familiaris,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624047,Intermediate
,9615.0,8170,Distribution in female dog thyroid 72 hours after administration.,,12870,50588,Canis lupus familiaris,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624048,Intermediate
,9615.0,8170,Distribution in female dog urine 24 hours after administration.,,12871,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874408,Intermediate
,9615.0,8170,Distribution in female dog urine 72 hr after administration.,,12872,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624049,Intermediate
,,14283,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,12873,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,,CHEMBL624050,Autocuration
,,5623,Plasma concentration at 7 hr after intravenous dosing,,12874,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624051,Autocuration
,10116.0,13477,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,12875,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623278,Intermediate
,10116.0,13477,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,12876,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623279,Intermediate
,10116.0,13477,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,12877,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623280,Intermediate
,10116.0,13477,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,12878,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623963,Intermediate
,10116.0,13477,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,12879,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623964,Intermediate
,10116.0,13477,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,12880,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623965,Intermediate
,10116.0,13477,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,12881,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623966,Intermediate
,10116.0,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,12882,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874415,Intermediate
,10116.0,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,12883,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623967,Intermediate
,10116.0,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,12884,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623968,Intermediate
,10116.0,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,12885,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623969,Intermediate
,10116.0,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,12886,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628409,Intermediate
,10116.0,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,12887,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628410,Intermediate
,10116.0,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,12888,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628411,Intermediate
,10116.0,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,12889,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628412,Intermediate
,,12553,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,12890,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628413,Autocuration
,,14548,The concentration in plasmat; Not determined,,12891,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628414,Autocuration
,10116.0,14393,Tissue level at 10 mg/kg/po in wistar rats in blood,,12892,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628415,Intermediate
,10116.0,14393,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,12893,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628416,Intermediate
,10116.0,14393,Tissue level at 10 mg/kg/po in wistar rats in heart,,12894,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628417,Intermediate
,10116.0,14393,Tissue level at 10 mg/kg/po in wistar rats in liver,,12895,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874908,Intermediate
,10116.0,14393,Tissue level at 10 mg/kg/po in wistar rats in plasma,,12896,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628418,Intermediate
,10116.0,14393,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,12897,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628419,Intermediate
,10116.0,14393,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,12898,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628420,Intermediate
,,1629,Water solubility at 37 degree C.,,12899,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628421,Autocuration
,,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,12900,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626726,Autocuration
,,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,12901,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626727,Autocuration
,10116.0,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12902,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626728,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12903,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626729,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12904,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626730,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12905,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626731,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12906,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626732,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12907,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626733,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12908,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626734,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12909,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626735,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12910,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874909,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12911,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626736,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12912,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626737,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12913,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630999,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12914,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631000,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12915,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631001,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12916,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631002,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12917,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631003,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12918,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631004,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12919,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631005,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12920,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631006,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12921,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631007,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12922,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631008,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12923,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631009,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12924,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631010,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12925,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631011,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12926,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631012,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12927,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630271,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12928,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630272,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12929,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630273,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12930,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630274,Intermediate
,10116.0,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12931,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630275,Intermediate
,10116.0,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,12932,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875782,Intermediate
,10116.0,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,12933,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630276,Intermediate
,10116.0,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,12934,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630277,Intermediate
,10116.0,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,12935,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630278,Intermediate
,10116.0,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,12936,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630279,Intermediate
,,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,12937,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630280,Autocuration
,,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,12938,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630281,Autocuration
,9986.0,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,12939,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630282,Intermediate
,9986.0,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,12940,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630283,Intermediate
,,5797,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,12941,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630284,Autocuration
,,7849,Alkylating activity was determined,,12942,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630285,Autocuration
,,14220,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,12943,22224,,Microsomes,,,,A,,,,1,0,BAO_0000251,U,,CHEMBL630286,Autocuration
,9986.0,8650,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,12944,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630069,Intermediate
,9986.0,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,12945,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630070,Intermediate
,9986.0,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,12946,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630071,Intermediate
,9986.0,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,12947,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630072,Intermediate
,9986.0,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,12948,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875110,Intermediate
,10116.0,7116,Compound was tested for antidiuretic activity in rats,,12949,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630073,Intermediate
,,14131,Compound was tested for inactivation kinetic values,,12950,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630074,Autocuration
,,7415,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,12951,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL630075,Autocuration
,,13178,Dissociation rate calculated from the first-order equation using the t1/2 value,,12952,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630076,Autocuration
,,8815,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,12953,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL630077,Autocuration
,,1450,Aqueous solubility was measured,,12954,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL630078,Autocuration
,,1450,Aqueous solubility was measured at a pH 4,,12955,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL630079,Autocuration
,,1450,Aqueous solubility (pH 7),,12956,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL630080,Autocuration
,,1450,Aqueous solubility was measured at a pH 9,,12957,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL630081,Autocuration
,,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,12958,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630082,Autocuration
,,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,12959,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630083,Autocuration
,,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,12960,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630084,Autocuration
,,15032,Aqueous solubility of the compound,,12961,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629198,Autocuration
,,9964,Aqueous solubility at 37 degree Celsius at pH 7.38,,12962,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629199,Autocuration
,,14962,Aqueous solubility in pH 7.4 phosphate buffer,,12963,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629200,Autocuration
,9615.0,12487,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,12964,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629201,Intermediate
,9615.0,12487,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,12965,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629202,Intermediate
,9606.0,10026,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,12966,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875111,Intermediate
,9606.0,10026,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,12967,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629203,Intermediate
,9606.0,10026,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,12968,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629204,Intermediate
,9606.0,10026,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,12969,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629205,Intermediate
,9606.0,10026,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,12970,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629206,Intermediate
,,10026,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,12971,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631185,Autocuration
,10116.0,7415,Compound was evaluated for the average bile flow rat in rats,,12972,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631186,Intermediate
,9986.0,17025,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,12973,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631187,Intermediate
,9986.0,17025,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,12974,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631188,Intermediate
,,10184,Average half life period was determined,,12975,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL876419,Autocuration
,,10184,Average half life period was determined,,12976,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631189,Autocuration
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,12977,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631190,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,12978,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631191,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,12979,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631192,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,12980,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632400,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,12981,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630564,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,12982,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630565,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,12983,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630566,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,12984,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631229,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,12985,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631230,Intermediate
,,6030,Calculated partition coefficient (clogP),,12986,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL876428,Autocuration
,,6147,Calculated partition coefficient (clogP),,12987,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631231,Autocuration
,,14556,Calculated partition coefficient (clogP) (MacLogP),,12988,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631232,Autocuration
,,768,Hydrophilicity was determined,,12989,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631233,Autocuration
,,14452,Calculated partition coefficient (clogP),,12990,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631234,Autocuration
,,5237,Increased absorption was determined,,12991,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL883126,Autocuration
,,14378,Lipophilicity value was evaluated,,12992,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631235,Autocuration
,,14418,Log P value of the compound.,,12993,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631236,Autocuration
,,5249,Partition coefficient of compound was determined,,12994,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631237,Autocuration
,,14621,Calculated partition coefficient (clogP),,12995,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631238,Autocuration
,,12542,Calculated partition coefficient (clogP),,12996,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL876429,Autocuration
,,12542,Partition coefficient was measured by medchem software; Not calculated,,12997,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631414,Autocuration
,,12542,Partition coefficient was measured by octanol-water using standard shake-flask method,,12998,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631415,Autocuration
,,15462,Calculated partition coefficient (clogP),,12999,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631416,Autocuration
,,14884,Partition coefficient (logP),,13000,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631417,Autocuration
,,16526,Calculated partition coefficient (clogP),,13001,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631418,Autocuration
,,13693,The Octanol/Water partition coefficient CLogP,,13002,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631419,Autocuration
,,13693,The pharmacokinetic parameter C Log p was reported,,13003,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631420,Autocuration
,,13779,Calculated partition coefficient (clogP),,13004,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631421,Autocuration
,,14772,Calculated partition coefficient (clogP),,13005,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631422,Autocuration
,,14393,Calculated partition coefficient (clogP),,13006,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631423,Autocuration
,10116.0,14793,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,13007,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876430,Intermediate
,10116.0,14793,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,13008,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631424,Intermediate
,9615.0,13744,Compound was administered intravenously in dog to evaluate plasma clearance values,,13009,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631425,Intermediate
,314293.0,13744,Compound was administered intravenously in monkey to evaluate plasma clearance values,,13010,22224,Simiiformes,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL631426,Autocuration
,10090.0,13744,Compound was administered intravenously in mouse to evaluate plasma clearance values,,13011,50594,Mus musculus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631427,Intermediate
,9615.0,13207,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,13012,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631428,Intermediate
,9544.0,5669,Intrinsic clearance in Rhesus liver microsome,,13013,50797,Macaca mulatta,Microsomes,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL631429,Intermediate
,9615.0,5669,Intrinsic clearance in dog liver microsome,,13014,50588,Canis lupus familiaris,Microsomes,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL631430,Intermediate
,10116.0,5669,Intrinsic clearance in rat liver microsome,,13015,50597,Rattus norvegicus,Microsomes,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vitro,CHEMBL631431,Intermediate
,9544.0,4853,Low plasma clearance was calculated in rhesus monkey,,13016,50797,Macaca mulatta,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631432,Intermediate
,9615.0,16452,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,13017,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631433,Intermediate
,,11954,Plasma clearance after intravenous dose of 0.3 mg/kg,,13018,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL631434,Autocuration
,,11954,Plasma clearance after intravenous dose of 1 mg/kg,,13019,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL631435,Autocuration
,,11954,Plasma clearance after intravenous dose of 3 mg/kg,,13020,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL631436,Autocuration
,,11954,Plasma clearance after intravenous dose of 3.87 mg/kg,,13021,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL631437,Autocuration
,10116.0,5669,Plasma clearance after peroral administration at 10 mpk in Rat,,13022,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631438,Intermediate
,9544.0,5669,Plasma clearance after peroral administration at 10 mpk in Rhesus,,13023,50797,Macaca mulatta,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876431,Intermediate
,9615.0,5669,Plasma clearance after peroral administration at 10 mpk in dog,,13024,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631439,Intermediate
,10116.0,13662,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,13025,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631440,Intermediate
,,8272,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,13026,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631441,Autocuration
,,13410,Critical Micellar concentration was determined,,13027,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631442,Autocuration
,,13410,Critical Micellar concentration of the compound. was determined,,13028,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626525,Autocuration
,,12628,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,13029,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627168,Autocuration
,,9675,Critical micellar concentration was measured in water by the dye solubilization method,,13030,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL875618,Autocuration
,,12628,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,13031,22224,,,,,,B,,,,1,0,BAO_0000019,U,,CHEMBL626612,Autocuration
,,12766,CMR value (relative to BAY K 8644),,13032,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626613,Autocuration
,,7849,Carbamoylating activity was determined,,13033,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626614,Autocuration
,314293.0,12187,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,13034,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL626615,Autocuration
,,2040,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,13035,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626616,Autocuration
,,2040,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,13036,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626617,Autocuration
,9615.0,14180,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,13037,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626618,Intermediate
,10116.0,14180,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,13038,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626619,Intermediate
,9615.0,14474,"Clearance rate at 0.46 mg/kg, iv, in dogs",,13039,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626620,Intermediate
,10116.0,14474,"Clearance rate at 5.5 mg/kg, iv, in rat",,13040,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626621,Intermediate
,9541.0,14548,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,13041,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626622,Intermediate
,9541.0,14548,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,13042,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626623,Intermediate
,9615.0,14548,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,13043,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626624,Intermediate
,10116.0,14548,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,13044,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626625,Intermediate
,10116.0,6125,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,13045,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,Ex vivo,CHEMBL626626,Intermediate
,,6874,Tested for the total clearance of the compound,,13046,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626627,Autocuration
,9615.0,15343,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,13047,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626628,Intermediate
,,6236,Total body clearance was determined,,13048,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626629,Autocuration
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,13049,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626630,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,13050,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626631,Intermediate
,,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,13051,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626632,Autocuration
,,8194,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,13052,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626633,Autocuration
,,8194,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,13053,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626634,Autocuration
,,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,13054,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626635,Autocuration
,,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,13055,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626636,Autocuration
,,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,13056,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626637,Autocuration
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,13057,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626638,Intermediate
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,13058,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626639,Intermediate
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,13059,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626640,Intermediate
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,13060,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626641,Intermediate
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,13061,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627272,Intermediate
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,13062,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627273,Intermediate
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,13063,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627441,Intermediate
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,13064,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628355,Intermediate
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,13065,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628356,Intermediate
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,13066,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628357,Intermediate
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,13067,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628358,Intermediate
,4754.0,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,13068,50339,Pneumocystis carinii,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622307,Intermediate
,,13118,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,13069,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622527,Autocuration
,,13118,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,13070,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622528,Autocuration
,,13118,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,13071,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622529,Autocuration
,,13118,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,13072,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622992,Autocuration
,,13118,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,13073,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622993,Autocuration
,,13118,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,13074,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622994,Autocuration
,10116.0,10633,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,13075,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622995,Intermediate
,10116.0,10633,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,13076,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622996,Intermediate
,10116.0,10633,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,13077,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622997,Intermediate
,10116.0,10633,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,13078,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622998,Intermediate
,,5767,Cp max following ip administration at 1 mg/kg,,13079,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL622999,Autocuration
,,3302,Maximum concentration in plasma was reported at 0.5 hour,,13080,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623000,Autocuration
,,3302,Maximum concentration in plasma was reported at 2 hour,,13081,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623001,Autocuration
,10090.0,12467,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,13082,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623002,Intermediate
,,11778,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,13083,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL623003,Autocuration
,,4321,Steady state concentration was evaluated,,13084,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623004,Autocuration
,,14884,Partition coefficient (logP),,13085,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623005,Autocuration
,,15234,Partition coefficient (logD7.4),,13086,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623006,Autocuration
,10116.0,14198,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,13087,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623007,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,13088,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623008,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,13089,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876654,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,13090,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623009,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,13091,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623010,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,13092,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623011,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,13093,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623012,Intermediate
,,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,13094,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623013,Autocuration
,,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,13095,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623014,Autocuration
,,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,13096,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL623015,Autocuration
,,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,13097,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL623016,Autocuration
,,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,13098,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL624858,Autocuration
,10116.0,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,13099,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624859,Intermediate
,10116.0,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,13100,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624860,Intermediate
,10116.0,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,13101,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624861,Intermediate
,10116.0,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,13102,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624862,Intermediate
,10116.0,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,13103,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624863,Intermediate
,10116.0,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,13104,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876655,Intermediate
,9615.0,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,13105,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624864,Intermediate
,9615.0,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,13106,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624865,Intermediate
,9615.0,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,13107,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624866,Intermediate
,9615.0,6996,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,13108,50588,Canis lupus familiaris,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL624867,Expert
,9615.0,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,13109,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624868,Intermediate
,9615.0,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,13110,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628450,Intermediate
,9615.0,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,13111,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628451,Intermediate
,9615.0,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,13112,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628452,Intermediate
,9615.0,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,13113,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628453,Intermediate
,9615.0,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,13114,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628454,Intermediate
,9615.0,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,13115,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628455,Intermediate
,9615.0,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,13116,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628456,Intermediate
,9615.0,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,13117,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628457,Intermediate
,9615.0,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,13118,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877505,Intermediate
,9615.0,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,13119,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628458,Intermediate
,9615.0,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,13120,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628459,Intermediate
,9615.0,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,13121,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628460,Intermediate
,9615.0,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,13122,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628461,Intermediate
,,6996,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,13123,22224,,,,,,B,,,,1,0,BAO_0000218,U,,CHEMBL628462,Autocuration
,9615.0,6996,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,13124,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628463,Intermediate
,10116.0,6996,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,13125,50597,Rattus norvegicus,,,,,F,,,,1,1,BAO_0000218,N,,CHEMBL625666,Expert
,,6996,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,13126,22224,,,,,,B,,,,1,0,BAO_0000218,U,,CHEMBL625667,Autocuration
,10116.0,6996,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,13127,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625668,Expert
,10116.0,6996,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,13128,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625669,Intermediate
,,7114,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,13129,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625670,Autocuration
,10116.0,7114,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,13130,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625671,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,13131,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625672,Intermediate
,10298.0,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,13132,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625673,Intermediate
,10298.0,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,13133,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625674,Intermediate
,10298.0,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,13134,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625675,Intermediate
,10298.0,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,13135,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627637,Intermediate
,10298.0,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,13136,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627638,Intermediate
,10298.0,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,13137,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627639,Intermediate
,10298.0,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,13138,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627640,Intermediate
,10298.0,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,13139,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627641,Intermediate
,10298.0,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,13140,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627642,Intermediate
,10298.0,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,13141,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877506,Intermediate
,10090.0,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,13142,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627275,Intermediate
,9669.0,11219,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,13143,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627643,Intermediate
,9669.0,11219,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,13144,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631246,Intermediate
,9669.0,11219,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,13145,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631247,Intermediate
,9669.0,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,13146,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629532,Intermediate
,9669.0,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,13147,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629533,Intermediate
,9669.0,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,13148,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629534,Intermediate
,9669.0,11219,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,13149,50506,Mustela putorius furo,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629535,Intermediate
,,14837,Pharmacokinetic parameter :drug bound to plasma was reported,,13150,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625932,Autocuration
,,14837,compound was evaluated for drug bound in plasma,,13151,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625933,Autocuration
,10116.0,15343,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,13152,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625934,Intermediate
,9347.0,13761,Bioavailability,,13153,22224,Eutheria,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL625935,Autocuration
,10116.0,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,13154,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625936,Intermediate
,10116.0,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,13155,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625937,Intermediate
,9615.0,13249,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,13156,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625938,Intermediate
,10116.0,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,13157,50597,Rattus norvegicus,,,Bile,1970.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625939,Intermediate
,10116.0,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,13158,50597,Rattus norvegicus,,,Bile,1970.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625940,Intermediate
,10116.0,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,13159,50597,Rattus norvegicus,,,Bile,1970.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874464,Intermediate
,10116.0,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,13160,50597,Rattus norvegicus,,,Bile,1970.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625941,Intermediate
,10116.0,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,13161,50597,Rattus norvegicus,,,Bile,1970.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625942,Intermediate
,10116.0,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,13162,50597,Rattus norvegicus,,,Bile,1970.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625943,Intermediate
,9606.0,15549,In vitro protein binding in human serum at 5 ug/ml,,13163,50587,Homo sapiens,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625944,Intermediate
,,10929,Serum protein binding ability was measured,,13164,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625945,Autocuration
,,15444,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,13165,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625946,Autocuration
,9615.0,12860,Oral bioavailability in dog,,13166,22224,Canis lupus familiaris,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625947,Autocuration
,10116.0,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,13167,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625948,Intermediate
,,15173,Absolute oral bioavailability at an iv dose of 14 mg/kg,,13168,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625949,Autocuration
,,15173,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,13169,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625950,Autocuration
,9347.0,15173,Oral bioavailability (dose 15 mg/kg i.v.),,13170,22224,Eutheria,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625951,Autocuration
,,15173,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,13171,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625952,Autocuration
,,15173,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,13172,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625953,Autocuration
,,15173,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,13173,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625954,Autocuration
,,15173,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,13174,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL882959,Autocuration
,9615.0,11767,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,13175,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625955,Intermediate
,9669.0,11219,Bioavailability in ferret,,13176,22224,Mustela putorius furo,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625956,Autocuration
,9541.0,12186,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,13177,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625957,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,13178,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625958,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,13179,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625959,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,13180,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626642,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,13181,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631330,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,13182,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631331,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,13183,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631332,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,13184,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631333,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,13185,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632018,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,13186,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632019,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,13187,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632020,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,13188,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632021,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,13189,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632022,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,13190,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632023,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,13191,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632024,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,13192,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874472,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,13193,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632025,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,13194,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632026,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,13195,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632027,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,13196,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632028,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,13197,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626430,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,13198,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626431,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,13199,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626432,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,13200,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626433,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,13201,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626434,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,13202,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627280,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,13203,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627281,Intermediate
,10116.0,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,13204,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627282,Intermediate
,,7199,Total body clearance was measured at given dose,,13205,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627283,Autocuration
,,7199,Total body clearance was measured at given dose.,,13206,22224,,,,,,A,,,,1,0,BAO_0000218,U,,CHEMBL627284,Autocuration
,10116.0,7095,Metabolic clearance from the body in rat,,13207,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627285,Intermediate
,,7095,Renal clearance from the body,,13208,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627286,Autocuration
,10116.0,7095,Renal clearance from the body in rat,,13209,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875477,Intermediate
,10116.0,12528,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,13210,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627287,Intermediate
,9615.0,12528,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,13211,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627288,Intermediate
,10116.0,7095,Total clearance from the body in rat,,13212,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627289,Intermediate
,10116.0,14223,Clearance into cortex from rat plasma or PBS,,13213,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627290,Intermediate
,,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,13214,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627291,Autocuration
,,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,13215,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627292,Autocuration
,,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,13216,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627293,Autocuration
,,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,13217,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627294,Autocuration
,,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,13218,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL875478,Autocuration
,,13979,Clearance was determined,,13219,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627295,Autocuration
,10090.0,14315,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,13220,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627296,Intermediate
,9986.0,14315,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,13221,50592,Oryctolagus cuniculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626119,Intermediate
,10116.0,14315,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,13222,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626120,Intermediate
,10116.0,12174,Clearance in rat after iv dose (100 ug/kg),,13223,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626121,Intermediate
,10141.0,12797,Clearance in guinea pig,,13224,22224,Cavia porcellus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626122,Autocuration
,10116.0,12797,Compound was evaluated for clearance in rat,,13225,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626123,Intermediate
,9615.0,12797,Compound was evaluated for the clearance in dog,,13226,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623456,Intermediate
,10116.0,12797,Compound was evaluated for the clearance in rat,,13227,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623457,Intermediate
,10116.0,11500,Compound was tested in vivo for clearance after iv administration in the rat,,13228,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623458,Intermediate
,,15173,IV clearance determined at an iv dose of 14 mg/kg,,13229,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623459,Autocuration
,,15173,IV clearance determined at an iv dose of 15.2 mg/kg,,13230,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL875484,Autocuration
,,15173,IV clearance determined at an iv dose of 15 mg/kg,,13231,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623460,Autocuration
,,15173,IV clearance determined at an peroral dose of 30 mg/kg.,,13232,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623461,Autocuration
,,15173,IV clearance determined at an peroral dose of 30.2 mg/kg.,,13233,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL623462,Autocuration
,,15173,IV clearance determined at an peroral dose of 30.3 mg/kg.,,13234,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627386,Autocuration
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,13235,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627387,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,13236,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627388,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,13237,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627389,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,13238,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627390,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,13239,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627391,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,13240,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627392,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,13241,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627393,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,13242,50597,Rattus norvegicus,,,Trachea,3126.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627394,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,13243,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627395,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,13244,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875485,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,13245,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627396,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,13246,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627397,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,13247,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627398,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,13248,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627399,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,13249,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627400,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,13250,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627401,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,13251,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627402,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,13252,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627403,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,13253,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627404,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,13254,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623101,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,13255,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877480,Intermediate
,10116.0,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,13256,50597,Rattus norvegicus,,,Trachea,3126.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623102,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,13257,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623103,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,13258,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623104,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,13259,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623105,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,13260,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623106,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,13261,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623107,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,13262,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623108,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,13263,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623109,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,13264,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623110,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,13265,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623111,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,13266,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625060,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,13267,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625061,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,13268,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625062,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,13269,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625063,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,13270,50597,Rattus norvegicus,,,Trachea,3126.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625064,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,13271,50597,Rattus norvegicus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625065,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,13272,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625066,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,13273,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625067,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,13274,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625068,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,13275,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622159,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,13276,50597,Rattus norvegicus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622160,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,13277,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622161,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,13278,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622162,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,13279,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622163,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,13280,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622313,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,13281,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622314,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,13282,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622315,Intermediate
,10116.0,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,13283,50597,Rattus norvegicus,,,Trachea,3126.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622316,Intermediate
,562.0,15599,Normal diffusion coefficient in water for Escherichia coli,,13284,50212,Escherichia coli,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877486,Intermediate
,,8204,Average max percent decrease in RVR (renal vascular resistance) was determined,,13285,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622317,Autocuration
,,8204,Average max percent decrease in RVR (renal vascular resistance) was determined.,,13286,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622318,Autocuration
,,6154,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,13287,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622319,Autocuration
,,6154,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,13288,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622320,Autocuration
,,6154,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,13289,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622321,Autocuration
,,6154,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,13290,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622322,Autocuration
,,7114,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,13291,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622323,Autocuration
,10116.0,7114,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,13292,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL622324,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,13293,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622325,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,13294,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622326,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,13295,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL877487,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,13296,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622327,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,13297,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622328,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,13298,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622329,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,13299,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622330,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,13300,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622331,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,13301,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622332,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,13302,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622333,Intermediate
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,13303,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL627658,Autocuration
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,13304,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL630428,Autocuration
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,13305,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL630429,Autocuration
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,13306,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL630430,Autocuration
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,13307,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL630431,Autocuration
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,13308,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630432,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,13309,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630433,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,13310,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630434,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,13311,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629372,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,13312,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629553,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,13313,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629554,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,13314,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874447,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,13315,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629555,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,13316,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629556,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,13317,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629557,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,13318,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629558,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,13319,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629559,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,13320,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629560,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,13321,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629561,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,13322,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629562,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,13323,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629563,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,13324,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629564,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,13325,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629565,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,13326,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629566,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,13327,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629567,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,13328,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629568,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,13329,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629569,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,13330,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629570,Intermediate
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,13331,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL629571,Autocuration
,10116.0,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,13332,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629572,Autocuration
,10116.0,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,13333,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629573,Autocuration
,9347.0,4985,Bioavailability (dose 20 mg/kg),,13334,22224,Eutheria,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629574,Autocuration
,9615.0,15145,Bioavailability in dog,,13335,22224,Canis lupus familiaris,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629575,Autocuration
,10116.0,14080,Bioavailability in rat (Sprague-Dawley) (male),,13336,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL874448,Autocuration
,9443.0,11219,Bioavailability in monkey (dose 10 mg/kg i.d.),,13337,22224,Primates,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629576,Autocuration
,10116.0,15145,Bioavailability in rat,,13338,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629577,Autocuration
,10116.0,15145,Bioavailability in rat,,13339,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629578,Autocuration
,9615.0,1202,Bioavailability in dog (dose 3.0 mg/kg p.o.),,13340,22224,Canis lupus familiaris,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629579,Autocuration
,9615.0,1202,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,13341,22224,Canis lupus familiaris,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL882958,Autocuration
,9598.0,1202,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,13342,50505,Pan troglodytes,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629580,Intermediate
,9347.0,4026,Bioavailability,,13343,22224,Eutheria,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629581,Autocuration
,9520.0,1492,Bioavailability in squirrel monkey,,13344,22224,Saimiri,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629582,Autocuration
,9615.0,12793,Bioavailability was evaluated in dog,,13345,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628522,Intermediate
,10026.0,12793,Bioavailability was evaluated in hamster,,13346,100712,Cricetinae,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625432,Intermediate
,10116.0,12793,Bioavailability in rat,,13347,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625433,Autocuration
,10116.0,14793,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,13348,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625434,Intermediate
,10116.0,14793,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,13349,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625435,Intermediate
,10116.0,14793,Bioavailability in rat (dose 10 mg/kg p.o.),,13350,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625436,Autocuration
,9541.0,14731,Bioavailability was measured in cynomolgus monkeys.,,13351,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874588,Intermediate
,10090.0,14731,Bioavailability was measured in nude mice.,,13352,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625437,Intermediate
,9669.0,12187,Bioavailability in ferret (dose 10 mg/kg i.d.),,13353,22224,Mustela putorius furo,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625438,Autocuration
,314293.0,12187,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,13354,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625439,Autocuration
,314293.0,12187,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,13355,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625440,Autocuration
,314293.0,12187,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,13356,22224,Simiiformes,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625441,Autocuration
,10116.0,12187,Bioavailability in rat (dose 10 mg/kg i.d.),,13357,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625442,Autocuration
,10116.0,12187,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,13358,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625443,Intermediate
,,17431,Bioavailability was determined; extremely poor,,13359,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625444,Autocuration
,10090.0,13318,% bioavailability in mice after oral administration of prodrug,,13360,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625445,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,13361,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625446,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,13362,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL882960,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,13363,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625447,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,13364,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625448,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,13365,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625449,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,13366,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874589,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,13367,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625450,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,13368,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625451,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,13369,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626584,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,13370,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626585,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,13371,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626586,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,13372,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626587,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,13373,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626588,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,13374,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626589,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,13375,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626590,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,13376,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626591,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,13377,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627181,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,13378,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628083,Intermediate
,,15173,IV clearance determined at an peroral dose of 15 mg/kg.,,13379,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628084,Autocuration
,102285.0,7732,Mouse oral clearance was measured against Hymenolepiasis nana.,,13380,50064,Hymenolepis nana,,,,,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628085,Expert
,6339.0,7732,Mouse oral clearance was measured against Nematospiroides dubius,,13381,50545,Heligmosomoides polygyrus,,,,,F,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628086,Expert
,,7732,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,13382,22224,,,,,,F,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628087,Autocuration
,10090.0,7732,Mouse oral clearance was measured against N. nana; NT is Not Tested,,13383,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628088,Intermediate
,,7732,Mouse oral clearance was measured against N. nana; NT is Not Tested,,13384,22224,,,,,,B,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628089,Autocuration
,,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,13385,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628090,Autocuration
,,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,13386,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628091,Autocuration
,,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,13387,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628092,Autocuration
,,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,13388,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628093,Autocuration
,,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,13389,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL875607,Autocuration
,,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,13390,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625710,Autocuration
,,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,13391,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625711,Autocuration
,,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,13392,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625712,Autocuration
,,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,13393,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625713,Autocuration
,9615.0,13376,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,13394,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625714,Intermediate
,9544.0,13477,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,13395,50797,Macaca mulatta,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625715,Intermediate
,10116.0,13477,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,13396,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625716,Intermediate
,10116.0,13477,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,13397,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625717,Intermediate
,10116.0,13313,Plasma clearance was determined for the compound in rats,,13398,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625718,Intermediate
,10116.0,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,13399,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625719,Intermediate
,10116.0,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,13400,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625720,Intermediate
,10116.0,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,13401,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625721,Intermediate
,10116.0,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,13402,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625722,Intermediate
,10116.0,13129,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,13403,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625723,Intermediate
,6339.0,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,13404,50545,Heligmosomoides polygyrus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625724,Intermediate
,6339.0,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,13405,50545,Heligmosomoides polygyrus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625725,Intermediate
,6339.0,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,13406,50545,Heligmosomoides polygyrus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625726,Intermediate
,6339.0,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,13407,50545,Heligmosomoides polygyrus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875608,Intermediate
,6339.0,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,13408,50545,Heligmosomoides polygyrus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625727,Intermediate
,10116.0,9278,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,13409,22224,Rattus norvegicus,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625728,Autocuration
,10116.0,9278,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,13410,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625729,Autocuration
,10116.0,9278,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,13411,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625730,Autocuration
,10116.0,9278,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,13412,22224,Rattus norvegicus,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL625731,Autocuration
,10116.0,9278,Urinary clearance was determined in rat at 25 mg/kg os dosage,,13413,22224,Rattus norvegicus,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626417,Autocuration
,9606.0,9278,Urinary clearance was determined at 100 mg/kg oral dosage in human,,13414,50587,Homo sapiens,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626418,Intermediate
,9615.0,9278,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,13415,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626419,Intermediate
,9615.0,5932,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,13416,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626592,Intermediate
,10116.0,5932,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,13417,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626593,Intermediate
,10116.0,5182,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,13418,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626594,Intermediate
,9615.0,10499,Clearance rate in dogs,,13419,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625035,Intermediate
,,6051,Compound was measured for intrinsic clearance,,13420,22224,,,,,,A,,,,1,0,BAO_0000019,U,In vitro,CHEMBL625036,Autocuration
,,17508,Calculated partition coefficient (clogP),,13421,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625037,Autocuration
,,6228,Calculated partition coefficient (clogP),,13422,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625038,Autocuration
,,6231,Calculated partition coefficient (clogP),,13423,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625039,Autocuration
,,17740,Calculated partition coefficient (clogP),,13424,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625040,Autocuration
,,6495,Calculated partition coefficient (clogP),,13425,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625041,Autocuration
,,2171,Calculated partition coefficient (clogP),,13426,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625042,Autocuration
,,3255,Partition coefficient of the compound,,13427,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL874411,Autocuration
,,6821,Permeability,,13428,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625043,Autocuration
,,2685,Calculated partition coefficient (clogP),,13429,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625044,Autocuration
,,17584,Partition coefficient (logD),,13430,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625045,Autocuration
,,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,13431,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625046,Autocuration
,,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,13432,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625047,Autocuration
,,16479,Calculated partition coefficient (clogP),,13433,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625048,Autocuration
,,11997,Calculated partition coefficient (clogP),,13434,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625049,Autocuration
,,2988,Calculated logarithm of partition coefficient (P) was determined,,13435,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625050,Autocuration
,,931,Calculated partition coefficient (clogP),,13436,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625051,Autocuration
,,4381,Calculated partition coefficient (clogP),,13437,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL874412,Autocuration
,,4397,Calculated partition coefficient (clogP),,13438,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625052,Autocuration
,,5889,Calculated partition coefficient (clogP),,13439,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL625053,Autocuration
,,6154,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,13440,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623250,Autocuration
,,6154,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,13441,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623251,Autocuration
,,6154,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,13442,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623252,Autocuration
,,6154,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,13443,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623253,Autocuration
,,6154,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,13444,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623254,Autocuration
,,6154,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,13445,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623255,Autocuration
,,6887,Percent degradation of compound at a pH of 1 over a 18 hr period,,13446,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626831,Autocuration
,,6887,Percent degradation of compound at pH of 1 over an 18 hr period,,13447,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL877494,Autocuration
,,14116,Delta Logarithm of Partition Coefficient value was determined.,,13448,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626832,Autocuration
,,11137,Delta logPoct-cyc,,13449,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626833,Autocuration
,,7230,Lipophilicity estimated on reversed phase TLC,,13450,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626834,Autocuration
,,15741,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,13451,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626835,Autocuration
,,9663,Delta logPoct-cyc,,13452,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626836,Autocuration
,,9663,Change in logarithm of partition coefficient of the compound,,13453,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626837,Autocuration
,,13807,Delta logD (pH 6.5),,13454,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626838,Autocuration
,,13807,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,13455,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626839,Autocuration
,,17425,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,13456,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626840,Autocuration
,,12143,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,13457,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626841,Autocuration
,,12608,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,13458,22224,,,,,,A,,,,1,0,BAO_0000219,U,,CHEMBL626842,Autocuration
,,12608,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,13459,22224,,,,,,A,,,,1,0,BAO_0000219,U,,CHEMBL626843,Autocuration
,10116.0,8649,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,13460,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626844,Intermediate
,10116.0,8649,Amount of deuterium retained was reported after normal workup in rats,,13461,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL877495,Intermediate
,10116.0,8649,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,13462,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626845,Intermediate
,10116.0,8649,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,13463,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626846,Intermediate
,10116.0,8649,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,13464,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626847,Intermediate
,10116.0,8649,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,13465,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628677,Intermediate
,10116.0,8649,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,13466,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628678,Intermediate
,,9659,Compound was subjected to electrochemical oxidation,,13467,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628679,Autocuration
,,9659,Compound was subjected to photochemical oxidation,,13468,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628680,Autocuration
,,9659,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,13469,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628681,Autocuration
,,9659,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,13470,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628682,Autocuration
,,9659,Oxidation of compound by methemoglobin in presence of hydroperoxide,,13471,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628683,Autocuration
,10116.0,9607,Percent diffusion through fuzzy rat skin after 48 h of incubation,,13472,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628684,Intermediate
,,7057,Dissociation constant (pKa),,13473,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL877501,Autocuration
,,7057,Dissociation constant value of the compound; ND means not determined.,,13474,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL628685,Autocuration
,10116.0,7911,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,13475,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628686,Intermediate
,10116.0,7911,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,13476,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628687,Intermediate
,10116.0,7911,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,13477,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628688,Intermediate
,10116.0,7911,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,13478,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628689,Intermediate
,10116.0,7911,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,13479,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628690,Intermediate
,10116.0,7911,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,13480,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629363,Intermediate
,10116.0,7911,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,13481,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629364,Intermediate
,10116.0,7911,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,13482,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629365,Intermediate
,10116.0,7911,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,13483,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629366,Intermediate
,10116.0,7911,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,13484,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629367,Intermediate
,10116.0,7911,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,13485,50597,Rattus norvegicus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629368,Intermediate
,10116.0,7911,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,13486,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL877502,Intermediate
,10090.0,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,13487,50594,Mus musculus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629369,Intermediate
,10090.0,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,13488,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629370,Intermediate
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,13489,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL629371,Autocuration
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,13490,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL626276,Autocuration
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,13491,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL626277,Autocuration
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,13492,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL631250,Autocuration
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,13493,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631251,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,13494,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631252,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,13495,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631253,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,13496,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631254,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,13497,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631255,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,13498,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631256,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,13499,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631257,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,13500,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628009,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,13501,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628010,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,13502,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628011,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,13503,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628012,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,13504,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628013,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,13505,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628014,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,13506,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628015,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,13507,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628016,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,13508,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874461,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,13509,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628017,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,13510,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628018,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,13511,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628019,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,13512,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628020,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,13513,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628021,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,13514,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628022,Intermediate
,9615.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,13515,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628023,Intermediate
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,13516,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL628024,Autocuration
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,13517,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL628025,Autocuration
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,13518,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL628026,Autocuration
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,13519,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL628027,Autocuration
,314293.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,13520,22224,Simiiformes,,,Urine,1088.0,A,,,,1,0,BAO_0000218,U,,CHEMBL628028,Autocuration
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,13521,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628029,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,13522,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628030,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,13523,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628031,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,13524,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628032,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,13525,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628033,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,13526,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628034,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,13527,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628035,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,13528,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628036,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,13529,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874462,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,13530,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628037,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,13531,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628123,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,13532,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628124,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,13533,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628125,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,13534,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628126,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,13535,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628127,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,13536,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628128,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,13537,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628129,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,13538,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628130,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,13539,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628131,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,13540,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628132,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,13541,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628133,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,13542,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628134,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,13543,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628135,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,13544,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628136,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,13545,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628137,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,13546,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628138,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,13547,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628139,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,13548,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628140,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,13549,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628141,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,13550,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628142,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,13551,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628143,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,13552,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628144,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,13553,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628145,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,13554,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628146,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,13555,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625355,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,13556,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625356,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,13557,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625357,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,13558,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625527,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,13559,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875473,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,13560,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625528,Intermediate
,10116.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,13561,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626304,Intermediate
,9615.0,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,13562,50588,Canis lupus familiaris,,,Artery,1637.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624138,Intermediate
,,6448,Calculated partition coefficient (clogP),,13563,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624139,Autocuration
,,17221,Calculated partition coefficient (clogP),,13564,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624140,Autocuration
,,6545,Calculated partition coefficient (clogP),,13565,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624141,Autocuration
,,577,Calculated partition coefficient (clogP),,13566,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624142,Autocuration
,,6285,Calculated partition coefficient (clogP),,13567,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624143,Autocuration
,,6500,Calculated partition coefficient (clogP),,13568,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624144,Autocuration
,,6716,Calculated partition coefficient (clogP),,13569,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624145,Autocuration
,,13658,Calculated partition coefficient (clogP),,13570,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624146,Autocuration
,,6549,Calculated partition coefficient (clogP),,13571,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624147,Autocuration
,,14685,Calculated partition coefficient (clogP) (MacLogP),,13572,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL883123,Autocuration
,,6893,Partition coefficient (logP),,13573,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624148,Autocuration
,,3687,Kinetic parameter was determined,,13574,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL874416,Autocuration
,,4207,Calculated partition coefficient (clogP),,13575,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624149,Autocuration
,,4626,Calculated partition coefficient (clogP),,13576,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624150,Autocuration
,,1021,Lipophilicity was determined,,13577,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624151,Autocuration
,,3777,Lipophilicity was determined,,13578,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624152,Autocuration
,,17533,Lipophilicity was determined,,13579,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622139,Autocuration
,,6524,Calculated partition coefficient (clogP),,13580,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622140,Autocuration
,,17533,Lipophilicity was determined,,13581,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622141,Autocuration
,,6480,Lipophilicity in octanol-water,,13582,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622142,Autocuration
,,17606,Calculated partition coefficient (clogP),,13583,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622143,Autocuration
,,6863,Octanol-water partition coefficient was determined,,13584,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622144,Autocuration
,,1356,Partition coefficient (logP),,13585,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL877473,Autocuration
,,3326,Calculated partition coefficient (clogP),,13586,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622145,Autocuration
,,1356,Partition coefficient was determined; ND means not determined,,13587,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622146,Autocuration
,,12984,Calculated partition coefficient (clogP),,13588,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622147,Autocuration
,,17363,Partition coefficient of the compound,,13589,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622148,Autocuration
,,6827,Permeability was determined,,13590,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL883124,Autocuration
,,261,The compound was evaluated for the partition coefficient,,13591,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622149,Autocuration
,,2685,Partition coefficient (logP),,13592,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622150,Autocuration
,,414,The lipophilicity was reported,,13593,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622151,Autocuration
,,15769,logarithm of the octanol-water partition coefficient for the compound,,13594,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL622152,Autocuration
,,17248,Clogp value was determined,,13595,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL622153,Autocuration
,,16935,Clp at a dose of 1.5 mg/kg,,13596,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL877474,Autocuration
,,16935,Clp at a dose of 2.0 mg/kg,,13597,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622154,Autocuration
,,14832,"Clp, plasma clearance at a dose of 10 mg/kg",,13598,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622155,Autocuration
,,14832,"Clp, plasma clearance at a dose of 50 mg/kg",,13599,22224,,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622156,Autocuration
,10116.0,2399,Compound was tested for plasma clearance in rat,,13600,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622157,Intermediate
,10116.0,2399,Compound was tested for plasma clearance in rat; Not determined,,13601,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622158,Intermediate
,10116.0,6227,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,13602,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622807,Intermediate
,9544.0,6227,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,13603,50797,Macaca mulatta,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622808,Intermediate
,,5623,Plasma clearance by iv administration at a dose 0.003 ug/mL,,13604,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622809,Autocuration
,,4854,Plasma clearance determined,,13605,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622810,Autocuration
,10026.0,4493,Plasma clearance after iv administration at 3 mg/kg in hamster,,13606,100712,Cricetinae,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876653,Intermediate
,10026.0,4493,Plasma clearance after iv administration at 4 mg/kg in hamster,,13607,100712,Cricetinae,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622811,Intermediate
,10116.0,14956,Rate of clearance in rat was determined,,13608,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622986,Intermediate
,10116.0,15372,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,13609,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622987,Intermediate
,10116.0,15372,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,13610,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622988,Intermediate
,10116.0,15372,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,13611,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622989,Intermediate
,10116.0,15372,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,13612,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622990,Intermediate
,314293.0,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,13613,22224,Simiiformes,,,Plasma,1969.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622991,Autocuration
,10116.0,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,13614,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622227,Intermediate
,9615.0,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,13615,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622228,Intermediate
,10116.0,14964,Clpl value in rat,,13616,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622229,Intermediate
,10141.0,15240,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,13617,50512,Cavia porcellus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622230,Intermediate
,10116.0,16449,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,13618,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622231,Intermediate
,9541.0,16449,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,13619,100710,Macaca fascicularis,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622232,Intermediate
,,12902,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,13620,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622233,Autocuration
,,12902,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,13621,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622234,Autocuration
,,12902,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,13622,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622235,Autocuration
,,12902,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,13623,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622236,Autocuration
,,12902,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,13624,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622237,Autocuration
,,12902,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,13625,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL877482,Autocuration
,,12902,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,13626,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622238,Autocuration
,,12902,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,13627,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622239,Autocuration
,,11149,Cmax was calculated as maximum concentration reached in the blood,,13628,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622240,Autocuration
,,11149,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,13629,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL622241,Autocuration
,10116.0,5669,Cmax was determine after peroral administration at 10 mpk in Rat,,13630,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631013,Intermediate
,9544.0,5669,Cmax was determine after peroral administration at 10 mpk in Rhesus,,13631,50797,Macaca mulatta,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631014,Intermediate
,9615.0,5669,Cmax was determine after peroral administration at 10 mpk in dog,,13632,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631015,Intermediate
,10116.0,5669,Cmax was determine after peroral administration at 160 mpk in Rat,,13633,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631016,Intermediate
,10116.0,5669,Cmax was determine after peroral administration at 20 mpk in Rat,,13634,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631017,Intermediate
,10116.0,5669,Cmax was determine after peroral administration at 50 mpk in Rat,,13635,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631018,Intermediate
,,4236,Cmax was determined,,13636,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL631019,Autocuration
,10090.0,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,13637,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875761,Intermediate
,10090.0,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,13638,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631020,Intermediate
,10090.0,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,13639,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631669,Intermediate
,10090.0,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,13640,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631670,Intermediate
,10090.0,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,13641,50594,Mus musculus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631671,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,13642,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631672,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,13643,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631673,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,13644,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631856,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,13645,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631857,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,13646,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631858,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,13647,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631859,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,13648,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631860,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,13649,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631861,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,13650,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631862,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,13651,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631863,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,13652,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631864,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,13653,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631865,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,13654,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631866,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,13655,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629360,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,13656,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629361,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,13657,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629362,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,13658,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630740,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,13659,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630741,Intermediate
,10116.0,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,13660,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630742,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,13661,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630743,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,13662,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630744,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,13663,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630745,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,13664,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630746,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,13665,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630747,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,13666,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630748,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,13667,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632056,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,13668,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632057,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,13669,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632058,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,13670,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632059,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,13671,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632060,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,13672,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632061,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,13673,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629207,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,13674,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629208,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,13675,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629209,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,13676,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629210,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,13677,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629211,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,13678,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629212,Intermediate
,10116.0,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,13679,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629213,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,13680,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629214,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,13681,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629215,Intermediate
,10116.0,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,13682,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL635154,Intermediate
,10116.0,6996,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,13683,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629216,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,13684,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629217,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,13685,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629218,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,13686,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629219,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,13687,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629220,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,13688,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629221,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,13689,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631127,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,13690,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631128,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,13691,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631129,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,13692,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631130,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,13693,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631131,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,13694,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631132,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,13695,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631133,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,13696,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631134,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,13697,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875120,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,13698,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631135,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,13699,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631136,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,13700,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631137,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,13701,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631138,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,13702,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631139,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,13703,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631140,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,13704,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631141,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,13705,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631142,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,13706,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631143,Intermediate
,10116.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,13707,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631144,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,13708,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631145,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,13709,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631146,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,13710,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631147,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,13711,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631148,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,13712,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631149,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,13713,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631150,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,13714,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631151,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,13715,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631152,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,13716,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631443,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,13717,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631444,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,13718,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631445,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,13719,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631446,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,13720,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631447,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,13721,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631448,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,13722,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631449,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,13723,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631450,Intermediate
,9615.0,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,13724,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629724,Intermediate
,10090.0,9716,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13725,50594,Mus musculus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629725,Intermediate
,10090.0,9716,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13726,50594,Mus musculus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629726,Intermediate
,10090.0,9716,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13727,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629727,Intermediate
,10090.0,9716,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13728,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630404,Intermediate
,10090.0,9716,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13729,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630405,Intermediate
,10090.0,9716,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13730,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630406,Intermediate
,10090.0,9716,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13731,50594,Mus musculus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630407,Intermediate
,10090.0,9716,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13732,50594,Mus musculus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630573,Intermediate
,10090.0,9716,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13733,50594,Mus musculus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630574,Intermediate
,10090.0,9716,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13734,50594,Mus musculus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630575,Intermediate
,10090.0,9716,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13735,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630576,Intermediate
,10090.0,9716,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13736,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630577,Intermediate
,10090.0,9716,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13737,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630578,Intermediate
,10090.0,9716,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13738,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630579,Intermediate
,10090.0,12192,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,13739,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630580,Intermediate
,10090.0,12192,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,13740,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630581,Intermediate
,10090.0,12192,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,13741,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630582,Intermediate
,10090.0,12192,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,13742,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630583,Intermediate
,10090.0,12192,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,13743,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630584,Intermediate
,10090.0,12192,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,13744,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630585,Intermediate
,10090.0,12192,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,13745,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630586,Intermediate
,10090.0,12192,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,13746,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630587,Intermediate
,10090.0,12192,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,13747,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630588,Intermediate
,10090.0,12192,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,13748,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630589,Intermediate
,10090.0,12192,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,13749,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630590,Intermediate
,,12192,Removal of 238-Plutonium(IV) in feces at 24 h,,13750,22224,,,,Feces,1988.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630591,Autocuration
,,12192,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,13751,22224,,,,Feces,1988.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630592,Autocuration
,,12192,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,13752,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630593,Autocuration
,,12192,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,13753,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630594,Autocuration
,,12192,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,13754,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630595,Autocuration
,,12192,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,13755,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630596,Autocuration
,,12192,Removal of 238-Plutonium(IV) in urine after 0-24 h,,13756,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630597,Autocuration
,,12192,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,13757,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630598,Autocuration
,,12192,Removal of 238-Plutonium(IV) in urine after 0-4 h,,13758,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630599,Autocuration
,,12192,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,13759,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630600,Autocuration
,,12192,Removal of 238-Plutonium(IV) in urine after 4-24 h,,13760,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630601,Autocuration
,,12192,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,13761,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630602,Autocuration
,,12192,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,13762,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630603,Autocuration
,,12192,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,13763,22224,,,,Urine,1088.0,A,,,,1,0,BAO_0000019,U,,CHEMBL630604,Autocuration
,10116.0,12017,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13764,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624869,Intermediate
,10116.0,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13765,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624870,Intermediate
,10116.0,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13766,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623189,Intermediate
,10116.0,12017,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13767,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623190,Intermediate
,10116.0,12017,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13768,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623191,Intermediate
,10116.0,12017,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13769,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623192,Intermediate
,10116.0,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13770,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623193,Intermediate
,10116.0,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13771,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623194,Intermediate
,10116.0,12017,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13772,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623195,Intermediate
,10116.0,12017,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13773,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623196,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,13774,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623197,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,13775,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623198,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,13776,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623199,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,13777,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623200,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,13778,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623201,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,13779,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623202,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,13780,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623203,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,13781,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623204,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,13782,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623205,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,13783,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623206,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,13784,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623207,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,13785,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623208,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,13786,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623209,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,13787,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623210,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,13788,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623211,Intermediate
,10116.0,11836,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,13789,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623212,Intermediate
,,12640,Tested in vitro for intrinsic activity relative to quinpirole,,13790,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623213,Autocuration
,,14218,"Relative ion enhancement, determined in pulsed ultrafiltration",,13791,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623214,Autocuration
,,11296,% ionization at the pH 7.4 at 37 degree Centigrade,,13792,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623215,Autocuration
,,10929,Percentage ionization was measured,,13793,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623216,Autocuration
,9913.0,13841,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,13794,50591,Bos taurus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL623217,Intermediate
,,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,13795,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623218,Autocuration
,,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,13796,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623913,Autocuration
,,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,13797,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL623914,Autocuration
,,8826,Compound was evaluated for the partition coefficient in octanol/water,,13798,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL623915,Autocuration
,,8826,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,13799,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL624080,Autocuration
,,9884,Equilibrium constant measured by the pulse radiolysis at pH 7,,13800,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL624081,Autocuration
,9606.0,9827,In vitro hydrolytic rate constant determined in human blood,,13801,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL624082,Intermediate
,9606.0,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,13802,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625054,Intermediate
,,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,13803,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL877485,Autocuration
,10090.0,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,13804,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625055,Intermediate
,10090.0,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,13805,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625056,Intermediate
,9606.0,10009,In vitro oxidation of compound in presence of human plasma,,13806,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625057,Intermediate
,,10009,In vitro oxidation of compound in presence of hydrogen peroxide,,13807,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625058,Autocuration
,10090.0,10009,In vitro oxidation of compound in presence of mouse brain homogenate,,13808,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625059,Intermediate
,10090.0,10009,In vitro oxidation of compound in presence of mouse liver homogenate,,13809,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629536,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,13810,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629537,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,13811,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629538,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,13812,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629539,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,13813,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL874445,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,13814,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629540,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,13815,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629541,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,13816,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629542,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,13817,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630243,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,13818,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630244,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,13819,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630245,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,13820,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630246,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,13821,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630247,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,13822,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630248,Intermediate
,10116.0,13100,Biodistribution in rat blood at 240 minutes after dose administration.,,13823,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630249,Intermediate
,10116.0,13100,Biodistribution in rat blood at 30 minutes after dose administration.,,13824,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630250,Intermediate
,10116.0,13100,Biodistribution in rat blood at 360 minutes after dose administration.,,13825,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630251,Intermediate
,10116.0,13100,Biodistribution in rat blood at 3 hr after dose administration.,,13826,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630252,Intermediate
,10116.0,13100,Biodistribution in rat blood at 60 minutes after dose administration.,,13827,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630408,Intermediate
,10116.0,13100,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,13828,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630409,Intermediate
,10116.0,13100,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,13829,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874446,Intermediate
,10116.0,13100,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,13830,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630410,Intermediate
,10116.0,13100,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,13831,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630411,Intermediate
,10116.0,13100,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,13832,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630412,Intermediate
,10116.0,13100,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,13833,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630413,Intermediate
,10116.0,13100,Biodistribution in rat cerebellum at 3 hr after dose administration.,,13834,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630414,Intermediate
,10116.0,13100,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,13835,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630415,Intermediate
,10116.0,13100,Biodistribution in rat cortex at 120 minutes after dose administration.,,13836,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630416,Intermediate
,10116.0,13100,Biodistribution in rat cortex at 1440 minutes after dose administration.,,13837,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630417,Intermediate
,10116.0,13100,Biodistribution in rat cortex at 15 minutes after dose administration.,,13838,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630418,Intermediate
,10116.0,13100,Biodistribution in rat cortex at 240 minutes after dose administration.,,13839,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630419,Intermediate
,10116.0,13100,Biodistribution in rat cortex at 30 minutes after dose administration.,,13840,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630420,Intermediate
,10116.0,13100,Biodistribution in rat cortex at 360 minutes after dose administration.,,13841,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630421,Intermediate
,10116.0,13100,Biodistribution in rat cortex at 3 hr after dose administration.,,13842,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630422,Intermediate
,10116.0,13100,Biodistribution in rat cortex at 60 minutes after dose administration.,,13843,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630423,Intermediate
,10116.0,13100,Biodistribution in rat heart at 120 minutes after dose administration.,,13844,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630424,Intermediate
,10116.0,13100,Biodistribution in rat heart at 15 minutes after dose administration.,,13845,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630425,Intermediate
,10116.0,13100,Biodistribution in rat heart at 240 minutes after dose administration.,,13846,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629462,Intermediate
,10116.0,13100,Biodistribution in rat heart at 30 minutes after dose administration.,,13847,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630426,Intermediate
,10116.0,13100,Biodistribution in rat heart at 360 minutes after dose administration.,,13848,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630427,Intermediate
,10116.0,13100,Biodistribution in rat heart at 3 hr after dose administration.,,13849,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625877,Intermediate
,10116.0,13100,Biodistribution in rat heart at 60 minutes after dose administration.,,13850,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625878,Intermediate
,10116.0,13100,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,13851,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625879,Intermediate
,10116.0,13100,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,13852,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625880,Intermediate
,10116.0,13100,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,13853,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625881,Intermediate
,10116.0,13100,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,13854,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625882,Intermediate
,10116.0,13100,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,13855,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625883,Intermediate
,10116.0,13100,Biodistribution in rat kidney at 120 minutes after dose administration.,,13856,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625884,Intermediate
,10116.0,13100,Biodistribution in rat kidney at 1440 minutes after dose administration.,,13857,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625885,Intermediate
,10116.0,13100,Biodistribution in rat kidney at 15 minutes after dose administration.,,13858,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628649,Intermediate
,10116.0,13100,Biodistribution in rat kidney at 240 minutes after dose administration.,,13859,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628650,Intermediate
,10116.0,13100,Biodistribution in rat kidney at 30 minutes after dose administration.,,13860,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628651,Intermediate
,10116.0,13100,Biodistribution in rat kidney at 360 minutes after dose administration.,,13861,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628652,Intermediate
,10116.0,13100,Biodistribution in rat kidney at 60 minutes after dose administration.,,13862,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628653,Intermediate
,10116.0,13100,Biodistribution in rat liver at 120 minutes after dose administration.,,13863,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628654,Intermediate
,10116.0,13100,Biodistribution in rat liver at 1440 minutes after dose administration.,,13864,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628655,Intermediate
,10116.0,13100,Biodistribution in rat liver at 15 minutes after dose administration.,,13865,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625238,Intermediate
,10116.0,13100,Biodistribution in rat liver at 240 minutes after dose administration.,,13866,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625239,Intermediate
,10116.0,13100,Biodistribution in rat liver at 30 minutes after dose administration.,,13867,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625240,Intermediate
,10116.0,13100,Biodistribution in rat liver at 360 minutes after dose administration.,,13868,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625241,Intermediate
,10116.0,13100,Biodistribution in rat liver at 60 minutes after dose administration.,,13869,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625242,Intermediate
,10116.0,13100,Biodistribution in rat lung at 120 minutes after dose administration.,,13870,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874587,Intermediate
,10116.0,13100,Biodistribution in rat lung at 1440 minutes after dose administration.,,13871,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625405,Intermediate
,10116.0,13100,Biodistribution in rat lung at 15 minutes after dose administration.,,13872,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625406,Intermediate
,10116.0,13100,Biodistribution in rat lung at 240 minutes after dose administration.,,13873,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625407,Intermediate
,10116.0,13100,Biodistribution in rat lung at 30 minutes after dose administration.,,13874,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625408,Intermediate
,10116.0,13100,Biodistribution in rat lung at 360 minutes after dose administration.,,13875,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625409,Intermediate
,10116.0,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,13876,50597,Rattus norvegicus,,,Thoracic aorta,1515.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625410,Intermediate
,10116.0,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,13877,50597,Rattus norvegicus,,,Thoracic aorta,1515.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625411,Intermediate
,10116.0,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,13878,50597,Rattus norvegicus,,,Thoracic aorta,1515.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625412,Intermediate
,10116.0,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,13879,50597,Rattus norvegicus,,,Thoracic aorta,1515.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625413,Intermediate
,10116.0,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,13880,50597,Rattus norvegicus,,,Thoracic aorta,1515.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625414,Intermediate
,10116.0,12361,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,13881,50597,Rattus norvegicus,,,Thoracic aorta,1515.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625415,Intermediate
,10116.0,12361,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,13882,50597,Rattus norvegicus,,,Thoracic aorta,1515.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625416,Intermediate
,10116.0,12712,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,13883,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625417,Intermediate
,10116.0,7415,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,13884,50597,Rattus norvegicus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625418,Intermediate
,10116.0,7415,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,13885,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625419,Intermediate
,10116.0,7415,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,13886,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625420,Intermediate
,10116.0,7415,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,13887,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626996,Intermediate
,10116.0,7415,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,13888,50597,Rattus norvegicus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626997,Intermediate
,10116.0,7415,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,13889,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626998,Intermediate
,10116.0,7415,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,13890,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626999,Intermediate
,10090.0,8050,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,13891,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627000,Intermediate
,10090.0,8050,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,13892,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627001,Intermediate
,10090.0,8050,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,13893,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627002,Intermediate
,10090.0,8050,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,13894,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627003,Intermediate
,10090.0,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,13895,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627004,Intermediate
,10090.0,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,13896,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627005,Intermediate
,10090.0,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,13897,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874594,Intermediate
,10090.0,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,13898,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627006,Intermediate
,10090.0,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,13899,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627007,Intermediate
,10090.0,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,13900,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627884,Intermediate
,10090.0,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,13901,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627885,Intermediate
,10090.0,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,13902,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627886,Intermediate
,10090.0,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,13903,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627887,Intermediate
,10090.0,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,13904,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627888,Intermediate
,10090.0,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,13905,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628057,Intermediate
,10090.0,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,13906,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627405,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,13907,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627406,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,13908,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627407,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,13909,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627408,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,13910,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627409,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,13911,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875486,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,13912,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627410,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,13913,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627411,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,13914,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627412,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,13915,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627413,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,13916,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627414,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,13917,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627415,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,13918,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627416,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,13919,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627417,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,13920,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627418,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,13921,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627419,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,13922,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627320,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,13923,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627321,Intermediate
,10116.0,12017,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13924,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627322,Intermediate
,10116.0,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13925,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627323,Intermediate
,10116.0,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13926,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627491,Intermediate
,10116.0,12017,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13927,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627492,Intermediate
,10116.0,12017,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13928,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627493,Intermediate
,10116.0,12017,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13929,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627494,Intermediate
,10116.0,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13930,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627495,Intermediate
,10116.0,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13931,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627496,Intermediate
,10116.0,12017,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13932,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627497,Intermediate
,10116.0,12017,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13933,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627498,Intermediate
,10116.0,12017,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13934,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627499,Intermediate
,10116.0,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13935,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627500,Intermediate
,10116.0,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13936,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627501,Intermediate
,10116.0,12017,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13937,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625616,Intermediate
,10116.0,12017,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13938,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625617,Intermediate
,10116.0,12017,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13939,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625618,Intermediate
,10116.0,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13940,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625619,Intermediate
,10116.0,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13941,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625620,Intermediate
,10116.0,12017,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13942,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625621,Intermediate
,10116.0,12017,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13943,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625622,Intermediate
,10116.0,12017,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13944,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625788,Intermediate
,10116.0,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13945,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625789,Intermediate
,10116.0,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13946,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625790,Intermediate
,10116.0,12017,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13947,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625791,Intermediate
,10116.0,12017,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13948,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622334,Intermediate
,10116.0,12017,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13949,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622335,Intermediate
,10116.0,12017,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13950,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622336,Intermediate
,10116.0,12017,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13951,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622337,Intermediate
,10116.0,12017,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13952,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622338,Intermediate
,10116.0,12017,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13953,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL622339,Intermediate
,10116.0,12017,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13954,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL624153,Intermediate
,10116.0,12017,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13955,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628430,Intermediate
,10116.0,12017,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13956,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628431,Intermediate
,10116.0,12017,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13957,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628432,Intermediate
,10116.0,12017,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13958,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628433,Intermediate
,10116.0,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,13959,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628434,Intermediate
,10116.0,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,13960,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626789,Intermediate
,10116.0,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,13961,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626790,Intermediate
,10116.0,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,13962,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626791,Intermediate
,10116.0,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,13963,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626792,Intermediate
,10116.0,12017,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,13964,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626793,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,13965,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627436,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,13966,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627437,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,13967,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627438,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,13968,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627439,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,13969,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627440,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,13970,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627602,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,13971,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627603,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,13972,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627604,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,13973,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627605,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,13974,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627606,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,13975,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627607,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,13976,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627608,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,13977,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627609,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,13978,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627610,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,13979,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627611,Intermediate
,10116.0,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,13980,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627612,Intermediate
,,8362,Octanol:water partition coefficient is evaluated,,13981,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL627613,Autocuration
,,8257,Partition coefficient in 1-octanol/water system,,13982,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL627614,Autocuration
,,8257,Partition coefficient in 1-octanol/water system measured using radio active compounds,,13983,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL627615,Autocuration
,,9468,Partition coefficient in octanol/water system was determined,,13984,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL627616,Autocuration
,,9468,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,13985,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL627617,Autocuration
,,10568,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,13986,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627618,Autocuration
,,10568,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,13987,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627619,Autocuration
,,15359,Pseudo-first-order rate constant of the compound,,13988,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627620,Autocuration
,,15359,Pseudo-first-order rate constant with 1-min time point,,13989,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627621,Autocuration
,,15359,Pseudo-first-order rate constant without 1-min time point,,13990,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627622,Autocuration
,,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,13991,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627623,Autocuration
,,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,13992,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627624,Autocuration
,,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,13993,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627625,Autocuration
,,15704,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,13994,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628523,Autocuration
,,15287,The alkaline hydrolysis second order rate constant(K OH) of the compound,,13995,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628524,Autocuration
,,7516,The efflux rate constant of the compound,,13996,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628525,Autocuration
,,12973,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,13997,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625732,Autocuration
,,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,13998,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625733,Autocuration
,,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,13999,22224,,,,,,F,,,,1,0,BAO_0000019,U,,CHEMBL625734,Autocuration
,,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,14000,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625913,Autocuration
,,8696,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,14001,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625914,Autocuration
,,15052,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,14002,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625915,Autocuration
,,15052,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,14003,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625916,Autocuration
,,10503,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,14004,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625917,Autocuration
,,8354,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14005,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625918,Autocuration
,,8354,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14006,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625919,Autocuration
,,8354,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14007,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625920,Autocuration
,,8354,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14008,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL874453,Autocuration
,,8354,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,14009,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625921,Autocuration
,,10503,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,14010,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625922,Autocuration
,,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14011,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625923,Autocuration
,,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14012,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625924,Autocuration
,,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14013,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625925,Autocuration
,,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14014,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625926,Autocuration
,10116.0,13100,Biodistribution in rat lung at 60 minutes after dose administration.,,14015,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627704,Intermediate
,10116.0,13100,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,14016,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627705,Intermediate
,10116.0,13100,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,14017,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627706,Intermediate
,10116.0,13100,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,14018,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627707,Intermediate
,10116.0,13100,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,14019,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627708,Intermediate
,10116.0,13100,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,14020,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628361,Intermediate
,10116.0,13100,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,14021,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628362,Intermediate
,10116.0,13100,Biodistribution in rat striatum at 120 minutes after dose administration.,,14022,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628363,Intermediate
,10116.0,13100,Biodistribution in rat striatum at 1440 minutes after dose administration.,,14023,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628364,Intermediate
,10116.0,13100,Biodistribution in rat striatum at 15 minutes after dose administration.,,14024,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628365,Intermediate
,10116.0,13100,Biodistribution in rat striatum at 240 minutes after dose administration.,,14025,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874454,Intermediate
,10116.0,13100,Biodistribution in rat striatum at 30 minutes after dose administration.,,14026,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628531,Intermediate
,10116.0,13100,Biodistribution in rat striatum at 360 minutes after dose administration.,,14027,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628532,Intermediate
,10116.0,13100,Biodistribution in rat striatum at 3 hr after dose administration.,,14028,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628533,Intermediate
,10116.0,13100,Biodistribution in rat striatum at 60 minutes after dose administration.,,14029,50597,Rattus norvegicus,,,Striatum,2435.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628534,Intermediate
,10116.0,13100,Biodistribution in rat thyroid at 120 minutes after dose administration.,,14030,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628535,Intermediate
,10116.0,13100,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,14031,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628536,Intermediate
,10116.0,13100,Biodistribution in rat thyroid at 15 minutes after dose administration.,,14032,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628537,Intermediate
,10116.0,13100,Biodistribution in rat thyroid at 240 minutes after dose administration.,,14033,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628538,Intermediate
,10116.0,13100,Biodistribution in rat thyroid at 30 minutes after dose administration.,,14034,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628539,Intermediate
,10116.0,13100,Biodistribution in rat thyroid at 360 minutes after dose administration.,,14035,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630297,Intermediate
,10116.0,13100,Biodistribution in rat thyroid at 60 minutes after dose administration.,,14036,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630298,Intermediate
,10116.0,13100,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,14037,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630299,Intermediate
,10116.0,13100,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,14038,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628094,Intermediate
,10116.0,13100,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,14039,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628095,Intermediate
,10116.0,13100,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,14040,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874648,Intermediate
,10116.0,13100,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,14041,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628096,Intermediate
,10116.0,13100,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,14042,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628097,Intermediate
,10116.0,13100,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,14043,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628098,Intermediate
,,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,14044,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628099,Autocuration
,,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,14045,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628100,Autocuration
,,13331,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,14046,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628101,Autocuration
,,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,14047,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628102,Autocuration
,,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,14048,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628103,Autocuration
,,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,14049,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628104,Autocuration
,,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,14050,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628105,Autocuration
,,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,14051,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628106,Autocuration
,10116.0,10086,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,14052,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628107,Intermediate
,,10086,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,14053,22224,,,,Urine,1088.0,F,,,,1,0,BAO_0000218,U,,CHEMBL628108,Autocuration
,10116.0,10086,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,14054,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628109,Intermediate
,,10086,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,14055,22224,,,,Urine,1088.0,F,,,,1,0,BAO_0000218,U,,CHEMBL625299,Autocuration
,10116.0,10086,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,14056,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625300,Intermediate
,10116.0,10086,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,14057,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625301,Intermediate
,10116.0,10086,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,14058,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625302,Intermediate
,10116.0,10086,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,14059,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874649,Intermediate
,10116.0,13248,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,14060,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625303,Intermediate
,10116.0,13248,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,14061,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625463,Intermediate
,9606.0,14527,In vitro metabolism in human liver microsomes,,14062,50587,Homo sapiens,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625464,Intermediate
,9606.0,3008,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,14063,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625465,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,14064,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625466,Intermediate
,9615.0,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,14065,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625467,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,14066,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625468,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,14067,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625469,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,14068,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625470,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,14069,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632418,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,14070,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627250,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,14071,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627251,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,14072,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627252,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,14073,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627253,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,14074,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627254,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,14075,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875471,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,14076,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627255,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,14077,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627256,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,14078,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627257,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,14079,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627258,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,14080,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627259,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,14081,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627260,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,14082,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623256,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,14083,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874413,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,14084,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623257,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,14085,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623258,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,14086,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623259,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,14087,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623260,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,14088,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623261,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,14089,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623262,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,14090,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623263,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,14091,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623264,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,14092,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623265,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,14093,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623266,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,14094,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623267,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,14095,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623268,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,14096,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623269,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,14097,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623270,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,14098,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623271,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,14099,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623272,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,14100,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623273,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,14101,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623274,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,14102,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL874414,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,14103,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623275,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,14104,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629150,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,14105,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623276,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,14106,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623277,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,14107,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623112,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,14108,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623113,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,14109,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623800,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,14110,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623801,Intermediate
,10116.0,12017,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,14111,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623802,Intermediate
,10116.0,12017,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14112,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623803,Intermediate
,10116.0,12017,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14113,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623970,Intermediate
,10116.0,12017,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14114,50597,Rattus norvegicus,,,Uterus,995.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623971,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,14115,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623972,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,14116,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623973,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,14117,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623974,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,14118,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623975,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,14119,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623976,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,14120,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623977,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,14121,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623978,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,14122,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623979,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,14123,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623980,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,14124,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL623981,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,14125,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626278,Intermediate
,10116.0,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,14126,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626279,Intermediate
,10090.0,14045,Biodistribution in mice bladder plus excreted urine was determined,,14127,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626280,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse blood, 10 minutes post injection",,14128,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626281,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse blood, 30 minutes post injection",,14129,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626282,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse blood, 5 minutes post injection",,14130,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626283,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse blood, 60 minutes post injection",,14131,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626284,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse brain, 10 minutes post injection",,14132,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626285,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse brain, 30 minutes post injection",,14133,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626286,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse brain, 5 minutes post injection",,14134,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626287,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse brain, 60 minutes post injection",,14135,50594,Mus musculus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626288,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse heart, 10 minutes post injection",,14136,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626289,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse heart, 30 minutes post injection",,14137,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626290,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse heart, 5 minutes post injection",,14138,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626291,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse heart, 60 minutes post injection",,14139,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL839888,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,14140,50594,Mus musculus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626292,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,14141,50594,Mus musculus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626293,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,14142,50594,Mus musculus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626294,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,14143,50594,Mus musculus,,,Intestine,160.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626295,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse liver, 10 minutes post injection",,14144,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627659,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,14145,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627660,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse liver, 5 minutes post injection",,14146,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627661,Intermediate
,10090.0,14045,Biodistribution in mice liver at 60 minutes of post injection,,14147,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627662,Intermediate
,10090.0,14045,Biodistribution in mice lungs at 10 min of post injection,,14148,50594,Mus musculus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627663,Intermediate
,10090.0,14045,"Percentage biodistribution in mouse lung, 30 minutes post injection",,14149,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627664,Intermediate
,10090.0,14045,"Percentage biodistribution in mousee lung, 5 minutes post injection",,14150,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL627665,Intermediate
,10090.0,14045,Biodistribution in mice lungs at 60 min of post injection,,14151,50594,Mus musculus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627666,Intermediate
,10090.0,14045,Percentage biodistribution in mouse spleen,,14152,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627667,Intermediate
,10090.0,14045,Percentage biodistribution in mouse stomach,,14153,50594,Mus musculus,,,Stomach,945.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627668,Intermediate
,10090.0,11745,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,14154,50594,Mus musculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627669,Intermediate
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,14155,22224,,,,Urinary bladder,1255.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627670,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,14156,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627671,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,14157,22224,,,,Bone element,1474.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627672,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,14158,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627673,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,14159,22224,,,,Kidney,2113.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627674,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,14160,22224,,,,Liver,2107.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627675,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,14161,22224,,,,Lung,2048.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627676,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,14162,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627677,Autocuration
,,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,14163,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627678,Autocuration
,10116.0,7095,Affinity for protein binding expressed as association constant in fresh rat serum,,14164,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627679,Intermediate
,,12185,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,14165,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627680,Autocuration
,,12185,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,14166,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627681,Autocuration
,,12185,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,14167,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627682,Autocuration
,,12185,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,14168,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627683,Autocuration
,,12686,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,14169,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627684,Autocuration
,,12686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,14170,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL874441,Autocuration
,,12686,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,14171,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627685,Autocuration
,,12686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,14172,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627686,Autocuration
,,8057,Apparent rate constant Koff for inactivation of dTMP synthase.,,14173,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627687,Autocuration
,,15778,The irreversible inhibitor activity by second order rate equation.,,14174,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627688,Autocuration
,10116.0,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,14175,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628038,Intermediate
,10116.0,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,14176,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628039,Intermediate
,10116.0,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,14177,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628040,Intermediate
,,13588,Dissociation rate calculated from the first-order equation using t1/2 value,,14178,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628041,Autocuration
,,15039,The compound was tested for Binding constant against DNA,,14179,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630226,Autocuration
,,9500,First order rate constant for cyclization of the compound,,14180,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628042,Autocuration
,,10014,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,14181,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625232,Autocuration
,,10014,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,14182,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625233,Autocuration
,,568,Hydrolysis rate constant was determined,,14183,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625979,Autocuration
,,10026,Observed first order rate constant,,14184,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625980,Autocuration
,,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,14185,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625981,Autocuration
,,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,14186,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625982,Autocuration
,,9680,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,14187,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625983,Autocuration
,,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14188,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625984,Autocuration
,,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14189,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625985,Autocuration
,,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14190,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625986,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14191,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625987,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14192,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625988,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14193,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625989,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14194,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625990,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14195,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625991,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14196,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625992,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14197,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625993,Autocuration
,,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14198,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631973,Autocuration
,,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14199,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632143,Autocuration
,,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14200,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632144,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14201,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632145,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14202,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632146,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14203,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632147,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14204,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632148,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14205,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632149,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14206,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632150,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14207,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632151,Autocuration
,9606.0,3008,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,14208,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632152,Intermediate
,9606.0,4509,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,14209,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632153,Intermediate
,9606.0,4509,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,14210,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632154,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,14211,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632155,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,14212,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632156,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,14213,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632157,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,14214,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632158,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,14215,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632159,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,14216,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626305,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,14217,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626306,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,14218,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626307,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,14219,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626308,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,14220,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626479,Intermediate
,10298.0,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,14221,50602,Human herpesvirus 1,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626480,Intermediate
,,6021,Calculated partition coefficient (clogP) (MlogP),,14222,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626481,Autocuration
,,9348,Equipotent potent ratio relative to carbachol (nicotinic activity),,14223,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626482,Autocuration
,9615.0,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,14224,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626483,Intermediate
,9615.0,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,14225,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626484,Intermediate
,,15592,Solubility at pH 7.4 in micro g/mL;NA denotes available,,14226,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626485,Autocuration
,,15592,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,14227,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626486,Autocuration
,,15592,Solubility at pH 7.4 in ug/mL;NA denotes not available,,14228,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626487,Autocuration
,9615.0,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,14229,50588,Canis lupus familiaris,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626488,Intermediate
,10116.0,7095,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,14230,50597,Rattus norvegicus,,,Serum,1977.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626489,Intermediate
,,16618,Area under the MAP curve measured over 5 min; ND means Not determined,,14231,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626490,Autocuration
,,16835,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,14232,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626491,Autocuration
,,15284,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,14233,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL626492,Autocuration
,,15750,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,14234,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626493,Autocuration
,10116.0,16618,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,14235,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626494,Intermediate
,,16618,Half life after oral tested,,14236,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626495,Autocuration
,10116.0,15812,Half life was determined in plasma of rat; NT indicates not tested,,14237,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626496,Intermediate
,10116.0,16618,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,14238,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626497,Intermediate
,,16618,Oral bioavailability after oral tested,,14239,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL626498,Autocuration
,10116.0,13098,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,14240,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626499,Intermediate
,10116.0,13098,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,14241,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626500,Intermediate
,10116.0,15812,half life was determined in plasma of rat; NT indicates not tested,,14242,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626501,Intermediate
,10116.0,15812,half life was determined in plasma of rat; NT means not tested,,14243,50597,Rattus norvegicus,,,Plasma,1969.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626502,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,14244,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626503,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,14245,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626504,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,14246,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626505,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,14247,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626506,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,14248,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626507,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,14249,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626508,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,14250,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626509,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,14251,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875480,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,14252,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626510,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,14253,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626511,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,14254,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL626512,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,14255,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628208,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,14256,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628209,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,14257,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628210,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,14258,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628211,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,14259,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628212,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,14260,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628213,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,14261,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628214,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,14262,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628215,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,14263,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628216,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,14264,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626595,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,14265,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626596,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,14266,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626597,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,14267,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626598,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,14268,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622242,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,14269,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622243,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,14270,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622244,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,14271,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622245,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,14272,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622246,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,14273,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622247,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,14274,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622248,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,14275,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL877483,Intermediate
,10116.0,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,14276,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622249,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,14277,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622250,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,14278,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622251,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,14279,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622252,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,14280,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622253,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,14281,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622254,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,14282,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622255,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,14283,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622256,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,14284,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622257,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,14285,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622258,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,14286,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622259,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,14287,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622927,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,14288,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622928,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,14289,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL622929,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,14290,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623182,Intermediate
,9615.0,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,14291,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623183,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,14292,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623184,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,14293,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623185,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,14294,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL877484,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,14295,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627274,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,14296,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623186,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,14297,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623187,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,14298,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL623188,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,14299,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628055,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,14300,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628056,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,14301,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628200,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,14302,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628201,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,14303,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628202,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,14304,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628203,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,14305,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628204,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,14306,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628205,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,14307,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628206,Intermediate
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,14308,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL628207,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,14309,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627220,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,14310,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627221,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,14311,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627222,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,14312,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627223,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,14313,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL632062,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,14314,22224,,,,Spleen,2106.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL632063,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,14315,22224,,,,Urinary bladder,1255.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL632064,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,14316,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL632065,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,14317,22224,,,,Bone element,1474.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL632066,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,14318,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL632067,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,14319,22224,,,,Kidney,2113.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629188,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,14320,22224,,,,Liver,2107.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629189,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,14321,22224,,,,Lung,2048.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629190,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,14322,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629191,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,14323,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629192,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,14324,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629193,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,14325,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629194,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,14326,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629195,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,14327,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629373,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,14328,22224,,,,Spleen,2106.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629374,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,14329,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629375,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,14330,22224,,,,Urinary bladder,1255.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629376,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,14331,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629377,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,14332,22224,,,,Bone element,1474.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629378,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,14333,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629379,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,14334,22224,,,,Kidney,2113.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629151,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,14335,22224,,,,Liver,2107.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629152,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,14336,22224,,,,Lung,2048.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629153,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,14337,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629154,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,14338,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629155,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,14339,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629156,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,14340,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629157,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,14341,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629158,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,14342,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629159,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,14343,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629160,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,14344,22224,,,,Spleen,2106.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629161,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,14345,22224,,,,Urinary bladder,1255.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629162,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,14346,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629163,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,14347,22224,,,,Bone element,1474.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629164,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,14348,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629165,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,14349,22224,,,,Liver,2107.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629166,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,14350,22224,,,,Lung,2048.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629167,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,14351,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629168,Autocuration
,,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,14352,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629169,Autocuration
,,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,14353,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629170,Autocuration
,,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,14354,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631153,Autocuration
,,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,14355,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL875121,Autocuration
,,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,14356,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631154,Autocuration
,,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,14357,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631155,Autocuration
,,568,Hydrolysis rate constant was determined,,14358,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631156,Autocuration
,,9680,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,14359,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631157,Autocuration
,,9680,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,14360,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631158,Autocuration
,,9680,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,14361,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631159,Autocuration
,,10026,Observed second order rate constant,,14362,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631160,Autocuration
,,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,14363,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631161,Autocuration
,,10014,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,14364,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631162,Autocuration
,,10014,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,14365,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630313,Autocuration
,,9680,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,14366,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630314,Autocuration
,,9680,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,14367,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630315,Autocuration
,,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14368,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630316,Autocuration
,,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14369,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630986,Autocuration
,,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14370,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630987,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,14371,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630988,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14372,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630989,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14373,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630990,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14374,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630991,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14375,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630992,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14376,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630993,Autocuration
,,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14377,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630994,Autocuration
,10116.0,10014,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,14378,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630995,Intermediate
,,9962,Association constant for compound at 31 degree C was determined,,14379,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629252,Autocuration
,,12029,Calculated antagonist equilibrium dissociation constant of the compound,,14380,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629253,Autocuration
,,12029,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,14381,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629944,Autocuration
,10141.0,10583,Dissociation constants vs LTE4 on guinea pig trachea,,14382,50512,Cavia porcellus,,,Trachea,3126.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629945,Intermediate
,,568,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,14383,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629946,Autocuration
,,568,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,14384,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629947,Autocuration
,,568,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,14385,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629948,Autocuration
,,568,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,14386,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL856024,Autocuration
,,7493,Affinity constant KD value was derived from TMP,,14387,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629949,Autocuration
,,8371,Apparent dissociation (binding) rate constant was evaluated,,14388,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629950,Autocuration
,,13114,Dissociation constant (KD) of the compound,,14389,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL630127,Autocuration
,,15515,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,14390,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL630128,Autocuration
,,522,Dissociation constant from ESR titration experiments,,14391,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL630129,Autocuration
,,13888,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,14392,22224,,,,,,,,,,1,0,BAO_0000019,U,,CHEMBL630130,Autocuration
,,2616,Dissociation constant was evaluated.,,14393,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL875234,Autocuration
,,3798,Dissociation constant was reported,,14394,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL630131,Autocuration
,10116.0,8731,Dissociation constant was determined in rat pituitary cells.,,14395,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630132,Intermediate
,,11892,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,14396,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630133,Autocuration
,,11892,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,14397,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630134,Autocuration
,,2582,Equilibrium dissociation constant of the compound,,14398,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630135,Autocuration
,,11892,Equilibrium dissociation constant was determined,,14399,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630136,Autocuration
,,13396,Kinetic constant KD was evaluated,,14400,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630137,Autocuration
,,603,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,14401,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630138,Autocuration
,,15673,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,14402,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630139,Autocuration
,,10368,Rate constant for hydrolysis in aqueous acetone.,,14403,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630140,Autocuration
,,14228,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,14404,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL875235,Autocuration
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,14405,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876439,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,14406,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630605,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,14407,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630606,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,14408,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630607,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,14409,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630608,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,14410,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630609,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,14411,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630610,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,14412,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630611,Intermediate
,10116.0,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,14413,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629552,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,14414,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629733,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,14415,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629734,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,14416,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629735,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,14417,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629736,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,14418,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629737,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,14419,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629738,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,14420,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629739,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,14421,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629740,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,14422,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629741,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,14423,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629742,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,14424,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629743,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,14425,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629744,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,14426,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629745,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,14427,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629746,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,14428,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629747,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,14429,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629748,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,14430,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629749,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,14431,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629750,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,14432,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629751,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,14433,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629752,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,14434,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629753,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,14435,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629754,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,14436,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629755,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,14437,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629756,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,14438,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629757,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,14439,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629758,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,14440,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629759,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,14441,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629760,Intermediate
,10116.0,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,14442,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876443,Intermediate
,9615.0,8310,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,14443,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629761,Intermediate
,9615.0,8310,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,14444,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629762,Intermediate
,10090.0,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,14445,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629763,Intermediate
,10090.0,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,14446,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629764,Intermediate
,10090.0,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,14447,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629765,Intermediate
,10090.0,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,14448,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629766,Intermediate
,10090.0,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,14449,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629767,Intermediate
,9615.0,8310,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,14450,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629768,Intermediate
,10090.0,8310,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,14451,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629769,Intermediate
,9615.0,8310,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,14452,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629770,Intermediate
,9615.0,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,14453,50588,Canis lupus familiaris,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629771,Intermediate
,10090.0,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,14454,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629772,Intermediate
,10090.0,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,14455,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL629773,Intermediate
,10090.0,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,14456,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625455,Intermediate
,10090.0,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,14457,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625456,Intermediate
,10090.0,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,14458,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625457,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,14459,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625458,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,14460,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625459,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,14461,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875483,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,14462,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL634779,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,14463,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625460,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,14464,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626117,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,14465,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626118,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,14466,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628342,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,14467,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628343,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,14468,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628344,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,14469,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628345,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,14470,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628346,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,14471,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628347,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,14472,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628348,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,14473,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628349,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,14474,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875611,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,14475,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628350,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,14476,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628351,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,14477,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628352,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,14478,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628353,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,14479,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628354,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,14480,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626667,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,14481,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626668,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,14482,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626669,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,14483,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626670,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,14484,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626671,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,14485,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626672,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,14486,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626673,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,14487,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626674,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,14488,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626675,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,14489,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626676,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,14490,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626677,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,14491,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626678,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,14492,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626679,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,14493,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875612,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,14494,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626680,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,14495,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626681,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,14496,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626682,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,14497,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626683,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,14498,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626684,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,14499,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626685,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,14500,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626686,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,14501,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626687,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,14502,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624978,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,14503,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624979,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,14504,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624980,Intermediate
,10116.0,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,14505,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624981,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,14506,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL624982,Intermediate
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,14507,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627564,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,14508,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627565,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,14509,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627566,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,14510,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627567,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,14511,22224,,,,Spleen,2106.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627568,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,14512,22224,,,,Kidney,2113.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627569,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,14513,22224,,,,Urinary bladder,1255.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627570,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,14514,22224,,,,Blood,178.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627571,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,14515,22224,,,,Bone element,1474.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627572,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,14516,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627573,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,14517,22224,,,,Kidney,2113.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627574,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,14518,22224,,,,Liver,2107.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627575,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,14519,22224,,,,Lung,2048.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627576,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,14520,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627577,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,14521,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627578,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,14522,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627579,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,14523,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627580,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,14524,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627581,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,14525,22224,,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627582,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,14526,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627583,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,14527,22224,,,,Spleen,2106.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627584,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,14528,22224,,,,Prostate gland,2367.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627585,Autocuration
,,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,14529,22224,,,,Muscle tissue,2385.0,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL627586,Autocuration
,10116.0,15413,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,14530,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627587,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,14531,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627588,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,14532,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628250,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,14533,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628251,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,14534,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628252,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,14535,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628253,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,14536,50597,Rattus norvegicus,,,Hypothalamus,1898.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628254,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,14537,50597,Rattus norvegicus,,,Hypothalamus,1898.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL877493,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,14538,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628255,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,14539,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628256,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,14540,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628257,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,14541,50597,Rattus norvegicus,,,Hypothalamus,1898.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628258,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,14542,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628259,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,14543,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628429,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,14544,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626862,Intermediate
,10116.0,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,14545,50597,Rattus norvegicus,,,Hypothalamus,1898.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL626863,Intermediate
,10116.0,15413,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,14546,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625886,Intermediate
,10116.0,15413,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,14547,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625887,Intermediate
,10116.0,15413,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,14548,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625888,Intermediate
,10116.0,15413,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,14549,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625889,Intermediate
,10116.0,15413,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,14550,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625890,Intermediate
,10116.0,15413,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,14551,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625891,Intermediate
,10116.0,15413,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,14552,50597,Rattus norvegicus,,,Hypothalamus,1898.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625892,Intermediate
,10116.0,15413,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,14553,50597,Rattus norvegicus,,,Hypothalamus,1898.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625893,Intermediate
,10116.0,15413,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,14554,50597,Rattus norvegicus,,,Cerebellum,2037.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625894,Intermediate
,10116.0,15413,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,14555,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625895,Intermediate
,,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,,14556,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625896,Autocuration
,,568,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,14557,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625897,Autocuration
,,568,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,14558,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625898,Autocuration
,,568,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,14559,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL625899,Autocuration
,,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,,14560,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL626124,Autocuration
,562.0,7624,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,14561,50212,Escherichia coli,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628500,Intermediate
,10116.0,7624,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,14562,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL857856,Intermediate
,10116.0,7624,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,14563,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628501,Intermediate
,,4643,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,14564,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628502,Autocuration
,,11532,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,14565,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628503,Autocuration
,,11018,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,14566,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628504,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,14567,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628505,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,14568,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL874452,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,14569,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628506,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,14570,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628507,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,14571,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628508,Autocuration
,,8949,Michaelis constant (KM) was evaluated,,14572,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628509,Autocuration
,,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,,14573,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628510,Autocuration
,,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,14574,22224,,,,,,B,,,,1,0,BAO_0000019,U,,CHEMBL628511,Autocuration
,,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,14575,22224,,,,,,B,,,,1,0,BAO_0000019,U,,CHEMBL628512,Autocuration
,,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,14576,22224,,,,,,B,,,,1,0,BAO_0000019,U,,CHEMBL628513,Autocuration
,,7625,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,14577,22224,,,,,,B,,,,1,0,BAO_0000019,U,,CHEMBL628514,Autocuration
,,12908,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,14578,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628515,Autocuration
,,10368,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,14579,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628516,Autocuration
,,13108,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,14580,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628517,Autocuration
,,13108,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,14581,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628518,Autocuration
,,15217,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,14582,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628519,Autocuration
,,15217,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,14583,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628520,Autocuration
,,10933,Binding constant was determined,,14584,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628521,Autocuration
,,2363,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,14585,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630443,Autocuration
,,2363,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,14586,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630444,Autocuration
,,2276,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,14587,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL857732,Autocuration
,,14915,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,14588,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL630445,Autocuration
,,8847,Catalytic rate constant of the compound,,14589,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630446,Autocuration
,,15357,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,14590,22224,,,,,,B,,,,1,0,BAO_0000019,U,,CHEMBL630447,Autocuration
,,2869,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,14591,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630448,Autocuration
,,3484,Catalytic rate constant against phospholipase A2 was determined,,14592,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630449,Autocuration
,,1373,"Compound was evaluated for catalytic constant, Kcat",,14593,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630450,Autocuration
,,8142,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,14594,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630451,Autocuration
,,14131,Kcat calculated from 0.693/T1/2,,14595,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630452,Autocuration
,,17269,Kcat was determined,,14596,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630453,Autocuration
,,3485,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,14597,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630454,Autocuration
,,3485,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,14598,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630455,Autocuration
,,3485,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,14599,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631487,Autocuration
,,5962,Kcat value was determined,,14600,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631488,Autocuration
,,3133,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,14601,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL876440,Autocuration
,,3133,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,14602,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631489,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,14603,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL857742,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,14604,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631490,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,14605,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631491,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,14606,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631492,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,14607,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631493,Autocuration
,,4892,Kinetic parameter for rate of conversion to PABA was determined,,14608,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631494,Autocuration
,,3133,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,14609,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631495,Autocuration
,10116.0,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,14610,50597,Rattus norvegicus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631496,Intermediate
,10116.0,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,14611,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631497,Intermediate
,10116.0,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,14612,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631498,Intermediate
,10116.0,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,14613,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629776,Intermediate
,10116.0,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,14614,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629777,Intermediate
,10116.0,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,14615,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL629778,Intermediate
,10116.0,11488,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,14616,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630456,Intermediate
,10116.0,11488,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,14617,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630457,Intermediate
,10116.0,11488,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,14618,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630458,Intermediate
,10116.0,11488,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,14619,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630459,Intermediate
,10116.0,11488,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,14620,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630460,Intermediate
,10116.0,11488,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,14621,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876550,Intermediate
,10116.0,11488,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,14622,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630461,Intermediate
,10116.0,11488,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,14623,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630462,Intermediate
,10116.0,11488,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,14624,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630463,Intermediate
,10116.0,11488,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,14625,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630464,Intermediate
,10116.0,11488,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,14626,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630465,Intermediate
,10116.0,11488,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,14627,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630466,Intermediate
,10116.0,11488,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,14628,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630467,Intermediate
,10116.0,11488,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,14629,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630633,Intermediate
,10116.0,11488,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,14630,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630634,Intermediate
,10116.0,11488,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,14631,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630635,Intermediate
,10116.0,11488,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,14632,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630636,Intermediate
,10116.0,11488,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,14633,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630637,Intermediate
,9986.0,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,14634,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630638,Intermediate
,9986.0,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,14635,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630639,Intermediate
,9986.0,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,14636,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630640,Intermediate
,9986.0,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,14637,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL876551,Intermediate
,9986.0,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,14638,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630641,Intermediate
,9986.0,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,14639,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630642,Intermediate
,9986.0,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,14640,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630643,Intermediate
,9986.0,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,14641,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630644,Intermediate
,9986.0,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,14642,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL630645,Intermediate
,9986.0,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,14643,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625599,Intermediate
,9986.0,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,14644,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625600,Intermediate
,9986.0,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,14645,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625601,Intermediate
,9986.0,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,14646,50592,Oryctolagus cuniculus,,,Feces,1988.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625602,Intermediate
,9986.0,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,14647,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627470,Intermediate
,9986.0,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,14648,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627471,Intermediate
,9986.0,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,14649,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627472,Intermediate
,9986.0,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,14650,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627473,Intermediate
,9986.0,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,14651,50592,Oryctolagus cuniculus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627474,Intermediate
,10116.0,13925,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14652,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627475,Intermediate
,10116.0,13925,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14653,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL627476,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,14654,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627477,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,14655,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627478,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,14656,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627479,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,14657,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627480,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,14658,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627481,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,14659,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627482,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,14660,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL627483,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,14661,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875636,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,14662,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625764,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,14663,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625765,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,14664,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625766,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,14665,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625767,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,14666,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625768,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,14667,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625769,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,14668,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625770,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,14669,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625771,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,14670,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625772,Intermediate
,9615.0,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,14671,50588,Canis lupus familiaris,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625773,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,14672,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625774,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,14673,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625775,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,14674,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625776,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,14675,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625777,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,14676,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625778,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,14677,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625779,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,14678,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625780,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,14679,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL625781,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,14680,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875637,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,14681,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626473,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,14682,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626474,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,14683,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626475,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,14684,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626476,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,14685,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL634397,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,14686,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL626477,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,14687,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631069,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,14688,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631070,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,14689,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631071,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,14690,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631072,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,14691,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631073,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,14692,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631074,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,14693,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631075,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,14694,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631725,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,14695,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631726,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,14696,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631727,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,14697,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631728,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,14698,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631729,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,14699,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631730,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,14700,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631731,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,14701,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631910,Intermediate
,10116.0,15413,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,14702,50597,Rattus norvegicus,,,Hippocampus,10000000.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631911,Intermediate
,10116.0,15413,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,14703,50597,Rattus norvegicus,,,Hypothalamus,1898.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631912,Intermediate
,10116.0,15413,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,14704,50597,Rattus norvegicus,,,Hypothalamus,1898.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631913,Intermediate
,10116.0,12017,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14705,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631914,Intermediate
,10116.0,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14706,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631915,Intermediate
,10116.0,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14707,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875778,Intermediate
,10116.0,12017,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14708,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631916,Intermediate
,10116.0,12017,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14709,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631917,Intermediate
,10116.0,12017,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14710,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631918,Intermediate
,10116.0,12017,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14711,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631919,Intermediate
,10116.0,12017,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14712,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631920,Intermediate
,10116.0,12017,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14713,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631921,Intermediate
,10116.0,12017,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14714,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631922,Intermediate
,10116.0,12017,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14715,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631923,Intermediate
,10116.0,12017,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14716,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631924,Intermediate
,10116.0,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14717,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630234,Intermediate
,10116.0,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14718,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630235,Intermediate
,10116.0,12017,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14719,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630236,Intermediate
,10116.0,12017,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14720,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630237,Intermediate
,10116.0,12017,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14721,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630238,Intermediate
,10116.0,12017,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14722,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630239,Intermediate
,10116.0,12017,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14723,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630303,Intermediate
,10116.0,12017,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14724,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630304,Intermediate
,10116.0,12017,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14725,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630305,Intermediate
,10116.0,12017,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14726,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630306,Intermediate
,10116.0,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14727,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630307,Intermediate
,10116.0,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14728,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630308,Intermediate
,10116.0,12017,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14729,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630309,Intermediate
,10116.0,12017,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14730,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629309,Intermediate
,10116.0,12017,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14731,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629993,Intermediate
,10116.0,12017,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14732,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629994,Intermediate
,10116.0,12017,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14733,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629995,Intermediate
,10116.0,12017,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14734,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631993,Intermediate
,10116.0,12017,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14735,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631994,Intermediate
,10116.0,12017,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14736,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631995,Intermediate
,10116.0,12017,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14737,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631996,Intermediate
,10116.0,12017,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14738,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631997,Intermediate
,10116.0,12017,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14739,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631998,Intermediate
,10116.0,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14740,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631999,Intermediate
,10116.0,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14741,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632000,Intermediate
,10116.0,12017,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14742,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632001,Intermediate
,10116.0,12017,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14743,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL874424,Intermediate
,10116.0,12017,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14744,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632002,Intermediate
,10116.0,12017,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14745,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL632003,Intermediate
,,3133,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,14746,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632004,Autocuration
,,2742,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,14747,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632005,Autocuration
,,2742,Compound was tested for amidase rate in the presence of N62C screen enzyme,,14748,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632006,Autocuration
,,2742,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,14749,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632007,Autocuration
,,2742,Compound was tested for amidase rate in the presence of S166C screen enzyme,,14750,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632008,Autocuration
,,2742,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,14751,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632009,Autocuration
,,2742,Compound was tested for esterase rate in the presence of N62C screen enzyme,,14752,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632010,Autocuration
,,2742,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,14753,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL857750,Autocuration
,,2742,Compound was tested for esterase rate in the presence of S166C screen enzyme,,14754,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632011,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,14755,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632012,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,14756,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632013,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,14757,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL632014,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,14758,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629622,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,14759,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629623,Autocuration
,,2276,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,14760,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629624,Autocuration
,,17269,Ratio of Kcat to that of Km was determined,,14761,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629625,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,14762,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629626,Autocuration
,,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,14763,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629627,Autocuration
,,15917,"Compound was evaluated for constant, Kd",,14764,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629628,Autocuration
,,10933,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,14765,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629629,Autocuration
,,10933,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,14766,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629630,Autocuration
,,14293,Dissociation Constant of compound determined,,14767,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL856030,Autocuration
,,6698,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,14768,22224,,,,,,B,,,,1,0,BAO_0000019,U,,CHEMBL629631,Autocuration
,,6698,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,14769,22224,,,,,,B,,,,1,0,BAO_0000019,U,,CHEMBL629632,Autocuration
,,4318,Dissociation constant of compound with Fructose was determined,,14770,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629633,Autocuration
,,4318,Dissociation constant of compound with Fructose was determined; Not determined,,14771,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629634,Autocuration
,,4318,Dissociation constant of compound with Lactulose was determined,,14772,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629635,Autocuration
,,4318,Dissociation constant of compound with Lactulose was determined; Not determined,,14773,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629636,Autocuration
,,14959,Dissociation constant of the Compound,,14774,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629637,Autocuration
,,5913,Dissociation constant by non-linear regression analysis,,14775,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629638,Autocuration
,,14218,Dissociation constant was determined,,14776,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629639,Autocuration
,,10689,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,14777,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629640,Autocuration
,,13925,Dissociation constant was determined,,14778,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629641,Autocuration
,,16359,Dissociation constant was determined,,14779,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL631344,Autocuration
,10116.0,10944,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,14780,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631345,Intermediate
,,11080,The dissociation constant determined by fluorescence displacement assay,,14781,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631346,Autocuration
,,17805,kd value surface plasmon resonance (SPR) method,,14782,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631524,Autocuration
,10116.0,10944,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,14783,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631525,Intermediate
,,16645,First dissociation constant of the binding of compound to V30M TTR,,14784,22224,,,,,,F,,,,1,0,BAO_0000019,U,,CHEMBL631526,Autocuration
,,16645,Second dissociation constant of the binding of compound to V30M TTR,,14785,22224,,,,,,F,,,,1,0,BAO_0000019,U,,CHEMBL631527,Autocuration
,,7793,"Compound was evaluated for equilibrium constant, Ke",,14786,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631528,Autocuration
,,12199,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,14787,22224,,,,Hypothalamus,1898.0,A,,,,1,0,BAO_0000019,U,,CHEMBL631529,Autocuration
,,12199,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,14788,22224,,,,Hypothalamus,1898.0,A,,,,1,0,BAO_0000019,U,,CHEMBL631530,Autocuration
,,9680,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,14789,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631531,Autocuration
,,9680,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,14790,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631532,Autocuration
,,9680,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,14791,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL631533,Autocuration
,10090.0,13758,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,14792,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL876552,Intermediate
,10090.0,13758,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,14793,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631534,Intermediate
,10090.0,13758,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,14794,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631535,Intermediate
,10090.0,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,14795,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631536,Intermediate
,10090.0,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,14796,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631537,Intermediate
,10090.0,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,14797,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631538,Intermediate
,10090.0,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,14798,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631539,Intermediate
,10090.0,13758,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,14799,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631540,Intermediate
,10116.0,14393,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14800,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625637,Intermediate
,10116.0,14393,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14801,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625638,Intermediate
,10116.0,15078,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,14802,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL625639,Intermediate
,10116.0,13925,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14803,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625640,Intermediate
,10116.0,13925,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14804,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625641,Intermediate
,10116.0,13925,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14805,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625642,Intermediate
,10116.0,13925,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14806,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625643,Intermediate
,10116.0,13925,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14807,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625644,Intermediate
,10116.0,13925,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14808,50597,Rattus norvegicus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625645,Intermediate
,10116.0,13925,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14809,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625646,Intermediate
,10116.0,13925,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14810,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625647,Intermediate
,10116.0,13925,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14811,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625648,Intermediate
,10116.0,13925,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,14812,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625649,Intermediate
,10116.0,13925,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14813,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625650,Intermediate
,10116.0,13925,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14814,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625651,Intermediate
,10116.0,13925,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14815,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625652,Intermediate
,10116.0,13925,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14816,50597,Rattus norvegicus,,,Zone of skin,14.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625653,Intermediate
,10116.0,13925,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14817,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625654,Intermediate
,10116.0,13925,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14818,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625655,Intermediate
,10116.0,9712,Biodistribution of Compound in rat blood after 15 minutes of administration,,14819,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625656,Intermediate
,10116.0,9712,Biodistribution of Compound in rat blood after 2 minutes of administration,,14820,50597,Rattus norvegicus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625657,Intermediate
,10116.0,9712,Biodistribution of Compound in rat brain after 15 minutes of administration,,14821,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625658,Intermediate
,10116.0,9712,Biodistribution of Compound in rat brain after 2 minutes of administration,,14822,50597,Rattus norvegicus,,,Brain,955.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625659,Intermediate
,10116.0,9712,Biodistribution of Compound in rat heart after 15 minutes of administration,,14823,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625660,Intermediate
,10116.0,9712,Biodistribution of Compound in rat heart after 2 minutes of administration,,14824,50597,Rattus norvegicus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625661,Intermediate
,10116.0,9712,Biodistribution of Compound in rat liver after 15 minutes of administration,,14825,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625662,Intermediate
,10116.0,9712,Biodistribution of Compound in rat liver after 2 minutes of administration,,14826,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL625663,Intermediate
,10116.0,9712,Biodistribution of Compound in rat lung after 15 minutes of administration,,14827,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL875621,Intermediate
,10116.0,9712,Biodistribution of Compound in rat lung after 2 minutes of administration,,14828,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628382,Intermediate
,10116.0,9712,Biodistribution of Compound in rat muscle after 15 minutes of administration,,14829,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628383,Intermediate
,10116.0,9712,Biodistribution of Compound in rat muscle after 2 minutes of administration,,14830,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628384,Intermediate
,10116.0,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,14831,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628385,Intermediate
,10116.0,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,14832,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875753,Intermediate
,10116.0,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,14833,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628386,Intermediate
,10116.0,6941,Organ distribution in rat blood 2 minutes after intravenous injection,,14834,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628387,Intermediate
,10116.0,6941,Organ distribution in rat blood 2 hr after intravenous injection,,14835,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628388,Intermediate
,10116.0,6941,Organ distribution in rat blood 30 minutes after intravenous injection,,14836,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628389,Intermediate
,10116.0,6941,Organ distribution in rat blood 30 min after intravenous injection,,14837,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL632756,Intermediate
,10116.0,6941,Organ distribution in rat brain 2 minutes after intravenous injection,,14838,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628390,Intermediate
,10116.0,6941,Organ distribution in rat brain 2 hr after intravenous injection,,14839,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631811,Intermediate
,10116.0,6941,Organ distribution in rat brain 30 minutes after intravenous injection,,14840,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631812,Intermediate
,10116.0,6941,Organ distribution in rat heart 2 minutes after intravenous injection,,14841,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631813,Intermediate
,10116.0,6941,Organ distribution in rat heart 2 hr after intravenous injection,,14842,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631814,Intermediate
,10116.0,6941,Organ distribution in rat heart 30 minutes after intravenous injection,,14843,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631815,Intermediate
,10116.0,6941,Organ distribution in rat kidney 2 minutes after intravenous injection,,14844,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631816,Intermediate
,10116.0,6941,Organ distribution in rat kidney 2 hr after intravenous injection,,14845,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL875758,Intermediate
,10116.0,6941,Organ distribution in rat kidney 30 minutes after intravenous injection,,14846,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631817,Intermediate
,10116.0,6941,Organ distribution in rat liver 2 minutes after intravenous injection,,14847,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631818,Intermediate
,10116.0,6941,Organ distribution in rat liver 2 hr after intravenous injection,,14848,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631819,Intermediate
,10116.0,6941,Organ distribution in rat liver 30 minutes after intravenous injection,,14849,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631820,Intermediate
,10116.0,6941,Organ distribution in rat lung 2 minutes after intravenous injection,,14850,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631821,Intermediate
,10116.0,6941,Organ distribution in rat lung 2 hr after intravenous injection,,14851,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631822,Intermediate
,10116.0,6941,Organ distribution in rat lung 30 minutes after intravenous injection,,14852,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL631823,Intermediate
,10116.0,6941,Organ distribution in rat muscle 2 minutes after intravenous injection,,14853,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631824,Intermediate
,10116.0,6941,Organ distribution in rat muscle 2 hr after intravenous injection,,14854,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631825,Intermediate
,10116.0,6941,Organ distribution in rat muscle 30 minutes after intravenous injection,,14855,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631826,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,14856,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631827,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,14857,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631828,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,14858,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631829,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,14859,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875759,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,14860,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631830,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,14861,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631831,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,14862,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631832,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,14863,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631833,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,14864,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631834,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,14865,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631835,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,14866,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631836,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,14867,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631837,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,14868,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631838,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,14869,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631839,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,14870,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631840,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,14871,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631841,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,14872,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631842,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,14873,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631843,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,14874,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631844,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,14875,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631845,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,14876,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631846,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,14877,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL875760,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,14878,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL632199,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,14879,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631847,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,14880,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL631848,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,14881,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628707,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,14882,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628708,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,14883,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628709,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,14884,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628710,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,14885,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628711,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,14886,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628712,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,14887,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628713,Intermediate
,10116.0,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,14888,50597,Rattus norvegicus,,,Urine,1088.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628714,Intermediate
,10116.0,7415,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,14889,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL628715,Intermediate
,,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,14890,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629179,Autocuration
,,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,14891,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629180,Autocuration
,,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,14892,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL875108,Autocuration
,,7570,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,14893,22224,,,,Adrenal cortex,1235.0,A,,,,1,0,BAO_0000019,U,,CHEMBL629181,Autocuration
,,7570,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,14894,22224,,,,Adrenal cortex,1235.0,A,,,,1,0,BAO_0000019,U,,CHEMBL629182,Autocuration
,,7570,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,14895,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629183,Autocuration
,,7570,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,14896,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629184,Autocuration
,,7570,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,14897,22224,,,,Adrenal cortex,1235.0,A,,,,1,0,BAO_0000019,U,,CHEMBL629185,Autocuration
,,7570,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,14898,22224,,,,Adrenal cortex,1235.0,A,,,,1,0,BAO_0000019,U,,CHEMBL629186,Autocuration
,,7570,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,14899,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629187,Autocuration
,,7570,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,14900,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629887,Autocuration
,,7570,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,14901,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629888,Autocuration
,,7570,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,14902,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629889,Autocuration
,,7570,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,14903,22224,,,,Adrenal cortex,1235.0,A,,,,1,0,BAO_0000019,U,,CHEMBL629890,Autocuration
,,7570,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,14904,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629891,Autocuration
,,7570,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,14905,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629892,Autocuration
,,7570,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,14906,22224,,,,Adrenal cortex,1235.0,A,,,,1,0,BAO_0000019,U,,CHEMBL629893,Autocuration
,,7570,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,14907,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629894,Autocuration
,,7570,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,14908,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629895,Autocuration
,9615.0,14122,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,14909,22224,Canis lupus familiaris,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL875109,Autocuration
,9541.0,16449,Absolute bioavailability in male cynomolgus monkeys,,14910,22224,Macaca fascicularis,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629896,Autocuration
,10116.0,16449,Absolute bioavailability in maleSprague-Dawley rats,,14911,22224,Rattus norvegicus,,,,,A,,,,1,0,BAO_0000218,U,In vivo,CHEMBL629897,Autocuration
,10116.0,12017,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14912,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL629898,Intermediate
,10116.0,12017,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14913,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630057,Intermediate
,10116.0,12017,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14914,50597,Rattus norvegicus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630058,Intermediate
,10116.0,12017,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14915,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630059,Intermediate
,10116.0,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14916,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630060,Intermediate
,10116.0,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14917,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630061,Intermediate
,10116.0,12017,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14918,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630062,Intermediate
,10116.0,12017,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14919,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630063,Intermediate
,10116.0,12017,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14920,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630064,Intermediate
,10116.0,12017,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14921,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630065,Intermediate
,10116.0,12017,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14922,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630066,Intermediate
,10116.0,12017,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14923,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630067,Intermediate
,10116.0,12017,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14924,50597,Rattus norvegicus,,,Lung,2048.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630068,Intermediate
,10116.0,12017,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14925,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631113,Intermediate
,10116.0,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14926,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631114,Intermediate
,10116.0,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14927,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631115,Intermediate
,10116.0,12017,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14928,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL631116,Intermediate
,10116.0,12017,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14929,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630528,Intermediate
,10116.0,12017,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14930,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630529,Intermediate
,10116.0,12017,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14931,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630530,Intermediate
,10116.0,12017,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14932,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630531,Intermediate
,10116.0,12017,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14933,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630532,Intermediate
,10116.0,12017,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14934,50597,Rattus norvegicus,,,Muscle tissue,2385.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630533,Intermediate
,10090.0,15045,Biodistribution in normal mice blood after 120 hr,,14935,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630534,Intermediate
,10090.0,15045,Biodistribution in normal mice blood after 24 hr,,14936,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630535,Intermediate
,10090.0,15045,Biodistribution in normal mice blood after 4 hr,,14937,50594,Mus musculus,,,Blood,178.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630536,Intermediate
,10090.0,15045,Biodistribution in normal mice bone after 120 hr,,14938,50594,Mus musculus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630537,Intermediate
,10090.0,15045,Biodistribution in normal mice bone after 24 hr,,14939,50594,Mus musculus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630538,Intermediate
,10090.0,15045,Biodistribution in normal mice bone after 4 hr,,14940,50594,Mus musculus,,,Bone,10000001.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630539,Intermediate
,10090.0,15045,Biodistribution in normal mice heart after 120 hr,,14941,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630540,Intermediate
,10090.0,15045,Biodistribution in normal mice heart after 24 hr,,14942,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630541,Intermediate
,10090.0,15045,Biodistribution in normal mice heart after 4 hr,,14943,50594,Mus musculus,,,Heart,948.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630542,Intermediate
,10090.0,15045,Biodistribution in normal mice kidney after 120 hr,,14944,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630543,Intermediate
,10090.0,15045,Biodistribution in normal mice kidney after 24 hr,,14945,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630544,Intermediate
,10090.0,15045,Biodistribution in normal mice kidney after 4 hr,,14946,50594,Mus musculus,,,Kidney,2113.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630545,Intermediate
,10090.0,15045,Biodistribution in normal mice liver after 120 hr,,14947,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630546,Intermediate
,10090.0,15045,Biodistribution in normal mice liver after 24 hr,,14948,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630547,Intermediate
,10090.0,15045,Biodistribution in normal mice liver after 4 hr,,14949,50594,Mus musculus,,,Liver,2107.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630548,Intermediate
,10090.0,15045,Biodistribution in normal mice spleen after 120 hr,,14950,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630549,Intermediate
,10090.0,15045,Biodistribution in normal mice spleen after 24 hr,,14951,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630550,Intermediate
,10090.0,15045,Biodistribution in normal mice spleen after 4 hr,,14952,50594,Mus musculus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876426,Intermediate
,10116.0,12017,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14953,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630551,Intermediate
,10116.0,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14954,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630552,Intermediate
,10116.0,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14955,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630553,Intermediate
,10116.0,12017,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14956,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630554,Intermediate
,10116.0,12017,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14957,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630555,Intermediate
,10116.0,12017,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14958,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630556,Intermediate
,10116.0,12017,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14959,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630557,Intermediate
,10116.0,12017,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14960,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630558,Intermediate
,10116.0,12017,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14961,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630559,Intermediate
,10116.0,12017,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14962,50597,Rattus norvegicus,,,Spleen,2106.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL630560,Intermediate
,10116.0,12017,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14963,50597,Rattus norvegicus,,,Thyroid gland,2046.0,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL876427,Intermediate
,10116.0,14941,The Kel values in female wistar rats.,,14964,50597,Rattus norvegicus,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL630561,Intermediate
,,4646,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,14965,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630562,Autocuration
,,8847,Hydrolysis rate constant of the compound,,14966,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL630563,Autocuration
,,11778,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,14967,22229,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629673,Autocuration
,,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,14968,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629674,Autocuration
,,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,14969,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629675,Autocuration
,,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,14970,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629676,Autocuration
,,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,14971,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629677,Autocuration
,,8371,Apparent inactivation rate constant was evaluated,,14972,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629678,Autocuration
,,14883,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,14973,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629679,Autocuration
,,14883,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,14974,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629680,Autocuration
,,4643,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,14975,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629681,Autocuration
,,3519,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,14976,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629682,Autocuration
,,10600,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,14977,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL629683,Autocuration
,,8501,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,14978,22224,,,,,,F,,,,1,0,BAO_0000019,U,,CHEMBL629684,Autocuration
,,8505,Dissociation constant was determined,,14979,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629685,Autocuration
,,9778,Dissociation constant was determined,,14980,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629686,Autocuration
,,9778,Dissociation constant at pH 7.4,,14981,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL872932,Autocuration
,,9778,Dissociation constant in presence of 1 mM dithiothreitol,,14982,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL629687,Autocuration
,,13007,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,14983,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL872931,Autocuration
,,13007,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,14984,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628151,Autocuration
,,13007,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,14985,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628152,Autocuration
,,13007,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,14986,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628153,Autocuration
,,11482,Kinetic constant for aromatization of androstenedione,,14987,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628154,Autocuration
,,11482,Kinetic constant for aromatization of testosterone,,14988,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628155,Autocuration
,,2303,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,14989,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628156,Autocuration
,,11964,Local inhibition constant was determined,,14990,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628157,Autocuration
,4932.0,3140,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,14991,50347,Saccharomyces cerevisiae,,,,,A,,,,1,1,BAO_0000218,N,,CHEMBL857533,Intermediate
,,10650,Dissociation constant value of the compound,,14992,22224,,,,,,P,,,,1,0,BAO_0000100,U,,CHEMBL628158,Autocuration
,,4667,In vitro permeability through cornea without epithelium,,14993,22224,,,,Cornea,964.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628159,Autocuration
,,4667,In vitro permeability through intact cornea,,14994,22224,,,,Cornea,964.0,A,,,,1,0,BAO_0000019,U,,CHEMBL875616,Autocuration
,9986.0,9199,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,14995,50592,Oryctolagus cuniculus,,,Cornea,964.0,A,,,,1,1,BAO_0000218,N,,CHEMBL628160,Intermediate
,,11966,Rate of enzyme inactivation for the compound was determined,,14996,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628161,Autocuration
,,4667,In vitro permeability through cornea without epithelium,,14997,22224,,,,Cornea,964.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628162,Autocuration
,,4667,In vitro permeability through intact cornea,,14998,22224,,,,Cornea,964.0,A,,,,1,0,BAO_0000019,U,,CHEMBL628163,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14999,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628164,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15000,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628165,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15001,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628166,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15002,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628167,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15003,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628168,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15004,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628169,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15005,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628170,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15006,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628171,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15007,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627434,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15008,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL627435,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15009,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628110,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15010,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628111,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15011,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628112,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15012,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628260,Autocuration
,,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15013,22224,,,,,,A,,,,1,0,BAO_0000019,U,,CHEMBL628261,Autocuration
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,15014,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628262,Intermediate
,9606.0,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,15015,50587,Homo sapiens,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628263,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,15016,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628264,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,15017,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628265,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,15018,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628266,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,15019,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628267,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,15020,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628268,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,15021,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628269,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,15022,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628270,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,15023,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628271,Intermediate
,10090.0,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,15024,50594,Mus musculus,,,,,A,,,,1,1,BAO_0000218,N,In vivo,CHEMBL628272,Intermediate
